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Genotype emm4 Streptococcus pyogenes constitute a major disease-causing emm-type worldwide, and have been 
associated with scarlet fever. Genotype emm4 are lysogenised by three toxigenic prophage, and an atoxigenic 
SpyCI, thought to regulate the DNA mismatch repair operon by growth-phase dependent excision. Phylogenetic 
analyses determined that emm4 in our collection and internationally, clustered with either reference genomes 
MGAS10750 or MEW427, the latter of which were found to have undergone substantial gene loss within 
prophage-encoding regions. Gene loss affected modules pertaining to lysogeny, genetic regulation, replication, 
and encapsidation, but not cognate toxins. Corresponding elements of M4complete emm4 were full-length and 
undegraded. The lineages associated with either MGAS10750 or MEW427 were thus denoted M4complete and 
M4degraded, respectively. Prophage of M4degraded isolates were shown to be cryptic, and incapable of excision, 
whereas prophage of M4complete isolates were inducible. Unexpectedly, this had little effect on cognate toxin 
expression, which was independent of induction and replication. Further, the emm4 SpyCI was found to be 
immobile, irrespective of gene content, and appears not to regulate the DNA MMR operon, as had been reported. 
A number of assays did not demonstrate lineage-specific phenotypes, however, M4complete isolates were 
significantly more virulent than M4degraded isolates in a Galleria mellonella infection model. Intriguingly, efforts 
to explore this response in more infection-relevant conditions revealed that co-culture with human tonsil cells 
greatly enhanced expression of the prophage-associated superantigen ssa, among both M4complete and M4degraded 
isolates, and this was also observed among emm3 and emm12. There may also be a hitherto unappreciated role 
for major bacterial regulators in the control and elicitation of this response. These data suggest that the relationship 
between S. pyogenes, their viral parasites and the human host may be much more complex than had been 
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1.1 Streptococcus pyogenes 
S. pyogenes is a major Gram-positive pathogen of humans (Carapetis et al., 2005). The bacterium, also known as 
the Lancefield Group A Streptococcus, carries the Lancefield Group A carbohydrate, but S. pyogenes is closely 
related to the Group C and G streptococci, particularly the equine pathogen S. equi sbsp. equi, with which it shares 
~80% DNA sequence similarity (Holden et al., 2009). The zoonotic pathogen S. equi sbsp. zooepidemicus is 
thought to be ancestral to S. equi sbsp. equi and also shares ~80% DNA sequence similarity with S. pyogenes. S. 
pyogenes also shares significant DNA sequence similarity with S. dysgalactiae sbsp. equisimilis, which carries 
the Group C/G carbohydrates, and occasionally the Group A carbohydrate (Brandt and Spellerberg, 2009; 
Chochua et al., 2019). Indeed, clinical manifestations of S. dysgalactiae sbsp. equisimilis infection are not 
dissimilar to those observed in S. pyogenes (Brandt and Spellerberg, 2009). Other clinically significant 
streptococcal species appear to have contributed to the evolution of S. pyogenes. Most notably the canine pathogen 
S. canis, and the human pathogen, the Group B Streptococcus, S. agalactiae (Lefébure et al., 2012). There is 
evidence of a shared pool of mobile genetic elements between S. pyogenes and a number of other pyogenic 
streptococcal species, and indeed the wider Streptococcaceae (Canchaya et al., 2003; Desiere et al., 2001; Holden 
et al., 2009; Lefébure et al., 2012). 
 
1.2 Clinical manifestations of S. pyogenes 
 Tonsillopharyngitis 
The primary anatomical niche of S. pyogenes is the tonsil, and tonsillopharyngitis is one of the most common 
manifestations of infection, with approximately 616 million incident cases per annum (Walker et al., 2014). 
Symptoms include fever, cervical lymphadenopathy and sore throat with patchy purulent exudate (Carapetis et 
al., 2005) (Figure 1.1). The role of specific virulence factors in the pathogenesis of streptococcal pharyngitis has 
not been fully elucidated, though a number of studies have indicated a role for prophage-encoded toxins, notably 
DNases and streptococcal superantigens, in colonisation, propagation and transmission of infection (Al-Shahib et 
al., 2016; Davies et al., 2019; Kasper et al., 2014; Zeppa et al., 2017). Pharyngitis is typically self-limiting, though 
if left untreated, may lead to potentially life-threatening complications, notably acute rheumatic fever and 





Figure 1.1: Oropharyngeal features of streptococcal tonsillopharyngitis 
A) S. pyogenes infection of the tonsil is associated with marked inflammation and pain, often with the presence of white 
patchy, or streaked purulent exudates. B) Erythematous papular palatal petechiae with pale foci (so called ‘doughnut lesions’), 
are occasionally observed, and though not always present, can be pathognomonic (Kobayashi and Iwasaki, 2019). "Strep 
throat2010.jpg" by James Heilman, MD is licensed under CC BY-SA 3.0. 
 
  Scarlet fever 
Scarlet fever is one of the classical childhood exanthems, principally transmitted by infectious droplets, and highly 
contagious. Symptoms of scarlet fever include malaise, fever, cervical lymphadenopathy, accompanying 
tonsillitis and a pathognomonic finely papular red rash on the face and body, which may desquamate (Basetti et 
al., 2017). Inflammation and swelling of the tongue (so called ‘strawberry tongue’) is also typical (Basetti et al., 
2017). Scarlet fever is believed to be a toxin-mediated disease, notably by streptococcal superantigens associated 
with prophage, particularly ssa, speC and speA, indeed, a number of epidemiological and molecular investigations 
have revealed an association between the genes encoding these toxins and scarlet fever (Chalker et al., 2017; 
Lynskey et al., 2019a; Silva-Costa et al., 2014; Turner et al., 2016; Walker, 2015). It is thought that these potent 
factors are secreted at a focus of infection, typically (though not exclusively) the tonsil and spread throughout the 
body triggering massive expansion of specific T-cell subsets (Proft and Fraser, 2016). The streptococcal 
superantigens have been shown to play a role in colonisation and infection at these sites (Brouwer et al., 2020; 
Kasper et al., 2014; Zeppa et al., 2017). With the discovery of antibiotics, and possibly other unknown factors, 
the incidence of scarlet fever gradually dwindled, as did the severity of disease (Carapetis et al., 2005; Chalker et 
al., 2017). However, in recent years there has been a dramatic resurgence of this disease in some countries and 
there have been a number of well-studied and ongoing scarlet fever outbreaks, particularly in the United Kingdom, 
Hong Kong and mainland China (Brockmann et al., 2018; Chalker et al., 2017; Lynskey et al., 2019a; Walker, 
2015). Genotype emm4 S. pyogenes are often associated with scarlet fever and paediatric infection in many parts 
of the world and are routinely recovered from throat swabs (Kim et al., 2019; Silva-Costa et al., 2014; Turner et 





Non-bullous impetigo is another common manifestation of S. pyogenes infection, affecting the outermost layer of 
the integumentary system, the stratum corneum (Stevens and Bryant, 2016). Most often, infection begins with a 
well-defined papule which progresses to a vesicular rash, surrounded by erythema. Gradually, these lesions form 
pustules filled with clear liquid which rupture and form a characteristic crust. These lesions may be observed 
anywhere on the body, but are common on the face and lower extremities (Pereira, 2014). In some parts of the 
world, particularly parts of Africa and the tropics, impetigo is a seasonal disease (Armitage et al., 2019). 
 
 Erysipelas 
Erysipelas is the radiating infection of the dermis and often efferent lymphatics, characterised by a red, raised rash 
with clear demarcation between involved and uninvolved tissues, which are most often lower extremities, or more 
rarely the skin on the face (Stevens and Bryant, 2016). When the lower extremities are affected, infection 
commonly follows minor damage to the integrity of the skin, such as burns or mild trauma. In facial erysipelas, 
there is often history of streptococcal pharyngitis (Cunningham, 2000). Erysipelas is perhaps the most superficial 
manifestation of S. pyogenes infection, and prognosis following antibiotic therapy is excellent, with 
complications, such as the involvement of underlying tissues, being rare (Stevens and Bryant, 2016). 
 
 Cellulitis 
Streptococcal cellulitis refers to the rapidly spreading inflammation of the skin and subcutaneous tissues, which 
may be accompanied by systemic symptoms such as fever and malaise, in addition to bacteraemia and 
lymphangitis (Stevens and Bryant, 2016). Although common, if untreated, cellulitis may progress to invasive 
disease in the surrounding and underlying tissues, and in at least one study has actually been associated with the 
highest risk of death versus other manifestations (Lamagni et al., 2009). Cellulitis, or indeed other superficial or 
relatively minor infections of the skin by S. pyogenes, may be accompanied by lymphangitis, which presents as 
red, tender, linear channels following the efferent lymphatics from the focus of infection and leading to regional 





Figure 1.2: Cellulitis and lymphangitis 
Skin and soft tissue infections of caused by S. pyogenes may be associated with lymphangitis. In this case, cellulitis of the 
third finger, was accompanied by lymphangitis, seen as a well demarcated linear streak from the focus of infection, toward 
regional lymph nodes. Reproduced with permission from Vindenes and McQuillen, 2015, Copyright Massachusetts Medical 
Society. 
 
 Necrotising fasciitis 
Necrotising fasciitis is a severe, fulminant and highly invasive manifestation of S. pyogenes infection involving 
the subcutaneous tissues, notably the fascia and fat. Extreme pain, profuse swelling, ecchymoses, and fluid-filled, 
violaceous bullae are typical, with a grey ‘dishwater’ exudate, which may be accompanied by systemic symptoms 
(Bisno and Stevens, 1996; Stevens and Bryant, 2017). While necrotising fasciitis may result from direct 
introduction of S. pyogenes by penetrating injury (Hagberg et al., 1997; Sablier et al., 2010), or as a complication 
of an existing skin and soft tissue infection, often, infection is cryptogenic with no obvious cause (Stevens and 
Bryant, 2017). There is some evidence that blunt force trauma, bruising or muscle strain may precipitate infection 
(Lamb et al., 2018a; Nuwayhid et al., 2007), possibly due to an antecedent episode of superficial infection, such 
as tonsillitis, scarlet fever, or asymptomatic carriage, either in the patient or a close contact (Watts et al., 2019) 
(Figure 1.3). The link between superficial manifestations and necrotising fasciitis are not completely clear, but 
recent evidence suggests that these may be linked by metastases of S. pyogenes from infectious foci at sites such 






Figure 1.3: S. pyogenes and cryptogenic necrotising fasciitis: pathogenesis 
Necrotising fasciitis caused by S. pyogenes may have no obvious cause, but can be associated with blunt force trauma and 
bruising. These (sometimes intangibly minor) traumas set in motion molecular cascades that appear to attract streptococci 
present in the circulation. The subsequent, progressive and devastating destruction of the deep tissues is wrought not by the 
propensity for S. pyogenes (the so-called ‘flesh-eating’) to consume its host, but rather the production of myriad, highly 
potent exotoxins by S. pyogenes colonising the subcutaneous tissues in necrotising fasciitis. Reproduced with permission 
from (Stevens and Bryant, 2017), Copyright Massachusetts Medical Society. 
 
 Puerperal sepsis 
Puerperal sepsis is defined by the World Health Organisation as an infection of the genitourinary tract at any stage 
between the rupture of membranes or the induction of labour and the 42nd day after delivery in which two or more 
of the following symptoms are present: fever, vaginal discharge, pelvic pain and/or delayed reduction of uterine 
size post-partum. Additionally, this may include infections elsewhere in the body during this time, such as 
haemorrhagic pneumonia (Turner et al., 2013). It remains the leading cause of direct maternal death, and S. 
pyogenes is the most common aetiologic agent (Turner et al., 2013). Genotype emm28 S. pyogenes are frequently 
associated with puerperal sepsis, possibly due to the acquisition of the RD2 ICE from the Group B Streptococcus, 
S. agalactiae, which encodes the putative adhesin AspA (Luca-Harari et al., 2009; Sitkiewicz et al., 2011; Zhang 
et al., 2006). Despite this, mortality attributed to this disease is disproportionately attributable to genotypes emm1 
and emm3 (Luca-Harari et al., 2009). Further, the prophage-encoded streptococcal superantigen speC has been 
linked to this devastating manifestation (Vlaminckx et al., 2003). Risk factors for postpartum sepsis include 





 Streptococcal toxic shock syndrome 
Streptococcal toxic shock syndrome (STSS) is a systemic and imminently lethal complication of S. pyogenes 
infection and has a strong association with high mortality and morbidity, with 81% of patients succumbing to 
illness within 7 days (Lamagni et al., 2009; Walker et al., 2014). STSS is ostensibly toxin-mediated, however, 
there is some debate over which toxins these might be, but a prevailing theory is that streptococcal superantigens 
are instrumental in the pathogenesis of this disease. This hypothesis holds that the production of streptococcal 
superantigens at a focus or foci of infection are released into the circulation and activate large numbers of antigen 
presenting cells and T-cells, which subsequently release huge quantities of cytokines, leading to systemic shock 
and multiorgan failure. Studies have implicated the potent chromosomally-encoded superantigen SMEZ and the 
prophage-encoded SpeA. Superantigenic activity, however, does not necessarily correlate with the genetic 
predisposition of a specific emm-type to cause STSS. Genotype emm3 S. pyogenes, for example, lack a functional 
smeZ allele and are poorly mitogenic despite their overrepresentation in cases of invasive disease and STSS 
(Lamagni et al., 2009, 2008; Turner et al., 2012).  
 
 Post-infectious immunological sequelae 
1.2.9.1 Acute rheumatic fever and rheumatic heart disease 
By far the most burdensome manifestation of S. pyogenes infection is rheumatic heart disease (Efstratiou and 
Lamagni, 2016). This syndrome typically follows streptococcal pharyngitis, and is characterised by arthritis and 
carditis, with or without the presence of neurological sequelae such as Sydenham’s chorea (Lee et al. 2009). 
Although a fairly rare manifestation in most affluent countries, rheumatic heart disease is devastating in regions 
with limited access to healthcare infrastructure and antibiotics. It is estimated that between 15.6-19.6 million 
people globally live with rheumatic heart disease, and almost 80% of these are in regions of the world with low 
economic status (Carapetis et al., 2005; Efstratiou and Lamagni, 2016). Acute rheumatic fever typically occurs 
between 4-8 weeks antecedent to an episode of streptococcal pharyngitis, and approximately 30% of cases of 
acute rheumatic fever will progress to rheumatic heart disease. The pathogenesis of acute rheumatic fever and 
rheumatic heart disease are unclear, but a number of mechanisms have been proposed. These include antibody 
cross-reactivity between the S. pyogenes M protein and proteins abundant in cardiac and skeletal muscles, notably 
myosin and tropomyosin (Cunningham, 2000). Another enduring hypothesis is that hyperencapsulation in specific 
emm-types may contribute to pathology (Smoot et al., 2002b; Stollerman and Dale, 2008). 
 
1.2.9.2 Acute post-streptococcal glomerulonephritis 
Acute post-streptococcal glomerulonephritis (APSGN) typically follows an episode of skin or soft tissue infection, 
such as impetigo or pyoderma by approximately 6 weeks, or 1-2 weeks following pharyngeal infection. There 
may be a genetic predisposition to PSGN, as ~40% of patients with PSGN have a positive family history 
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(Rodriguez-Iturbe and Haas, 2016). However, this could conceivably be confounded by intra-familial 
transmission of the same isolate or clone, or indeed shared socioeconomic factors that might also play a role. 
Some 470,000 cases of PSGN occur per annum (Carapetis et al., 2005), and is disproportionately burdensome in 
regions of low economic status, constituting the most common cause of paediatric renal injury in the Middle East, 
Africa and parts of Australasia (Rodriguez-Iturbe and Musser, 2008). Indeed, 97% of all reported PSGN cases are 
in regions of low economic growth. The precise pathologic mechanisms of PSGN are not presently known, though 
the deposition of antigen-antibody complexes in renal glomeruli and is a prevailing theory and similar propositions 
have been made by multiple lines of scientific inquiry (Cunningham, 2000).  
 
 Asymptomatic carriage 
Asymptomatic carriage of S. pyogenes can occur within the oropharynx, the female genital tract, the rectum, and 
on the skin (Efstratiou and Lamagni, 2016; Walker et al., 2014). Generally, a carrier is defined as a patient who 
is culture or rapid antigen detection test positive for S. pyogenes in the absence of symptoms, and often, where 
feasible, without evidence of anti-S. pyogenes antibodies on serial serological testing (Martin, 2016). Pharyngeal 
and rectal or vaginal asymptomatic carriage is rare in healthy adults, usually <5% and <1%, respectively 
(Efstratiou and Lamagni, 2016; Steer et al., 2012). Carriage in the absence of clinical symptoms is more common 
in children, with a meta-analysis based on the systematic review of 29 studies indicating a pooled prevalence of 
12% (95% confidence interval 9-14%) (Shaikh et al., 2010). Other studies corroborate these data, placing 
asymptomatic carriage at between 15-20% (Martin, 2016). One of the few longitudinal studies on carriage in 
children deduced that over a four year period, 50% of children were carriers (Shet and Kaplan, 2004). Some 
studies place a high value on the burden of these patients in driving outbreaks of disease (Cockerill et al., 1997; 





Figure 1.4: Selected transmission and clinical manifestations of S. pyogenes 
Transmission of S. pyogenes can occur via. a number of routes, and can manifest a diversity of clinical manifestations, though 
not all exposures lead to clinical disease or asymptomatic carriage. (Carapetis et al., 2005; Cunningham, 2000). The role of 
the asymptomatic carrier or subclinical patient is not well understood, and may be more important in children, but physical 
association or shared vicinity, either with asymptomatic carriers or patients experiencing a range of sequelae, even the most 
debilitating, remain potential contributories to the transmission of this highly adaptable and protean pathogen. Post-infectious 
immunological sequalae are not depicted, but are highly burdensome consequences of transmission and infection. Figure 
created by the author with BioRender.com. 
 
1.3 Control and prevention of S. pyogenes infection 
 
 Treatment 
Generally, uncomplicated and superficial manifestations of S. pyogenes infection, such as tonsillitis, are treated 
with phenoxymethyl penicillin, though another treatment option, particularly where penicillin may not be 
tolerated, are macrolide antibiotics such as erythromycin (Pelucchi et al., 2012). To remediate more severe and 
invasive disease, such as necrotising fasciitis, antibiotics alone are insufficient and early surgical debridement of 
fascial planes is necessary (Machado, 2011; Wood et al., 1993). In these cases, antibiotics such as clindamycin 
are administered intravenously, often in conjunction with passive immunotherapy in the form of intravenous 
immunoglobulin (IVIG) (Carapetis et al., 2014; Raithatha and Bryden, 2012), which may reduce mortality and 
sequalae associated with toxic shock syndrome (Sriskandan et al., 2006). Due to the increased risk of invasive 
disease among household contacts and neonates of invasive disease patients, swift antibiotic prophylaxis may be 




 Antimicrobial resistance 
Until very recently, it was thought that S. pyogenes resistance toward beta lactam antibiotics was vanishingly rare. 
However, reduced in-vitro susceptibility to these antimicrobials has been observed in numerous diverse emm-
types owing to mutations within the pbp2x penicillin binding protein gene (Musser et al., 2020; Vannice et al., 
2019). Although these mutations do not confer full resistance in S. pyogenes, similar mutations observed in S. 
pneumoniae forebode that attaining reduced susceptibility in this manner may represent a stepwise strategy in this 
direction, which is cause for concern (Grebe and Hakenbeck, 1996; Vannice et al., 2019). Inasmuch as this 
transition toward manifest beta lactam resistance in S. pyogenes is, as yet, incomplete, treatment failure may still 
occur in some 35% of tonsillopharyngitis cases (Sela and Barzilai, 1999). It has been suggested that -lactamase 
producing bacteria also present at non-sterile sites might protect S. pyogenes from elimination with these 
antibiotics (Brook and Gober, 2006; Pichichero and Casey, 2007). The ability of S. pyogenes to invade host cells, 
becoming internalised and shielded from antibiotics, particularly penicillin, is now well described (Kaplan et al., 
2006; Kreikemeyer et al., 2004; Marouni et al., 2004), and might contribute to treatment failure (Sela and Barzilai, 
1999). Resistance to macrolide and tetracycline antibiotics among S. pyogenes is comparatively more common, 
though more so in some regions than others. In Hong Kong and mainland China in particular, the recent resurgence 
of scarlet fever has been driven, in part, by the acquisition of resistance determinates reducing the efficacy of 
macrolides (Tse et al., 2012; Walker, 2015). In the United Kingdom, non-susceptibility to macrolides appears to 
be increasing, and as of 2020, has risen from ~4-6% in the previous five seasons, to ~10%. Reduced susceptibility 
to tetracycline and clindamycin also appears to be increasing (HPA, 2020). Reduced susceptibility to macrolide 
and tetracycline antibiotics is typically mediated by mobile genetic elements, and the contribution of these to 
resistance in S. pyogenes is discussed in greater detail in section 1.5.5.1. 
 
 Vaccines 
No commercial vaccine is presently licensed for the prevention of S. pygoenes infection. Efforts to develop a safe 
and efficacious vaccine have been hampered, in large part, due to the extensive global genetic diversity and 
considerable dispensable gene pool of S. pyogenes (Davies et al., 2019; Steer et al., 2009). Concerns regarding 
crossover between S. pyogenes and human antigens theoretically triggering autoimmunity have also mired vaccine 
efforts (Massell et al., 1969; Steer et al., 2009; Steer et al., 2016) While a number of candidate vaccines have 
been explored in animal models, arguably the most robustly studied is the 26-valent vaccine based upon the N-
terminal sequence of 26 different genotypes (Hu et al., 2002; McNeil et al., 2005). The 26-valent vaccine evoked 
a >4-fold increase in geometric mean antibody titres above baseline in healthy adults, and a significant reduction 
of bacterial counts in patient sera obtained post-immunisation. Reassuringly, no evidence of autoimmune sequalae 
was detected, nor were antibodies towards human tissues detected (McNeil et al., 2005). A 30-valent M-protein 





1.4 The S. pyogenes genome and genotypes 
Historically, S. pyogenes isolates were subclassified serologically according to reactivity to M protein, also a 
major virulence factor, expressed as fibrils at the cell surface. The N-terminal region of M is hypervariable and 
type-specific and as such, can be classified with specific antisera to discern a serotype (Lancefield, 1962). More 
recently, this system was ratified and expanded by sequencing, wherein the 5’ hypervariable sequence of emm is 
sequenced, with an emm genotype assigned according to >95% sequence homology with an existing emm specific 
sequence (CDC, 2008; (Efstratiou, 2000). Within emm types, diversity between isolates is relatively low, whereas 
inter-emm type diversity is comparatively high (Figure 1.5) and often attributable predominantly to prophage and 
mobile genetic elements (Beres et al., 2002; Ferretti et al., 2001; Smoot et al., 2002a; Turner et al., 2019b). 
 
 
Figure 1.5: Diversity within and between emm genotypes 
A) S. pyogenes isolates predominantly cluster by emm genotype, with little diversity observed within genotypes. Conversely, 
diversity is observed when isolates from different emm genotypes are compared, (including the majority of isolates in the 
present thesis). Maximum likelihood phylogenetic tree constructed from 113,805 core SNPs extracted after genome sequence 
data from all isolates to emm89 reference strain H293 (star). Notably, emm44, emm90 and emm101 did not, and are denoted 
by two separate lineages (black dots). Branches are shaded according to bootstrapping support scale. S. pyogenes genotypes 
are denoted by coloured boxes corresponding genotype number. B) The number of SNPs both within and between emm 
genotypes reflects similarity inferred by the phylogenetic tree, with a high number of SNPs between emm types (black bars), 
but a much lower number of SNPs when genomes of isolates belonging to the same emm genotype were compared (red bars). 
(Image taken, with permission, from Turner et al., 2019). 
 
Genotyping is an indispensable tool for epidemiological surveillance and has bolstered current understandings of 
the population biology of S. pyogenes. Indeed, non-random associations between emm-types and specific disease 
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manifestations are observed in many parts of the world, as are fairly predictable patterns of emm-type dominance. 
Though this is not always observed, and a number of regions (particularly those in whom the burden of S. pyogenes 
disease is especially high) comprise large and diverse populations of emm-types that are often uncommon 
elsewhere, with little of the genotype competition and dominance observed in much of the rest of the world. This 
poses obvious problems for efforts to develop an S. pyogenes vaccine which hitherto has focused principally on 
conferring immunity to the emm protein of globally prevalent emm-types. 
 
1.5 Mobile genetic elements and S. pyogenes 
The S. pyogenes metagenome comprises multiple functional, satellite and cryptic prophage, in addition to 
integrative and conjugative elements (ICE) and chromosomal islands (SpyCI), or evidence thereof (Beres and 
Musser, 2007; Panchaud et al., 2009; Rezaei Javan et al., 2019). Although it appears that S. pyogenes may be able 
to undergo transformation in biofilm, and possibly when adherent to nasopharyngeal-associated lymphoid tissue, 
there is a remarkable paucity of mechanistic evidence for transformation in S. pyogenes (Marks et al., 2014a). 
Thus, a tempting and prevailing hypothesis is that mobile genetic elements (MGE) such as prophage, ICE and 
SpyCI are the principal vehicles of genetic variation in this organism, and indeed its close relatives (Holden et al., 
2009). The majority of diversity between emm-types is attributable to prophage and other mobile genetic elements, 
with most (but not all) isolates lysogenised with at least one prophage, and some containing as many as eight 
elements integrated into the bacterial chromosome (McShan and Nguyen, 2019).  
 
 Lysogenic bacteriophage 
S. pyogenes has an intimate and longstanding evolutionary relationship with lysogenic prophage. The majority of 
these prophage, like many other streptococcal phages, are viruses assigned to the large Caudovirales order, with 
the vast majority belonging to the family Siphoviridae. These are tailed, double-stranded DNA viruses with 
circular genomes, and a similar genomic structure to coliphage Lambda, with contiguous genes comprising 
discernible modules dedicated to specific functions, in a roughly predictable arrangement (Canchaya et al., 2003; 
McShan and Nguyen, 2019). Comparative genomics has revealed considerable homology between prophage of 
S. pyogenes and those of other pathogenic streptococci of clinical and veterinary importance, and interestingly, 
non-pathogenic streptococci (Desiere et al., 2001; Holden et al., 2009). It also seems that the prophage of 
streptococci conform to the modular evolution model, proposed in the early 1980’s as a mechanism by which 
genetic diversity is achieved in bacterial viruses, with selection apparently acting on functional modules, as 




 General genomic features of streptococcal phage 
The lysogenic phage of S. pyogenes conform to a typically lambdoid genomic arrangement, with largely distinct 
modules dedicated to performing specific functions. Typically, this includes modules dedicated to replication, 
regulation, lysogeny and lysogenic conversion, capsid and tail fibre assembly, and host cell lysis (Figure 1.6) 




Figure 1.6: Genomic architecture of S. pyogenes lysogenic prophage 
Lysogenic prophage of S. pyogenes genomes exhibit similarities in genetic organisation to prototype lysogenic coliphage 
lambda (Canchaya et al., 2003). Discrete modules comprising genes dedicated to specific functions, such as replication 
(green), regulation (dark purple), the formation of progeny virions (yellow; lilac; pale blue), and lysogenic conversion are 
frequently observed, but are not always obvious. Toxin genes, such as superantigens (speC; red) and DNases (spd1; orange) 
are typically situated at distal ends of integrated viruses, though are not always present. Unclassifiable genes (black) are 
common. This genomic arrangement is exemplified in SF370 prophage 370.1 (Canchaya et al., 2002). Figure taken and 
adapted, with permission, from Dr. Claire. E. Turner Turner et al., 2015). 
 
1.5.2.1 Prophage integration and excision 
Like other lysogenic prophage, in S. pyogenes, these elements integrate into the bacterial chromosome by site-
specific recombination between homologous sequences in the bacterial (attB) and phage (attP) genomes, which 
vary in length from as little as 5 bp, to in excess of 100 bp. This process is mediated by prophage-encoded integrase 
and excisionase proteins, usually, though not exclusively, in conjunction with repressor and antirepressor genes, 
akin to those found in coliphage Lambda (Figure 1.7). Attachment sites are well conserved between emm-types, 
and there are approximately 20 such sites in the core genome (McShan and Nguyen, 2019). Most often, attB sites 
are found on the lagging strand (3’), relative to the origin of replication, and within open reading frames (ORF) 
and might not be expected to modulate expression of these genes. To a lesser extent, attB sequences also include 
intergenic regions, and the 5’ strand, in which case integration of prophage and other MGE may impact the 





Figure 1.7: Prophage integration and excision mediated by integrase and excisionase 
Prophage retain their ability by using site-specific integrase and excisionase genes, which permit the prophage to both exit 
and enter the bacterial genome at specific attachment site(s). "Viral genome excision" by ViralZone is licensed under CC BY 
4.0. 
1.5.2.2 Prophage induction 
Although prophage induction may occur spontaneously at relatively low levels (Nanda et al., 2015), in a number 
of bacterial pathogens, prophage excision is controlled, in part, by the SOS response (Oppenheim et al., 2005) 
(Figure 1.8). Ordinarily, the SOS-response is triggered following DNA damage by oxidative stress and exposure 
to other agents such as ultraviolet light and antibiotics (Fernández De Henestrosa et al., 2000; Maiques et al., 
2006; Michel, 2005; Oppenheim et al., 2005; Zhang et al., 2000). The conserved inducer RecA is subsequently 
activated, which binds single-stranded DNA, thus forming a nucleoprotein filament, promoting proteolysis of the 
repressor, LexA and the expression of SOS-response genes. Cleavage of LexA results in the de-repression of the 
SOS regulon, triggering the response. The lambdoid repressor cI is subject to autocatalytic cleavage following 
SOS-response initiation, similarly to LexA.  Once cI is cleaved, repression by cI is relieved, and genes that mediate 
excision from the bacterial chromosome, particle assembly and egress are expressed, inducing the lytic cycle. 
Thus, Lambdoid phage are sensitive to stimuli in the extracellular milieu and inextricably linked to the condition 
of the bacterial host (Oppenheim et al., 2005). Although this full complement of genes required to initiate the 
SOS-response are thought to be absent from S. pyogenes and other streptococcal species, analogous mechanisms 





Figure 1.8: The SOS-response 
The bacterial SOS-response is triggered by DNA damage, and is intimately linked to the maintenance of lysogeny and 
induction of lysogenic prophage by the repressor LexA. "SOS response" by Allen Gathman is licensed under CC BY-NC-
SA 2.0 
 
 Satellite and cryptic prophage 
As has been observed in other clinically relevant bacteria, occasionally, prophage elements are found to have 
decayed, becoming immobile, stably integrated and more permanent features of the bacterial chromosome 
(Desiere et al., 2001; Rezaei Javan et al., 2019). Satellite prophage are prophage which have lost the necessary 
components for independent replication, and are reliant on other prophage, and indeed their bacterial hosts for 
survival (Rezaei Javan et al., 2019). By contrast, cryptic prophages are those which have degraded or decayed, 
existing as stably integrated elements. Although in some cases they may excise, cryptic prophage do not affiliate 
with helper phage, do not form infectious particles and do not lyse the host cell (Canchaya et al., 2003). It is 
thought that these elements are of fundamental importance to the evolution of many bacterial pathogens, and 
certainly, there is evidence for this in S. pyogenes (Banks et al., 2002; Stephen B. Beres et al., 2004; Kaneko et 
al., 1998; Panchaud et al., 2009). 
 
Defective and decayed prophage in S. pyogenes have been explicitly described previously in emm1 strain SF370 
(Canchaya et al., 2002; Scott et al., 2012), some emm4 isolates (Henningham et al., 2014), emm5 strain Manfredo 
(Canchaya et al., 2003), emm28 strain MGAS6180 (Green et al., 2005) and some emm89 strains (Turner et al., 
2015). It seems likely that this is may not be representative of the true frequency of cryptic and satellite prophage 
in S. pyogenes genomes, the detection of which until relatively recently has been constrained by the inability of 
short-read sequencing to resolve repetitive and paralogous sequences that are typical of prophage encoding 
regions. In the same vein, many phage genes and proteins remain uncharacterised and undescribed, however, as 
these are scrutinised more closely, additional layers of both complexity and understanding prophage and S. 
pyogenes are expected. 
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A recent genomic survey of 50 S. pyogenes genomes from a variety of emm-types identified 44 unique putative 
satellite phage, with an average size of ~12.8 kb and an average of 23 genes (Rezaei Javan et al., 2019). Through 
acting as molecular ‘parasites of parasites’, interfering with the replication of functional phage elements, satellite 
prophage may actually benefit the host bacterium and promote survival (Novick, 2003; Novick et al., 2010; 
Penadés and Christie, 2015). Additional roles for defective elements in bolstering the fitness of the host may 
include reduced susceptibility to antimicrobials, osmotic, oxidative and acid stressors, enhanced biofilm 
production, and reduced metabolic burden versus lysogeny with a fully functional element (Wang et al., 2010). 
Such elements can also provide alternative promoters that maintain the expression of genes and regulons within 
which they are integrated (Scott et al., 2012). While satellite prophages have been implicated in increased 
virulence and other phenotypic modulations in a number of other bacterial pathogens (Rezaei Javan et al., 2019), 
at the time of writing, there does not appear to be substantial mechanistic evidence for the role of prophage 
satellitism in the biology of S. pyogenes. 
 
Despite often being referred to as defective or decayed prophage which have undergone or are undergoing 
mutational decay, evidence suggests that streptococcal satellite prophage may be conserved for decades, 
maintaining almost complete nucleotide similarity throughout the genome, even against the highly recombinant 
genetic scaffold of the pneumococcus (Rezaei Javan et al., 2019). The finding that full-length prophage and 
satellite prophage among the streptococci are in fact phylogenetically distinct groups, with 93% of all satellite 
prophage-encoded genes (>70% amino acid sequence similarity) not detected in any full-length elements 
corroborates this hypothesis (Rezaei Javan et al., 2019) . 
 
1.5.3.1 Lysogeny module 
The ability for lysogenic bacteriophages to establish a stable infection within the host cell without immediately 
inducing lysis is a defining feature, and is regulated by the expression of genes within the lysogeny module. The 
lysogeny module encodes a site-specific integrase and an excisionase (Figure 1.7), in addition to repressor and 
antirepressor proteins, such as cI and cro, respectively (McCullor et al., 2018; McShan and Nguyen, 2019) (Figure 
1.6). Among the Siphovoridae, integrase enzymes typically utilise a catalytic tyrosine to initiate strand cleavage 
and site-specific recombination, and may require other additional prophage-, bacterium-encoded cofactors (Groth 
and Calos, 2004). Although the integrase mediates integration, and the excisionase mediates excision, the loss of 
function of the integrase, but retention of the excisionase would presumably lead to rapid loss of the vulnerable 
extrachromosomal element from the population, whereas loss of the excisionase might be expected to lead to a 
persistent integrative state wherein the excisionase were functionally redundant. There is however some evidence 
that depending on the degree of homology between the integrase gene of one phage, and the attachment sequences 
of another, such an element might be able to utilise the enzyme of a prophage that has retained a functional enzyme 




The loss of the ability to integrate by deletion events affecting this module can lead to the conversion of a lysogenic 
element to either a lytic prophage (McCullor et al., 2018) or a permanently integrated prophage, which lacks the 
ability to exist as an independently replicative entity ((da Silva Duarte et al., 2019; Frígols et al., 2015). Lysogeny 
is maintained by the expression of cI, which suppresses the lytic activator cro and this is maintained by 
autoregulation of cI (Bednarz et al., 2014). When transcription of cI is not maintained at a sufficient level, 
transcription of cro may occur, which prevents the expression of cI and thus induces the lytic cycle (Bednarz et 
al., 2014). Lysogeny is a highly stable state that may persist for millions of bacterial cell generations (Bednarz et 
al., 2014; Zong et al., 2010). However, this condition may be interrupted upon induction of the prophage by a 
number of signals, such as the initiation of the SOS-response (Figure 1.8)  (Nanda et al., 2015). During lysogeny, 
prophage may be largely transcriptionally silent, occasionally with the notable exception of genes believed to 
confer an advantage to the host bacterium, which promote the retention of such elements in the population 
(Ventura et al., 2002a). While this phenomenon is mutually beneficial for both the virus and the bacterium, there 
is some evidence that genes that are subject to silencing may be lost, leading to the domestication of prophage as 
stably integrated elements or ‘remnants’ (Bobay et al., 2014; Ventura et al., 2002a). 
 
1.5.3.2 Head and tail fibre genes and capsid assembly 
Capsid and tail fibre genes are generally required for the assembly of nascent virus particles and subsequent 
transmission, and particle formation and encapsidation is a multistep process. Empty viral procapsids are 
icosahedral shells comprising multiple copies of the major capsid protein arranged as an icosahedral lattice, the 
assembly of which requires the major capsid protein itself, and often a scaffold and portal protein (Dokland, 1999; 
Murialdo and Becker, 1978). The scaffold protein is generally required for geometric fidelity, and in its absence, 
procapsid formation may become dysregulated and aberrant (Dokland, 1999). The mechanism by which the 
scaffold protein facilitates correct geometric architecture of the procapsid is not known (Aksyuk and Rossmann, 
2011). Most dsDNA tailed viruses assemble the procapsid from multiple copies of one major capsid gene and one 
copy of gene encoding the scaffold protein though occasionally more are observed (Rao and Feiss, 2008). One of 
the capsids 12 fivefold vertices comprises a dodecameric cone-shaped portal protein, subunits of which are 
organised radially around a central channel which facilitates the translocation of the viral chromosome during 
packaging. After packaging, the icosahedral lattice of the procapsid is subject to a conformational change, 
expanding to become a mature shell. Though this process is not always triggered by packaging, this often occurs 
when packaging has begun, as the shell is being packaged (Aksyuk and Rossmann, 2011; Fuller et al., 2007). 
Stringent evolutionary linkage dictates the association between capsid size and genome length (Rao and Feiss, 
2008). The formation of infectious particles may not be required for lethal disease mediated by toxins encoded by 
prophage genes, such as Shiga toxin 2 by enterohaemorrhagic E. coli (Balasubramanian et al., 2019). Prophage 
which lack their own structural genes have been described in S. pyogenes (Remmington et al. 2020; Canchaya et 





1.5.3.3 Portal proteins, terminases and DNA packaging 
DNA packaging is initiated by the small terminase, and occasionally the portal protein (Rao and Feiss, 2008). For 
the majority of dsDNA viruses, the viral genome is packaged into capsids following the formation of a packaging 
motor complex which comprises the phage terminase and portal proteins, and is driven by ATP hydrolysis (Rao 
and Feiss, 2008). A concatemeric or multimeric template of multiple copies of the viral genome is processed and 
translocated through the portal protein and into the empty capsid. When one or more copies of the viral genome 
have been packaged into the procapsid, the DNA is cleaved by the phage terminase (Aksyuk and Rossmann, 
2011). 
 
1.5.3.4 Neck and tail genes and completion of capsid assembly 
After packaging, the capsid must be closed, and for many bacteriophages, this is followed by tail fibre attachment. 
In tailed phage, capsid closure is achieved by two general mechanisms: a conformational change which closes the 
portal channel or by the assembly of connector proteins. In the former, the portal protein serves as the binding site 
for the join between the tail protein and the capsid (Aksyuk and Rossmann, 2011; Rao and Feiss, 2008). When 
connector and neck proteins are implemented, these are the site for tail fibre binding (Orlova et al., 2003). In 
addition to preventing premature egress of DNA due to the extreme pressures within the capsid, these proteins 
may also mediate the injection of the viral genome on attachment with a new host (Aksyuk and Rossmann, 2011; 
Orlova et al., 2003; Rao and Feiss, 2008). 
1.5.3.5 Tail and tail-fibre genes, assembly and capsid attachment 
Most bacteriophage particles feature a proteinaceous tail (Ackermann and Prangishvili, 2012). The Siphoviridae, 
the family to which the majority of the phage of S. pyogenes belong, this tail is long, flexible and noncontractile 
and lacks a sheath. By contrast, the tails of the Podoviridae are short and noncontractile, whereas the Myoviridae 
have long and contractile tails (Nobrega et al., 2018). Siphoviral and myoviral tail assembly occurs separately to 
capsid assembly, and thus, preformed tails are bound to preformed capsids, as opposed to being sequentially 
attached, as is the case for the Podoviridae (Aksyuk and Rossmann, 2011). The tail is essential for onward 
transmission and infection of new bacterial hosts by progeny virions, and is critical for the recognition of bacterial 
receptors at the host cell surface (Nobrega et al., 2018). Among the Siphoviridae this cylindrical structure 
comprises multiple copies of the same tail tube protein, at the terminal end of which are the tail spike, tail fibres 
and a baseplate or initiator complex, (hereafter referred to as the baseplate) (Ackermann and Prangishvili, 2012; 
Aksyuk and Rossmann, 2011; Nobrega et al., 2018). The baseplate is adorned with proteins that recognise specific 
receptors at the bacterial cell surface (Farenc et al., 2014; Nobrega et al., 2018). Among the lactococcal 
siphoviruses, the baseplate contains multiple receptor binding proteins, and this may be the same for those of the 
streptococci (Farenc et al., 2014). When the receptor binding proteins bind with their targets at the bacterial cell 
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surface, this induces a conformational change, whereupon the tail polymerises, and the virus binds irreversibly to 
the host, subsequently injecting its nucleic acid into the bacterium (Nobrega et al., 2018). Often, but not always, 
the phage of S. pyogenes (Canchaya et al., 2003; McShan and Nguyen, 2019) and closely related species (Desiere 
et al., 2001; Holden et al., 2009; Singh et al., 2014) features a hyaluronidase as part of the tail, which may aid in 
penetrating the HA capsule expressed by some isolates.  
 
1.5.3.6 Phage-associated hyaluronidases 
Though they are not homologous at the DNA sequence level and are immunologically distinct from 
chromosomally encoded hyaluronidases (Halperin et al., 1987), many of the phage of S. pyogenes carry genes 
encoding hyaluronidases, denoted HylP’s (Hynes et al., 1995), including many encapsulated emm-types (Beres et 
al., 2002; Stephen B. Beres et al., 2004; Canchaya et al., 2003; McShan and Nguyen, 2019; Nasser et al., 2014; 
Smoot et al., 2002a). The HylP enzymes of S. pyogenes are capable of degrading both HA and chondroitin 
sulphate (Mishra et al., 2006; Mishra and Bhakuni, 2009), but lack an N-terminal signal peptide, and do not appear 
to be actively secreted from the bacterial cell, instead forming part of the phage tail fibre (Hynes et al., 1995; 
Mishra et al., 2006). It has been proposed that the function of these enzymes is to degrade the HA capsule (Hynes 
et al., 1995). Serological studies have demonstrated that humans are exposed to HylPs during infection (Halperin 
et al., 1987), and if one rejects the hypothesis that these play a supplemental role in virulence for the bacterium, 
perhaps this is due to prophage induction and transmission among streptococci in-vivo (Banks et al., 2016; Broudy 
and Fischetti, 2003; Fischetti, 2007), though what utility activity towards other glycosaminoglycans might confer 
is unclear, adaptive immunity to phage components is well described (Krut and Bekeredjian-Ding, 2018; Van 
Belleghem et al., 2019). In the equine pathogen S. equi sbsp. equi, which shares ~80% genome sequence identity 
with S. pyogenes (Holden et al., 2009), a HylP has been shown to interact with a major human cell surface receptor 
for HA, CD44, and similar results were achieved with HylP derived from S. pyogenes (Singh et al., 2014). 
 
1.5.3.7 Holins and lysins 
Virtually all dsDNA bacteriophage encode both a holin and a lysin (Young, 2014). Lysins are peptidoglycan 
hydrolases that disrupt the cell wall from within, and thus compromise the structural integrity of the bacterium 
which undergoes lysis, subsequently releasing progeny virions into the extracellular milieu (Pohane and Jain, 
2015). Holins are small transmembrane proteins that facilitate the passive diffusion of lysins from cytoplasm to 
the periplasm, by forming a pore in the cytoplasmic membrane (Savva et al., 2014). Although lysins are only 
required at the end of the infectious cycle, surprisingly, their transcription commences in the early stages in both 
lytic and lysogenic phage (Luke et al., 2002; Pohane and Jain, 2015; Ventura et al., 2002b) though often mature 
proteins are not detected until later stages (Luke et al., 2002; Pohane and Jain, 2015). This is both inference of the 
ability of endolysin genes to be transcribed by host RNA polymerases and of post-transcriptional regulation of 
these genes. Suppression of endolysin mRNA translation is, in some cases, achieved by stable hairpin loops 
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(Pohane and Jain, 2015). Use of host bacterium-derived transcription factors to regulate endolysin expression has 
also been reported in some phage of both streptococci and other bacterial genera (Berdygulova et al., 2011; Garcia 
et al., 2002). Endolysin regulation can also be achieved by regulation of holin genes, although holin-independent 
translocation of endolysin have been described. In the pneumococcus, trafficking of endolysins that lack a signal 
sequence may be mediated by LytA (Frias et al., 2013). Similarly, holins may act independently of endolysin-
mediated lysis. Indeed, in some cases, holins form smaller pores in the cytoplasmic membrane, insufficient in size 
to permit endolysin translocation, but sufficient to lead to the compromised integrity of the host bacterial cell 
(Pang et al., 2013). Having induced lysis of their host, and imbued with the capacity to degrade the cell wall (and 
if necessary, capsule) of prospective bacterial hosts, the lifecycle of the prophage recommences. 
 
1.5.3.8 Lysogenic conversion module 
From an evolutionary perspective, prophage must confer some advantage to the host bacterium that would 
neutralise otherwise deleterious effects of lysogeny on the lysogen (Abedon and LeJeune, 2005). In S. pyogenes, 
prophage often carry genes encoding bacterial virulence factors. Specifically, streptococcal superantigens, 
DNases and a secreted phospholipase (Proft et al., 2003; Remmington and Turner, 2018; Sitkiewicz et al., 2006). 
Such genes are located in the lysogenic conversion module. Prophage and similar elements also exist which do 
not appear to carry any genes with an immediately obvious benefit to the bacterium or potential detriment to 
human health (McShan and Nguyen, 2019). These integrate into the bacterial chromosome at sites that are fairly 
conserved, and have occasionally been purported to influence the regulation and expression of genes at their 
respective attachment sites, notably CRISPR loci (Beres et al., 2002; Nozawa et al., 2011). Presumably, retaining 
non-toxigenic prophage confers some advantage, perhaps genomic stabilisation (Nakagawa et al., 2003) or 
immunity to bacteriophage superinfection (Labrie et al., 2010), resistance to environmental stressors (Wang et 
al., 2010), and enhanced biofilm formation (Carrolo et al., 2010), though perhaps toxigenic phage immediate 
similar phenotypic modulations also. 
 
1.5.3.9 Paratox 
 Paratox is a small gene, often contiguous with prophage-encoded toxin genes, that has recently been characterised 
in S. pyogenes (Mashburn-Warren et al., 2012). It appears that the role of paratox is to reduce yet further the 
frequency at which S. pyogenes acquires exogenous DNA by transformation. Experimental evidence suggests that 
this is achieved through interfering with the binding of XIP with ComR, which ordinarily form a complex involved 
in the activation of genes that mediate transformation and recombination (Mashburn-Warren et al., 2018). 
Although it has previously been reported that all sequenced S. pyogenes strains contain at least one copy of paratox 
(Mashburn-Warren et al., 2018, 2012), this seems to have been an oversight (Turner et al., 2015; Zhu et al., 
2015b). Intriguingly, deletion of paratox in the emm1 background increased the in-vitro transformation efficiency 
of the isolate by >100,000 fold, versus wildtype (Mashburn-Warren et al., 2018). 
35 
 
 Integrative and conjugative elements of S. pyogenes 
Integrative and conjugative elements (ICE) of S. pyogenes are increasingly recognised as major virulence 
determinates and, like bacteriophage, constitute an expedient artifice for the exchange of genetic material with 
other bacterial species. Of these, one ICE has been studied in some detail and linked to pathogenic processes in 
S. pyogenes, denoted region of difference 2 (RD2). RD2 is an inducible element, comprising approximately 30 
genes, is not found in all isolates, but has been identified in emm2, emm4 and emm28, and is best characterised in 
the latter genotype. This ICE encodes 7 secreted proteins, and 4 hypothetical cell surface-anchored proteins, two 
of these have been identified and characterised as virulence factors, Spy1325/aspA and Spy1336/R28 (Green et 
al., 2005; Kachroo et al., 2019; Zhang et al., 2006). AspA has been identified as an important adhesin required 
for upper respiratory tract colonisation (Franklin et al., 2013). A homologue of this gene in the Group B 
Streptococcus, S. agalactiae was similarly shown to mediate adherence to vaginal epithelial cells (Rego et al., 
2016). A second RD2-associated virulence gene, Spy1336/R28, encodes an additional surface protein which has 
recently been implicated in increased virulence, also in genotype emm28 (Kachroo et al., 2019).  
 
 S. pyogenes chromosomal islands 
Formerly believed to be degraded prophage, but subsequently recognised as distinct biological entities and 
denoted S. pyogenes chromosomal islands (SpyCI), these elements are similar to the staphylococcal pathogenicity 
islands (SaPI), and like SaPI, may retain mobility in the absence of structural genes encoding capsid proteins by 
affiliation with auxiliary ‘helper’ phage (Frígols et al., 2015). A number of emm-types variably host these elements 
integrated into the bacterial chromosome at various sites, most notably emm1, emm4 and emm28, but also emm2, 
emm5, emm6, emm18, emm31, emm37, emm49, emm53, emm59 and emm123 (Nguyen and McShan, 2014; Scott 
et al., 2008). Homologous elements are also found in other streptococcal species, such as S. dysgalactiae sbsp. 
equisimilis, S. canis and S. anginosus (Nguyen and McShan, 2014). SpyCI are not typically toxigenic, but may 
regulate gene expression at by growth-phase integration and excision at attachment sites, often the DNA MMR 
operon (Scott et al., 2008). 
 
Figure 1.9: Genomic architecture of SpyCI 
Similar to prophage, though not phylogenetically so, SpyCI such as SpyCIM1 of emm1 SF370 do appear to bear some 
semblance of modular arrangement, though SpyCI are substantially smaller than prophage, as are putative modules. In 
general, SpyCI genome sequences are dominated by genes of unknown function (black arrows) with few classifiable genes. 
These elements do not encode toxins, and their true role in the molecular biology of S. pyogenes is not well understood, but 
their prevalence among the streptococci suggests they may fulfil a hitherto undetermined purpose Figure created using 
EasyFig (Sullivan et al., 2011) and sequence derived from completed reference genome SF370 (Ferretti et al., 2001). 
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1.5.5.1 Mobile genetic elements, antibiotic resistance and S. pyogenes 
Although antibiotic resistance in S. pyogenes is not exclusively mediated by mobile genetic elements (Cattoir, 
2015; Musser et al., 2020; Vannice et al., 2019), in addition to encoding bacterial virulence factors, MGE of S. 
pyogenes may also mediate reduced susceptibility to antimicrobials by carrying resistance genes. Specifically, 
these elements confer variable resistance to macrolides and/or tetracyclines, by carrying mef and tet genes, 
respectively (Giovanetti et al., 2005, 2003). Of the macrolide efflux pump encoding  (mef) genes, mefA is the most 
common variant and interestingly, is carried on a prophage which in turn harbours a transposon, itself carrying 
mefA (Brenciani et al., 2010; Clancy et al., 1996). Prophage-associated tetracycline resistance in S. pyogenes is 
often mediated by tetO, which encodes a ribosomal protection protein (Giovanetti et al., 2003). Although tetO is 
typically found in association with mefA on the same transposon, for instance on the archetypal S. pyogenes 
resistance-mediating prophage, ΦM46.1 (Brenciani et al., 2010), tetO may be found without mefA on other mobile 
elements (Giovanetti et al., 2012). Similarly, mefA may also be found alone, for instance on transposon inserted 
into other prophages, such as Φ1207.3 or Φ10394.4 (Brenciani et al., 2004). In other streptococcal species, 
homologous transposons carrying resistance determinants may be found alone, integrated at other sites within the 
bacterial chromosome and not associated with a prophage (Santagati et al., 2000). Worryingly, in-vitro 
experiments have shown that ΦM46.1 is also able to transduce S. agalactiae, S. gordonii and S. suis, though for 
now, these remain absent from surveillance data (Giovanetti et al., 2014). ICE are also capable of carrying genes 
that confer resistance, notably ICESp1116, which encodes the ribosomal methylase ermB, ICESp2905 (actually 
one ICE integrated into another), which encodes ermA and tetO and ICE-emm12, encoding tetO and tetM 
(Giovanetti et al., 2012; Walker, 2015). Unlike carriage of prophage-encoded exotoxins, the incidence of isolates 
in which MGE-encoded resistance determinates appears to vary considerably geographically, and may reflect 
prescribing practices. For example, such isolates are dominant in outbreaks of scarlet fever in Hong Kong and 
mainland China, but are comparatively scarce in the United Kingdom (Lynskey et al., 2019a; Tse et al., 2012; 
Turner et al., 2016; Walker, 2015). 
 
1.6 S. pyogenes and host immunity 
 Innate immunity 
The innate immune system is sufficient for clearance of S. pyogenes, and T-cell deficient mice are still able to 
clear infection (Medina et al., 2001). The potency of innate immunity against S. pyogenes is perhaps reflected in 
the myriad diverse strategies that they have evolved to thwart detection and elimination by this system (Walker 
et al., 2014). The interface between host and pathogen represents a highly dynamic convergence of tightly 
coordinated molecular events from both sides. The physiological and anatomical barriers of the host represent the 
primary interface in the interaction between host and pathogen. Before a response is triggered, the human host is 
passively protected by the physical barriers of the dry, desquamating, nutrient poor, low pH and high salinity 
environment of the integumentary system, and also the mucosal membranes, notably within the human 
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oropharynx. Like the integumentary system, mucosal membranes are prone to sloughing of superficial layers in 
addition to the secretion of antimicrobial enzymes such as lysozyme and antimicrobial peptides. These barriers 
are conferred additional protection by native microorganisms, which are highly efficacious in precluding invading 
pathogens by secreting antimicrobial compounds and other metabolites, sequestering nutrients and competing for 
space. 
 
1.6.1.1 Immunological recognition of S. pyogenes 
Invading pathogens are detected by the recognition of specific epitopes known as pathogen-associated molecular 
patterns (PAMPs), triggering an immune response. These sequences are recognised by receptors known as 
pathogen recognition receptors (PRRs), which are expressed on a multitude of cell types, including those lining 
the primary infection sites of S. pyogenes, the skin and oropharynx, and effector cells of the immune system. Data 
is available suggests a multitude of molecular intermediates and considerable functional redundancy in the 
detection of S. pyogenes-specific PAMPs by PRRs. 
 
1.6.1.2 Toll-like receptors and S. pyogenes 
Toll-like receptors (TLRs) are membrane anchored PRRs that are expressed on most innate immune effector cells 
and some adaptive immune cells, the stimulation of which activates the transcription factor NFkB and the 
interferon regulator family (IRF) transcription factors (Kawai and Akira, 2010). The expression of TLRs can also 
be upregulated on epithelial and endothelial cells (Iwasaki and Medzhitov, 2004). Macrophages and dendritic 
cells are critical in the host immune response to, and  the control of infection and express TLRs both at the cell 
surface and intracellularly (Goldmann et al., 2004; Loof et al., 2007; Takeda et al., 2003). In S. pyogenes infection, 
as is the case for many other Gram-positive bacteria, TLRs represent an important mechanism for recognition and 
signalling, and the induction of immunological and inflammatory responses. Recent evidence suggests that the 
adaptor molecule myeloid differentiation primary response protein (MyD88) is critical in the instigation of a 
functional immunological response to S. pyogenes and indeed a number of TLR are known to signal via. this 
protein (Loof et al., 2010, 2008). Classically, TLR-2 was thought to recognise a number of Gram-positive bacterial 
epitopes including lipoteichoic acids and peptidoglycan. However, recent evidence suggests that peptidoglycan is 
in fact recognised by the intracellular receptors Nod1 and Nod2, and that lipoteichoic acids are synergistically 
recognised by TLR-1 and TLR-2, but peptidoglycan is not (Travassos et al., 2004). Interestingly, it appears that 
despite being a major component of the immune response to a number of Gram-positive bacteria, TLR-2 may not 
be a key PRR in immunity to S. pyogenes. Indeed, TLR-2 deficient mice are only marginally more sensitive to S. 
pyogenes infection (Mishalian et al., 2011). Conversely, mice that are deficient of MyD88 exhibit markedly 
hampered recruitment of neutrophils and dramatically enhanced susceptibility to infection with S. pyogenes (Loof 




1.6.1.3 Other pattern recognition receptors and S. pyogenes 
S. pyogenes is also recognised by non-TLR PRR during infection. Recently, S. pyogenes has been shown to trigger 
the activation of the NOD-like receptor (NLRP) inflammasome, NLRP3, which in turn leads to the release of IL-
1 through the activity of macrophage caspase-1 (Harder et al., 2009). Experimentally, this response has been 
shown to be induced by the pore-forming cytolysin streptolysin O, which is secreted by S. pyogenes. Interestingly, 
this pathway is independent of TLR- and MyD88-mediated signalling, and unlike the activation of these receptors, 
proceeds without the requirement for ATP (Harder et al., 2009). PRR stimulation may also occur via. TREM-1, 
a PRR expressed on myeloid cells, notably neutrophils, monocytes and macrophages, potentiating the pro-
inflammatory response to S. pyogenes (Colonna and Facchetti, 2003; Horst et al., 2013). Indeed, inhibition of this 
receptor ameliorated the inflammatory response of macrophages in-vitro, and mitigated many of the clinical 
features of STSS in a murine model of infection, significantly reducing systemic levels of IL-6 and TNF- (Horst 
et al., 2013). Most macrophage subsets express scavenger receptors at the surface, and of these, scavenger receptor 
A (SRA) recognises Gram-positive organisms, specifically by binding LTA, mediating direct, non-opsonic uptake 
of bacteria to confer resistance to infection (Peiser et al., 2002; Platt and Gordon, 2001; Thomas et al., 2000). 
SRA readily recognises bacterial ligands at the cell surface of S. pyogenes, however expression of M-protein, 
specifically emm5 and emm6, has been shown to dramatically dampen this recognition (Areschoug et al., 2008). 
One report describes a mechanism by which scavenger receptor B (SRB), also known as CD36, recognises some 
S. pyogenes isolates in whole blood, in a fashion that may be mediated by the binding of LDL to the streptococcal 
collagen-like protein Scl1, acting as an opsonin (Zhou et al., 2016). 
 
1.6.1.4 The inflammatory response 
Recognition of PAMPs by PRR induces the inflammatory response; a molecular cascade that if not carefully 
coordinated, can prove highly problematic for both human hosts and invading bacteria (Mogensen, 2009). 
Typically, this involves the secretion of inflammatory cytokines such as such as IL-1, IL-6, IL-8, IL-12 and 
TNF-, largely by immune cells, but also by epithelial and endothelial cells. Once initiated, the inflammatory 
response modulates changes to the microvasculature within and around infectious foci, promoting vascular 
dilation which in turn engenders increased perfusion, coupled with a concomitant decrease in the rate of flow. 
The endothelial surface upregulates adhesion molecules in response to these signals, expressing more E- and P-
selectin and ICAM-1 which promotes increased binding and diapedesis of neutrophils which follow inflammatory 
signals to the site of infection. The corollary of these inflammatory events is the increased exposure of effector 
cells with inflamed or damaged cells and tissues, as well as the offending agent or agents. The induction of a 
functional inflammatory response by dendritic cells in response to S. pyogenes is subject to an absolute 
requirement of MyD88 (Loof et al., 2008). In mice that are deficient for MyD88, the inflammatory response is 
not properly initiated and subcutaneous infection with S. pyogenes rapidly results in lethal systemic infection and 
multiorgan failure (Loof et al., 2010). On the other hand, an overzealous inflammatory response, particularly in 
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response to exotoxins released by S. pyogenes, can be equally damaging, particularly when these are released into 
the circulation causing sepsis and STSS, which is associated with high mortality rates (Lamagni et al., 2008). 
 
1.6.1.5 Phagocytes 
The primary phagocytic cells involved in the prevention and control of S. pyogenes infection are neutrophils, mast 
cells, macrophages and dendritic cells (Di Nardo et al., 2008; Loof et al., 2007; Matsui et al., 2011; Valderrama 
and Nizet, 2018; Voyich et al., 2004). These cells, in addition to producing inflammatory cytokines themselves, 
follow these signals to infectious or inflammatory foci wherein they begin to trap and phagocytose offending 
bacteria. Phagocytosed bacteria are subsequently destroyed in intracellular vesicles by the activity of superoxide, 
hydrogen peroxide and hypochlorous acid following the formation of the phagolysosome by the fusion of the 
phagosome and lysosome (Uribe-Quero and Rosales, 2017). Both mast cells and neutrophils have been shown to 
extrude extracellular traps that ensnare and neutralise invading microorganisms (Brinkmann et al., 2004; 
Goldmann et al., 2008). These traps comprise chromatin, histones and other proteolytic and antimicrobial peptides 
(Brinkmann et al., 2004). In addition to reducing the mobility of infectious agents and facilitating phagocytosis, 
they also exert antimicrobial activity independent of uptake-mediated elimination. Until relatively recently, there 
was some debate about whether NETs were produced in-vivo, however this phenomenon has since been 
demonstrated in-vivo using intravital microscopy and other techniques (Alasmari, 2020; Kolaczkowska et al., 
2015). Perhaps the most effective illustration of the importance of neutrophils in defending against S. pyogenes 
infection are the myriad extraordinary ways in which the bacterium strives to avoid them (Goldblatt et al., 2019; 
Lin et al., 2009; Lynskey et al., 2017; Remmington and Turner, 2018; Turner et al., 2009a; Uchiyama et al., 2012; 
Von Köckritz-Blickwede and Nizet, 2009; Von Pawel-Rammingen, 2012; Voyich et al., 2004). Mast cells employ 
similar means of pathogen elimination, and have been implicated in host resistance to cutaneous infection with S. 
pyogenes (Di Nardo et al., 2008; Matsui et al., 2011). Paradoxically, there is also evidence that S. pyogenes will 
readily survive and replicate within neutrophils (Medina et al., 2003). 
 
Macrophages, unlike neutrophils and mast cells, are more heterogenous and constitute a self-renewing population 
of professional phagocytes supplemented by contribution from differentiating monocytes. Macrophages are thus 
found resident within tissues in the absence of disease, as well as in the circulation (Gordon and Plüddemann, 
2017). These phagocytes recognise bacteria by interaction between surface and endosome expressed PRR and SR 
and their cognate PAMP and DAMP ligands. Compared to other phagocytes, macrophages acidify more strongly 
and indeed more rapidly (Yates et al., 2005). A number of lines of investigation have demonstrated the 
fundamental contribution of macrophages to the innate immune response to S. pyogenes. Experimental 
knockdown of these cells has highlighted their role in neutralising S. pyogenes in the bloodstream (Goldmann et 
al., 2004). Further, in mice depleted of macrophage, cutaneous infection with S. pyogenes was significantly more 
likely to disseminate systemically and progress to invasive disease involving multiple internal organs (Mishalian 
et al., 2011). Despite this, there is evidence that S. pyogenes is able to resist phagolysosome acidification and 
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intracellular processing and readily replicates within these cells (Bastiat-Sempe et al., 2014; Hertzén et al., 2010; 
Thulin et al., 2006). Dendritic cells are able to directly recognise S. pyogenes by TLRs (Loof et al., 2008) and this 
recognition has been shown to drive dendritic cell maturation in-vitro (Veckman et al., 2004) and in-vivo, 
whereupon they release pro-inflammatory cytokines (Loof et al., 2007). Following dendritic cell ablation in mice, 
cutaneous infection with S. pyogenes was more likely to spread to efferent lymph nodes and internal organs (Loof 
et al., 2007). There is evidence to suggest that the bacterium is also able to inhibit dendritic cell maturation, resist 
destruction within the phagolysosome and survive within (Cortés and Wessels, 2009). 
 
 Complement 
Complement comprises a highly abundant, hierarchical system of over 30 plasma and cell surface-associated 
proteins activated by interlinked, cascading pathways (Figure 1.10). Complement is triggered following the 
recognition of pathogenic microorganisms, in addition to other insults, and culminates in the production of pro-
inflammatory effectors, opsonisation of the invading organism or biological entity, and the formation of the 
membrane attack complex (MAC) and subsequent lysis of the pathogen (Dunkelberger and Song, 2010). 
Complement is activated by three distinct pathways denoted the classical pathway, the lectin pathway, and the 
alternative pathway. The classical pathway is activated by the formation of the immune complex by the binding 
of C1q with the serine proteases C1r and C1s, which subsequently bind to the Fc-region of immunoglobulins, 
often IgG and IgM, which are sequestered at the surface of invading microorganisms. Further, the activation of 
the two serine proteases promotes the cleavage of C4 and C2 and the formation of C3 convertase. When C3 
convertase is formed, C3 is cleaved to yield C3a and C3b, and this inflection point of complement activation is 
the bottleneck at which all three complement activation pathways converge. The production of C3b enables this 
molecule to bind to and identify non-self-entities by decorating their surface, and in turn, this promotes further 
complement activation, eventually culminating in the production of anaphylatoxins and assembly. In contrast, the 
lectin pathway is initiated by a similar but distinctly immunoglobulin-independent mechanism wherein PAMPs 
are recognised via. carbohydrate ligands by mannose-binding lectins. Analogous to the aforementioned C1 
complex of the classical pathway, mannose-binding-lectin forms an immunological complex with affiliated serine 
proteases which cleave C2 and C4, subsequently generating C3 convertase. The final major mechanism by which 
complement can be activated is the alternative pathway, triggered by spontaneous hydrolysis of C3, which is 
highly abundant in plasma, and yields a hydrated molecule that is analogous to C3b. The hydrated analogue, 
denoted C3(H2O), binds to and facilitates the cleavage of Factor B to yield Bb and Ba by Factor D. By this 
mechanism, the C3 convertase of the alternative pathway, C3(H2O)Bb, is formed, promoting the cleavage of C3 
and the production of C3a and C3b. The activation of complement again is convergent in the activation of three 
major effector pathways. Broadly, these are the MAC-mediated lysis of the pathogen, the production of pro-
inflammatory mediators, and finally, opsonin mediated clearance of the organism or organisms and priming of 
phagocytic cells (Dunkelberger and Song, 2010). As complement straddles both the innate and adaptive immunity 
and involves multiple arms of the human immune system, the mechanisms by which it curtails S. pyogenes 
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colonisation and infection are numerous. Factor B appears to be important to complement mediated immunity 
towards S. pyogenes, and facilitates C3b deposition at the surface of the bacterium via. the alternative pathway 
(Yuste et al., 2006). Indeed, it seems that the alternative pathway might be the more instrumental activation 
pathway in the clearance of S. pyogenes infection by innate immunity, specifically mediated by C1q, which 
interestingly, may also exert activity against S. pyogenes in a fashion that is independent of complement in both 
humans and mice. In the same study, both Factor B and C1q-deficient mice exhibited enhanced susceptibility to 
invasive disease and C1q deficient serum of both human and mice exhibited impaired capacity to induce 
opsonophagocytic killing of S. pyogenes (Yuste et al., 2006). In addition to expressing a multitude of factors 
which interfere with the potent antibacterial activity of complement at multiple levels (Laabei and Ermert, 2018), 
S. pyogenes appears to take advantage of the complement interference strategies of other pathogens, notably the 
Sarcoptiforme ectoparasitic mite Sarcoptes scabei which secretes a potent serine protease inhibitor, and indeed 




Figure 1.10: Complement pathway 
The three iterations of the complement pathway are the alternative, classical and lectin pathways. Though these pathways 
follow distinct molecular mechanisms, they each converge on the production of convertase C3. The C3 convertase promotes 
the synthesis and release of chemoattractant C3a and C5a. C5b, C6-9 coalesce to form the membrane attack complex (also 
known as the terminal complement complex) (Dunkelberger and Song, 2010). "Complement 
activation.jpg" by Hofman.martijn is licensed under CC BY-SA 4.0. 
 
 Antibodies and adaptive immunity 
There is substantive evidence that anti-S. pyogenes antibodies are produced late in infection or in convalescence 
following infection with this bacterium (Beachey et al., 1988; Mortensen et al., 2015; Shet et al., 2003), and a 
lasting adaptive response appears to be mediated by both T cells, notably Th1 and Th17, and immunoglobulins, 
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predominantly IgG1 and IgG3, and IgA (Bessen and Fischetti, 1988; Fluckiger et al., 1998; Mortensen et al., 
2015; Soderholm et al., 2017). The humoral response to S. pyogenes infection can be broadly classified as being 
M protein specific and non-M protein specific. Lasting immunity to specific isoforms of M protein is well-
described, and forms the basis for efforts to develop a vaccine (Davies et al., 2019), and abundant anti-M protein 
directed CD4+ T cells which secrete pro-inflammatory cytokines can be found in tonsillar tissue derived from 
patients with recurrent streptococcal tonsillitis, versus patients with tonsillar hypertrophy, which does not have an 
infectious aetiology (Gogos and Federle, 2019). Other proteins, including C5a peptidase, immunogenic secreted 
protein and SpyCEP similarly induce protective antibodies and are also appealing targets (Turner et al., 2009b; 
Davies et al., 2019). Antibodies to the streptococcal superantigens SpeA and SpeC are capable of inhibiting their 
mitogenic potential (Norrby-Teglund et al., 1996), and the peptidase activity of C5a peptidase is abrogated by 
antibody neutralisation (Cleary et al., 2004). Anti-S. pyogenes adaptive immunity is thus multifactorial, and 
typically begins at the mucosal surfaces of the pharynx. Here, IgA serves to protect against adherence and 
colonisation of the bacterium in the early stages, binding to the C-repeat region of M-protein (Bessen and Fischetti, 
1988; Cunningham, 2000; Fluckiger et al., 1998). Intranasal immunisation of mice with C5a peptidase derivatives 
was observed to confer resistance of the host to colonisation by S. pyogenes mediated by stimulating salivary 
secretory IgA (Ji et al., 1997). The second arm of protective immunity to S. pyogenes is mediated by IgG, which 
prevents internalisation and invasion, inhibiting the progression to established, deep-set infection and entry to the 
bloodstream by promoting phagocytosis and clearance in conjunction with complement (Fluckiger et al., 1998). 
The production of IFN- γ also appears to play a role in the bodies defence against S. pyogenes, although children 
appear to produce inferior quantities of IgG3 and IFN- γ compared to adults (Mortensen et al., 2015), and this 
may go some way to explaining why children are particularly susceptible to infection, though perhaps recurrent 
exposures over time contribute to the more robust protection observed in adults, mediated by a mechanism that is 
independent of opsonisation (Cunningham, 2000). 
 
1.7 S. pyogenes virulence factors 
 M protein and M-like proteins 
In addition to forming the basis of the widely used basis for genotyping S. pyogenes isolates, the emm or M-
protein is an important virulence factor (Figure 1.11). M-protein is an -helical coiled coil that exists as a fibrillar 
adhesin projecting from the cell surface. Anchored within the peptidoglycan of S. pyogenes by a C-terminal 
LPXTG motif, this reasonably conserved region is followed by 4 heterogenous repeat domains, denoted A-D. 
These domains are variable in their sequence and size according to the number of heptad repeats. As the protein 
extends towards the N-terminus, sequence variability increases, ultimately culminating in the terminal ~50 
residues of the A repeat domain. This hypervariable region confers serospecificity, and the DNA sequence confers 
the genotype. Though the M protein has been subject to intense experimental scrutiny over the years, due to the 
highly variable nature of M, it is often helpful, and indeed important, to interpret such studies in the context of 
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genetic background. Arguably the best described function of M-protein as a virulence factor is its capacity as an 
anti-phagocytic molecule, which is achieved by a number of proposed mechanisms. In some cases, this is thought 
to be mediated by the mature protein forming complexes with fibrinogen and other host-derived proteins, or 
alternatively, possibly due to the M-protein interfering with the activity of convertases at the cell surface (Carlsson 
et al., 2005), both mechanisms reportedly prevent or reduce complement deposition. While this has been observed 
in the M4 and M5 isoforms (Carlsson et al., 2005; Courtney et al., 2006a), this was not observed in M6 
(Horstmann et al., 1992). The M1 protein, when in complex with fibrinogen, may be released from the cell surface 
(possibly by the activity of SpeB), subsequently activating neutrophils, promoting inflammation and vascular 
leakage (Påhlman et al., 2006). There is also some evidence to suggest that some M-protein isoforms (notably 
M5) may have superantigenic activity (Bisno, 1991; Robinson and Kehoe, 1992). Another well substantiated 
mechanism of M-proteins implication in pathogenesis is as an adhesin (Smeesters et al., 2010). Isogenic S. 
pyogenes strains differing only in their emm allele exhibit markedly different adhesive properties to various cell 
types, and indeed bind to these in different ways to elicit this effect (Berkower et al., 1999). The M-protein may 
also promote invasion of host epithelial cells, and there is some evidence to suggest that this is mediated by 
binding of fibronectin by M-protein, specifically in this case the M1 isoform (Cue et al., 2001). Despite the 
putative adhesin and invasin properties of M-protein, it is surprising that it does not appear to play a major role in 
biofilm formation, as the capacity to propagate these structures can vary considerably within emm-types (Afshar 
et al., 2017; Lembke et al., 2006; Turner et al., 2015). Though the M-protein may not be the critical determinate 
of biofilm formation, in emm5 isolates, the M5 protein does appear to play some role in the initial stages of 
adherence (Cho and Caparon, 2005). The amino acid sequence homology of certain M-isoforms to human fibrillar 
proteins is curious if not completely surprising in an organism as adept at interfering and inhibiting host immunity 
as is S. pyogenes. Certainly, a number of distinct M-proteins share significant homology and indeed induce 
antibodies that are cross-reactive with host proteins such as keratin, myosin, tropomyosin, and laminin (Fischetti, 
1989; Robinson and Kehoe, 1992). It stands to reason that this immunological phenomenon may go some way to 
explaining the association of some emm-types with the oft neglected post-infectious sequelae (Bessen et al., 1989; 
Bisno, 1991; Fischetti, 1989; Robinson and Kehoe, 1992). Chimeric emm alleles, the products of splicing events 
between emm and downstream enn have been described in a number of emm types (DebRoy et al., 2018; Frost et 
al., 2020).The phenotypic impact of this event on these isolates, and indeed the effect this might have on coverage 








Figure 1.11: M Protein: selected mechanisms of action 
The M protein of S. pyogenes is capable of interfering with and interacting with the human host through myriad mechanisms. 
These appear to vary between isoforms, but notable functions include binding immunoglobulins, resisting phagocytosis, 
binding fibrinogen, and acting as a potent mitogen. Figure created by the author with BioRender.com 
 
 Hyaluronic acid capsule 
The capsule of S. pyogenes is comprised of hyaluronic acid (HA), a high molecular weight glycosaminoglycan, 
also found in the tissues of many eukaryotic organisms, including in the connective tissues of humans (Crater et 
al., 1995). Capsule biosynthesis is mediated by the three HA synthetases which together comprise the capsule 
operon, hasA, hasB and hasC (Wessels, 2019).  Many mechanisms of putative capsule functions have been 
proposed, with arguably the most prevailing being immune evasion and resistance to opsonophagocytic killing 
(Dale et al., 1996; Wessels, 2016). Until relatively recently, it was believed that the HA capsule of S. pyogenes 
was an essential facet of S. pyogenes, necessary for immune-evasion and virulence (Ashbaugh et al., 1998). 
However, numerous lines of enquiry have shown that capsule is inessential for S. pyogenes to attain full virulence 
and cause severe disease (Flores et al., 2019, 2012; Galloway-Peña et al., 2016; Henningham et al., 2014; Turner 
et al., 2019b, 2015). Indeed, loss of capsule may actually be advantageous in certain contexts, enhancing adhesion 
to epithelial cells and promoting persistence and longer-term shedding (Flores et al., 2014; Kawabata et al., 1999; 
Turner et al., 2019b, 2015; Vega et al., 2020).  
 
Though there is substantive evidence that capsule is inessential, encapsulation in S. pyogenes might be regarded 
as very much variations on a theme, with modulations to capsule production resulting from mutations in 
transcriptional regulators (Lynskey et al., 2013; Sumby et al., 2006), polymorphisms within the hasABC operon 
( Ashbaugh et al., 1998; Turner et al., 2019b), loss of the  operon (Flores et al., 2019; Turner et al., 2015) or 
possibly simultaneous degradation of capsule by hyaluronidases secreted by the bacterium (Henningham et al., 
2014; Starr and Engleberg, 2006) (Figure 1.12). In this way, expression of capsule varies temporally, and in 
response to environmental and immunological stimuli during growth and during infection, including strong 
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upregulation on growth in human blood (Berkower et al., 1999; Biswas and Scott, 2003; Gryllos et al., 2001; Li 
et al., 2014; Lynskey et al., 2013; Shea et al., 2011; Unnikrishnan et al., 1999; Virtaneva et al., 2005). 
Experimental restoration of capsule expression in acapsular emm-types may enhance whole blood survival, and 
elimination of capsule expression in encapsulated emm-types, perhaps unsurprisingly, appears to reduce whole 
blood survival in some emm-types (Vega et al., 2020), though not others (Henningham et al., 2014). It is 
interesting however that in genotype emm89 isolates, those that have naturally undergone capsule loss survive 
just as well in whole blood as encapsulated isolates (Turner et al., 2015), though this could conceivably be due to 
a compensatory of other noteworthy mutations characteristic of contemporaneous emm89  isolates. Inasmuch as 
a growing body of evidence appears to support the dispensability of the S. pyogenes capsule, many studies have 
conversely indicated that hyper-encapsulated strains may exhibit enhanced virulence or propensity to cause severe 
disease (Schrager et al., 1996; Tamayo et al., 2010). Like many aspects of S. pyogenes biology, it seems likely 
that genetic background may play an appreciable role in defining the consequences of capsule loss, and indeed 
there is some experimental evidence for this using a small number of emm-types (Vega et al., 2020).  
 
Notably acapsular emm-types include emm4, 22, 28, 87, although increasingly, emm-types are being found to 
comprise both encapsulated and non-encapsulated strains (Flores et al., 2019, 2012; Turner et al., 2019b, 2015). 
Increasingly, it seems that a number of emm-types may compensate for a lack of capsule with increased expression 
of SLO and NADase (Turner et al., 2019b). Recent adaptation of the infant mouse pneumococcal transmission 
model to S. pyogenes suggests that encapsulated emm-types might be better suited to rapid transmission, whereas 
acapsular emm-types may persist and transmit at lower levels, albeit for longer periods of time (Vega et al., 2020). 
The same study found that the prototype encapsulated emm3 strain required a lower index:contact ratio, whereas 











Figure 1.12: Variable expression of hyaluronic acid capsule by S. pyogenes 
Overexpression of capsule can have marked impact on phenotype. A) An isolate of S. pyogenes on Columbia horse blood 
agar, which is not overexpressing capsule. B) An isolate of S. pyogenes over expressing capsule. Colonies are characteristic 
in their ‘snotty’ or ‘oil-drop’ appearance, are glossy, and lack well circumscribed colony margins, surrounded by irregular -
haemolytic halos. Some genotypes, or lineages thereof, are genetically acapsular (Flores et al., 2012; Turner et al., 2019a, 
2015), while others are consistently highly encapsulated (Lynskey et al., 2013). Image adapted from Bacteria In Photos & 
Tamayo et al., 2010. 
 
 Streptolysin S 
Streptolysin S (SLS) is a potent cytotoxin with high activity against erythrocytes, and a number of other human 
cells, including platelets, neutrophils, lymphocytes and epithelial and myocardial cells (Dale et al., 2002; Datta et 
al., 2005). SLS is produced by the sag operon that comprises 9 genes, all of which are necessary and sufficient 
for the production of the active protein (Nizet et al., 2000). The first gene in this operon, sagA, produces a 
precursor molecule which is subsequently modified and processed by the remaining genes immediately 
downstream (Datta et al., 2005). Though the most obvious role of SLS is as one of two haemolysins, as can be 
seen when S. pyogenes is propagated on blood agar, (Figure 1.12), the toxin also may play a role in the disruption 
of mucosal barriers and enhancing cellular invasion by driving calpain mediated proteolysis of E-cadherin 
expressed by epithelial cells (Rios-Doria et al., 2003; Sumitomo et al., 2011). Indeed, isogenic sagA mutants were 
significantly less able to form necrotic lesions and spread systemically in a murine model of disease (Datta et al., 
2005). 
 
 Streptolysin O and NADase 
The secreted cytolysin streptolysin O (SLO) and the co-toxin NAD+ glycohydrolase (NADase) are encoded by 
the co-transcribed genes slo and nga, along with the gene encoding the NADase inhibitor, ifs. SLO is cytotoxic, 
and is one of the major haemolysins of S. pyogenes, though unlike SLS, SLO is cholesterol dependent, and triggers 
osmolysis of human cells by the formation of transmembrane pores. SLO also mediates the activity of its co-toxin 
by facilitating the translocation of NADase across the cell membrane, and by this mechanism, the two toxins act 
synergistically to induce lysis of human keratinocytes (Bricker et al., 2005; Madden et al., 2001; Michos et al., 
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2006; Velarde et al., 2017), though NADase is cytotoxic in its own right (Chandrasekaran and Caparon, 2015; 
Sharma et al., 2016). These two virulence factors may also promote invasion and intracellular survival, possibly 
by interfering with autophagocytic killing (Hsieh et al., 2018). Interestingly, enhanced expression of the nga-ifs-
slo locus by the acquisition of a high activity promoter variant has been associated with a number of successful 
lineages, and thus increased production of these potent cytotoxins appears to confer an appreciable advantage 
(Nasser et al., 2014; Turner et al., 2019b, 2015; Zhu et al., 2015a). 
 
 Chromosomally-encoded hyaluronidases 
Hyaluronidases encoded on the core chromosome of S. pyogenes, denoted HylA, are generally considered to be 
spreading factors, serving to expedite streptococci or their toxins and other large molecules through tissue planes 
in the human host (Hynes and Walton, 2000; Starr and Engleberg, 2006). It has been reported that encapsulated 
S. pyogenes isolates lack a functional hylA gene owing to a SNP, resulting in the substitution of a D for a V at 
position 199 of the protein (Hynes et al., 2009). Subsequent work has suggested that the expression of capsule 
and the retention of a functional hylA genes are mutually exclusive, possible evidence of competitive evolution, 
though they may be co-expressed in Group C streptococci (Henningham et al., 2014; Maclennan, 1956). The S. 
pyogenes hyaluronidase might serve a possible nutritive function during pathogenesis, wherein S. pyogenes may 
use HA as a carbon source (Starr and Engleberg, 2006). Studies investigating the role of HylA in virulence are 
scarce, but along with the previous report that a significant number of major encapsulated emm-types lack a 
functional allele, suggest that either HylA are not major virulence factors or that there is some functional 
redundancy to these enzymes (Henningham et al., 2014; Hynes et al., 2009; Starr and Engleberg, 2006).  
 
 Serum opacity factor 
Serum opacity factor (SOF) is a pleiotropic virulence factor produced by 45-50% of emm-types, and 
approximately 50% of invasive isolates (Courtney and Pownall, 2010). SOF is so named due to the opacifying 
effect it exerts on mammalian serum by binding to apolipoprotein moieties of high density lipoprotein (HDL) in 
human blood, triggering the release of their lipid cargo, which coalesces as droplets (Courtney and Pownall, 2010). 
Different emm-types secrete immunologically distinct isoforms of the mature SOF protein, and hence, the ability 
of anti-SOF antisera to inhibit the opacification of serum by S. pyogenes in-vitro can be used in a fashion similar 
to the erstwhile M serotyping scheme to subclassify S. pyogenes isolates, and indeed SOF-types correlate well 
with established emm-types (Johnson et al., 2006). Some emm-types do however carry multiple SOF allelic 
variants (Beall et al., 2000). There is evidence to suggest that SOF acts as an adhesin, possibly by interacting with 
integrins and fibulin-1 receptors in epithelial tissues (Courtney et al., 2009; Courtney and Pownall, 2010; Gillen 
et al., 2008; Schwarz-Linek et al., 2006). There is also evidence for a role in promoting survival in whole blood, 
conferring resistance to phagocytosis (Courtney and Pownall, 2010). Additionally, SOF may promote bacterial 






Figure 1.13: Serum opacification by SOF 
Overnight incubation of human serum with recombinantly expressed SOF (right-hand vial) produces marked opacification 
relative to the untreated human serum control (left-hand vial). Image: "Opacification of Human serum by SOF" reproduced 
with permission from Courtney and Pownall, 2010 as licensed under CC BY-3.0. 
 
 Streptococcal pyrogenic exotoxin B 
The cysteine protease, streptococcal pyrogenic exotoxin B (SpeB), despite its name, is neither a pyrogen nor an 
exotoxin, but is nonetheless a highly promiscuous and broadly acting virulence factor of S. pyogenes (Gerlach et 
al., 1994). The myriad contributions of SpeB in the infection biology of S. pyogenes are at times paradoxical, and 
despite extensive study, direct assessments of its precise function remain elusive. This is perhaps due to notable 
variations in expression between anatomical sites and different environments (Lukomski et al., 1999; Olsen et al., 
2012), genetic background (Friães et al., 2015), mutations in transcriptional regulators (Sumby et al., 2006), and 
indeed the propensity of mature SpeB to degrade not only itself, but also many other virulence factors (Nelson, et 
al., 2011). The production of SpeB is tightly controlled, and begins with the synthesis of the zymogen, SpeBz, 
which is cleaved to yield an active enzyme, denoted SpeBm, by mature SpeB (Carroll and Musser, 2011). 
Ordinarily, this might constitute somewhat of a causality dilemma, though fortunately for the bacterium, the serine 
protease HtrA (DegP) has also been shown to activate the zymogen in this way, and perhaps unsurprisingly has 
been shown to be essential for the production of SpeBm (Lyon and Caparon, 2004). There appears to be a clear 
role for SpeB in the proteolysis of bacterial factors which are often susceptible to degradation or modification. 
Bacterial substrates include M-protein (Raeder et al., 1998), SmeZ (Nooh et al., 2006), EndoS (Allhorn et al., 
2008) and Sda1 (Walker et al., 2007), all of which are potent mediators of virulence. This represents an interesting 
paradigm for the regulation of virulence by S. pyogenes wherein redundant factors are degraded, or desirable 
factors are cleaved and activated by SpeB. Mature SpeB also degrades a litany of eukaryotic factors, degrading 
immunoglobulins (Collin et al., 2002; Collin and Olsén, 2001; Eriksson and Norgren, 2003), and chemokines 
(Egesten et al., 2009). SpeB also appears to  promote tissue damage and epithelial cell apoptosis (Tamura et al., 
2004; Tsai et al., 1999), and may trigger  inflammation (Kapur et al., 1993), promote vasodilation, and also induce 
pain (Herwald et al., 1996). While some studies have drawn an association between increased expression of SpeB 
and enhanced virulence (Lukomski et al., 1999, 1998), others report an inverse relationship or indeed report 
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having found no relationship at all (C. D. Ashbaugh et al., 1998; Ashbaugh and Wessels, 2001; Kansal et al., 
2000; Talkington et al., 1993). It is important to note however, that early studies, particularly those conducted 
prior to the widespread application of WGS, may be confounded by the association of other mutations and variants 
with invasive (or non-invasive) disease, and therefore might benefit from reappraisal with hindsight (Horstmann 
et al., 2011; Ikebe et al., 2010; Lynskey et al., 2019b; Shea et al., 2011; Sumby et al., 2006; Turner et al., 2009). 
 
 Immunoglobulin degrading enzymes 
As S. pyogenes major anatomical niches are mucosal surfaces, and occasionally sterile sites and the bloodstream, 
in addition to evading innate immunity, the bacterium must also avoid elimination by adaptive immune effectors. 
While the cysteine protease SpeB is capable of degrading immunoglobulins in-vitro, this does not appear to 
extrapolate to more physiologically relevant conditions (Persson et al., 2013). In actuality, it seems unlikely that 
SpeB is able to degrade immunoglobulins with any appreciable efficiency, owing to the promiscuity and non-
specificity of this enzyme (Persson et al., 2013). Surprisingly given its typical habitat, S. pyogenes seems to lack 
a specific IgA-degrading enzyme (Von Pawel-Rammingen, 2012), but has demonstrable capacity to degrade IgG 
and prevent effector functions by activity of the cysteine protease IdeS (IgG degrading enzyme of S. pyogenes) 
(Agniswamy et al., 2004; Lei et al., 2002; Vincents et al., 2008; Von Pawel-Rammingen, 2012). There are two 
allelic variants of ideS (also known as mac), encoding two functionally divergent complexes with overlapping 
substrate specificities, but importantly, quite distinct roles in IgG-mediated immune interference (Lei et al., 2002). 
The substrate for complex I is a region within the IgG molecule, the cleavage of which inactivates the 
immunoglobulin, though this protease has some limited capacity for IgM cleavage also (Agniswamy et al., 2004). 
Complex II on the other hand acts by blocking the phagocyte-bound Fc receptor CD16 (Agniswamy et al., 2004). 
Curiously, IdeS also appears to interfere with the antibacterial action of neutrophils by arresting ROS production 
(Von Pawel-Rammingen, 2012). Antibodies to IdeS are found in low concentrations in acute-phase sera, but are 
abundant in convalescent sera of patients with both superficial and invasive S. pyogenes infection, indicating the 
production of both complexes in-vivo (Lei et al., 2002, 2001). Further, a cofactor of IdeS, cystatin C, has been 
identified, which greatly increases its efficiency, and may sustain its immune-evading properties even at distal 
sites where the enzymatic concentration of the endopeptidase might be otherwise dampened by human protease 
inhibitors (Vincents et al., 2008). IgG effector functions are further stymied by the activity of the glycan hydrolase, 
EndoS. EndoS has specificity for the N-glycan moiety of IgG, enabling S. pyogenes to evade opsonophagocytic 
killing through the dual action of impeding Fc-receptor binding and induction of complement activation pathways 
(Allhorn et al., 2008; Collin et al., 2002). 
 
 Immunoglobulin binding proteins 
Although S. pyogenes appears to lack an IgA degrading protease, the capacity for some genotypes to sequester 
IgA at the cell surface has been described, occurring via. a hitherto uncharacterised N-terminal binding domain 
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of M-protein (Johnsson et al., 1994). In pattern C, D and E isolates, the M-like protein enn can facilitate the 
sequestration of IgA at the cell surface in-vitro. The M22 protein encoded by emm22 also reportedly binds IgA 
(Carlsson et al., 2003). The highly conserved bacterial cell surface-associated protein SibA has been shown to 
bind both the Fc- and Fab-regions of IgA, as well as IgM and IgG. There is also some evidence that SibA can also 
be secreted, possibly acting as a decoy to bind immunoglobulins (Fagan et al., 2001). Interaction with IgG has 
been reported in some genotypes, mediated again by M protein. Although the M protein of some genotypes may 
bind all IgG subclasses, others can only bind specific isoforms such as IgG3 (Reglinski and Sriskandan, 2014; 
Retnoningrum and Cleary, 1994). Remarkably, the M1 protein appears to differentially bind IgG in response to 
concentrations of the immunoglobulin in the extracellular milieu (Nordenfelt et al., 2012). The authors of this 
elegant study demonstrated that in the throat, where IgG concentrations in saliva are low, IgG was preferentially 
bound to M1 by the Fc-region. However, in the blood, where there are high concentrations of IgG, binding 
preferentially occurred via. Fab, and were less protective (Figure 1.14). Genotypes belonging to patterns D and E 
produce an M-like protein, denoted Mrp, the C-terminal region of which features two leucine zipper domains, 
thought to mediate binding to immunoglobulins of this class (Hamada et al., 2015; Krebs et al., 1996). 
 
Figure 1.14: Differential, concentration-dependent binding of IgG by M1 
Negatively stained electron micrographs showing differential IgG binding by M1 A). IgG (false-coloured red) binding by 
M1(false-coloured green) in the low-IgG conditions of the throat occurs preferentially by the Fab-domain, and are protective.  
B) In the blood, where IgG (false-coloured red) concentrations are high, M1 (false-coloured green) preferentially sequesters 
IgG by the Fc-domain, in the reverse orientation, reducing protection. Scale bars: 100nm. Image reproduced and adapted 
with permissions from ‘Antibodies at the surface of S. pyogenes isolated from a patient with invasive disease’ in Nordenfelt 





The S. pyogenes cell-envelope protease (SpyCEP) has broad truncating activity against a number of ELR+ 
chemokines, that is, chemokines such as IL-8 which feature a Glu-Leu-Arg motif at their N-terminus (Goldblatt 
et al., 2019). These chemokines are fundamental is promoting neutrophil recruitment, diapedesis and margination 
to the site of infection in tissues (Bachelerie et al., 2014; Zlotnik and Yoshie, 2012). In order for chemokines such 
as IL-8 to elicit the activation of this response, they are sequestered by micromolar affinity by glycosaminoglycans 
at the cell surface of leukocytes, as part of immune surveillance (Bachelerie et al., 2014; Goldblatt et al., 2019; 
Zlotnik and Yoshie, 2012). In S. pyogenes infection, in spite of often overwhelming bacterial burden, there can 
be a remarkable dearth of neutrophils at infectious foci (Edwards et al., 2005; Zinkernagel et al., 2008). This has 
been shown to be mediated by the cleavage of IL-8 and other chemokines by SpyCEP, resulting in a dimerised, 
less potent, and less efficacious molecule that is significantly less able to induce leukocyte recruitment and 
chemotaxis (Edwards et al., 2005; Zinkernagel et al., 2008; Turner et al., 2009; Goldblatt et al., 2019) (Figure 
1.15). Indeed, cleaved IL-8 molecules are thus vastly impaired in their capacity to bind with cognate receptors 
(CXCR1 and CXCR2) on the leukocyte surface, markedly dampening the induction and recruitment of neutrophils 
(Goldblatt et al., 2019). In addition, experimental evidence suggests that truncated IL-8 may be less able to be 
sequestered by the neutrophil glycocalyx, which maintains local concentrations of chemokines in close proximity 
to their cognate receptors (Goldblatt et al., 2019). The corollary of these events in-vivo is a dramatic reduction in 
the capacity for IL-8, and other ELR+ chemokines to signal to neutrophils and promote their migration to the site 
of infection, in many cases, leaving S. pyogenes to proliferate, destroying host tissues and migrating to distal 
anatomical sites, unhindered by these crucial effectors of innate immunity (Edwards et al., 2005; Goldblatt et al., 











Figure 1.15: Neutrophil diapedesis and margination is abrogated by SpyCEP 
A) Neutrophils follow inflammatory signals released by phagocytes and affected tissues in acute inflammation, ‘rolling’ ‘R’ 
along the luminal surface of the blood vessel ‘V’, before traversing the endothelial barrier, entering the tissues ‘L’ and 
travelling to the site of inflammation (not visible). B) S. pyogenes cell envelope protease (SpyCEP) cleaves ELR+ 
chemokines, notably IL-8, markedly reducing the capacity efficiency at which leukocytes 'L’ to travel to infectious foci on 
receipt of these signals, to tackle S. pyogenes at infectious foci ‘C’ and control infection (Edwards et al., 2005; Turner et al., 
2009). Image A: "Margination of neutrophils in acute inflammation.jpg" by Department of Pathology, Calicut Medical 
college is licensed under CC BY-SA 4.0. Image B taken from Edwards et al. 2005. N.b. Images are intended to illustrate a 
comparison, but are unrelated, differentially stained and magnified, and represent different tissues, and conditions. 
 
 C5a peptidase  
Similarly to SpyCEP, the C5a peptidase of S. pyogenes (ScpA) is a highly conserved cell envelope protease that 
reduces the recruitment of neutrophils and other phagocytes to infectious foci (Yinduo et al., 1996; Ji et al., 1997; 
Lynskey et al., 2017). This is achieved by degrading the chemotaxin C5a, and despite its name, C3 and C3a also 
(Cleary et al., 1992; Lynskey et al., 2017). By degrading C3, the downstream antibacterial effectors of this 
cascade, including C5a, are inhibited (Lynskey et al., 2017). In crippling the complement cascade, S. pyogenes is 
able to reduce opsonisation, phagocytosis and clearance and is imbued with an enhanced ability to survive in 
whole human blood, disseminate to distal anatomical sites and persist (Ji et al., 1998, 1997; Lynskey et al., 2017; 
Yinduo et al., 1996). Auxiliary functions of ScpA include promoting bacterial adhesion to epithelial and 
endothelial cells, and surprisingly, there is evidence of a further role in pathogenesis that is independent of either 
C3 or C5, which may or may not be related to the role of this virulence factor as an adhesin (Lynskey et al., 2017). 
  
 Streptococcal inhibitor of complement 
The streptococcal inhibitor of complement (SIC) is a secreted protein that interacts and interferes with the 
complement cascade and formation of the membrane attack complex (Åkessont et al., 1996; Fernie-King et al., 
2001). Subsequent studies have shown that SIC also inhibits the activity of secreted eukaryotic antimicrobial 
molecules, including lysozyme and LL-37 (Fernie-King et al., 2002; Pence et al., 2010). SIC is also rapidly 
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internalised by human cells, wherein it disrupts the cytoskeleton (Hoe et al., 2002). There are in excess of 300 
alleles encoding SIC variants, and these variants have been shown to occur at high frequency during outbreaks, 
possibly due to selective pressures exerted by secreted immunoglobulins at the mucosal surface of the oropharynx 
(Hoe et al., 1999). Indeed, it seems that pharyngeal carriage and passage of emm1 isolates in mice can yield a 
large number of allelic sic variants, though conversely, this level of variation was not observed by passaging the 
same isolate in-vitro (Hoe et al., 1999). SIC variants were similarly not identified in a separate study, passaging 
isolates in a murine model of invasive infection (Stockbauer et al., 1998). Although SIC is best studied in genotype 
emm1 S. pyogenes, it has subsequently been occasionally detected in a number of other emm-types (Ma et al., 
2002). 
 
 Secreted phospholipase 
S. pyogenes isolates carrying a prophage encoding the streptococcal superantigen speK often also carry the 
contiguous gene sla, which encodes a secreted phospholipase A2. This virulence factor is arguably most 
thoroughly studied in emm3, wherein it has been found to strongly promote colonisation and infection the 
pharynges in cynomolgus macaques and mediate adhesion to human epithelial cells in-vitro (Sitkiewicz et al., 
2006). SLA may play a crucial role in the notably invasive phenotype of emm3 infection, contributing to the 
clinical features of STSS, notably leukostasis, endothelial injury and vascular leakage, via. the arachidonic acid 
pathway (Oda et al., 2017). Isogenic sla mutants also exhibit an attenuation of virulence in murine infection 
models, producing smaller infectious foci (Sitkiewicz et al., 2006). 
 
 DNases of S. pyogenes 
Another major mechanism of virulence in S. pyogenes is the production of nucleic acid degrading enzymes, 
DNases. There are presently 8 described DNases, 6 encoded by genes carried on prophage; sda1, sda2, spd1, 
spd3, spd4, sdn and 2 which are encoded by genes within the bacterial chromosome; spdB and spnA (Remmington 
and Turner, 2018). The majority of the DNases in S. pyogenes are secreted enzymes, however spnA is cell wall-
anchored, featuring an LPXTG motif (Hasegawa et al., 2010). At least two DNase genes are produced by all S. 
pyogenes isolates (Remmington and Turner, 2018), inference that these enzymes confer an evolutionary 
advantage. Perhaps the best supported role for DNases in infectious processes is the degradation of NETs 
(Buchanan et al., 2006; Sumby et al., 2005c; Walker et al., 2007), and it is in this capacity that these virulence 
factors are believed to enhance virulence in both vertebrate and invertebrate models (Buchanan et al., 2006; 
Sumby et al., 2005; Hasegawa et al., 2010; Chalmers et al., 2017) (Figure 1.16). DNases also appear to have a 
role in the propagation of infection in the nasopharynx (Al-Shahib et al., 2016; Sumby et al., 2005c). Similarly, 
there is evidence to suggest that these nucleases may serve to dampen host immunity by preventing TLR-9 
signalling and the recognition of unmethylated CpG-rich bacterial DNA by macrophages, degrading it before it 
can be detected (Uchiyama et al., 2012). When one considers the nature of pyogenic streptococcal infections, it 
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is reasonable to surmise that in the midst of an infectious focus, wherein S. pyogenes is likely to be deprived of 
nutrients and possibly facing imminent threat of elimination by host immunity, DNases might present a useful 
escape mechanism – liquefying the extracellular milieu and facilitating escape and spread. Indeed early ex-vivo 
experiments would appear to support this, though recent proteomic analyses on aspirates derived from invasive 
infections caused by multiple emm-types, did not detect any DNases (Sherry, Johnson and Tillett, 1949; Edwards 
et al., 2018). 
 
 
Figure 1.16: Streptococcal DNases promote expedition of bacteria ensnared in NETs 
By producing both cell wall-anchored and secreted DNases, S. pyogenes, and indeed other streptococcal species, are imbued 
with a potent mediator of neutrophil interference, by degrading neutrophil extracellular traps both those deposited in the 
immediate extracellular environment around the bacterium, but also beyond infectious foci by diffusing through the 
extracellular milieu (Remmington and Turner, 2018). Figure created by the author with BioRender.com. 
 
 Streptococcal superantigens 
There are presently 13 described streptococcal superantigens in S. pyogenes, 5 of these are encoded on the 
bacterial chromosome: smeZ, speG, speJ, speQ and speR. The remaining 8 are encoded by genes carried on 
prophage: ssa, speA, speC, speH, speK, speI, speL and speM   (Commons et al., 2014; Reglinski et al., 2019). 
These exist as multiple alleles within and between emm-types and other streptococcal species (Commons et al., 
2014) 
 
At the cellular level, superantigens bypass ordinary epitope processing and presentation, instead binding 
irreversibly to the variable region of the -chain on specific T-cell subsets. This binding triggers massive 
expansion of these subsets, and precipitates the release of large quantities of proinflammatory cytokines. The 
precise role of streptococcal superantigens in infection is debated, but their carriage is presumably advantageous 
to the bacterium in some way given that every isolate tested to date has encodes at least one allele. In experimental 
models of superficial disease, streptococcal superantigens in S. pyogenes have been demonstrated to promote 
nasopharyngeal colonisation (Kasper et al., 2014; Zeppa et al., 2017), reduce immunoglobulin secretion, impair 
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chemotactic responses, and induce B cell lysis (Davies et al., 2019) (Figure 1.17). In systems designed to emulate 
invasive manifestations, it would appear that these toxins mediate many of the clinical features of STSS and 
systemic inflammation (Sriskandan et al., 1996). On a larger scale, streptococcal superantigens have been 
recurrently epidemiologically associated with scarlet fever and streptococcal pharyngitis (Chalker et al., 2017; 
Silva-Costa et al., 2014) and occasionally rheumatic fever (Commons et al., 2014). 
 
 
Figure 1.17: Streptococcal superantigens: selected mechanisms of action 
The precise role of the streptococcal superantigens in the pathogenesis of disease in S. pyogenes is not completely clear. As 
potent stimulators of T-cell subsets, thus promoting copious release of pro-inflammatory cytokines, it is thought that these 
molecules are major mediators of STSS (Commons et al., 2014). Streptococcal superantigens also appear to be able to 
modulate host immunity to their benefit, inducing B-Cell death, T-Cell proliferation, and markedly reducing the release of 
antibodies in the human tonsil (Davies et al., 2019). They may also play a role in colonisation and infection of these tissues 
(Afshar et al., 2017; Brouwer et al., 2020). Figure created by the author with BioRender.com. 
 
1.8 Transcriptional regulation in S. pyogenes 
 Two-component regulatory systems 
To date, 13 two-component regulatory systems (TCS) have been described in S. pyogenes (Kreikemeyer et al., 
2003). As in other bacteria, these are typically a transmembrane sensor histidine kinase, and a cognate cytoplasmic 
DNA-binding response element, which is regulated by phosphorylation. The sensor kinase possesses auto-kinase 
activity, which is enhanced or suppressed in response to environmental stimuli (Jung et al., 2012). 
 
1.8.1.1 CovRS 
The TCS CovRS (control of virulence regulator/sensor kinase) is a cell membrane-associated histidine kinase 
comprised of two proteins; the membrane bound sensor kinase CovS and the cytoplasmic response regulator 
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CovR. To exert control over its regulatory targets, CovS undergoes autophosphorylation at its cytoplasmic 
domain, promoting the subsequent phosphorylation of CovR, thereby increasing its affinity for specific binding 
sites within the promoters of target gene (Horstmann et al., 2018). These targets are many, and it is thought that 
CovRS regulates approximately 15% of the S. pyogenes genome, mostly acting to repress target genes (Graham 
et al., 2002). A large number of these regulatory targets play pivotal roles in virulence and infection, among these 
are the cysteine protease SpeB, the HA capsule biosynthesis operon, SIC, NADase and co-transcribed streptolysin 
O, SpeA, the DNases spd3 and sda, SpyCEP and C5a peptidase (Federle, McIver and Scott, 1999; Graham et al., 
2002; Sumby et al., 2006; Turner et al., 2009). Indeed, there is evidence for the longitudinal coordination of the 
CovRS regulome throughout pharyngeal infection (Virtaneva et al., 2005).  
 
A number of factors have been shown to signal through CovRS, notably extracellular magnesium, and the human 
antimicrobial peptide LL-37 (Figure 1.18), although at concentrations below those required to exert antibacterial 
activity, and apparently independent of this (Gryllos et al., 2008, 2007). Virulence modulating homologues of 
CovRS are found in many other pathogenic streptococci of clinical and veterinary significance, including S. 
agalactiae, S. dysgalactiae sbsp. equisimilis and S. suis, although in the latter, covR is not accompanied by a 
cognate sensor kinase, and is an orphan regulator (Jiang et al., 2008; Pan et al., 2009). A homologous system is 
present in S. equi sbsp. zooepidemicus, though its phenotypic influence remains as yet unexplored (Velineni and 
Timoney, 2015). In S. pyogenes, CovRS itself is negatively regulated by the orphan regulator RocA (Biswas and 
Scott, 2003; Lynskey et al., 2019b).  
 
Mutations in this regulator are thought to arise during invasive infection, possibly due to pressure from host 
immunity, and are detected in as many as 40% of invasive S. pyogenes isolates (Ikebe et al., 2010; Li et al., 2014; 
Shea et al., 2011; Walker et al., 2007). Because of the sheer breadth of genes regulated by CovRS, and variations 
thereof between emm-types, it is challenging to make general assessments on the overall impact of loss of function 
mutations in covR and/or covS. Most sources agree, however, that CovRS mutants exhibit increased virulence, 
and are associated with increased mortality and morbidity in humans (Cole et al., 2006; Sumby et al., 2006; 





Figure 1.18: Transcriptional regulation by CovRS 
CovRS comprises two components, CovS, the sensor kinase, and CovR, the response regulator. CovRS regulates ~15% of 
the S. pyogenes genome, and is largely repressive in its influence. This is achieved by phosphorylation of the cytoplasmic 
effacing domain of CovS, which in turn, promotes the phosphorylation of CovR. CovS is receptive to signalling by host-
derived factors, such as LL-37 and extracellular magnesium (Gryllos et al., 2008). The phosphorylation of CovR enhances 
the affinity for CovR and binding sites within the streptococcal genome, which include a large number of virulence factors, 
such as speB, cepA and speA (Sumby et al., 2006; Turner et al., 2009), and in encapsulated isolates, the HA capsule, giving 
encapsulated isolates a glossy, mucoid appearance (Gryllos et al., 2008). Figure created by the author with BioRender.com 
 
1.8.1.2 Ihk/Irr 
In the context of virulence and pathogenesis, evidence suggests that Ihk/Irr (isp adjacent histidine kinase/isp 
adjacent response regulator) is involved in the transcriptional response by S. pyogenes following phagocytosis by 
macrophages and neutrophils, and resistance to killing therein (Hertzén et al., 2012; Voyich et al., 2004, 2003). 
In support of these observations, this TCS has been found to regulate a number of genes pertaining to resistance 
to ROS and neutrophil-associated antimicrobial peptides in addition to genes involved in  cell wall biogenesis 
(Voyich et al., 2004). Well characterised, specific virulence factors in the Ihk/Irr regulome are surprisingly few, 
but include the DNases spd3 and spdB, the haemolysin SLS and fbp (fibronectin binding protein), as revealed by 
global transcription studies (Voyich et al., 2004). Orthologues of Ihk/Irr are found in S. suis and have similarly 
been implicated in resistance to killing by macrophages and enhanced survival in environments with low pH and 
abundant oxidative stressors in-vitro (Han et al., 2012). 
1.8.1.3 FasBCAX 
Evidence suggests that the fibronectin/fibrinogen-binding/haemolytic activity/streptokinase (fas) operon mediates 
in S. pyogenes the transition from colonisation and adhesion stages of infection, to those of dissemination and 
spread. The system comprises four genes, encoding a putative response regulator, two predicted sensor kinases, 
and a small regulatory RNA (sRNA) effector molecule, denoted fasA, fasB, fasC, and fasX, respectively 
(Kreikemeyer et al., 2001; Miller et al., 2014). The hypothesis that the fasBCAX operon promotes the two 
opposing phenotypes of colonisation and dissemination is largely born of the relationship of the regulator with 
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adhesins such as Prtf1 and Prtf2 (Danger et al., 2015b), and minor collagen-binding minor pilus protein, Cpa (Liu 
et al., 2012), while at the same time regulating the expression of the well-studied spreading factor, streptokinase 
(Ramirez-Peña et al., 2010). Indeed, fasX is able to bind to mRNAs and prevent translation and protein expression, 
as is the case for Cpa, and this is achieved by obstructing access for ribosomes at ribosomal binding sites on the 
transcript (Liu et al., 2012). FasX may also bind to streptokinase mRNAs to promote stability, thereby increasing 
transcript abundance and promoting a ~10-fold increase in the production of this virulence factor (Ramirez-Peña 
et al., 2010). The regulatory influence of this operon extends to a number of virulence genes, may be growth-
phase dependent (Kreikemeyer et al., 2001), and as is the case with other regulatory networks in S. pyogenes, 
appears to exhibit variability between isolates and genotypes (Danger et al., 2015a; Perez et al., 2009). 
 
 Standalone Transcriptional Regulators 
1.8.2.1 Rgg/RopB 
Rgg, also known as RopB (regulator of protease B) has been shown to modulate various processes in S. pyogenes. 
The regulation of speB by Rgg is well demonstrated, and it is required for expression of this toxin (Olsen et al., 
2012). As such, a number of lines of investigation have demonstrated a central role in virulence and disease 
association, notably pharyngitis (Carroll et al., 2011; Olsen et al., 2012). Other virulence genes that are directly 
or indirectly regulated by Rgg include the secreted DNases spdB and spd3 and the gene encoding NADase, nga 
(Anbalagan and Chaussee, 2013; Dmitriev et al., 2006). Additional work is indicative of a role in metabolism 
also, specifically the metabolism of carbon sources in some emm-types (Dmitriev et al., 2006). 
 
1.8.2.2 Mga 
The Mga (multi-gene regulator of GAS) regulon includes approximately 10% of the S. pyogenes genome, and 
includes the regulators RofA and Rgg/RopB. In sensing carbohydrates and other sugars in the extracellular milieu, 
Mga plays a critical role in regulating the expression of a number of virulence factors, modulating phenotypes 
that promote survival in soft tissues and human blood, in addition to the formation of biofilms (Cho and Caparon, 
2005; Graham et al., 2005). Other signals reportedly include temperature, environmental gases, salinity and iron 
levels (Hondorp and McIver, 2007; McIver et al., 1995; Podbielski et al., 1992). Because of the sensitivity of 
Mga to a multitude of signals, it has been proposed that Mga allows S. pyogenes to respond to its extracellular 
environment and new niches, adjusting to a transcriptional profile that is optimal for survival (Cho and Caparon, 
2005; Graham et al., 2005; Musser and DeLeo, 2005). With such a strong association with such a large portion of 
the genome, including other regulators, it is perhaps unsurprising that multiple lines of investigation have 
associated Mga mutants with attenuated virulence (Kihlberg et al., 1995; Terao et al., 2001). Longitudinal 
transcriptome studies of pharyngeal infection in cynomolgus macaques found Mga activity to be at its greatest 
when symptoms were most severe (Virtaneva et al., 2005). Mga may exert its influence through responding to the 
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abundance of sugars by phosphorylating conserved histidine residues in target sequences, similarly to other 
carbohydrate activated virulence regulators in other bacterial pathogens, notably the AtxA virulence regulator, an 
Mga homologue in Bacillus anthracis (Hondorp and McIver, 2007). 
 
1.8.2.3 RofA and RofA-like protein type regulators 
RofA and RofA-like protein type regulators (RALPs) constitute a family of four stand-alone transcriptional 
regulators, RofA, Nra, RALP-3 and RALP-4 (Granok et al., 2000). RofA has multiple functions, including sensing 
oxidative stressors and environmental gases, mostly acting as a positive regulator of target genes (Fogg and 
Caparon, 1997). Mutations in rofA have been linked to increased toxin production, including SLS, M-protein and 
SpeA in some emm-types (Beckert et al., 2001; Lynskey et al., 2019a). RofA mutants have also been shown to 
exhibit reduced adherence to- and invasion of human epithelial cells, possibly due to modulations in the 
production of toxins and adhesins, including emm and hasB (Beckert et al., 2001). A homologue of rofA, denoted 
nra, exhibits ~60% DNA sequence similarity to rofA and also has regulatory function, though conversely, largely 
as a negative influencer (Podbielski et al., 1999). A survey of over 100 isolates detected either rofA or nra in all 
strains, and similarly to RofA, Nra similarly regulates a number of genes involved in adhesion and virulence, 
including those that are also regulated by RofA, including speA, speB and the mga regulon (Luo et al., 2008). 
Both regulators are thought to regulate the biosynthesis of pilus, and the inactivation of nra is associated with 
attenuated virulence (Lizano et al., 2008; Luo et al., 2008). 
 
1.9 Mobile genetic elements & S. pyogenes: impact on host phenotype 
As the prophage complement within a given emm-type is fairly conserved, it is perhaps not surprising that their 
loss and/or gain can lead to striking phenotypic changes as well as changes to the circulating bacterial population 
and sometimes devastating epidemiological shifts. Particularly with the application of WGS, the population 
biology of S. pyogenes is being scrutinised with increasing resolution, and a number of studies have successfully 
identified the emergence of nascent successful lineages and have demonstrated relationships between these events 
and epidemiological surveillance data. Often in S. pyogenes, such events are catalysed by changes in prophage 
complement and therefore the constellation of phage-encoded virulence factors in a given emm-type or successful 
clone (Beres et al., 2006; Davies et al., 2015; Al-Shahib et al., 2016; Afshar et al., 2017; Brouwer et al., 2020).  
 
 Enhanced toxin expression at the host-pathogen interface 
Multiple lines of scientific enquiry have demonstrated that prophage-encoded DNases and superantigens are 
expressed in-vivo (Kazmi et al., 2001; Sriskandan et al., 1999; Virtaneva et al., 2005) and on co-culture with 
human pharyngeal cells (Broudy, Pancholi and Fischetti, 2001, 2002; Banks, Lei and Musser, 2003) models of 
infection, and an appealing hypothesis is that these virulence factors contribute to increased fitness of the host 
bacterium. The streptococcal superantigen SpeA has been shown to dysregulate the function of tonsillar immunity, 
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specifically driving a proliferative T-cell phenotype, triggering B-cell apoptosis, and abrogating the release of 
IgA, IgM and IgG. Taken together,  the data suggest that expression of SpeA may confer a survival advantage to 
superantigen expressing bacteria at the host-pathogen interface (Davies et al., 2019). 
 
 Enhanced nasopharyngeal shedding 
A nationwide increase in invasive disease in the United Kingdom was attributed to the emergence of a novel 
lineage within the emm3 S. pyogenes population (Al-Shahib et al., 2016). Following genomic analyses, it was 
established that the acquisition of an additional speC-spd1 encoding prophage, ΦUK-M3.1, and the simultaneous 
loss of two canonical emm3 prophage, the non-toxigenic Φ315.1, and the ssa-encoding prophage, Φ315.2, had 
occurred among isolates belonging to the emergent lineage. Isolates belonging to the emergent lineage were 
characterised by significantly greater DNase activity, in addition to prolonged infection and enhanced 
nasopharyngeal shedding in a murine model of disease (Al-Shahib et al., 2016) (Figure 1.19).  Interestingly, a 
similar emm3 variant had emerged twice previously in North America, and was also associated with transient 
increases in invasive disease (Beres et al., 2004). There also appears to be a role for synergy between prophage-
associated toxins, specifically Spd1 and SpeC, in promoting nasopharyngeal infection by genotype emm12 
isolates, and a reliance on host-derived factors for their activation and potentiation (Brouwer et al., 2020). 
 
 
Figure 1.19: Enhanced nasopharyngeal infection associated with epidemic emm3 lineage 
A sudden upsurge in invasive S. pyogenes infections in the United Kingdom in 2008/2009 was associated with an emergent 
lineage of emm3, denoted Lineage C. Lineage C emm3 had lost two of the canonical emm3 prophage, including one carrying 
ssa, but had gained a new prophage carrying speC/spd1 (Al-Shahib et al., 2016). The lineage, though no more virulent than 
ancestral strains, Lineage C was found to be associated with enhanced nasopharyngeal infection and airborne shedding in 
murine models. This was attributed to the acquisition of the novel prophage, specifically, the DNase, Spd1 (Afshar et al., 
2017). Figure created by the author with BioRender.com. 
 
 Clonal expansion and extinction 
Modulations to the complement of mobile genetic elements present in the genome of the S. pyogenes can lead to 
striking changes to bacterial population dynamics. Acquisition of the speA-encoding prophage Φ315.5 in emm3 
S. pyogenes was shown to be associated with clonal expansion, whereas isolates lacking this prophage were more 
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likely to undergo clonal extinction (Beres et al., 2004). A possible explanation for the increased fitness of these 
isolates is that genotype emm3 isolates that are positive for speA have been associated with recurrent episodes of 
pharyngitis, and might therefore be more likely to persist in a population (Musser et al., 1992). In Hong Kong and 
mainland China, an ongoing nationwide upsurge in scarlet fever has been attributed to multiple distinct lineages 
of genotype emm12 S. pyogenes expressing high levels of the streptococcal superantigen SSA (Walker, 2015). A 
significant association between scarlet fever cases and isolates carrying two copies of ssa on two separate 
prophages, ΦHKU.vir (speC, spd1 and ssa) and ΦHKU.ssa (ssa alone) was found, in addition to macrolide 
resistance genes, also affiliated with mobile genetic elements. In the United Kingdom, the dramatic resurgence of 
scarlet fever in recent years was attributed to a novel M1T1 variant expressing high levels of the prophage-
encoded superantigen SpeA (Lynskey et al., 2019a). Genome sequencing has also demonstrated that acquiring 
novel allelic variants of specific prophage-encoded virulence factors can also favour the emergence of successful 
lineages with a significantly different phenotype to parental isolates (Banks et al., 2002; Barnett et al., 2019; 
Wilkening and Federle, 2017). 
 
 Remodelling of the bacterial chromosome 
Not all prophage and prophage-like elements encode genes with an immediately obvious role in virulence. In fact, 
a number of these elements either integrate at sites which result in pronounced changes to the genome and 
phenotype of the host bacterium. In genotype emm3, large-scale genomic inversions have been reported, mediated 
in part by homologous recombination between prophage genes, yielding not only novel variants of prophage by 
virulence factor translocation, but large scale rearrangements of the bacterial chromosome (Nakagawa et al., 
2003). Although this report is not complimented by epidemiological analyses, it was hypothesised that the 
resultant emm3 variant was associated with a coincident resurgence in rheumatic fever and invasive infections in 
Japan occurring from the 1990’s onwards. Later work in North America found no association between this variant 
and any infection type, but demonstrated that the generation of either genomic conformation occurs frequently 
throughout growth in-vitro (Beres et al., 2004).  
 
 Regulation of gene expression at attachment sites 
The SpyCI of S. pyogenes are reported to regulate the expression of the DNA MMR operon, through a dynamic 
process of integration and excision. During exponential growth, SpyCI is in its excised state, permitting the 
transcription of the MMR operon by a common promoter upstream of mutS. During stationary phase, the element 
is more stably integrated, blocking transcription of genes downstream of mutS, and promoting a more mutable 
phenotype (Nguyen and McShan, 2014; Scott et al., 2012) (Figure 1.20).  In subsequent work, isolates cured of 
this element not only were unable to attain the mutator phenotype, but were found to have significant 
transcriptional modulations to a large number of genes, including increased expression of many pertaining to 
virulence, notably emm, nga, slo and the capsule biosynthesis operon  (Hendrickson et al., 2015).  Whether these 
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changes would be observed following natural loss of the element in-vivo is unclear. Further investigation also 
illuminated a mechanism by which these chromosomal islands can rescue aberrant and irreversible induction of a 
mutator phenotype in the event of their decay. In an emm5 isolate in which the integrase of the SpyCIM5 element 
is a pseudogene preventing excision and integration from the bacterial chromosome, it was hypothesised that the 
isolate would exhibit a persistent mutator phenotype. However, this was found not to be the case and closer 
scrutiny revealed that in fact, the integrase ORF serves as an alternative cryptic promoter for this operon, enabling 
the transcription of mutL and other MMR genes, despite their permanent separation from the native promoter 
(Scott et al., 2012). Prophage that do not appear to carry any virulence genes can also be found integrated into the 
CRISPR loci of emm3 isolates, which may impact the expression of these genes (Beres et al., 2002). Presumably, 
this confers some advantage to the bacterium, as although this has at times been lost by epidemic emm3 lineages, 
these have not persisted and this appears to be a transient, less stable phenomenon (Al-Shahib et al., 2016; Stephen 
B. Beres et al., 2004). 
 
 
Figure 1.20: SpyCI mediated regulation of gene expression in S. pyogenes 
The growth-phase dependent regulation of the DNA MMR operon in an SF370 emm1 isolate was attributed to the mobility 
of the S. pyogenes chromosomal island SpyCIM1. SpyCIM4, ordinarily integrated within the operon between mutS and mutL, 
was excised during exponential growth, and the operon transcribed. During stationary phase, the element was stably 
integrated and did not excise, separating genes downstream of mutL from the native promoter, and blocking transcription. 
This was shown to promote a more mutable phenotype, ostensibly to overcome challenges, such as overcrowding, or nutrient 
deprivation, by increasing the frequency at which successful escape mutants might emerge (Nguyen and McShan, 2014; Scott 
et al., 2008). Figure created by the author with BioRender.com. 
 
 Enhanced adhesion and colonisation 
In a humanised murine model of nasopharyngeal infection, it was demonstrated that the prophage-encoded 
streptococcal superantigen speA was essential for colonisation with a genotype emm18 isolate (Kasper et al., 
2014), providing additional insight into the benefit of carrying these elements. Additional insight into the role of 
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superantigens in the propagation of infection is provided by a separate study by the same authors, which 
demonstrates that superantigens are instrumental in the manipulation of specific T cells to promote colonisation 
in S. pyogenes, using SpeA and heterologous expression of staphylococcal enterotoxin B as a paradigm (Zeppa et 
al., 2017). Very recent work suggests that among emm12 isolates, SpeC and Spd1, which are invariably 
contiguous on the same prophage, may act in synergy to bolster nasopharyngeal infection in mice (Brouwer et al., 
2020). These findings echo earlier, similar reports on the possible importance of speC/spd1-associated prophage 
and nasopharyngeal infection that was observed among an epidemic emm3 lineage, as aforementioned (Afshar et 
al., 2017). The streptococcal adhesin AspA, encoded by a gene present on the ICE RD2 appears to plays a major 
role in adhesion and the propagation of upper respiratory tract infection (Franklin et al., 2013). Isogenic aspA 
mutants are significantly less able to adhere to epithelial cells in-vitro, and more prone to clearance from the upper 
respiratory tract of mice. It was also shown that AspA potentiates resistance to phagocytosis by macrophages. 
 
 Enhanced virulence 
It has been suggested that the resurgence of S. pyogenes infections globally, coupled with the observation that the 
bacterium appeared to be gaining virulent potential, might be explicable by the acquisition of speA by emm1 and 
emm3 genotypes, among others (Marshall and Kelch, 1986). The RD2 encoded Spy1336/R28 has been implicated 
in increased virulence. Remarkably, a single nucleotide insertion in the intergenic region between R28 and an 
upstream transcriptional regulator Spy1337 was found to significantly enhance the binding of the regulator to the 
intergenic homopolymeric nucleotide tract and subsequently increase the expression of not only R28, but a number 
of other chromosomally-encoded virulence factors (Kachroo et al., 2019). Isolates with this single nucleotide 
insertion were significantly more virulent in a murine model of necrotising myositis, and were more resistant to 
killing by human PMN leukocytes (Kachroo et al., 2019) (Figure 1.21). The insertion and enhanced virulence 
were not associated with any specific population or location, however, suggesting that possibly, this phenotype 
was not overtly associated with overall enhanced fitness. Given the association between emm28, the female 
genitourinary tract and puerperal sepsis, perhaps a less virulent, more transmission and colonisation oriented 
phenotype is favourable (Luca-Harari et al., 2009). Yet more recently, and indeed conversely, a transposon mutant 
library of emm28 S. pyogenes screening genes that contributed to fitness during the first 24-hours of colonisation 
in a cynomolgus macaque model, did not identify any RD2 associated genes (Zhu et al., 2020). This might be due 
to the timeframe of sampling (only genes contributing at 24 hours), perhaps issues with recapitulation between 
models (notably mice, cell culture and macaques), or due to heterogeneity within the inoculum wherein wild type 






Figure 1.21: Enhanced virulence associated with the insertion of a single nucleotide 
The insertion of a single nucleotide within intergenic sequence between R28 and an upstream transcriptional regulator was 
associated with a dramatic enhancement in the virulent potential of emm28 isolates. Transcriptional changes extended far 
beyond the mobile genetic element, RD2, to a number of chromosomal genes, including well-studied virulence factors such 
as streptokinase. This was attributed to enhanced binding of the transcriptional regulator Spy1337 to the intergenic sequence 
(Kachroo et al., 2019). Figure created by the author with BioRender.com. 
 
1.10 Conclusions and research justifications 
S. pyogenes is a protean, and highly dynamic human pathogen, with a seemingly boundless capacity for complex 
interplay with host immunity through the expression of a vast armamentarium of virulence factors, evoking a 
similarly broad spectrum of clinical manifestations (Carapetis et al., 2005). Unusually, S. pyogenes is not 
prominent in concerning trends of antimicrobial resistance like a number of other clinically significant Gram-
positive bacterial agents such as Staphylococcus aureus, Enterococcus spp., and S. pneumoniae (Cattoir, 2015). 
Unlike these microorganisms however, the epidemiology of S. pyogenes in recent years has been tempestuous, 
particularly in the United Kingdom and the far east, which have seen the dramatic resurgence of scarlet fever and 
antecedent increases in invasive disease (Afshar et al., 2017; Al-Shahib et al., 2016; Banks et al., 2002; Ben 
Zakour et al., 2015; Chalker et al., 2017; Efstratiou and Lamagni, 2016; Lynskey et al., 2019a; Tse et al., 2012; 
Walker, 2015). These events are being retrospectively delineated with increasing resolution by the application of 
WGS, providing a fascinating but worrisome insight into this highly adaptable and often unpredictable pathogen, 
the behaviour of which appears to be inextricably linked to the acquisition, loss and regulation of mobile genetic 
elements, which certainly deserve further study. 
 
 Hypotheses 
Genome analyses of S. pyogenes isolates submitted to the British Society for Antimicrobial Chemotherapy from 
multiple sites across England and Wales was recently undertaken by this laboratory (Turner et al., 2019b). The 
genotype emm4 isolates in this collection were found to cluster with either of the two completed reference 
genomes, MGAS10750 (Beres and Musser, 2007) and MEW427 (Jacoba et al., 2016), forming two small lineages 
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(Remmington et al. 2020) in corroboration with a recent description (DebRoy et al., 2018). Gubbins SNP analysis 
revealed four areas of putative recombination within regions encoding four mobile genetic elements in those 
isolates clustering with MEW427. These included the prophage Φ427.1/10750.1, Φ427.2/10750.2 and 
Φ427.3/10750.3, encoding speC/spd1, spd3 and ssa, respectively, and the integrative and conjugative element 
SpyCI, also known as Φ10750.4. The ability of prophage to excise and thus elicit a gene dosing effect may play 
an important role in the expression of cognate virulence factors in S. pyogenes (Banks et al., 2016; Broudy et al., 
2002, 2001) and other bacteria (Balasubramanian et al., 2019). Φ10750.4 has been shown to regulate the 
expression of the DNA MMR operon in a number of emm-types (Scott et al., 2012). This is achieved a manner 
that is growth-phase dependent, regulated by the dynamic integration and excision of the element from the 
bacterial chromosome (Hendrickson et al., 2015; Nguyen and McShan, 2014; Scott et al., 2012). It was therefore 
hypothesised that these elements may be unable to excise from the chromosome in some genotype emm4 isolates, 
but not others, and thus investigating the molecular biology of these isolates might serve as a valuable paradigm 
for understanding the regulation and expression of prophage-encoded virulence factors in S. pyogenes and the 
impact on bacterial phenotype. 
 
 Project aims 
 To characterise the specific prophage genes and modules that have been subject to deletion or loss in 
MEW427-like isolates relative to MGAS10750-like isolates 
 To establish whether the excision potential of prophage elements in MEW427-like isolates was different 
to those in MGAS10750-like isolates 
 To establish when the prophage-encoded virulence factors are expressed 
 To determine whether or not the expression of cognate bacterial factors encoded by the prophage of 
genotype emm4 is subject to a gene dosing effect 
 To characterise the lineages in our emm4 collection and determine any potential phenotypic impact of 
prophage gene loss on these isolates 
 To investigate whether environmental stimuli are able to induce the differential expression of prophage-











2. Materials and Methods 
2.1 Materials 
 S. pyogenes isolates 
British Society for Antimicrobial Chemotherapy (BSAC) isolates were collected by the society’s Bacteraemia 
Resistance Surveillance Program, from multiple hospitals across England, between 2001 and 2011 (Turner et al., 
2019b). The programme collected 344 isolates in total, of which emm4 (n=10) comprised ~2.9% and all were 
included in the present work. A smaller sample (n=5) of emm3 and emm12 and a single emm6 were also selected 
from the collection. Genotype emm89 H293 was isolated in 1995 by the Central Public Health Laboratory 
(Colindale, UK) (Sriskandan et al., 2000), is well-characterised (Lamb et al., 2018a; Reglinski et al., 2015; 
Sriskandan et al., 2000; Turner et al., 2009; Turner et al., 2012; Unnikrishnan et al., 2002), and has been WGS to 
completion, revealing no integrated prophage (Turner et al., 2015). Genotype emm1 H305 is an M1T1 scarlet 
fever isolate collected in the 1880s, and is also robustly characterised, including for superantigenicity (Lamb et 
al., 2018; Sriskandan et al., 2001, 1999; Turner et al., 2009; Unnikrishnan et al., 1999). 
 
 





Region Date isolated 
BSAC_bs192a 
 
4 4 Sheffield 2001 
BSAC_bs400a 
 
4 4 Manchester 2002 
BSAC_bs468a 
 
4 4 Southampton 2002 
BSAC_bs472a 
 
4 4 London 2002 
BSAC_bs696a 
 
4 4 London 2003 
BSAC_bs916a 
 
4 4 Manchester 2004 
BSAC_bs105a 
 
4 4 Birmingham 2005 
BSAC_bs134a 
 







  emm-type* Subtype† Region Date isolated 
BSAC_bs138a 
 
4 4 Newcastle 2006 
BSAC_bs180a 
 
4 4 Birmingham 2008 
BSAC_bs25b 
 
3 3.2 Kent 2001 
BSAC_bs515b 
 
3 3.2 Kent 2003 
BSAC_bs821b 
 
3 3.1 Cambridge 2004 
BSAC_bs975b 
 
3 3.17 Truro 2004 
BSAC_bs181b 
 
3 3.1 Bristol 2008 
















12 12 Chester 2008 
BSAC_bs230b 
 
12 12 Bristol 2010 
BSAC_bs2438d 
 
6 6.5 Southampton 2010 
H293c 
 
89 89 London 1995 
H305d 1 1 London 1880s 
     
* Isolates were genotyped using emm gene sequences derived from de novo assembled sequence data, per CDC guidelines (Turner et al., 
2019b). Genotypes were designated based on the DNA sequence encoding the hypervariable N-terminal region of M protein, which in turn 
determines serospecificity, with a submission query match of >90 bp to determine emm-genotype. † emm-subtypes were assigned according 
to 100% sequence similarity of the 180 bp subtype-encoding sequence of emm for each isolate, which includes the signal sequence and a 
portion of the mature protein, per CDC guidelines. 
a 




 Used in chapters 4 and 6,
d
 used in Chapter 5. 
 
 
 Bacteriological growth media 
 Columbia Horse Blood agar (Oxoid, Basingstoke, UK or VWR)  
 Todd-Hewitt Broth (THB) (Oxoid, Basingstoke, UK) 
 Todd-Hewitt Agar (THA)  
– THB 2% (w/v) bacteriological agar (Oxoid) 
 Luria Bertani Broth (Oxoid) 
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 Luria Bertani Agar (LBA) 
– LB 2% (w/v) bacteriological agar 
 Antibiotics 
 Ampicillin (Sigma) 
 Penicillin/streptomycin (Sigma) 
 
 Human cell lines 
Immortalised human tonsillar keratinocytes (E6/E7-HTE) (Ximbio, London), were isolated from routine bilateral 
tonsillectomy specimens, had been immortalised by transfection with retroviral vectors encoding Human 
papillomavirus type 16  oncogenes E6 and E7, previously (Grayson et al., 2018; Spanos et al., 2008) and kindly 
provided by  Professor Craig Murdoch, University of Sheffield. A459s are an immortalised human pneumocyte 
cell line, that have been widely applied to infection work with S. pyogenes (LaPenta et al., 1994; Lieber et al., 
1976; Lynskey et al., 2017). 
 
 Human cell culture media and supplements 
 Cell culture PBS (Gibco, Fisher Scientific) 
 Ham’s F12 Nutrient Mixture (Gibco, Fisher Scientific) 
 Dulbecco’s Modified Eagle’s Medium (DMEM) (Gibco, Fisher Scientific) 
 RPMI (Gibco, Fisher Scientific) 
 Foetal calf serum (FCS) (Gibco, Fisher Scientific) 
 Adenine (Sigma)  
 Human recombinant insulin (Sigma) 
 3, 3, 5- Tri-iodothyronine (Sigma) 
 Apo-transferrin (Sigma) 
 Epidermal growth factor (Sigma) 
 Modified Green’s (adenine- and flavin-enriched) Media 
– DMEM 66% (v/v) 
– Ham’s F12 21.6% (v/v) 
– FCS 10% (v/v) 
– Adenine 0.025g/mL 
– Human recombinant insulin (Sigma) 5g/mL 
– 3, 3, 5- Tri-iodothyronine (Sigma) 
– Apo-transferrin (Sigma) 1.36ng/mL/5g/mL 




 Turbo DNA-free DNase (Ambion, Cambridgeshire, UK) 
 Transcriptor reverse transcriptase (Roche Applied Science, Burgess Hill, UK) 
 SYBR Green Jumpstart™ Taq Readymix™ (Sigma) 
 OneTaq Quick-Load 2X Master mix (New England Biolabs) 
 Phusion® High-Fidelity DNA Polymerase (New England Biolabs)  
 Mutanolysin (Sigma) 
 Lysozyme (Sigma) 
 Proteinase K (Sigma) 
 T4 DNA Ligase (New England Biolabs) 
 Restriction enzymes (New England Biolabs): BamHI 
 1X Trypsin-EDTA solution (Insight Biotechnology) 
 
 Standard solutions and buffers 
 Phosphate buffered saline (PBS) 
– 137 mM NaCl 
– 2.7 mM KCl 
– 10 mM Na2HPO4 
– 2 mM KH2PO4 
 
 Tris-acetate buffer (TAE) 50X 
– 2 M Tris (w/v) 
– 57.1 mL/L Glacial acetic acid (w/v) 
– 50 mM EDTA (w/v) dissolved at pH 8 
 
 SET Buffer 
– 75 mM NaCl 
– 25 mM EDTA 
– 20 mM Tris pH 7.5  
 
 Sodium acetate pH 5.5 buffer 
– 0.1% (v/v) Sodium dodecyl sulphate (SDS) 
– 30 mM Na-Acetate pH 5.5 
 
 DNA loading buffer 
– 0.25% (w/v) bromophenol blue (Sigma) 
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– 0.25% (w/v) xylene cyanole (Sigma) 
– 30% (v/v) glycerol (AnalR) 
 Kits 
 Monarch® DNA Gel Extraction Kit (New England Biolabs) 
– Gel dissolving buffer 
– DNA wash buffer 
– DNA elution buffer 
– DNA clean-up columns 
 
 Monarch® PCR DNA Clean Up Kit (New England Biolabs) 
– DNA clean up binding buffer 
– DNA wash buffer 
– Elution Buffer 
 
 Monarch® DNA Plasmid Miniprep Kit (New England Biolabs) 
– Plasmid resuspension buffer 
– Plasmid lysis buffer 
– Plasmid neutralisation buffer 
– Plasmid wash buffer 1 
– Plasmid wash buffer 2 
– DNA elution buffer 
 pCR2.1 TA cloning kit (Invitrogen) 
– Linearised pCR®2.1 (25 ng/L in 10mM Tris-HCl, 1mM EDTA, pH 8) 
– ExpressLink T4 DNA Ligase (5.0 Weiss units/L) 
– 5X ExpressLink T4 DNA Ligase Buffer (50 mM Tris-HCl, pH 7.6 , 50 mM MgCl2, 5 mM ATP, 
5 mM dithiothreitol, 25 % (w/v) polyethylene glycol-8000) 
– 10X PCR Buffer (100 mM Tris-HCl, pH 8.3 (at 42C), 500 mM KCl, 25 mM MgCl2, 0.01% 
(w/v) gelatine) 
– 50 mM dNTP’s (12.5 mM, dATP, dCTP, dGTP and dTTP, pH 8). 
– DNA template control 0.1g/L (10 mM Tris-HCl, 1 mM EDTA, pH 8 
– Control PCR Primers each at 0.1 g/L (10 mM Tris-HCl, 1 mM EDTA, pH 8) 
– SOC medium (2% tryptone (w/v), 0.5% (w/v) yeast extract, 10 mM NaCl, 2.5 mM KCl, 10 mM) 





 5-bromo-2’-deoxyuridine (BrdU) ELISA (Colourimetric) (Roche) 
– BrdU Labelling Reagent (1000X) 
– FixDenat (Ready-to-Use) 
– Anti-BrdU-peroxidase antibody 
– Antibody Dilution Solution (Ready-to-Use) 
– Washing Buffer (10X PBS) 
– Substrate Solution TMB (Ready-to-Use) 
 Miscellaneous reagents 
 Aqueous phenol (Sigma) 
 Phenol:chloroform:isoamyl alcohol (25:24:1)  (Sigma) 
 X-Gal (5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside) (Bioline) 
 RNaseIn RNase Inhibitor (Sigma) 
 All primers were supplied by Sigma (Dorset, UK) 






Table 2.2: Primers used in this study 
Primer Sequence (5’-3’) Function 
10750.1 A 
 






















































CTTGAAGCGGGGTCATATTC  mutS transcript detection 








CCAGTCAAACGACGCAAACG Construction of qPCR.1 (Salim et al., 2005) 
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GCACCATAGAAATCAAATTGAAG Construction of qPCR.1 
SSAR 
 
ATATAGCCTGTCTCGTACGGAG Construction of qPCR.1 
SPD3Fa 
 
GGCGATCTTGACAATCTGC Construction of qPCR.1 
SPD3R 
 
AATTATGCCAGCCAGGAGG Construction of qPCR.1 
SPECF 
 
CATAGATGTACTCACCGGTGTG Construction of qPCR.2 
SPD1R 
 
TCATGGGTAATGAATCGTGG Construction of qPCR.2 
gyrA-RT_F 
 
AGCGAGACAGATGTCATTGCTCAG qPCR (Salim et al., 2005) 
gyrA-RT_R 
 

















M13_R CAGGAAACAGCTATGACC pCR2.1 sequencing 
 
a modified from original sequence(s) following Sanger sequencing of completed plasmid 
 
2.2 Methods 
 Bacterial strains and media 
All S. pyogenes isolates were stored in suspension with THB + 20-30% (v/v) glycerol at -80°C.  Frozen stocks 
were recovered by inoculation of CBA plates (Oxoid, Basingstoke, UK) to achieve individual colonies, and 
incubated overnight at 37°C in an atmosphere supplemented with 5% (v/v) CO2 throughout the project. For 
standard liquid culture, sweep inocula (2-3 colonies) were propagated statically in THB (Oxoid) overnight, unless 
otherwise stated. 
 
E. coli stocks were maintained in suspension in LB +20-30% (v/v) glycerol and 50μg/mL ampicillin, frozen at -
80°C. Stocks were recovered by inoculation of LB agar plates supplemented with 50 μg/mL ampicillin and 
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incubation at 37°C, under aerobic conditions. For liquid culture, LB broth (50 μg/mL ampicillin) was inoculated 
and incubated at 37°C under aerobic conditions, with shaking at 200-220 rpm. 
 
 S. pyogenes DNA extraction 
S. pyogenes DNA extraction was performed using the method of Pospiech and Neumann (Pospiech and Neumann, 
1995). Bacterial suspensions were pelleted by centrifugation at 2,000 x g for 10 minutes and the supernatant 
discarded. The bacterial pellet was resuspended in 1 mL sterile PBS with 20 U/mL mutanolysin (Sigma) and 200 
μg/mL lysozyme (Sigma) and incubated at 37°C for 10 minutes. The suspension was then centrifuged at 200 x g 
for 10 minutes, the supernatant discarded and the pellet resuspended in 500 μL SET buffer (5 mM NaCl, 25 mM 
EDTA, 20 mM Tris pH 7.5) with 1% (v/v) SDS and 0.5 mg/mL proteinase K (Sigma). The suspension was then 
incubated with occasional mixing at 55oC for two hours. After incubation, 1/3 volume of 5 M NaCl and 1 volume 
of chloroform was then added and the suspension incubated at room temperature for 30 minutes. The suspension 
was then centrifuged for 16,000 x g for 15 minutes, and the aqueous phase was transferred to a fresh tube, and the 
DNA precipitated by the addition of 1 volume of isopropanol. The DNA pellet was recovered by centrifugation 
at 16,000 x g for 5 minutes, and washed with 70% (v/v) ethanol before being allowed to dry and subsequent 
resuspension in 20-200 μL molecular grade water (Honeywell). DNA was quantified and quality measured by 
nano drop. 
 
 S. pyogenes RNA Extraction 
S. pyogenes were collected by centrifugation at 2000 x g for 10 minutes, and lysed in 500 L sodium acetate 
buffer (0.1% (v/v) SDS, 30 mM Na-Acetate pH 5.5) and 500 L hot acidic aqueous phenol (Sigma) at 65C for 
10 minutes with occasional mixing. The suspension was centrifuged again at maximum speed for 10 minutes. The 
aqueous phase was subsequently aspirated and transferred to a fresh tube containing 500 L 
phenol:chloroform:isoamyl alcohol (25:24:1) (Sigma). After centrifugation for a further 5 minutes at maximum 
speed, the aqueous phase was aspirated and transferred to a fresh tube containing 500 L isopropanol and 500 L 
3M sodium acetate buffer pH 7 and stored at -20C overnight to precipitate RNA. The following morning, to 
complete RNA precipitation, tubes were centrifuged at 16,000 x g for 30 minutes at 4C, before being washed in 
freshly prepared, pre-chilled (-20C) 80% (v/v) ethanol. Finally, once dry, RNA pellets were resuspended in 50 
l of MGW and stored at -80C. The concentration and quality of the RNA was measured by nanodrop prior to 
use. 
 
 PCR and agarose gel electrophoresis 
Phusion® High-Fidelity DNA Polymerase (New England Biolabs) was used for all standard (non-real time) PCR. 
Primers were reconstituted with molecular grade water to 100 M and stored at - 20oC, and used at a final of 10 
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M, unless otherwise stated. Reaction mixtures were gently vortexed to mix constituents, and briefly pulse-
centrifuged to concentrate reaction mixtures. For PCR reactions without incorporated loading dye, DNA loading 
buffer (0.25% (w/v) bromophenol blue (Sigma), 0.25% (w/v) xylene cyanole (Sigma), 30% (v/v) glycerol (AnalR) 
was added before loading onto 0.5-2% (w/v) agarose gels stained with SYBR Safe (Sigma) and underwent 
electrophoresis in agarose gels in TAE at 120V for ~30 minutes. Gels were visualised by UV transillumination. 
DNA ladder 1kb plus (Invitrogen) was used to infer product size. Extension and annealing times and temperatures 
were modified as appropriate for each reaction. 
 
 Detection of prophage excision by PCR 
To detect prophage and SpyCI excision, four primers were designed using a method adapted from Aziz et al. 
(Aziz et al., 2005). These were designed to detect each emm4 prophage or SpyCIM4 in its integrated and extra-
chromosomal state. Primer combination A and B and combination C and D flanked the attachment sites at each 
end of the prophage-encoding region, where the viral genome and the bacterial chromosome meet, such that 
amplification by these primer combinations could only occur if the element was integrated. Combining primers 
B and C, the prophage was detectable in its excised state, amplifying across a junction of viral DNA unified by 
re-circularisation. Excision was confirmed by amplification with primer pair A and D, which amplified across the 
attachment site in the bacterial chromosome, but was only able to do so if the attachment site was unoccupied by 
prophage (Figure 2.1). 
 
Figure 2.1: Schematic of prophage conformation PCR 
Primer combination A (white arrow) and B (green arrow), and combination C (yellow arrow) and D (blue arrow) amplify 
across the junction at which the bacterial chromosome (pink) and the prophage genome (purple) meet when the prophage is 
integrated, attR and attL, respectively. Prophage absence, or excision of the prophage from the bacterial chromosome, and 
thus the vacation of the attachment site, permits amplification with primers A and D. The circularised, extra-chromosomal 
conformation of the excised prophage (purple circle) is detectable by amplification with primers B and C across attP, the 




 Purification of PCR products 
The Monarch PCR and DNA Clean-up Kit (New England Biolabs) was used to purify and concentrate all PCR 
and ligation products, per manufacturers guidelines. All centrifugation steps were carried out at 16,000 x g. PCR 
amplicon was mixed with DNA Binding Buffer at a ratio of 2:1 or 5:1, dependent on product size. Binding 
Buffer/PCR reaction mixtures were transferred to spin columns and centrifuged for 1 minute, before discarding 
flow-through, and transferring the column to a collection tube. Columns were washed twice with 200L DNA 
Wash Buffer, and flow-through discarded. DNA was eluted in 20-200L molecular grade water into a clean tube 
by centrifugation. Eluents were quantitated by nano drop and stored at -20C, unless otherwise stated. 
 
 Purification of DNA following electrophoresis 
PCR products were excised from the agarose gel under UV transillumination from 0.9% (w/v) agarose gels, using 
a clean razor blade, and purified using the Monarch DNA Gel Extraction Kit (New England Biolabs). Excised 
slices were dissolved in 4 volumes Gel Dissolving Buffer per 1 volume agarose, and incubating at 50C for 5-10 
minutes, with occasional vortex. The mixture was transferred to a binding column, which had been inserted into 
a collection tube, and bound by centrifugation for 1 minute at 16,000 x g, with flow-through discarded. The 
column was washed twice with 200 L DNA Wash Buffer, spinning for 1 minute at 16,000 x g following each 
wash, and discarding subsequent flow-through. Washed columns were transferred to clean 1.5 mL tubes and DNA 
eluted in 10-20 L molecular grade water after incubating at room temperature for 1 minute. Eluents were 
quantitated by nano drop and stored at -20C, unless elsewise described.  
 
 Plasmid purification 
Overnight 5 mL cultures of TOP10 E. coli carrying the desired plasmid were harvested by centrifugation, 
supernatants discarded and pellets resuspended in 200 L Plasmid Resuspension Buffer, and thoroughly 
emulsified by pipetting. 200 L Plasmid Lysis Buffer was added to the suspension, which was mixed by inversion 
at room temperature for ~1 minute. Lysis was stopped by addition of 400 L Plasmid Neutralisation Buffer, and 
for 2 minutes, again gently mixed by inversion until colour change and precipitation were observed. Lysate was 
centrifuged for 5 minutes at 16,000 x g, with this centrifugal force applied to all subsequent spins. Supernatant 
was aspirated, transferred to a binding column inserted into a collection tube, and spun for 1 minute, flow-through 
was discarded. The column was then subject to two washing steps, once with 200 L Wash Buffer 1 followed by 
a 1-minute spin, and then a second, using Wash Buffer 2 at a volume of 400 L, and centrifugation for 1 minute. 
Columns were transferred to clean 1.5 mL tubes and DNA eluted in 30-50 L molecular grade water. Eluents 
were quantitated by nano drop and stored at -20C prior to use. 
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 Construction of plasmids for quantitative real-time PCR 
A qPCR method to accurately detect and measure the copy number of RNA transcripts or target genes was 
developed previously and has since been adapted and applied to both S. pyogenes and Staphylococcus aureus 
(Subramenium et al., 2015; Lynskey et al., 2019a, 2013; Sharma et al., 2019; Turner et al., 2009).  These method 
uses a plasmid constructed to contain concatenated regions of each target gene. The copy number of this plasmid 
can be determined and serial dilutions provide a standard curve against which copies of corresponding target 
genes in samples can be measured. 
 
To measure copies of the housekeeping gene gyrA, and target prophage genes ssa and spd3, primers were designed 
to amplify 100-220bp regions of each Beginning with ssa and gyrA, followed by subsequent genes, fragments 
were amplified with Phusion® High-Fidelity DNA Polymerase (New England Biolabs) to produce blunt-ended 
templates, purified with Monarch® PCR purification Kit (New England Biolabs). These were subject to overnight 
blunt-end ligation with T4 ligase (New England Biolabs) at 14C. Primers gyrA-F and ssa-R primers were then 
used to amplify from the ligation reaction a fragment comprising one copy of gyrA and one copy of ssa ligated 
together, and purified from the agarose electrophoresis gel using the Monarch® DNA Gel Extraction Kit (New 
England Biolabs). To the gyrA-ssa fragment, spd3 was ligated, and the process repeated until all three genes were 
successfully ligated. An additional three DNase genes were also ligated to this fragment (sdn, spd4 and spdB) but 
were ultimately not used due to a change in direction of the project (Figure 2.2). The completed fragment was 
subjected to PCR with OneTaq Quick-Load 2X Master mix (New England Biolabs) to achieve fresh TA-
overhangs,purified using the Monarch® PCR purification Kit (New England Biolabsand ligated into pCR2.1 using 
the TA Cloning Kit (Invitrogen), to yield a plasmid hereafter referred to as qPCR.1. This plasmid was then used 
to transform TOP10 E. coli (Invitrogen)by heat-shock, following manufacturers guidelines. 
 
LB agar plates supplemented with 50 μg/mL ampicillin and spread with X-Gal (Sigma) were used to select for 
transformants, identifiable as white colonies. 5 mL aliquots of LB broth supplemented with 50 μg/mL ampicillin 
were inoculated with individual putative transformants using a sterile pipette tip, and incubated overnight. Plasmid 
DNA was extracted from pelleted cultures the following morning using the Monarch® DNA Plasmid Miniprep 
Kit (New England Biolabs). External Sanger sequencing (Eurofins Scientific) confirmed successful 
transformation of TOP10 E. coli with qPCR.1. Two of the original primers were subsequently modified to 
accommodate unintentional sequence variations in the insert, introduced during the cloning process; SPD3, and 
SSAF, to yield spd3-RT_F, and ssa-RT_F, respectively. A plasmid carrying speC and spd1 was already available, 
qPCR.2, and this was used to detect transcription of these genes. The copy number of both plasmids was calculated 
using the size of the plasmid and the concentration of purified DNA. Finally, qPCR.1 and qPCR.2 were linearised 
using BamHI (New England Biolabs), and diluted to 2 x 108, respectively, in coliphage lambda DNA (Sigma), 




Figure 2.2: Schematic of the plasmids constructed for qPCR quantification 
Simplified schematic representation of plasmids constructed to quantify qPCR data. Each contains a single copy of a fragment 
corresponding to an emm4 gene of interest; gyrA, ssa and spd3 cloned into qPCR.1; and speC and spd1 cloned into qPCR.2. 
Additional genes were cloned in to qPCR.1 prior to a change in project focus from genotype emm3 S. pyogenes (dotted 
square). 
 qPCR primer matrices 
Primer matrices for qPCR primers designed to amplify each target gene were conducted to determine optimal 
primer concentrations for qPCR, to achieve a standard with an R2=1, a low negative control, and PCR efficiencies 
for each run that were within ≤5% of one another, to permit precise comparisons of each gene across separate 
experiments and replicates. This was accomplished using serial dilutions of the qPCR.1 and qPCR.2, and 
subjecting these to qPCR with reactions containing alternating combinations of forward qPCR primer, diluted 1:5, 
1:10 and 1:20, paired with a corresponding dilution of a reverse qPCR primer. Consequently, amplification of the 
plasmid standards with reactions containing each possible combination of forward and reverse primers for each 
target gene, to identify the most suitable combinations for all qPCR primers. 
 
 Reverse transcription and quantitative real-time PCR 
RNA samples were DNase treated with Turbo DNA-free (Ambion) for 30 minutes at 37C to remove genomic 
DNA. Concentration and quality of RNA was determined by nanodrop, and between 1-5 g was converted to 
cDNA by reverse transcription with Transcriptor reverse transcriptase (Roche Applied Science). The reaction was 
then heated to 65C with 4 L of 10 M random hexaoligos (Sigma), before transferring immediately to ice. 
Following the addition of 8L RT Buffer, 0.5L reverse transcriptase, 4L 10mM dNTPs and 0.5L RNAseIn 
(RNAse inhibitor, Sigma), reverse transcription proceeded at 25C for 10 minutes, 55C for 30 minutes and 85C 
for 5 minutes. After reverse transcription, molecular grade H2O was added to achieve a final concentration of 40 
ng/ μL of cDNA. Corresponding reverse transcription negative reactions, without reverse transcriptase and 
RNaseIn (RNase Inhibitor, Sigma Aldrich), were prepared in parallel to each sample in order to confirm the 
79 
 
absence of genomic DNA contamination following DNase treatment. DNA was also standardised to 40 ng/μL for 
qPCR to detect gene copies, where indicated. 
SYBR Green Jumpstart Taq Readymix (Sigma) was used for all qPCR, with 200ng cDNA template per reaction, 
measured in triplicate. Forward and reverse real-time qPCR primers were diluted appropriately (either 1:10 or 
1:20) from 100 M stocks and added to a master mix of 12.5 L SYBR Green Jumpstart Taq Readymix (Sigma), 
7 L MgCl2, 10 L molecular grade water.  For each run, serial dilutions of the appropriate plasmid (2 x108 to 2 
x 101 copies per reaction) were included to generate a standard, to which values were normalised and subsequently 
expressed as either target gene copies, or target transcript copies, per 10,000 copies of gyrA, with cycling 
parameters specific to each target gene(s) (Figure 2.3). Each reaction was measured in triplicate. 
 
Figure 2.3: Target gene qPCR cycling parameters 
qPCR cycling parameters for quantitation of transcript and gene copies A) Cycling parameters to quantitate speC and gyrA 
transcript/gene copies, which have identical parameters B) Cycling parameters for the quantitation of spd3 transcript/gene 




  Maintenance of human cell lines 
All cell culture media was prepared in batches of 500 mL and stored at 4C for up to 1 month to maintain cells 
prior to infection experiments. Human tonsil epithelial cells were sustained using Green’s flavin and adenine rich 
media (Allen-Hoffmann and Rheinwald, 1984; Grayson et al., 2018) (recipe provided in materials section 2.1.5). 
The standard preparation of Green’s Media was modified by the exclusion of penicillin/streptomycin, 
amphotericin B, hydrocortisone, and cholera toxin, as prior work with Green’s Media in this laboratory, and a 
collaborating laboratory previously found these constituents to be either unnecessary or deleterious to the 
applications described here. With these modifications, HTE cells grew well, without visible cytopathic effect 
across multiple experiments. A549 cells were sustained using RPMI +10% (v/v) FCS without antibiotics, as has 























3. Bioinformatic characterisation of emm4 isolates 
3.1 Introduction 
Although emm4 isolates (n=10) constitute just 2.9% of the BSAC bacteraemia collection (n=344), genotype emm4 
S. pyogenes are a major disease causing emm-type in high income countries globally (Efstratiou and Lamagni, 
2016), occasionally even superseding the consistently dominant emm1 genotype (Kim et al., 2019; Whitehead et 
al., 2011). This emm-type is genetically acapsular (Flores et al., 2012), and a frequent cause of both invasive and 
non-invasive clinical manifestations, though associations between emm4, scarlet fever and paediatric infection 
have been reported (Flores et al., 2019; Galloway-Peña et al., 2016; Jaggi et al., 2005; Kim et al., 2019; Silva-
Costa et al., 2014; Turner et al., 2016; Whitehead et al., 2011). Based on two completed emm4 reference genome 
sequences, MGAS10750 and MEW427, emm4 isolates are lysogenised by three prophages; a prophage encoding 
the superantigen speC and the DNase spd1, a second prophage encoding an additional DNase, spd3, and a third 
prophage encoding a further streptococcal superantigen, ssa, referred to therein and hereafter as 
Φ10750.1/Φ427.1, Φ10750.2/Φ427.2 and Φ10750.3/Φ427.3, respectively (Beres and Musser, 2007; Jacoba et al., 
2016). These prophage are also found in clinical emm4 isolates globally (Athey et al., 2016, 2014; Beres and 
Musser, 2007; Chalker et al., 2017; Chochua et al., 2017; Jacoba et al., 2016; Kapatai et al., 2017; Turner et al., 
2019b, 2017, 2016). An S. pyogenes chromosomal island (SpyCI) is also common in emm4, typically integrated 
into the DNA MMR operon (Nguyen and McShan, 2014), and appears to regulate the expression of adjacent genes 
through a dynamic growth-phase dependent pattern of integration and excision in some genotypes (Hendrickson 
et al., 2015; Nguyen and McShan, 2014; Scott et al., 2012). 
Recent WGS of a longitudinal sample of S. pyogenes bloodstream isolates in the United Kingdom was undertaken 
in collaboration with the BSAC and included ten emm4 isolates (Turner et al., 2019b). Gubbins analysis indicated 
multiple SNP clusters in those isolates clustering with reference genome MEW427, indicative of possible regions 
of recombination. The majority of the remaining five isolates in this small collection clustered with reference 
genome MGAS10750, and did not exhibit SNP clustering. Four of the six SNP clusters were located within each 




Figure 3.1. Putative regions of recombination within MEW427-like BSAC isolates 
Whole genome sequence data for BSAC emm4 isolates (n=10) were mapped to completed reference genome strains 
MGAS10750 and MEW427. Gubbins analysis indicated putative regions of recombination in half (n=5) of these isolates, 
which clustered with MEW427. These regions were not identified in isolates clustering with MGAS10750 (n=4) and 
BSAC_bs468. The regions of predicted recombination were within the three prophage and a SpyCI element typical of the 
genotype, denoted here as 10750.1, 10750.2, 10750.3, and SpyCIM4 (10750.4), respectively. Blue lines indicate SNP 
clustering specific to a single isolate, red lines indicate SNP clustering present in multiple isolates. Two additional clusters 
of SNPs are visible in isolates associated with MEW427 and correspond to emm and spy0485, a putative microcin immunity 
factor. The phylogenetic tree (left) was generated from 556 polymorphic sites following the exclusion of putative recombinant 
regions. The scale bar adjacent to the phylogenetic tree represents the number of SNPs, whereas the scalebar below the boxed 
region (right) indicates genomic position, relative to completed reference genome MGAS10750. Figure taken from 
Remmington et al. 2020. 
 
3.2 Chapter aims and hypotheses 
The aims of this Chapter were to investigate the bioinformatic features of the genotype emm4 isolates within the 
BSAC collection, in particular, with a view to establish characteristics that set those emm4 isolates clustering with 
reference genome MEW427 from those clustering with MGAS10750. The BSAC emm4 were also characterised 
using de novo assembled WGS data to inform and aid in the interpretation of phenotypic work using these isolates 
in subsequent chapters. It was hypothesised that putative SNP clustering within prophage-encoding regions might 
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indicate regions of recombination within isolates clustering with MEW427, though additional lineage-specific 
features were expected, as the phylogenetic tree (Figure 3.1) is drawn based on core SNPs, excluding putative 
regions of recombination. Isolate specific genetic features were also examined. 
 
3.3 Methods 
 Genomic comparison of reference genomes 
Publicly available completed emm4 whole genome reference sequences for MGAS10750 (Beres and Musser, 
2007) and MEW427 (Jacoba et al., 2016) were compared using the Artemis Comparison Tool (ACT) release 
18.0.3 (Rutherford et al., 2000). 
 
 Bioinformatic comparison of prophage-encoding regions 
De novo assemblies for BSAC emm4 isolates was performed previously using Velvet (Turner et al., 2019b) and 
was repeated with SPAdes (Bankevich et al., 2012) to clarify prophage regions. The DNA sequences from all 
annotated coding regions for all three prophage and SpyCIM4 were extracted from MGAS10750 and were used to 
BLAST de novo assemblies to determine gene presence or absence. Genes with >98% identity over 100% length 
were classified as present. Amino acid sequences for each gene were subject to BLAST to determine putative 
function, and these were categorised as either integrase, replication, regulation, structural (encompassing capsid, 
neck, and tail fibre genes), hyaluronidase, infection (holin/lysin), and superantigen/DNase, and uncharacterised 
(hypothetical proteins). 
 
 Variable factor typing of BSAC emm4 isolates 
Sequences were obtained for the 13 superantigen (ssa, speA, speC, speG, speH, speI, speJ, speK, speL, speM, 
speQ, speR and smeZ) and 8 DNase genes (spnA, spdB, sda1, sda2, spd1 spd3, spd4 and sdn) found in S. pyogenes, 
from publicly available WGS data. The presence or absence of these genes in the BSAC emm4 isolates was 
determined by BLAST analysis against the de novo assemblies. 
 
 Lineage specific SNPs 
Reads from de novo assembled WGS data constructed using Velvet and SPAdes obtained for each BSAC emm4 
isolate were mapped to completed emm4 reference genome MGAS10750 using SMALT, and SNPs were 




 Pangenome analysis 
De novo assembled WGS data were annotated using Prokka (Seemann, 2014), and the pangenome was estimated 
using Roary (Sitto and Battistuzzi, 2020). This data was generated by the project supervisor, Dr. Claire E. Turner, 
but analysed by the author to identify gene presence and absence, and also to provide possible evidence of phage 




 Gene loss within prophage-encoding regions of reference genome MEW427 
Gubbins analysis had indicated putative areas of recombination within prophage-encoding regions of emm4 
isolates clustering with the reference genome MEW427 (Jacoba et al., 2016), but not those clustering with 
reference genome MGAS10750 (Beres et al., 2006). The completed reference genomes were therefore compared, 
revealing that putative recombinant sequences were in fact regions of gene loss within prophage- and SpyCI-
encoding regions (Figure 3.2). The large (~49kb) erythromycin resistance-associated ICE 10750-RD.2 present in 









Figure 3.2: Comparison of emm4 reference genomes MGAS10750 and MEW427 
Completed emm4 reference genomes MGAS10750 (top sequence) and MEW427 (bottom sequence) were compared in ACT. 
This comparison revealed regions within MGAS10750 that were absent in MEW427. On closer examination, these regions 
were determined to be mobile genetic element-encoding sequences. Specifically, regions of the speC/spd1-, spd3- and ssa-
encoding prophage of MGAS10750, denoted Φ10750.1, Φ10750.2 and Φ10750.3, respectively. Portions of these were absent 
in the corresponding elements of MEW427, Φ427.1, Φ427.2, and Φ427.3, respectively. Further, the emm4 SpyCI of 
MGAS10750 was also found to contain a region comprising multiple genes that was not present in the corresponding SpyCI 
of MEW427. The approximate location of each mobile genetic element within emm4 reference genome MGAS10750 are 
indicated with black arrows. 10750-RD.2 is a large (~49kb) integrative and conjugative element associated with the 
erythromycin resistance gene ermA present in MGAS10750 but absent from MEW427 (Beres and Musser, 2007). 
 
 Bioinformatic features of MGAS10750 and MEW427 prophage 
BLAST analysis of the three prophage-encoding regions of MGAS10750 and MEW427 revealed a typically 
lambdoid genomic arrangement, with discrete modules dedicated to specific functions. Relative to the prophage 
of MGAS10750, those derived from MEW427 had smaller genomes, with variable loss of structural genes and 
site-specific integrase genes across the three phage, but consistent absence of replicative and regulatory modules. 
Intriguingly, prophage-associated virulence genes, speC and the contiguous spd1, spd3, and ssa, were not lost, 
and were present at full-length associated with Φ10750.1/Φ427.1, Φ10750.2/Φ427.2 and Φ10750.3/Φ427.3, 
respectively (Figure 3.3). The speC/spd1-associated Φ10750.1 was observed to have undergone the most dramatic 
reduction in size, reducing in size from 63 genes/43,457bp at full length, to just 16 genes/13,487bp in Φ427.1, a 
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loss of ~78% of its original gene content (Figure 3.3A). The spd3-associated prophage Φ10750.2 comprised 59 
genes/37,606bp at full-length, but having lost ~50% of its genes, in Φ427.2, consisted of 29 genes or 20,018bp 
(Figure 3.3B). The ssa prophage, Φ427.3, exhibited the least gene loss, with a ~26% reduction in genome size, 
reducing from 53 genes (or 35,302bp) at full-length, to 35 genes (or 26,301bp) relative to Φ10750.3 (Figure 3.3C). 
 
 
Figure 3.3: Comparison of gene content between MGAS10750 and MEW427 prophage  
The three prophage encoding regions of reference genomes MGAS10750 and were compared, revealing gene loss in the 
prophage of MEW427, relative to those of MGAS10750, which were full-length. Recurrently, genetic modules pertaining to 
regulatory and replicative functions were lost. A) The canonical speC/spd1 emm4 prophage 10750.1 (top) comprises 63 
genes, while the corresponding element in MEW427 (bottom) carries just 16, having lost ~78% of its gene content. B) The 
spd3-associated emm4 prophage of 10750.2 (top) contained 59 genes, whereas the corresponding MEW427, 427.2, 
contained 29, having lost ~50% gene content. C) The ssa-associated prophage 10750.3 of MGAS10750 (top) was observed 
to have lost ~26% of its genetic content, decreasing in size from 53 genes to 35 in the corresponding region derived from 
completed reference genome MEW427, 427.3. Scale bars indicate DNA sequence similarity between coding sequences. 
Gene function was determined by BLAST analysis of amino acid sequence and placed into eight categories based on predicted 
function: integrase (navy), regulatory (pale blue), replication (purple), structural (yellow), infection (grey), hyaluronidase 
(green) and superantigen/DNase (red). Image taken from Remmington et al., 2020.  
 
 Superantigen and DNase typing of BSAC emm4 isolates 
To determine how similar the BSAC emm4 isolates might be to the reference genomes, first BLAST analysis was 
used against the de novo assemblies to confirm the presence of the variable superantigen and DNase genes (Figure 
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3.4). All ten BSAC emm4 carried prophage-associated superantigen genes speC and ssa, and the chromosomally-
encoded smeZ. Although the speC allele was identical among all ten BSAC emm4, these isolates carried a slightly 
different allele to MGAS10750, owing to a missense mutation of C:A at 13bp, translating to the replacement of 
histidine to aspartic acid, at 5 aa. The ssa and smeZ alleles of the BSAC emm4 were 100% identical to those of 
MGAS10750. Isolate BSAC_bs192 carried an additional prophage-associated superantigen speK. All BSAC 
emm4 were positive for the prophage-associated DNases spd1 and spd3. BSAC_bs1802 also carried an additional 
prophage-associated DNase, sdn. Chromosomally-encoded spdB and spnA were detected in all isolates, and 
exhibited 100% DNA sequence similarity between the BSAC emm4 and MGAS10750. 
 
 
Figure 3.4 Variable factors present in BSAC emm4 isolates 
Superantigen and DNase typing of BSAC emm4 isolates revealed a variable factor complement consistent with that of 
completed emm4 reference genomes MGAS10750 and MEW427. All isolates were positive for speC, spd3, ssa and smeZ. 
BSAC_bs192 uniquely carried speK/sla-. and BSAC_bs1802, carried the DNase sdn. 
 
 Bioinformatic features of BSAC emm4 prophage 
To establish the prophage content associated with the variable factors of the BSAC emm4 isolates, DNA sequences 
were extracted from annotated coding regions of the three canonical emm4 prophage present in MGAS10750, 
Φ10750.1, Φ10750.2, Φ10750.3. SpyCIM4 was extracted along with the flanking mutL and mutS, and gene content 
determined identically. These were used to BLAST de novo assemblies for the BSAC emm4 isolates, using a cut 
off of ≥99% sequence similarity over 100% length.  
 
Five BSAC emm4 isolates, BSAC_bs468, BSAC_bs916, BSAC_bs1052, BSAC_bs1349, BSAC_bs1388, were 
lysogenised by three prophages that appeared to be as complete or near-complete (92-100% gene presence) as 





















































MEW427 and carried the same predicted recombination (BSAC_bs192, BSAC_bs400, BSAC_bs472 and 
BSAC_bs696), were found to carry prophage that exhibited marked gene loss across all three elements (21-66% 
gene presence across Φ427.1, Φ427.2, and Φ427.3). Patterns of gene loss within these isolates was highly similar 
to that observed in the prophage of MEW427, and predominantly related to loss of functional modules dedicated 
to prophage replication, genetic regulation, lysogeny and to a lesser and more variable extent, structural and tail 
fibre genes. Isolates clustering with MGAS10750, without prophage degradation, were thus denoted M4complete, 
and those clustering with MEW427 and exhibiting gene loss were denoted M4degraded. 
 
3.4.4.1 Loss of functional prophage-encoded integrases in M4degraded isolates 
Integrase genes of both Φ10750.1 and Φ427.1, denoted therein spy0560 and 02750, respectively, were identical, 
and were identified in the corresponding prophage of all BSAC emm4 isolates. However, relative to the 1,140bp 
integrase gene of Φ10750.2, spy0831, the corresponding gene in Φ427.2, 03820, was lacking the first 264bp of 
the gene, including the start codon. Identical deletion events were observed in the Φ427.2 elements of all 
M4degraded, relative to M4complete BSAC emm4, in which this gene was full-length, as it is in MGAS10750. While 
Φ10750.3 carried a full-length 1,143bp integrase gene, spy1328, the Φ427.3 integrase, 05920, comprised just 
547bp, lacking the initial 546bp, including the start codon. The same deletion was found in all M4degraded. 
 
3.4.4.2 Loss of prophage regulatory modules in M4degraded isolates 
Regulatory genes were identified as those predicted to influence gene expression, including, where present, genes 
that maintain lysogeny or promote induction, but not those that are associated with the replication process. 
Φ10750.1 carries four identifiable putative regulatory genes, spy0562, spy0565, spy0569 and spy0571, however, 
these are entirely absent in Φ427.1 of MEW427, and all M4degraded BSAC emm4. Φ10750.2 carries four genes with 
putative regulatory function, which were absent in Φ427.2 of MEW427 and MEW427-like isolates. Only two 
genes could be assigned putative regulatory function in Φ10750.3; spy1326 and spy1327. These were not present 
in Φ427.3 of MEW427 or BSAC emm4. The Φ10750.3/Φ427.3 element of BSAC_bs1802, which is only partially 
degraded, carries both spy1326 and spy1327. 
 
3.4.4.3 Loss of prophage replicative modules in M4degraded isolates 
Genes with putative replicative function, was defined as those predicted to be involved in the replication of the 
prophage genome, and those encoding proteins that facilitate packaging of DNA into nascent capsids.  Φ427.1 
did not carry any full-length genes to which a putative replicative function could be ascribed. One gene from this 
module, which included 3 classifiable genes, spy0575, spy0577 and spy0578, was partially present in Φ427.1. 
This gene, 0275, appeared to be the product of the truncation of spy0575. 
Φ10750.2 carried a five-gene module with putative replicative function, comprising spy0843-spy0847. All were 
absent in Φ427.2, and MEW427-like BSAC emm4 including BSAC_bs1802. Φ10750.3 encoded five genes with 
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putative replicative function, spy1327, spy1323, spy1321, spy1320, spy1317. Of these, only spy1321 is present in 
Φ427.3, wherein it shares 100% DNA sequence similarity with spy1321 over the full length. This was not detected 
in the majority of M4degraded BSAC emm4, however, one M4degraded isolate, BSAC_bs696, retained spy1317. 
Unusual MEW427-like isolate BSAC_bs1802, which carries a near full-length Φ10750.3/Φ427.3, lacked only 
one gene from the putative replicative module, spy1321. 
 
3.4.4.4 Variable structural gene loss across all three emm4 prophage 
Thirteen genes carried by Φ10750.1 were classified as having a possible structural function, encoding proteins 
dedicated to the assembly of phage particles, including major and minor capsid proteins, tail fibre, head, neck, 
head and neck joining, and portal proteins. All of these were detected in Φ10750.1 of the M4complete BSAC emm4 
but were either absent or had been subject to deletion or possible splicing in MEW427 and M4degraded BSAC emm4. 
Φ427.1 of MEW427 carried an annotated 1,968bp gene denoted 02270 which had arisen from the fusion of regions 
corresponding to spy0609, spy0612 and spy0614 of Φ10750.1, wherein they are predicted to encode tail fibre 
genes. Φ10750.2 carried eleven genes predicted to encode structural proteins, spy0860, spy0861, spy0864, 
spy0865, spy0869-spy0871 and spy0874-spy0877, all found in M4complete. Only two were lost in Φ427.2 of 
MEW427 and M4degraded, spy0860 and spy0861, encoding a phage terminase and portal protein, respectively. 
Putative tail protein encoding gene spy0874 in Φ10750.2 was also partially deleted in Φ427.2 with the loss of the 
first 229 aa/1800bp of the gene. Seven genes encoding proteins with predicted structural function were identified 
in Φ10750.3 and these were all present in Φ427.3 prophage of MEW427 and M4degraded. 
 
3.4.4.5 Unusual prophage of BSAC_bs1802 
BLAST and pangenome analyses of BSAC_bs1802 indicated that speC/spd1 may be carried on a different phage 
than Φ10750.1/Φ427.1. Although the exact composition of this prophage could not be determined from the de 
novo assembly as it was divided over multiple contigs, subsequent long-read sequencing confirmed that the 
prophage was most closely related to emm87 prophage Φ743.4 (Athey et al., 2016), hereafter Φ1802.1 
(Remmington et al., 2020). The 3’ regions of Φ1802.1 and Φ743.4 integrase genes are highly similar to that of 
Φ10750.1/ Φ427.1. The spd3- and ssa-associated prophage of BSAC_bs1802 were similar to corresponding 









Figure 3.5: Bioinformatic comparison of prophage-encoding regions for emm4 isolates 
Gene presence and absence across the three canonical prophage of emm4 S. pyogenes. Genes are represented by coloured 
arrows in reference genomes MGAS10750 and MEW427, and coloured lines in BSAC isolates.  A) Φ10750.1 B) Φ10750.2 
C) Φ10750.3 were present at full-length in MGAS10750 and M4complete isolates BSAC_bs468, BSAC_bs916, BSAC_bs1052, 
BSAC_bs1349 and BSAC_bs1388. Similar corresponding prophage were detected in MEW427; A) Φ427.1 B) Φ427.2 C) 
Φ427.3, however these were found to have undergone marked gene loss across all three elements. Near identical degraded 
prophage were identified in the majority of M4degraded isolates; BSAC_bs192, BSAC_bs400, BSAC_bs472 and BSAC_bs696. 
A greater number of prophage-associated genes were detected in BSAC_bs1802 compared to the other M4degraded, and the 
speC/spd1-encoding prophage of this M4degraded isolate (Φ1802.1) (indicated with grey box) was dissimilar to 
Φ10750.1/Φ427.1, with some DNA sequence homology, but assembled with genes that were not detected in MGAS10750 
or MEW427. Φ10750.1 gene spy0619 was split into two separate genes in MEW427 and the BSAC isolates, but not 
MGAS10750. Locus numbers are indicated above and below reference genome sequences in 5 gene increments for MEW427. 
Annotated genes present in reference sequences but not BSAC emm4 sequences are indicated with an asterisk. Amino acid 
sequences for CDS were subject to BLAST and assigned COG classifications and colour codes per figure key. BSAC isolate 




 Bioinformatic features of MGAS10750 and MEW427 SpyCI 
In addition to typically harbouring three prophage, emm4 S. pyogenes are also host to a SpyCI, usually 
integrated within the DNA MMR operon (Scott et al., 2012), hereafter SpyCIM4. SpyCIM4 was compared for 
MGAS10750 and MEW427, revealing gene loss within the MEW427 variant ( 
Figure 3.6). A number of SpyCIM4 genes could not be classified by BLAST, and this element does not encode 
any known bacterial virulence factors. There was, however, a notable absence of genes with putative replicative 
function in MEW427 SpyCIM4 compared to MGAS10750.  
 
Figure 3.6.: Comparison of gene content between SpyCIM4 of MGAS10750 and MEW427 
SpyCI-encoding regions derived from completed emm4 reference genomes MGAS10750 (top) and MEW427 (bottom) were 
compared, revealing gene loss, largely restricted to genes with replicative function (purple). Integrase genes and genes 
dedicated to regulation (pale blue) were unaffected. The holin/lysin of the MGAS10750 variant was not present in the 
MEW427 variant. A number of unclassifiable genes were also absent in the MEW427 variant, when compared to 
MGAS10750. Shaded grey bar indicates sequence similarity. 
 
3.4.5.1 Gene loss within M4degraded SpyCIM4 
As was observed in MEW427 a large region in the centre of SpyCIM4 of the M4complete isolates had been lost in 
the corresponding element of M4degraded (Figure 3.7). This included predominantly genes of unknown function, 
but also a holin/lysin, spy1916, and four genes to which putative replicative function were assigned; two putative 
DNA primases, spy1909, and spy1910, and an ATPase-encoding gene, spy1915, were uniformly absent in 
MEW427 and M4degraded BSAC emm4 SpyCIM4. The SpyCI of BSAC_bs1802 was unlike SpyCIM4, but was 





Figure 3.7: Bioinformatic comparison of BSAC SpyCIM4 
The SpyCIM4 element is integrated between mutL and mutS, in the DNA MMR operon (red arrows). At full-length, in 
reference genome MGAS10750, SpyCIM4 comprises 25 genes, all of which were detected in M4complete isolates. The 
SpyCIM4 of M4degraded isolates comprised just 11 genes, having lost ~56% of its gene content. The pattern of gene loss was 
common to all M4degraded isolates. BSAC_bs1802 did carry a SpyCI element, however this was highly similar (~99%) to a 
different element, and was not compared. Locus numbers are provided above and below the reference genome SpyCIM4 
sequences, and MEW427 is labelled at 5-gene increments. A gene that was annotated in MGAS10750 and all BSAC emm4 
isolates but was not annotated in MEW427, and a gene that was annotated in MEW427 and all emm4, but not annotated in 
MGAS10750 are indicated with asterisks. 
 
 M4degraded lineage-specific SNPs 
As well as the regions of gene loss within prophages and SpyCIM4, there were also a number of lineage specific 
core genome SNPs detected in all M4degraded BSAC emm4 isolates (including BSAC_bs1802), relative to 
completed reference genome MGAS10750 and all M4complete isolates. Of these, 19 were nonsynonymous, (Table 
3.1), 10 were synonymous (Table 3.2), and 5 were situated within intergenic sequences (Table 3.3). Analysis of 
lineage-specific SNPs raised some interesting questions on possible phenotypes that might have been attributable 
to M4degraded, particularly, though not exclusively, non-synonymous SNPs. Two fibronectin-binding proteins, 
spy0114 and spy0115, carried a non-synonymous SNP each, Glu319Gly and Met11191Ile, respectively. A 
premature stop codon after 12aa in Spy0196, which encodes a carbonic anhydrase, was noted in M4degraded isolates. 
A gene encoding a putative helix-turn-helix, an apparently uncharacterised transcriptional regulator, spy0642, also 
featured a premature stop codon after 176aa in M4degraded. All M4degraded isolates in the BSAC collection carried a 
non-synonymous SNP in rgg/ropB (Thre104Ile). A non-synonymous SNP was also observed in a Pbp1a family 
penicillin binding protein spy1846 (Gly741Ser). 
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Table 3.1: Non-synonymous M4degraded lineage-specific SNPs 






Amino acid changec 
Spy0114 Fibronectin-binding protein 1,620 539 G:C 955bp Glutamine to Glycine  
319 aa 
Spy0115 Fibronectin-binding protein 4,104 1,367 G:A 
3,573bp 





3,774 1,257 C:A 
1,645bp 
Leucine to Isoleucine 
549 aa 
Spy0196 Carbonic anhydrase 501 166 C:T 37bp Stop after 12aa 
Spy0435 NADPH-dependent quinone 
reductase 
666 221 A:G 301bp Serine to Glycine 
101 aa 




1,485 494 G:T 529bp Stop after 176 aa 
Spy0996 Ribose-phosphate 
diphosphokinase 
987 326 C:T 809bp Proline to Leucine  
270 aa 
Spy1077 Lipoate protein ligase 1,020 339 T:C 956bp Isoleucine to Threonine 
319 aa 










Table 3.1 continued 






Amino acid changec 
Spy1085 Phosphopantothenoyl cysteine 
decarboxylase 
546 181 G:A 517bp Alanine to Threonine 
173 aa 
Spy1130 Cation diffusion facilitator 
family transporter 
1,236 411 C:T 668bp Alanine to Valine 
223 aa 
Spy1181 GTPase 1,314 437 G:A 752bp Serine to Asparagine 
251 aa 
Spy1419 Sugar transport system 
permease 




978 325 C:T 572bp Serine to Leucine 
191 aa 
Spy1573 Aspartate aminotransferase 1,251 416 T:A 19bp Tyrosine to Asparagine 5aa 
Spy1807 C5a peptidase 3,498 1,165 C:A 646bp Leucine to Isoleucine 216aa 
Spy1831 Rgg1/RopB 843 280 C:T 311bp Threonine to Isoleucine 104 
aa 
Spy1846 Pbp1a family penicillin 
binding protein 
2,337 778 G:A 2,221 Glycine to Serine 
741 aa 
a CDS as annotated in completed emm4 reference genome MGAS10750, b nucleotide change and position 
relative to the beginning of the CDS as annotated in MGAS10750, c amino acid change relative to the 








Table 3.2: Synonymous M4degraded lineage-specific SNPs 
CDSa Putative function Size (bp) Size (aa) Nucleotide Changeb 
Spy0065 30S Ribosomal protein S5 495 164 C:T 177 bp 
Spy0192 ABC transporter ATP-binding 
protein 
1,788 595 T:C 1,287 bp 
Spy0467 Glycosyl-transferase 990 329 C:T 603 bp 
Spy0731 Glutamine-hydrolyzing carbamoyl-
phosphate synthase small subunit 
1,083 360 T:C 246 bp 
Spy0821 Single-stranded-DNA-specific 
exonuclease 
2,211 736 C:T 1,221 bp 
Spy1009 FAD:Protein FMN transferase 939 312 C:T 681 bp 
Spy1082 NADH-dependent flavin 
oxidoreductase 
1,200 399 G:A 738 bp 
Spy1222 Phosphoenolpyruvate-protein 
phosphotransferase 
1,734 577 C:T 1,581 bp 
Spy1810 Mrp 1,176 388 T:C 75 bp 
Spy1863 Urocanate hydratase 2,031 676 C:T 1,035 bp 
a CDS as annotated in completed emm4 reference genome MGAS10750, b nucleotide change and position 










Table 3.3: Intergenic M4degraded lineage-specific SNPs 





































PolC-type DNA polymerase III 
 
Spy1767 





a CDS as annotated in completed emm4 reference genome MGAS10750, b nucleotide change and position 
relative to the beginning of the CDS as annotated in MGAS10750 
3.4.6.1 Regulator sequence analysis for BSAC emm4 
Sequences for transcriptional regulators derived from WGS data for BSAC emm4 were analysed and compared 
to both emm89 strain H293, and both completed emm4 reference genomes, MGAS10750 and MEW427. These 
included genes encoding the transcriptional regulators RofA, CovRS, Rgg1/RopB, Rgg2/MutR, Rgg3, 
Rgg4/ComR, FasBCAX, RivR and RocA. None of the BSAC emm4 were found to carry nonsynonymous SNPs 
in rgg2/mutR, rgg3, rgg4/comR, rivR or rocA relative to MGAS10750, MEW427 and H293. However, some 
variation was observed in a small number of the isolates in the regulators rofA, covRS, rgg1/ropB, and fasB of the 
fasBCAX operon. 
 
Specifically, two M4degraded isolates carried nonsynonymous SNPs in rofA. Relative to the rofA allele of 
MGAS10750, BSAC_bs192 carried a G:A substitution at 38bp, resulting in the change from Gly to Glu at 13aa. 
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The rofA allele of BSAC_bs400 featured a premature stop codon after 177 aa, due to a G:T substitution at 532bp. 
Three isolates carried nonsynonymous sequence variations in the CovRS locus, BSAC_bs468, BSAC_bs1388 
and BSAC_bs1802. Isolate BSAC_bs1802 was the only isolate carrying a nonsynonymous SNP in the response 
covR, with this allele featuring a missense substitution of G:A at 272bp, translating to a Gly to Asp at 91aa in the 
mature protein. Two isolates carried SNPs in the gene encoding the sensor kinase covS, BSAC_bs468, and 
BSAC_bs1388, though these SNPs were not identical. BSAC_bs468 carried two missense mutations in covS, one 
at A:C 640bp, translating to Thr to Pro 214aa within the histidine kinase/adenylyl cyclase/methyl-binding 
proteins/phosphatases (HAMP) domain, and a further missense mutation at G:A 1,135bp, resulting in Ala to Thr 
at 379aa. The covS allele of BSAC_bs1388 carries a deletion at 79bp which had led to a frameshift and the 
introduction of a premature stop codon after 36aa. 
 
M4degraded BSAC emm4 carried a SNP in ropB, with a C:T missense mutation at 311bp, translating to Threonine 
to Isoleucine at 104 aa. This SNP was not found in MGAS10750, M4complete isolates, MEW427, or H293. A 
singular MEW427-like isolate, BSAC_bs192, carried an additional SNP in this gene, in which a substitution of 
T:A at 459bp resulted in the introduction of a premature stop codon after 153aa, with RopB/Rgg expected to be 
281aa at full-length in the other BSAC emm4, H293, MGAS10750 and MEW427. One isolate, BSAC_bs1349, 
carried a non-synonymous SNP in fasB, a gene encoding a histidine protein kinase and forming part of the 
fasBCAX operon. In BSAC_b1349, fasB carries a missense substitution T:C at 226bp, resulting in the substitution 
of Serine for Proline at 76 aa. 
 
 Additional genetic characteristics of M4complete and M4degraded 
Analysis of the bacterial pangenome revealed a number of lineage-specific SNPs. A novel emm4 allele was 
detected in MEW427 and all M4degraded BSAC emm4, but not MGAS10750 nor M4complete BSAC emm4. This allele 
was the product of a fusion event between emm4, which encodes the emm4 M-protein, and the downstream emm-
like enn, specifically, the 5’ region of emm4 and the downstream 3’ region of enn.  This fusion was predicted to 
yield a novel M-protein variant. MGAS10750 carries the canonical emm4 gene, encoding M4, whereas MEW427 
chimeric emm/enn gene encodes the 350aa isoform. The five M4complete BSAC emm4 isolates also encode the 
canonical M4, whereas the five M4degraded BSAC emm4 carry a chimeric allele, which encodes a distinct isoform 
of 392aa in length. The chimeric gene of MEW427 differs from that of the BSAC emm4 MEW427-like isolates 
by a 126bp deletion, which is predicted to yield a protein that is thus 42aa shorter. Both the MEW427 variant 
(M4C350) and the MEW427-like BSAC emm4 variant (M4C392) were recently identified in a localised population 
of emm4 isolates at a single hospital in Houston, Texas, USA (DebRoy et al., 2018), which also detected four 
other variants of the chimeric protein. While emm4 with the canonical emm and enn genes are classically 
considered pattern E S. pyogenes (‘generalists’) according to the arrangement of the FCT region and predicted 
tissue tropism (Bessen et al., 1996),  genotype emm4 isolates carrying the novel allele may constitute a novel 




A 1,020bp gene encoding a putative microcin C7 self-immunity protein of 339 aa, denoted spy0485, was detected 
in MGAS10750 and M4complete isolates. This gene is predicted to encode an LD-carboxypeptidase, and may thus 
be responsible for catalysing the hydrolysis of tetrapeptide moieties in peptidoglycan (Barendt et al., 2011). This 
gene shared 100% DNA sequence similarity across MGAS10750 and M4complete BSAC emm4, but was not found 
in MEW427, nor M4degraded BSAC emm4. When present, the spy0485 gene appeared to form a four-gene cluster, 
along with three other genes located immediately downstream, spy0486, spy0487 and spy0488, all of which are 
predicted to encode three histidyl-tRNA synthetases of 201bp/66aa, 486bp/161aa and 417bp/138aa in size, 
respectively. These genes were each detected in MGAS10750 and the M4complete isolates, and shared 100% DNA 
sequence similarity in each case. However, these genes were absent in MEW427 and M4degraded isolates. A BLAST 
database search revealed that both the presence and absence of this cluster between the flanking genes spy0484 
and spy0489 are common in S. pyogenes genomes of multiple major emm-types, and neither variation is unique 
to emm4. 
 
 Non-canonical prophage among emm4 isolates resolved by long-read sequencing 
For some emm4 isolates, there was evidence of prophage genes not associated with the canonical emm4 prophages, 
Φ10750.1/ Φ427.1, Φ10750.2/ Φ427.2 or Φ10750.3/Φ427.3, albeit these had not been resolved using short-read 
sequencing. Virulence factor typing had indicated that BSAC_bs192 and BSAC_bs1802, carried speK/sla, and 
sdn, respectively. Pangenome analyses suggested the presence of non-canonical emm4 prophage genes in these 
two isolates, as well as in BSAC_bs472 and BSAC_bs1388, and prophage had also not assembled within a single 
contig for some isolates due to the introduction of contig breaks. These isolates were subject to long-read 
Nanopore sequencing, revealing additional prophage assembled within single contigs, that are not typically part 
of the emm4 prophage complement. Interestingly, these appeared not to have undergone degradation 
(Remmington et al., 2020) (Figure 3.8). BSAC_bs1802 carried an additional prophage (hereafter Φ1802.2), which 
was associated with sdn, and most closely related to emm87 NGAS743 prophage Φ743.3 (Athey et al., 2016) 
integrated 12 genes downstream of Φ1802.1. BSAC_bs192 carried a speK/sla-associated prophage (hereafter 
Φ192.1), integrated between spy1388 (yesN) and spy1389 (msrA). Both BSAC_bs472 (integrated at the same site 
as Φ192.1) and BSAC_bs1388 were each lysogenised by a non-toxigenic prophage; hereafter Φ472.1 and 
Φ1388.1, respectively, integrated between spy0673 (pheT) and spy0674. Φ192.1, Φ472.1 and Φ1388.1, all were 
most closely related to an undesignated emm28 prophage of MGAS292984 (Kachroo et al., 2019; Remmington 
et al., 2020), although the lysogeny module of Φ192.1 was near-identical to an undesignated ssa-associated 
prophage of emm75 isolate NCTC13751. Comparison of BSAC_bs400, which was not subject to long-read 
sequencing, with the completed sequence of BSAC_bs1388 revealed an additional prophage in this isolate, 





Figure 3.8: Additional non-canonical prophage identified by long-read sequencing 
A) Long-read sequencing confirmed the presence of an sdn-associated prophage within BSAC_bs1802. (Φ1802.2), which 
was near-identical to emm87 NGAS743 Φ743.3 (Athey et al., 2016). B) BSAC_bs192 was confirmed to harbour a speK/sla 
prophage (Φ192.1), which was closely related to an unnamed speK/sla-associated prophage of emm75 NCTC13751. Φ192.1 
was highly similar non-toxigenic prophage resolved by long-read sequencing in BSAC_bs1388, (Φ1388.1), and 
BSAC_bs472 (Φ472.1). Although the lysogeny module of Φ192.1 was almost identical to that of the NCTC13751 prophage, 
Φ192.1, Φ427.1 and Φ1388.1 were most closely related to a non-toxin-encoding emm28 prophage in isolate MGAS29284 
(Kachroo et al., 2019). Predicted gene function was determined by BLAST, and assigned COG classification; integrase; 
navy, regulation; pale blue, hyaluronidase; green, infection (holin/lysin); grey, replication; purple, structural; yellow, 
superantigen/phospholipase; red, transposon; orange. Shaded grey scale bar indicates DNA sequence similarity (%). Figure 
taken from Remmington et al. 2020. 
 
3.5 Discussion 
A small population of emm4 isolates was collected by the BSAC from multiple locations in the United Kingdom 
between 2001 and 2011 (Turner et al., 2019b). The BSAC emm4 were subject to typing for variable factors, 
specifically superantigens and DNases, revealing a generally consistent complement of these virulence factors 
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that was common to all ten. All ten isolates, like both MGAS10750 and MEW427, carried a speC/spd1 prophage 
integrated at the 3’ attB site of the putative dipeptidase gene, pepD/Spy_0623; an spd3-encoding prophage at the 
3’ attB site of the dTDP-glucose-4,6-dehydratase, Spy_0890; an ssa-associated prophage at the 5’ attB site of the 
DNA-binding protein encoding gene, hup/Spy_1329, and the emm4 SpyCI element at the 5’ attB of the DNA 
MMR protein mutL/Spy_1896. All ten isolates also carried the chromosomal DNases spdB and spnA, and the 
chromosomal superantigen smeZ. 
 
Intriguingly, these isolates were largely divided into two clades, associated with either of two completed emm4 
reference genomes, MGAS10750 and MEW427. Gubbins analyses identified clusters of SNPs, putative regions 
of recombination, within prophage-encoding regions of completed emm4 reference genome MEW427 and BSAC 
emm4 isolates that were more closely related to MEW427, BSAC_bs192, BSAC_bs400, BSAC_bs472, 
BSAC_bs696, and BSAC_bs1802. However, these regions were not observed in those isolates that were more 
closely related to MGAS10750, BSAC_bs468, BSAC_bs916, BSAC_bs1052, BSAC_bs1349 and 
BSAC_bs1388, nor MGAS10750 itself. Subsequent analysis revealed that these regions were not recombinant 
sequence, but rather regions of gene loss within MEW427 and the BSAC emm4 isolates clustering with this 
reference. The gene loss was found to have occurred within prophage-encoding regions, specifically, the three 
canonical genotype emm4 prophage Φ10750.1/Φ427.1, Φ10750.2/Φ427.2, Φ10750.3/Φ427.3, and SpyCIM4. 
Φ427.1 was found to have lost ~70% of its gene content relative to the corresponding element, Φ10750.1, in 
MGAS10750. Φ427.2 was found to have lost ~50% of its gene content relative to the full-length Φ10750.2, and 
Φ427.3, was found to have lost ~26% of its genome when compared to the MGAS10750 prophage, Φ10750.3. 
The MEW427 SpyCIM4, was observed to have only ~44% of the genes that were found in the full-length element 
in MGAS10750. Similar patterns of loss were identified in four of the five BSAC emm4 clustering with MEW427. 
However, one isolate, BSAC_bs1802, despite clustering with MEW427, carried a different speC/spd1 prophage 
to the other BSAC isolates (Φ1802.1) and a near-complete, only partially degraded Φ10750.3. Φ427.2 of 
BSAC_bs1802 was identical to the that of other BSAC emm4 clustering with MEW427. Gene loss, when 
observed, was noted to principally affect prophage genetic modules involved in genetic regulation, prophage 
excision/integration and replication, and to a less and more variable extent, structural genes required for the 
assembly of infectious particles. The loss of functional integrase genes in particular would be expected to preclude 
excision and particle formation.  
 
Other M4degraded lineage-specific SNPs were present, that might impact bacterial phenotype, particularly those 
which were non-synonymous Two fibronectin-binding proteins, spy0114 and spy0115, carried a non-synonymous 
SNP each, (Glu319Gly and Met11191Ile, respectively) that were considered in their capacity to modulate 
adhesion among the emm4 isolates to fibronectin in-vitro or -in-vivo (Brouwer et al., 2016). A non-synonymous 
SNP was detected in Spy0196, a putative carbonic anhydrase encoding gene, leading to the introduction of a 
premature stop codon after 12 aa.  These enzymes are perhaps best studied in S. pneumoniae and S. mutans, 
wherein they appear to mediate survival in ambient air, and fluctuations in other atmospheric and environmental 
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conditions (Burghout et al., 2010), and thus might thus alter bacterial growth. All M4degraded and MEW427 carried 
a naturally occurring Rgg/RopB variant (Thr104Ile), but this was not predicted to affect activity based on 
comparison to published sequences (Ikebe et al., 2010). Gene Spy1846, encoding a putative penicillin binding 
protein, also carried a non-synonymous SNP in M4degraded (Gly741Ser). However, none of the BSAC emm4, which 
had previously been subject to rigorous and well-standardised antimicrobial sensitivity testing by the BSAC, 
demonstrated a phenotype of reduced sensitivity or resistance to -lactams (Turner et al., 2019b). This variant 
was unrelated to penicillin binding protein SNPs to which reduced sensitivity to -lactams in S. pyogenes was 
recently described (Musser et al., 2020; Vannice et al., 2019). A naturally occurring C5a peptidase variant was 
also observed (Leu216Ile), but this appeared to fall within a repeat region. Three isolates carried variant CovRS 
alleles; BSAC_bs468 (CovS; Thr241Pro and Ala379Thr), BSAC_1388 (CovS; 36aa-STOP) and BSAC_bs1802 
(CovR; Gly91Asp), which may have a number of far-reaching, isolate-specific consequences depending on the 
impact of the SNP, including enhanced virulence and changes in toxin expression (Federle et al., 1999; Galloway-
Peña et al., 2018; Graham et al., 2002; Sumby et al., 2006; Turner et al., 2009). 
 
The presence of an equal number of M4complete and M4degraded emm4 isolates in the BSAC collection, coupled with 
the data in this Chapter on prophage content, prompted the examination of the larger emm4 population. This 
proved highly illuminating, and the initial observation that the isolates in this small population formed two 
lineages clustering with either reference genome, was recapitulated by further work carried out by project 
supervisor Dr. Claire E. Turner (Remmington et al., 2020). This confirmed that the international population of 
emm4 S. pyogenes, ratified by the inclusion of all available emm4 whole genome sequence data, comprised two 




Figure 3.9: International emm4 lineage associated with cryptic prophage 
A mid-rooted phylogenetic tree was constructed using core SNPs following mapping of publicly available short-read WGS 
data from 223 international emm4 isolates, and completed reference genomes MGAS10750 and MEW427, indicated with 
black arrows. Lineages were defined as isolates clustering with MGAS10750 (unshaded), those clustering with MEW427 
(shaded), and a small lineage comprising UK 13 isolates with partially degraded, or variant MGE relative to the rest of the 
population (dotted box). Prophage gene content was determined for each isolate by BLAST for each canonical emm4 
prophage Φ10750.1 (column 1), Φ10750.2 (column 2), and Φ10750.3 (column 3), and used to calculate a percentage, 
expressed as colour scale per figure key. SpyCIM4 variants corresponded with these respective lineages (column 4). Those 
associated with the M4degraded lineage carrying the degraded variant (blue bar), and those associated with M4complete carrying 
the full-length SpyCIM4 (red bar), as determined by sequence alignment. BSAC_bs1802 SpyCI, unique among the emm4 
population, is shown as a black bar. Where elements were absent, this is indicated with a white bar. Isolate names are linked 
to corresponding branches by dotted lines, and colour coded by geographical origin, per figure key (UK; red, and North 




Intriguingly, the North American population of emm4 S. pyogenes comprised predominantly M4degraded isolates, 
whereas both M4complete and M4degraded isolates were found in the United Kingdom. Although it is clear from the 
nature of the BSAC collection as bloodstream isolates that full-length prophage are inessential for emm4 to attain 
full virulence, the geographic distribution of these two lineages raised interesting questions on the difference 
between M4complete and M4degraded isolates. There may be other factors responsible, in addition to, or independent 
of prophage degradation, notably a chimeric emm gene, formed by the splicing of emm and the emm-like enn 
(DebRoy et al., 2018). This chimeric gene was indeed detected in the MEW427-like BSAC emm4, and as 
previously reported, MEW427, and chimeric emm genes have subsequently been identified in multiple emm-types 
(Frost et al., 2020). 
 
Resolving prophage regions in bacterial genomes with short-read sequencing methods is difficult due to the 
homologous and mosaic nature of prophage. Unless an element is located within a single contig, discerning gene 
presence and absence is challenging. It is reassuring, however, that for all isolates, bar BSAC_bs1802, patterns of 
gene loss were identical, or near identical to the corresponding completed reference genome sequences. Detecting 
additional phage that are ‘atypical’ of the genotype is also a noted constraint, which is especially concerning given 
the potentially calamitous epidemiological consequences that loss and gain of prophage in S. pyogenes can evoke 
(Al-Shahib et al., 2016; Stephen B. Beres et al., 2004; Davies et al., 2015; Tse et al., 2012).  
 
Long-read sequencing of four BSAC emm4 post hoc confirmed the gene content of Φ1802.1, as had been achieved 
by repeating assembly using alternative software (Remmington et al., 2020). Long-read sequencing also 
demonstrated the presence of four non-canonical and hitherto unidentified emm4 prophage in these isolates, which 
was not achieved with short-read sequencing; Φ192.1 and Φ1802.2, carrying speK/sla and sdn, respectively, and 
Φ472.1, Φ1388.1 and, Φ400.1, which carried no toxin genes. Interestingly, these prophage did not appear to have 
undergone substantive gene loss. The similarity of these prophage to existing elements of other genotypes infers 
the exchange of prophage between and within genotypes, in this case emm28 and emm75, and this was supported 
in the literature (Brüssow and Desiere, 2001; Desiere et al., 2001; Canchaya et al., 2003). Given the human-
restricted nature of S. pyogenes, such exchanges likely occurs in humans, and can be recapitulated in murine 
models of infection (Broudy and Fischetti, 2003). However, it seems likely that streptococci with less restricted 
host-ranges, such as the emerging pathogen S. dysgalactiae sbsp. equisimilis (Chochua et al., 2019), may augment 
accessibility of this arsenal to substantially more discerning species, such as S. pyogenes or the equine pathogen 
S. equi sbsp. equi (Holden et al., 2009; Turner et al., 2019a). As long-read sequencing becomes more affordable 
and widely available, it seems likely this technology will further illuminate the role prophage play in the biology 
of S. pyogenes and related species. 
 
The data in this chapter led to the hypothesis that prophage of M4degraded emm4, having undergone marked gene 
loss in prophage- and SpyCIM4-encoding regions would exhibit differential prophage excision, with M4degraded 
104 
 
prophage unable to exit the bacterial chromosome. If proven, this could conceivably impact the growth, toxin 
expression and overall virulence of these isolates. These hypotheses were explored in subsequent chapters. 
 
 Chapter 3: Key findings 
 Substantial gene loss was observed within prophage- and SpyCI-encoding regions in completed emm4 
reference genome MEW427 but not MGAS10750 
 Gene loss primarily affected prophage modules concerned with genetic regulation, replication and to a 
lesser extent, structural genes and thus may impact prophage excision and integration 
 Cognate virulence genes were not lost 
 The patterns of gene loss observed in MEW427 were also observed in half of the BSAC emm4 isolates, 
specifically those clustering phylogenetically with MEW427 
 BSAC emm4 that clustered phylogenetically with MGAS10750 did not exhibit gene loss in prophage-
encoding regions 
 The global emm4 population includes an international lineage broadly associated with gene loss within 


















4. Prophage induction and gene expression 
4.1 Introduction 
Lysogenic toxin-encoding bacteriophage are important contributories to the molecular biology and pathogenesis 
of number of Gram-positive and Gram-negative bacteria, and frequently encode bacterial toxins (Canchaya et al., 
2003; Holmes, 2000; Krüger and Lucchesi, 2015; McShan and Nguyen, 2019; Sakaguchi et al., 2005; Xia and 
Wolz, 2014). Much of their lifecycle is spent as a stably integrated element, a state which is under tight regulatory 
control (Oppenheim et al., 2005). Although integrated prophages are transmitted to daughter cells by vertical gene 
transfer, and perhaps by recombination (Turner et al., 2015), to achieve high-frequency transmission to new hosts, 
prophage must excise from the bacterial chromosome and enter the lytic cycle, eventually forming prophage 
particles.  
 
Prophage induction may occur in response to external stimuli and the initiation of the SOS-response by the host 
bacterium. In many bacterial species, this response is triggered by DNA damage or interference with DNA 
synthesis. Antibiotics such as ciprofloxacin and other fluoroquinolones, chemotherapeutic agents such as 
mitomycin C, in addition to other chemical and physical agents including hydrogen peroxide and ultraviolet light, 
have well-described potential to elicit this effect (Banks et al., 2003; Fernández De Henestrosa et al., 2000; 
Maiques et al., 2006; Michel, 2005; Oppenheim et al., 2005; Zhang et al., 2000). These insults can damage DNA 
in a variety of ways, such as creating double-strand breaks, and inducing crosslinks. In a number of bacterial 
species, the highly conserved DNA repair and maintenance protein and inducer RecA is activated by DNA 
damage, binding ssDNA to form a nucleoprotein filament and promoting self-cleavage of the downstream 
repressor, LexA. This cleavage subsequently de-represses SOS genes and triggers the SOS-response. The phage-
encoded repressor cI is also cleaved on the initiation of the SOS-response, resulting in the relief of its repressive 
activity over genes which are involved in prophage induction, and interlacing DNA damage with prophage 
induction, and inextricably linking the fate of the lysogenic virus with the lysogen (Oppenheim et al., 2005). 
Prophage induction may also occur at comparatively lower frequencies throughout bacterial growth (Alexeeva et 
al., 2018; Cortes et al., 2019; Nanda et al., 2015), possibly due to low-level initiation of the SOS-response as the 
corollary of accumulated DNA damage sustained during binary fission (Nanda et al., 2015). 
 
The classical genetic apparatus associated with the SOS-response have hitherto not been identified in a number 
of the streptococci, including S. pyogenes (Gasc et al., 1980; Varhimo et al., 2007). However, analogous 
compensatory systems are reported (Boutry et al., 2013; Varhimo et al., 2007; Žgur-Bertok, 2013), and the 
prophage of S. pyogenes and other streptococci are inducible with DNA-damaging agents (Banks et al., 2003; 
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Euler et al., 2016; Hyder and Streitfeld, 1978; Ingrey et al., 2003; López et al., 2014). There is also evidence for 
spontaneous prophage induction in S. pyogenes (Banks et al., 2003), and other streptococci of clinical interest 
(Alexeeva et al., 2018; Brassil et al., 2020; Carrolo et al., 2010). It seems likely that the two occur simultaneously, 
particularly in-vivo, wherein one might expect myriad immunological, anatomical and possibly pharmacological 
inducers will coincide with the expansion of bacterial populations, itself leading to the accumulation of genetic 
and biochemical spontaneous inducers. 
 
Prophage excision, both induced and spontaneous, appears to play a role in the transcriptional control of cognate 
virulence factors in S. pyogenes and other bacteria. Occasionally, but not exclusively, this may be due to a gene 
dosing effect, or evidence thereof (Aertsen et al., 2005; Balasubramanian et al., 2019; Banks et al., 2003; Broudy 
et al., 2001; Broudy and Fischetti, 2003; Cortes et al., 2019; Ingrey et al., 2003). There is also evidence that other, 
less well-studied mobile genetic elements of S. pyogenes can impact the expression of genes beyond the elements 
themselves (Eraso et al., 2020; Kachroo et al., 2019), and that this influence can be mediated by their capacity to 
excise and integrate (Nguyen and McShan, 2014; Scott et al., 2012), as is observed among the SpyCI. The 
regulation, control and utilisation of prophage-borne toxins is thus far from clear, particularly in the context of 
infection. Even less well described are the roles of degraded, decayed or ‘defective’ prophage. 
 
4.2 Chapter hypotheses and aims 
The present chapter sought to characterise the inducibility of the prophage and the SpyCI of emm4 S. pyogenes.  
Specifically, to determine if, between the M4complete and M4degraded isolates, differential induction could be 
demonstrated. It was further hypothesised that M4complete isolates might express higher levels of prophage-encoded 
virulence factors, relative to M4degraded isolates, possibly, in the case of the former, owing to an inability to leave 
the chromosome, replicate, and elicit a gene dosing effect. On the part of SpyCIM4, it was hypothesised that 
permanent integration, if observed, would abolish expression of mutS. 
 
4.3 Methods 
 Prophage and SpyCI induction using mitomycin C 
Overnight liquid cultures of all 10 BSAC emm4 were diluted 1:10 and grown to OD600 0.3, whereupon these were 
split into two tubes; one aliquot was treated with mitomycin C (Sigma) (0.2 μg/mL) and the second served as an 
untreated control, as previously described (Banks, Lei and Musser, 2003). Cultures were incubated for an 
additional 3 hours at 37°C in an atmosphere enriched with 5% (v/v)  CO2, before the bacterial pellet was harvested 
and frozen at -20°C for DNA extraction the following day (for full protocol, see main methods section 2.2.2), 
before application of the prophage induction PCR(s) (Figure 2.1). Cultures were initially also treated with 
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hydrogen peroxide (Sigma) (0.5mM), however, this was found to induce prophage less strongly and more variably 
than mitomycin C, which consistently and strongly induced phage.  
 
 Spontaneous prophage and SpyCI induction experiments 
For spontaneous prophage induction experiments, overnight cultures of all 10 BSAC emm4 S. were washed once 
in fresh THB (Oxoid), diluted 1:10 and OD600 measured hourly. Bacteria were harvested by centrifugation at 3, 5 
and 8 hours, based on the correspondence of these timepoints with early-, mid- and late-log stages of bacterial 
growth, as determined by growth curve (these data are shown later in Chapter 5, Figure 5.1). To detect SpyCI 
excision, cultures of BSAC_bs1349 and BSAC_bs696 were harvested by centrifugation at 30 minutes intervals 
for the first 3 hours, and hourly thereafter, with the final timepoint being 8 hours. All pellets were immediately 
frozen at -20°C and DNA extracted and standardised the next day before being subject to PCR with 
prophage/SpyCI induction primers. 
 
 Detection of gene expression and copy number by RT-qPCR and qPCR 
Synthesis of cDNA and qPCR was carried out also as described in the main methods (section 2.2.11), without 
modification. Transcript copies of speC, spd3 and ssa were measured by qPCR using a method to include a 
standard curve, generated using a plasmid (per section 2.2.9 of main methods) and transcript copies of the target 
gene were thus normalised using housekeeping gene gyrA transcripts. DNA extraction was performed on thawed 
samples, (as described in methods section 2.2.2) and was standardised to 40 ng/μL (200ng per reaction) for qPCR 
to detect gene copies of speC, using the aforementioned qPCR method, and speC gene copies were normalised to 
copies of housekeeping gene gyrA (for cycling parameters, see main methods Figure 2.3). 
 
 Semi-quantitative detection of mutS and mutL transcripts 
RNA was extracted and converted to cDNA for all 10 BSAC emm4 after 3 hours growth in THB. cDNA from 
this timepoint was selected as this corresponds with the stage of growth at which, according to published literature 
(Nguyen and McShan, 2014; Scott et al., 2012), excision of SpyCIM4 was purportedly lowest, and expression of 
mutS thus abolished. For each isolate, 50 ng of cDNA per reaction, and the corresponding RT-negative were 
probed by standard PCR to measure mutL and mutS transcripts, semi-quantitatively, by agarose gel electrophoresis 





 Prophage of M4complete are inducible but prophage of M4degraded are not 
To test experimental induction of emm4 prophage, liquid cultures were treated with mitomycin C and DNA was 
extracted. Primers were used to detect integrated prophage, and where present, excised phage. As hypothesised, 
1075.1 of M4complete isolates were induced spontaneously in untreated samples (c. 6 hours growth), and were 
more strongly induced following treatment with mitomycin C (Figure 4.1A). Contrarily, 427.1 of M4degraded were 
not induced spontaneously in the untreated cultures, nor cultures treated with mitomycin C (Figure 4.4B). The 
exception to this was unusual M4degraded BSAC_bs1802. For this isolate, the unique speC/spd1-encoding 1802.1 





Figure 4.1. 10750.1/427.1 induction in liquid culture using mitomycin C 
Amplification with the two primer combinations denoted ‘In’ indicate an integrated prophage, whereas amplification with 
the two primer combinations denoted ‘out’ indicate excision of this prophage. A) 10750.1 in all five M4complete  was 
detected, and found to be induced spontaneously during growth in liquid culture, and was more strongly induced with 
mitomycin C. B) The corresponding 427.1 of M4degraded was detected in its integrated conformation, however, this prophage 
was not observed in its extra-chromosomal state in untreated cultures, nor could the excised prophage be detected in DNA 
samples extracted from bacterial cultures exposed to mitomycin C. C) 1802.1 of BSAC_bs1802 was detected as an 
integrated and excised element in both culture conditions. D) H293 DNA was used as an internal control, as it has no 
prophage, and this was confirmed by amplification with AD. No bands were observed in MGW control. DNA was 




The same DNA samples were probed for integration and excision of 10750.2/427.2. It was only in DNA 
extracted from M4complete that the excised prophage could be detected (Figure 4.2A). In these cases, the full-length, 
excised prophage was detected weakly in DNA extracted from untreated cultures, and was more strongly induced 
in those treated with mitomycin C. Conversely, 427.2 of M4degraded was not detected as having excised under 









Figure 4.2.: 10750.2/427.2 induction in liquid culture using mitomycin C 
Two primer combinations were used to detect integrated prophage ‘in’, and a further two were used to detect prophage in 
their extra-chromosomal conformation following excision from the bacterial chromosome (‘out’). A) Excision of 10750.2 
was detected in all five M4complete isolates and could be induced to excise more strongly with mitomycin C. B) 427.2 in all 
four M4degraded and BSAC_bs1802 was not induced under either culture condition. C) H293 DNA was used as an internal 
control, as it has no prophage, and this was confirmed by amplification with AD. No bands were observed in the MGW 






Primers were also designed to detect the emm4 prophage encoding the streptococcal superantigen ssa, 
10750.3/427.3. These were applied to the same standardised DNA samples to determine the excision potential 
of these prophage. Full-length M4complete 10750.3 could be induced by mitomycin C, and were found to be 
induced to a lesser extent in untreated cultures (Figure 4.3A). Conversely, 427.3 of M4degraded isolates appeared 
unable to excise from the chromosome under either culture conditions (Figure 4.3B). Unusual isolate 








Figure 4.3. 10750.3/427.3 induction in liquid culture using mitomycin C 
Prophage excision (‘in’) was detected with two pairs of primers, and by alternating the combination of these primers, the 
excised prophage (‘out’), where present, could be detected. A) PCR on DNA extracted from cultures of all five M4complete 
isolates demonstrated that 10750.3 was weakly induced in untreated cultures, and to a comparatively stronger degree 
following treatment with mitomycin C. B) 427.3 in M4degraded isolates was not detected in its induced, excised conformation 
under either culture conditions. C) 1802.3 of BSAC_bs1802 exhibits only very minor gene loss, and was strongly induced 
under both conditions. D) H293 DNA was used as an internal control, as it has no prophage, and this was confirmed by 
amplification with AD. No bands were observed in MGW negative. DNA was standardised to 40 ng/L prior to testing. 
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 Prophage induction during S. pyogenes growth in THB 
Prophage may be induced spontaneously during bacterial growth (Alexeeva et al., 2018; Cortes et al., 2019; 
Nanda et al., 2015). It was unclear whether this may occur in M4complete or M4degraded, or if these events might be 
associated with a particular timepoint among isolates from either lineage. To establish this, DNA was extracted 
from bacteria harvested at early-, mid-, and late-log and tested for prophage induction by PCR. As expected, 
10750.1 of M4complete were weakly spontaneously induced during bacterial growth (Figure 4.4A), however, 
427.1 of M4degraded were not induced at any sampling time (Figure 4.4B). 1802.1 of BSAC_bs1802 was found 
to be strongly induced throughout growth (Figure 4.4C). It did not appear that induction of M4complete was occurring 
more so at one timepoint than others, though possibly amplification with primer combination AD was more readily 




Figure 4.4.: Spontaneous 10750.1/427.1 induction during bacterial growth 
Amplification with two primer combinations was used to detect integrated prophage (‘In’), and different combinations of 
these same primers were used to produce a further two combinations was used to detect excised prophage (‘out’). A) 
10750.1 was weakly induced at least one timepoint per isolate. B) 427.1 of M4degraded did not exhibit the capacity 
spontaneous induction. C) M4degraded BSAC_bs1802 carries a different speC/spd1-encoding prophage to the other BSAC 
emm4 and this was detectable as being strongly induced throughout growth. DNA samples were standardised to 40 ng/L 
before PCR. D) H293 DNA was used as an internal control, as it has no prophage, and this was confirmed by amplification 




Primers for 10750.2/427.2 were applied to the same standardised DNA samples. As was expected, 10750.2 
was weakly spontaneously induced during growth, though it did not appear that induction occurred at any specific 











Figure 4.5.: Spontaneous 10750.2/427.2 induction during bacterial growth 
Two primer pairs were used to detect the prophage in its integrated state within the bacterial chromosome (‘In’), and different 
combinations of these same primers were used to detect its extra-chromosomal conformation (‘out’). A) 10750.2 induction 
was observed throughout growth in all bar one M4complete, BSAC_bs1388. B) 427.3 of M4degraded could not be detected as 
induced at any of the three time points. C) H293 DNA was used as an internal control, as it has no prophage, and this was 
confirmed by amplification with AD. No amplification occurred in MGW negative. DNA was standardised to 40 ng/L prior 
to PCR.  
 
By applying the 10750.3/427.3 phage conformation PCR to the same DNA samples, it was found, that 
prophage of M4complete isolates were induced throughout growth, and were similar across all timepoints (Figure 
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4.6A). Conversely, 427.3 was not induced during bacterial growth at any of the three timepoints (Figure 
4.6B).but 10750.3 of BSAC_bs1802 was spontaneously induced (Figure 4.6C). 
 
 
Figure 4.6.: Spontaneous 10750.3/427.3 induction during bacterial growth 
Two primer pairs were used to identify the integrated prophage element (‘in’), and two pairs were used to detect the excised 
prophage (‘out’). A) M4complete 10750.3 was strongly spontaneously induced throughout growth. B) 427.3 of M4degraded 
was not induced at any time point. C) 10750.3/427.3 of BSAC_bs1802 was detectable as a spontaneously induced 
element. D) H293 DNA was used as an internal control, as it has no prophage, and this was confirmed by amplification with 




 Prophage toxin gene expression during bacterial growth 
Prophage induction in S. pyogenes may increase the expression of cognate virulence factors in S. pyogenes (Banks 
et al., 2016; Broudy et al., 2002, 2001). Having demonstrated that the of M4complete isolates exhibit full capacity 
for excision across all three canonical genotype emm4 prophage, and confirmed that the corresponding prophage 
of M4degraded isolates could not be induced, it was apposite to examine what impact this might have on toxin gene 
transcription, if any. RNA samples collected from the same experiments as the timepoint DNA samples were thus 
probed for expression of speC, spd3 and ssa, encoded by 10750.1/427.1, 10750.2/427.2, 
10750.3/427.3, respectively. 
 
At three and five hours, speC expression was similar between M4complete and M4degraded isolates (p=0.395, Mann 
Whitney, and p=>0.9999, and Mann Whitney, respectively). However, at eight hours, the expression of speC by 
all emm4 isolates increased, and began to diverge, with M4complete isolates expressing speC more highly than 
M4degraded isolates though this did not reach significance (p=0.0952, Mann-Whitney) (Figure 4.7A). Intriguingly, 
the increased expression did not appear to be associated with a precipitant increase in speC gene copies (Figure 
4.7B). Two isolates did exhibit an increase in gene copies at eight hours and were found to carry naturally 
occurring variants of CovS; BSAC_bs1388 (36aa-STOP) and CovR; BSAC_bs1802 (Gly91Asp), respectively. 







Figure 4.7.: Expression of speC and gene copies during growth in THB 
A) Expression of speC in THB was similar for all emm4 isolates at three (p=0.3095, Mann-Whitney) and five hours 
(p=>0.9999, Mann-Whitney), but higher at eight hours, though there was a difference in expression between complete (black 
circles) and degraded isolates (white circles), with M4complete expressing speC more highly (p=0.0952, Mann-Whitney). B) 
DNA extracted from the same samples was probed for copies of the speC gene by qPCR. An increase in speC gene copy 
numbers was not observed in either M4complete (black circles) or M4degraded (white circles) at eight hours (p=0.3095, Mann-
Whitney). Variant covS isolates BSAC_bs468 and BSAC_bs1388 are highlighted as a red circles and blue circles, 
respectively. covR variant BSAC_bs1802 is indicated as yellow circles. Data are the mean of three independent RNA/DNA 
samples, measured in triplicate and normalised and expressed as copies of speC transcript or gene copy per 10,000 copies of 
housekeeping gene gyrA transcripts or gene copy. Horizontal bars indicate the median. Dotted line represents the point at 
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Expression of spd3, carried by 10750.2/427.2, was similarly expressed at comparable levels between M4complete 
and M4complete isolates at three (p=>0.9999, Mann Whitney), five (p=>0.9999, Mann Whitney), and eight hours 
(p=>0.9999). A single M4complete isolate expressed spd3 more highly than the other isolates at 8 hours, 
BSAC_bs1349 (Figure 4.8).  
 
   
Expression of the DNase spd3 was comparable between M4complete (black circles) and M4degraded isolates (white circles). There 
was no major difference between expression of spd3 in these two groups at three (p=>0.9999, Mann-Whitney), five 
(p=>0.9999, Mann-Whitney), or eight hours (p=>0.9999, Mann-Whitney). Variant covS isolates BSAC_bs468 and 
BSAC_bs1388 are indicated as a red and a blue circle, respectively. Variant covR isolate BSAC_bs1802 is represented by a 
yellow circle. Isolate BSAC_bs139 is highlighted with an arrow. Data are the mean of three independent RNA samples 
measured in triplicate, and normalised to 10,000 copies of gyrA transcripts. Horizontal bars indicate the median. 
 
Expression of ssa also showed similar patterns of transcriptions throughout growth with a subtle elevation 
observed for all isolates at five hours ( 
Figure 4.9), although expression of ssa between  both M4complete and M4degraded  were comparable at three 
(p=0.8413, Mann Whitney), five (p=>0.9999, Mann Whitney) and eight hours (p=0.0952, Mann Whitney). At 
eight hours, a single M4complete isolate and a single M4degraded isolate expressed ssa more highly than the other 
BSAC emm4, BSAC_bs1349 and BSAC_bs192, respectively. Isolates with variant CovRS alleles did not appear 
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Figure 4.9.: Expression of ssa during growth in THB 
The expression of ssa in THB was similar for M4complete (black circles) and M4degraded (white circles) at three (p=0.8413, 
Mann-Whitney), five p=>0.9999, Mann-Whitney) and eight hours (p=0.0952, Mann-Whitney). Variant covS isolates 
BSAC_bs468 and BSAC_bs1388 are indicated with a red and a blue circle, respectively. Variant covR isolate BSAC_bs1802 
represented with a yellow circle. BSAC_bs1394 and BSAC_bs192 expressed ssa more highly than did the other isolates at 
eight hours, and are highlighted with arrows. Data are the mean of three independent RNA samples measured in triplicate 
and normalised per 10,000 copies of gyrA transcripts. Horizontal bars indicate the median. 
 
 SpyCIM4 of M4complete and M4degraded are not inducible 
SpyCI of M4complete are full-length, whereas M4degraded were observed to have undergone gene loss, in a fashion 
similar to that described here between lysogenic prophage. An analogous integration and excision PCR was 
designed and applied to SpyCIM4, the mobility of which was believed to regulate the expression of the DNA 
MMR operon in S. pyogenes (Nguyen and McShan, 2014; Scott et al., 2012). The applicability of this regulatory 
mechanism between SpyCI and expression of the DNA MMR operon was investigated by MSc student Samuel 
Haywood, co-supervised by the author and Dr. Claire E. Turner. Unexpectedly, neither the SpyCIM4 of M4complete 
or M4degraded were inducible with mitomycin C (Figure 4.10A), nor were they found to be mobile during 
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Figure 4.10: SpyCIM4 induction with mitomycin C and during growth in THB 
A) M4complete isolate BSAC_bs1349 and M4degraded isolate BSAC_bs696 were treated with mitomycin C to induce 
SpyCI. SpyCI could not be detected in its excised conformation for M4complete, nor M4degraded. B) Both isolates were grown 
for 8 hours, and at no timepoint was SpyCI detected as an excised element in either M4complete or M4degraded. H293 has no 
SpyCI was used as an internal control, with amplification only occurring to confirm the absence of SpyCI at the attachment 
site. DNA was standardised to 40 ng/L prior to PCR. 650bp and 400bp arrows indicate position relative to 1kb plus DNA 
ladder (Invitrogen). 
 
SpyCIM4 of both M4complete and M4degraded were unable to excise, which was not expected. It was thus hypothesised 
that the permanent integration of SpyCIM4, would, as described in published reports, block transcription of mutL, 
and the rest of the DNA mismatch repair (MMR) operon (Nguyen and McShan, 2014; Scott et al., 2012). 
Transcripts for both mutL and mutS at 3-hours growth were therefore measured semi-quantitively for all BSAC 
emm4. Transcripts for both genes were detected in all isolates (Figure 4.11), suggesting that in emm4, SpyCIM4 




Figure 4.11: mutS and mutL expression during bacterial growth  
RNA was extracted from all BSAC emm4 after 3 hours growth, DNase treated, and converted to cDNA by reverse 
transcription. cDNA was probed semi-quantitatively for mutS and mutL transcripts by PCR. For all isolates, mutS and mutL 
transcripts were detected. For each isolate, an RT-negative was prepared in parallel (lacking reverse transcriptase and 
RNaseIn) to serve as a control for contaminating DNA, and loaded after each corresponding sample and neither cDNA nor 
genomic DNA were detected. H293, which has no SpyCI, was included as an internal control. No transcripts were detected 
in the MGW negative control. Arrows indicate ~400bp on 1kb plus DNA ladder (Invitrogen). 
 
4.5 Discussion 
Although the constellation of canonical lysogenic prophage and SpyCIM4 superficially appear to be the same 
between emm4 isolates, the gene content of these prophage is variable between M4complete and M4degraded emm4 
isolates. Prophages could only be induced to excise from the bacterial chromosome among M4complete isolates. 
427.1 was found to be stably integrated under the same conditions in which 10750.1 was inducible, in spite 
of the former retaining a functional integrase. This might suggest that integrase retention alone is not sufficient to 
abolish excision potential. It is possible that other gene losses in this prophage are responsible for this observation, 
particularly regulatory and replicative prophage modules. 427.2 could not be induced to excise experimentally, 
nor was it found to be induced during growth in THB at any stage. Conversely, 10750.2, was induced under 
identical conditions. In addition to having lost regulatory and replicative modules, 427.2 was predicted to lack 
a functional integrase, any and all of which might be expected to impact excision potential. 427.3 was similarly 
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decayed, having lost identifiable replicative and regulatory modules, in addition to harbouring an integrase that 
was predicted to be a defective. This element could not be induced in M4degraded isolates, but the corresponding 
10750.3, was inducible with mitomycin C and during exponential growth. Spontaneous induction of prophage 
did not seem to correlate convincingly with specific timepoint as might be expected if spontaneous prophage 
induction is due to the accumulation of DNA damage over successive generations (Cortes et al., 2019), though 
this may occur at later stages of growth not sampled or perhaps dynamically within a comparatively smaller subset 
of the larger bacterial population. 
 
It was interesting to observe that levels of transcription of spd3 and ssa attained by emm4 during growth in THB 
were generally comparable between both lineages. CovRS represses spd3 in emm1 (Sumby et al., 2006) and 
repression by CovRS is known to be maximal at early- and mid-log, but relieved at later stages of growth (Graham 
et al., 2005). Despite this, CovRS variant emm4 isolates were not made obvious by their expression of spd3. There 
is also, however, evidence that spd3 may be regulated by Rgg1/RopB (Anbalagan and Chaussee, 2013). Although 
the veracity of the emm4 CovRS variants was not confirmed, regulatory variation between genotypes may also 
have a part to play in these findings. Transcription of speC was found to be greater in M4complete than M4degraded 
isolates at eight hours, an increase of ~4-fold observed in the former, versus ~2-fold in the latter, from the previous 
timepoint of five hours. The differential increase in the expression of speC between the two types of emm4 isolates 
might translate to differential SpeC expression.  
 
A thought-provoking observation was that although in M4complete isolates, 10750.1 was detected by PCR as 
having excised spontaneously during growth, an increase in speC gene copies was not generally observed. This 
suggests that while induction may occur, it is not necessarily followed by extra-chromosomal replication of the 
element, demonstrating that prophage induction, but not replication and induction of the phage lytic cycle may be 
required for the enhancement of speC expression. A similar phenomenon has been observed in 
enterohaemorrhagic E. coli 0157, wherein expression of shiga toxin (Stx1 and/or Stx2) and the elicitation of the 
lethal effect in a murine model of shigellosis, requires only prophage induction, not necessarily replication and 
the assembly of phage particles (Balasubramanian et al., 2019). CovS variant BSAC_bs1388 (36aa-STOP), and 
CovR variant BSAC_bs1802 (Gly91Asp) exhibited a marked increase in speC gene copies, suggesting the 
speC/spd1 prophage of these isolates may have been undergoing replication, though the association with CovRS 
may be merely coincidental, and it must be noted that in BSAC_bs1802, this prophage is unlike any other in the 
emm4 population both in our collection, nor indeed the international population (Remmington et al., 2020). The 
prophage conformation PCR detected excision in these two isolates at eight hours, but not as strongly as might be 
expected. 
 
The expression of spd3 was similar between M4complete and M4degraded isolates, and did not appear to be growth-
phase dependent, despite the capacity for 10750.2 to induce, whilst 427.2 could not. Expression of ssa was 
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also very similar between the emm4 isolates, regardless of whether or not the prophage was degraded, and despite 
10750.3 being inducible, while 427.3 was not. It was curious that neither spd3 nor ssa appeared to be growth-
phase dependent, as are many other virulence genes in S. pyogenes, including those which are encoded by 
prophage (Chaussee et al., 2008; Turner et al., 2009; Unnikrishnan et al., 1999). This suggests that perhaps, to 
attain enhanced expression of these genes, in emm4, excision of one or more of these prophage may be 
unnecessary, as appears to be the case for speA in emm3, albeit under different conditions and against a very 
different genetic background (Banks et al., 2003).  
 
Inasmuch as these observations held true for the majority of the emm4 prophage, one isolate was discordant; 
BSAC_bs1802. Despite clustering with MEW427 by core SNPs, this isolate was dissimilar to the other BSAC 
isolates belonging to the M4degraded lineage, and indeed, the international emm4 population at large, in a number 
of ways. 1802.1, (the speC/spd1-associated prophage of this isolate) is most similar (~99%) to prophage present 
in emm28 MGAS29284 (Kachroo et al., 2019), and could be induced and notably, a subtle increase in intensity 
in induction of 1802.1 was observed at 8-hours. Gene copies of speC also were markedly higher at this 
timepoint, which was not observed for the majority of the other emm4 isolates. Intriguingly, this did not appear 
to evoke an appreciable enhancement in speC transcription for this isolate. 427.2 of BSAC_bs1802 is identical 
to that of the other M4degraded BSAC isolates, and similarly, could not be induced to excise, and expression of spd3 
was unremarkable. 10750.3 of BSAC_bs1802 was readily inducible, though again, expression of ssa by this 
isolate was unremarkable. 
 
Published reports that describe the growth-phase dependent control of DNA MMR operon gene expression by 
SpyCI integration and excision (Nguyen and McShan, 2014; Scott et al., 2012) were, unexpectedly, not supported. 
It was interesting to note that in both M4complete and M4degraded with complete and degraded SpyCI, respectively, 
the element did not was not induced by mitomycin C, nor was SpyCI induced during bacterial growth at any 
timepoint tested. Further, transcripts for both mutS and mutL were readily detected in all BSAC emm4 at 3 hours 
growth, when excision of the element and expression of the operon were purportedly minimal according to 
existing reports (Nguyen and McShan, 2014; Scott et al., 2012). These data thus suggest that expression of the 
DNA MMR operon may not be regulated in this way in genotype emm4.  
 
Taken together, the data in this chapter clarify that for the large part, M4degraded isolates, which exhibit marked 
gene loss in prophage-encoding regions, have been rendered immobile; are not induced during bacterial growth 
in THB; nor can they be induced experimentally with mitomycin C. It was hypothesised that this may be due to 
the loss of functional prophage modules dedicated to regulatory and replicative modules, and owing in part to loss 
of function mutations to prophage-encoded integrase genes in 427.2 and 427.3. Yet, with the possible 
exception of speC, this did not appear to evoke differential expression of spd3 and ssa between isolates of the two 
lineages. These data might not necessarily reflect expression in more realistic and infection-relevant systems, for 
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example, expression and induction might be appreciably different on co-culture with human cells, or using ex-
vivo or in-vivo models (Banks et al., 2003; Broudy et al., 2002, 2001; Sitkiewicz et al., 2010; Virtaneva et al., 
2005; Zhu et al., 2020, 2017). The possible phenotypic consequences of these observations in more infection-
relevant conditions were therefore explored in subsequent chapters. 
 
 Chapter 4: Key findings 
 Degraded prophage present in the genomes of M4degraded isolates could not be induced experimentally, 
nor were they induced throughout bacterial growth 
 Conversely, complete or full-length prophage of M4complete isolates were inducible experimentally and 
were weakly induced during growth 
 M4complete isolates expressed more speC in THB at eight hours than did M4degraded isolates 
 Increased expression of speC at eight hours by M4complete was not associated with an increase in speC 
copy number 
 Expression of spd3 and ssa was comparable between M4complete and M4degraded throughout bacterial 
growth and did not appear to be dependent on growth-phase 
 SpyCIM4 could not be induced in M4complete or M4degraded and did not appear to regulate the expression of 
















 Chapter 5 
5. Phenotypic characterisation of emm4 isolates 
5.1 Introduction 
Emergent S. pyogenes lineages are often characterised by marked phenotypic modulations relative to their 
ancestral clones. Frequently, such lineages are associated with the loss and/or acquisition, or differential regulation 
of bacterial virulence factors encoded by mobile genetic elements (Afshar et al., 2017; Al-Shahib et al., 2016; 
Kachroo et al., 2019; Lynskey et al., 2019a; Nasser et al., 2014; Turner et al., 2019b, 2015; Zhu et al., 2015b, 
2015a). There have been a number of broad phenotypic S. pyogenes studies incorporating singular or small 
numbers of emm4 isolates (Flores et al., 2012; Galloway-Peña et al., 2018; Henningham et al., 2014; Loh et al., 
2013; Menschner et al., 2020), and studies to characterise specific molecular mechanisms within the genotype 
(Galloway-Peña et al., 2018; Vega et al., 2020). However, genotype emm4 S. pyogenes, in spite of their disease 
burden and global prevalence (Efstratiou and Lamagni, 2016), have not been subject to robust phenotypic 
characterisation hitherto. This is certainly the case when one reflects on the many largescale studies that have 
greatly enhanced our understanding of other major emm-types, and associated lineages thereof (Walker et al., 
2007; Tse et al., 2012; Venturini et al., 2013; Turner et al., 2015; Walker, 2015; Afshar et al., 2017; Kachroo et 
al., 2019). 
 
Work in Chapter 3 determined that genotype emm4 isolates in the BSAC collection were associated either with 
the M4complete lineage, or the M4degraded lineage. Further, it was demonstrated that those isolates associated with the 
M4degraded lineage, were incapable of prophage induction, while the prophage of M4complete could be induced to 
excise. With the exception of speC transcription, which was elevated at 8-hours growth, and higher in M4complete, 
than M4degraded, growth-phase dependent expression of prophage toxin genes spd3 and ssa was not observed, and 
transcription of spd3 and ssa were similar between isolates of both lineages. Analysis of pangenome data and 
regulator sequence analyses also revealed a number of additional lineage- and isolate-specific SNPs that could 
conceivably contribute to a differential phenotype that may be associated with either groups of isolates, such as 
the fusion of emm and enn among M4degraded isolates, or naturally occurring CovRS variants, as described in 
Chapter 3. 
 
5.2 Chapter hypotheses and aims 
With a clear phylogenetic distinction between M4complete and M4degraded isolates, and the demonstrable for M4complete 
prophage to induce, while M4degraded could not, it was hypothesised that these differences might evoke a polarising 
phenotype between isolates belonging to either lineage. The phenotypic consequences of additional lineage- and 
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isolate-specific SNPs, beyond those pertaining to prophage gene content, were also considered. As such, the work 
described in this chapter sought to characterise these isolates using a number of well-described models and 
systems that have been applied to characterise S. pyogenes, and other pathogenic streptococci. 
 
5.3 Methods 
 Lancefield assay 
Overnight S. pyogenes cultures were diluted 1:5 in fresh THB (Oxoid) and grown to an OD600 of 0.3. Cultures 
were briefly vortexed, and diluted 1:10,000 in sterile PBS (Gibco) to achieve inocula of approximately 50-100 
CFU/mL and 30 L aliquots were plated on THA to determine CFU/mL for confirmation. Blood was freshly 
drawn by venepuncture from two healthy human donors, and 170L of heparinised blood was transferred to 
1.5mL tubes and inoculated with 30 L S. pyogenes/PBS suspension, in triplicate, per isolate. Samples were 
placed in a rotary for gentle mixing, and incubated at 37°C for 3 hours. At the end of the incubation, 10L was 
plated in triplicate from each of the three tubes, for all emm4 isolates and used to inoculate THA to determine 
CFU/mL. A multiplication factor was calculated by dividing the mean final CFU/mL per tube, by the CFU/mL of 
the corresponding inocula (Lancefield, 1959). 
 
 Superantigenicity assay 
The superantigenic activity of M4complete and M4degraded emm4 isolates was measured by BrdU incorporation ELISA 
kit (Roche) per manufacturers guidelines (methods section 2.1.8). Overnight cultures for all BSAC emm4 isolates 
were grown in RPMI +10% (v/v) FCS (Gibco), incubated overnight at 37°C in an atmosphere enriched with 5% 
(v/v)  CO2. Genotype emm1 strain H305 was included as a well characterised, highly superantigenic internal 
control (Sriskandan et al., 1999; Turner et al., 2012; Unnikrishnan et al., 2002). Overnight cultures were 
centrifuged at 10,000 x g for 15 minutes and supernatants filter sterilised through 0.2  filters (Sartorius, AG, 
VWR). 
 
Whole blood was drawn from healthy donors and diluted 1:1 with pre-warmed 37°C PBS (Gibco). Ficoll-Paque 
(Amersham Pharmacia Biotech) was overlaid with an equal volume of blood:PBS and centrifuged at 800 x g for 
35 minutes at room temperature. The buffy coat was carefully aspirated with a sterile Pasteur pipette and washed 
once with pre-warmed 37°C Hanks’ Balanced Salt Solution (Gibco) at 800 x g for 10 minutes at room temperature. 
The resultant human PBMC pellet was resuspended in pre-warmed RPMI (+10% (v/v) FCS) with 50 U/mL 
penicillin and 50g/mL of streptomycin (Sigma) and seeded in 96-well plates (Corning) at 2x105 cells per well, 
in a volume of 200 L. 20 L of sterilised culture supernatant was added to triplicate wells and incubated for 120 
hours incubation in a humidified environment supplemented with 5% (v/v)  CO2 at 37°C. A negative control of 
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fresh RPMI +10% (v/v) FCS was included as a negative control; absorbance values of which were deducted from 
sample absorbances, which were then expressed as the mean of technical triplicates.  
 
 Galleria mellonella virulence assay 
Overnight cultures of emm4 isolates were washed twice in pre-warmed PBS to remove secreted toxins and waste 
products. Groups of 10 wax moth larvae (Galleria mellonella) (LiveFoods Direct Ltd, Sheffield, UK) were 
infected with 105-106 CFU per larvae, with one of each of the ten BSAC emm4 S. pyogenes by injection with an 
ultra-fine insulin needle (BD) at the base of the left hind proleg, as standardised previously (Afshar et al., 2017; 
Loh et al., 2013; Olsen et al., 2011). Larvae were then incubated in petri dishes lined with filter paper at 37°C, in 
an atmosphere supplemented with 5% (v/v) CO2. Larvae were scored for survival every 24 hours for 7 days. An 
uninfected PBS control group was included per experiment. 
 
 Gram’s crystal violet adhesion assay 
Bacterial adhesion was assayed using an established method, with modification (O’Toole, 2011), which has been 
applied to S. pyogenes (Turner et al., 2015). Overnight cultures of BSAC emm4 isolates and emm6 control strain 
BSAC_bs2438 were diluted 1:10 in fresh THB, and 150 L was pipetted into triplicate wells, per isolate. Sterile 
THB was used as a negative control, triplicate averages of which was deducted from triplicate averages of test 
wells and the internal control. Plates were incubated for 24 or 48 hours, as indicated, at 37°C in an atmosphere 
supplemented with 5% (v/v)  CO2. Isolates were assayed for adhesion to ECM components by pre-treating 96-
well polystyrene cell culture plates (Corning) with 50g/mL of either fibronectin (Sigma), fibrinogen (Sigma), 
and type IV collagen (Sigma), overnight at 4°C. Treated plates were washed once with sterile PBS prior to 
inoculation and incubation, as above. Following incubation, supernatants and non-adherent bacteria were 
discarded, and wells washed twice with water, before staining with 120 L 0.1% (w/v) Gram’s Crystal Violet 
(Sigma) at room temperature for 10 minutes. Excess stain was discarded, and plates washed twice in water before 
being blotted onto paper towels. Gram’s stain was solubilised by the addition of 120 L 100% (v/v) ethanol 
(Sigma), and incubated at room temperature for 10 minutes. Absorbance was measured at OD600 by 
spectrophotometry, samples were measured in triplicate. Where values are expressed as % difference of the 
internal control, this was achieved by dividing the sample mean OD600 by the positive control mean OD600, and 
multiplying by 100 to achieve a percentage. 
 
5.4 Results 
 Growth in THB 
To determine whether the two emm4 lineages exhibited a difference in growth characteristics, BSAC emm4 
isolates were grown in THB (Figure 5.1). Isolates were cultured exponentially and OD600 determined by 
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spectrophotometry each hour for eight hours. Aliquots were taken at 3, 5 and 8 hours (determined to be early-, 
mid- and late-log cultures, respectively) to determine CFU/mL.  No significant difference was observed between 
M4complete and M4degraded isolates in liquid culture (p=0.6905, Mann-Whitney) or by plating for viable counts 




Figure 5.1. Growth characteristics of emm4 isolates 
A) Exponential growth in THB was not significantly different between M4complete (solid black line, black circles) and M4degraded 
isolates (dotted black line, white circles) (p=0.6905, Mann-Whitney on Area under curve values for complete and degraded 
isolates). Data represent the mean (±standard deviation) from three biological repeats of five M4complete isolates, and five 
M4degraded isolates. B) CFU/mL similarly determined that there was no significant difference in CFU/mL in liquid culture 
between M4complete and M4degraded (p=>0.9999, Kruskal-Wallis). Data represent the mean of five M4complete isolates (solid black 
line, black circles), and five M4degraded isolates (dotted black line, white circles). 
 
 Lancefield assay: survival of emm4 in whole human blood 
Although growth in bacteriological media was similar between isolates associated with either lineage, it was 
important to ascertain whether these observations might be expanded to more physiologically relevant conditions. 











































With this in mind, isolates were grown in whole human blood, a well described phenotypic assay to measure S. 
pyogenes replication ex-vivo (Lancefield, 1959; Reglinski et al., 2016; Todd, 1927). The isolates from either emm4 
lineage survived comparably well in whole human blood on the first (Figure 5.2A) and second occasions (Figure 
5.2B). In each case one isolate grew slightly better than the other emm4, on both occasions this was an M4degraded 




Figure 5.2. Survival of emm4 isolates in whole human blood. 
A) There was no significant difference in the survival M4complete (black circles) and M4degraded isolates (white circles) 
(p=>0.9999, Mann-Whitney). Strains were grown in triplicate using a single healthy donor and multiplication factor was 
calculated by dividing the mean final CFU/mL per isolate, by the CFU/mL of the corresponding inoculum after three hours 
incubation. B) The experiment was repeated with a second healthy donor, and yielded similar results; again, no significant 
difference was observed between M4complete (black circles) and M4degraded isolates (white circles) (p=>0.4206, Mann-Whitney). 
Variant covS isolates BSAC_bs468 and BSAC_bs1388 are indicated with a red and a blue circle, respectively. Variant covR 
isolate BSAC_bs1802 is indicated with a yellow circle. Horizontal bars indicate the median. 
 
 Superantigenicity of emm4 culture supernatants 
Culture supernatant filtrates harvested from fresh overnight cultures of the BSAC emm4 isolates grown in RPMI 
+10% (v/v) FCS were assayed for their mitogenicity towards human lymphocytes. The supernatants collected 
from M4complete isolates were comparable in superantigenic activity to those collected from M4degraded isolates, and 

































































Figure 5.3. Superantigenic activity of emm4 isolates 
Superantigenic activity of overnight culture supernatants from emm4 isolates towards human peripheral blood mononuclear 
cells. There was no significant difference in superantigenic activity in overnight culture supernatant filtrates from M4complete 
(black circles) and M4degraded (white circles) isolates (p=0.4206, Mann-Whitney), emm1 strain H305 (red star) was included 
as a well-characterised positive control. Isolates were grown overnight at 37°C with 5% (v/v) CO2 in RPMI media, 
supplemented with 10% (v/v) FCS. Human lymphocytes were isolated by Ficoll-Paque gradient, and stimulated with fresh 
filtered culture supernatants. Mitogenicity of human T-lymphocytes was measured by ELISA to detect BrdU incorporation, 
and expressed as OD450. Data represent the mean OD450, minus the mean OD450 of the sterile media negative control. 
Lymphocytes were harvested from one donor and samples were measured in triplicate. Horizontal bars indicate the median. 
 
 Galleria mellonella virulence assay with emm4 isolates 
To assay for general differences in virulence between M4complete and M4degraded, the Galleria mellonella infection 
model was used. This model is well described for assaying general virulence in S. pyogenes (Afshar et al., 2017; 
Chalmers et al., 2017; Loh et al., 2013; Olsen et al., 2011).  Larvae were infected at 105-106 CFU per larvae, and 
unexpectedly, M4complete isolates were found to be significantly more virulent than M4degraded isolates (p=0.0016, 
Mantel-Cox log rank test) (Figure 5.4A). The experiment was repeated in its entirety with a second batch of larvae, 
using a similar dose, and again, significantly enhanced virulence was observed in M4complete isolates relative to 
M4degraded isolates (p=0.0014, Mantel-Cox log rank test; Figure 5.4B). When the experiment was repeated a third 
time using a lower dose (104-105 CFU per larvae), the findings were recapitulated, again demonstrating the 
















   
Figure 5.4: Galleria mellonella virulence assay 
 
A) M4complete isolates (solid black line) are significantly more virulent than M4degraded (dotted black line) in a wax moth larvae 
model of invasive disease (p=0.0016, Mantel-Cox Log-rank test). 50 larvae per group (ten larvae per isolate) were infected 
with 105-106 CFU per larvae, incubated at 37C, and scored for survival every 24 hours for seven days post infection. B) 
Repeating the experiment, a second time on a second batch of larvae, yielded similar results (p=0.0014, Mantel-Cox Log-
rank test). C) The entire experiment was repeated with a third batch of G. mellonella larvae but a lower dose of 104-105 CFU 
per larvae and yielded similar results, again demonstrating increased virulence associated with M4complete emm4 isolates, 
compared to M4degraded isolates (p=0.0012, Mantel-Cox Log-rank test). 































































 Biofilm formation and adhesion of emm4 isolates 
The capacity for biofilm formation and adhesion to a number of substrata were explored in a project co-supervised 
by the author, in collaboration with MSc student Jordan Finlay, using standard crystal violet adhesion assays in 
96-well plates (Corning). Genotype emm4 S. pyogenes were found to be capable of forming robust biofilms after 
24-hours. There were no major differences observed in the adhesion to polystyrene by isolates of either lineage, 
though M4complete isolates did slightly exceed the adhesion of M4degraded at both 24- and 48-hours. At both 
timepoints, a single M4complete isolate, BSAC_bs1349, demonstrated higher adhesion than did the other isolates, 
this was most obvious after 24-hours, though this difference narrowed after 48-hours, as did the difference 
between M4complete and M4degraded (Figure 5.5). 
 
 
Figure 5.5: Adhesion of emm4 isolates to polystyrene 
Adhesion of emm4 isolates to polystyrene 96-well plates when cultured in THB, as determined by Gram’s crystal violet 
adhesion assay. At both 24- and 48-hours, M4complete isolates (black circles) adhered marginally better to polystyrene than did 
M4degraded isolates (white circles). This was not statistically significant at 24- (p=0.2222, Mann-Whitney) or 48-hours 
(p=0.2222, Mann-Whitney).  The mean of triplicate negative control wells (sterile THB) was deducted from OD600 of test 
wells. Data represent the mean of four experimental repeats, measured in triplicate on each occasion. Horizontal bars indicate 
the data median.  
 
S. pyogenes is exquisitely attuned to the human host, and expresses a litany of virulence factors and adhesins to 
attain colonisation, carriage and infection (Brouwer et al., 2016). Thus, the adhesion of genotype emm4 isolates 
to physiologically important substrates, fibronectin, type IV collagen and fibrinogen, was tested. The crystal violet 
assay was applied to 96-well plates pre-coated with each substrate, and optical densities were expressed as 
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percentage change relative to internal positive control emm6 BSAC_bs2438, which was included on each 96-well 
plate. This isolate was shown in prior work in this laboratory to adhere robustly, consistently and reproducibly 
under a variety of conditions. After 24-hours incubation, emm4 isolates of both lineages adhered comparably to 
wells coated with fibronectin and type IV collagen, albeit being less adherent than the emm6. However, enhanced 
adhesion, (comparable to, or in excess of the control emm6 isolate) was observed when emm4 were cultured in 
plates pre-treated with fibrinogen. A single M4degraded isolate, BSAC_bs1802, adhered better than did the other 
emm4 isolates of both lineages in wells treated with fibrinogen (Figure 5.6). 
 
 
Figure 5.6: Adhesion of emm4 isolates to eukaryotic substrata 
Polystyrene plates were pre-coated with fibronectin, collagen IV and fibrinogen and emm4 isolates assayed for adhesion, 
relative to OD600 internal control emm6 isolate BSAC_bs2438 after 24-hours incubation in THB. Samples were measured in 
triplicate, and OD600 of negative control wells (sterile THB) was deducted from all sample and positive control wells. The 
percentage OD600 of positive control was calculated by dividing triplicate means of sample wells by triplicate mean of the 
positive the control, multiplied by 100 to yield a percentage. Data indicate a single experimental repeat. Horizontal bars 
indicate data median. 
 
5.5 Discussion 
The data in this Chapter successfully characterised emm4 isolates by growth in THB and whole human blood, and 
in terms of virulence in the G. mellonella model. Growth of M4degraded and M4complete isolates was very similar both 
in THB, and in whole human blood. Superantigenic activity, although challenging, irreproducible, and thus open 
to interpretation, appeared to demonstrate comparable superantigenicity of overnight RPMI +10% (v/v) FCS 
supernatant filtrates derived from isolates belonging to either emm4 lineage. Perhaps most intriguingly, M4complete 
were significantly more virulent than M4degraded in a G. mellonella model of infection. 
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There was no demonstrable growth phenotype associated with isolates from either lineage when measured by 
optical density or CFU/mL at 3-, 5-, and 8-hours of growth in THB (Figure 5.1), indicating that none of the 
lineage-specific (or isolate-specific) SNPs contribute significantly growth under these conditions. These data 
would also appear to preclude the possibility for spontaneous prophage induction and bacterial lysis, if correlated 
with a specific timepoint, to be sufficient to evoke a drop in viable bacterial counts. This was expected, as data in 
Chapter 4 suggested this would not be the case. 
 
Despite being genetically acapsular, emm4 isolates survived and grew well in whole human blood, in 
corroboration with the burgeoning body of published literature that the HA capsule is inessential for whole blood 
survival, certainly in specific genotypes (Flores et al., 2012; Henningham et al., 2014; Turner et al., 2015), and 
both M4complete and M4degraded isolates survived comparably in both donors. There was some variation between the 
two donors used, but this did not appear to be due to specific immunity to M4.The two isolates carrying variant 
CovS isoforms, BSAC_bs468 (Thr241Pro and Ala379Thr), BSAC_bs1388 (36aa-STOP), and BSAC_bs1802, 
and the isolate carrying a variant covR allele (Gly91Asp), did not exhibit enhanced growth relative to the other 
emm4 isolates. The emm/enn splicing event identified in M4degraded isolates in Chapter 3 does not appear to enhance 
or diminish survival in whole human blood, at least in this population of emm4 isolates, and using these donors. 
 
The superantigenicity of overnight culture supernatants collected from emm4 isolates was not significantly 
different between M4complete and M4degraded isolates (Figure 5.3). This may be accurate, however, the BrdU ELISA 
implemented here inherently lacks the power to discriminate between the activity of each superantigen present in 
the respective isolates and therefore can only detect overall activity. Regardless of this fact, it was unexpectedly 
challenging to generate reproducible data using the Roche BrdU ELISA kit on multiple attempts, and it did not 
seem to be amenable to the intended application. Certainly, the observation that internal control H305 appeared 
less mitogenic than emm4 isolates, was noted with suspicion.  
 
Previous studies suggest that recombinant SMEZ appears to be more potent than SpeC, while both appear to be 
more potent still than SSA (Afshar et al., 2017; Nooh et al., 2006; Proft and Fraser, 2016; Reglinski et al., 2019). 
Very recent work describes a mechanism by which the release and activity of SSA is dependent on SLO mediated 
glutathione efflux (Brouwer et al., 2020). As such, the activity of SSA might be further diminished under the 
conditions described here, due to a possible paucity of glutathione, posing further potential technical difficulties 
in extracting meaningful data from the assay, particularly in the absence of isogenic mutants. Future work may 
thus benefit from the supplementation of culture supernatants with this antioxidant. CovS variant isolates 
BSAC_bs468 (Thr241Pro and Ala379Thr) and BSAC_bs1388 (36aa-STOP), and CovR variant BSAC_bs1802 
(Gly91Asp) were not significantly more superantigenic than other emm4 isolates. The major regulator CovRS has 
been reported to repress the expression of prophage-encoded virulence factors, including the streptococcal 
superantigen speA (Sumby et al., 2006). Although genotype emm4 isolates do not typically carry speA, nor was it 
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detected in any of the BSAC emm4 isolates, it was possible that against the emm4 background, CovRS regulated 
the expression of ssa, smeZ and/or speC in RPMI +10% (v/v) FCS, in which overnight cultures for this specific 
assay were grown, might vary. 
 
The observation that M4complete isolates were more virulent than M4degraded isolates was unexpected, although the 
majority of larval death occurred within 24-hours of challenge in all three experiments. Although G. mellonella 
larvae are insensitive to streptococcal superantigens, lacking an adaptive immune system, this model is sensitive 
to secreted nucleases and a number of other streptococcal virulence factors (Huang et al., 2015; Olsen et al., 
2011). Data in Chapter 4 demonstrated a difference in the expression of speC at 8-hours growth in THB, which is 
co-transcribed with the DNase spd1 (Broudy et al., 2002). It was therefore conceivable that a similar phenomenon 
was occurring during G. mellonella, which were assayed for 7 days. A number of subsets of haemocytes in G. 
mellonella also have phagocytic capacity, and extrude structures similar to NETs (Altincicek et al., 2008; Olsen 
et al., 2011), so it is possible that enhanced DNase activity, inferred by polarised expression of speC among 
M4complete isolates relative to M4degraded isolates, could explain these findings. Though equally, this could also be 
due to chromosomally-encoded, secreted DNases, which were not measured. 
Empirical evidence of S. pyogenes as being heavily reliant on fomite persistence and environmental reservoirs 
such as children’s toys and other inert surfaces, are both scant and conflicting (Efstratiou and Lamagni, 2016; 
Ingham et al., 2006; Marks et al., 2014b). Typically, transmission requires contact, or shared vicinity with 
members of the community, such as family members or healthcare workers, who may be colonised and carrying 
S. pyogenes or are experiencing clinical disease, whereby exposure to infectious respiratory droplets or colonised 
tissue can be achieved (Afshar et al., 2017; Flores et al., 2017; Galloway-Peña et al., 2016; Turner et al., 2013). 
As a human-restricted pathogen, however, the capacity for S. pyogenes adhere both to and persist within the host 
is undeniable (Ryan and Juncosa, 2016), so it was apposite to attempt to probe these associations. In this case with 
emm4 isolates appeared to exhibit a predilection for fibrinogen, relative to other tested substrata, and certainly in 
preference to polystyrene, relative to other substrates. The reason for this is unclear, however, it has been 
suggested that a number of M4- and M-like proteins of emm4 may mediate fibrinogen binding, with variable 
success (Courtney et al., 2006b; Podbielski et al., 1996). The acapsular nature of emm4 may also play a role 
(Flores et al., 2012). In S. pneumoniae, prophage induction has been associated with enhanced biofilm formation 
(Carrolo et al., 2010). Under the conditions explored herein, if this does contribute to the adhesion of emm4 with 
inducible prophage, it does not appear to be a major mechanism. 
 
Taken together, the data in this Chapter, and those before it, raise a number of questions regarding how emm4 
isolates, both M4complete and M4degraded, might behave in more faithful reproductions of the host-pathogen interface. 




 Chapter 5: Key findings 
 Both M4complete and M4degraded isolates grew comparably in THB and survived and multiplied comparably 
in whole human blood 
 Adhesion to polystyrene and eukaryotic substrata was also comparable between both M4complete and 
M4degraded 
 Using a crude model to assay overall virulence, G. mellonella infection experiments suggested that 
M4complete isolates may be more virulent than M4degraded 
























6. Modulation of superantigen expression by HTE co-culture 
6.1 Introduction 
 
S. pyogenes is a dynamic pathogen capable of causing a variety of human diseases both at distinct anatomical sites 
such as the skin or tonsil, and systemically, surviving in blood and lymph and even within immune cells such as 
neutrophils and macrophages (Armitage et al., 2019; Carapetis et al., 2005; Cunningham, 2000; Lynskey et al., 
2015; O’Neill et al., 2016; Siggins et al., 2020; Valderrama and Nizet, 2018). In order to economise, the bacterium 
must adapt, regulate and coordinate the expression of specific necessary genes at each stage of infection and 
within each niche, and minimise the expression of genes that are not useful (Banks et al., 2016; Broudy et al., 
2002, 2001; Kachroo et al., 2019; Sitkiewicz et al., 2010; Virtaneva et al., 2005; Zhu et al., 2017). This Chapter 
will focus on the primary infection site of S. pyogenes, the human tonsil, and the role of prophage-encoded 
virulence factors at this critical interface between host and pathogen. Streptococcal superantigens appear to play 
a role in host colonisation (Afshar et al., 2017; Zeppa et al., 2017) and modulating immunity in the human tonsil 
to benefit the pathogen (Davies et al., 2019). The role of the streptococcal DNases, the putative pathogenic 
influence of which was, until relatively recently, largely thought to be constrained to promoting the expedition of 
ensnared streptococci from NETs (Buchanan et al., 2006; Derré-Bobillot et al., 2013; Ma et al., 2017; Sumby et 
al., 2005a), may also promote infection and colonisation in the nasopharynx (Afshar et al., 2017), and may even 
act in synergy with the streptococcal superantigens to this end (Brouwer et al., 2020). 
 
It was previously reported that co-culture of S. pyogenes with human pharyngeal cells induced toxigenic prophage 
and increased expression of SpeC and Spd1, as inferred by plaque enumeration, Western blot, and visualisation 
of phage particles (Broudy et al., 2002, 2001). The former study described (though did not demonstrate) that a 
similar inducing effect had been observed following co-culture of S. pyogenes and a breast cancer (mcf-7) cell 
line. A study published the following year, using emm3 strain MGAS315, infers prophage induction by PCR to 
detect toxin genes in purified phage DNA extracts, derived from supernatant filtrates recovered following co-
culture, using speB as a control for contaminating genomic DNA (Banks et al., 2003). Of the five canonical emm3 
prophage, co-culture appears to increase the induction of Φ315.4 and Φ315.6, carrying speK/sla and sdn, 
respectively. Evidence of the remaining prophage in filtrates were undetectable. Subsequent RT-qPCR analyses 
demonstrated that transcription of sdn was enhanced, whereas speK transcripts were found to decrease, while 
transcripts of sla increased. This was mirrored in quantities of these toxins detected in filtrates, as determined by 
Western blot. Notably caveats to these experiments are that MGAS315 does not carry an speC/spd1 prophage 
(Al-Shahib et al., 2016; Beres et al., 2002), the authors do not measure ssa transcripts, nor SSA toxin expression, 




As the published literature stands, the authors suggest that a specific molecule secreted by human cells is 
responsible. This is referred to specifically in the earlier two of the three studies, and hereafter, as SPIF (soluble 
phage inducing factor) (Broudy et al., 2002, 2001). The identity of SPIF is not known, and at the time of writing, 
identification and characterisation of the molecule does not appear to have continued. Earlier work suggests that 
SPIF may be a soluble molecule of <10kDa in size that is resistant to protease digestion, heating to 100C, and 
storage at -20C over a number of months (Broudy et al., 2001). 
 
In Chapter 4, it was shown that in THB, spontaneous prophage induction did not convincingly correlate with a 
specific bacterial growth timepoint. Additionally, with the exception of speC transcription, which was raised at 
late-log, transcription of spd3 and ssa were similar between lineages, and across timepoints in THB. The elevated 
transcription at 8-hours of speC, as observed in Chapter 4, did not appear to be associated with an increase in 
speC gene copies. Reflecting on these published data, and the data described in the present work, it was apposite 
to determine if tonsil cells were able to induce 10750.1/427.1, 10750.2/427.2, and 10750.3/427.3, and 
further, to determine if these cells could enhance the expression of cognate toxins. 
 
6.2 Chapter hypotheses and aims 
Work described in this Chapter continued prior efforts to demonstrate a polarising phenotype between M4complete 
like and M4degraded isolates. These isolates were studied in a more physiologically- and infection-relevant system, 
one designed to emulate the conditions of the host-pathogen interface between S. pyogenes and its primary 
anatomical niche; the human tonsil. Under these conditions, the hypothesis that differential prophage induction 
between M4complete and M4degraded described in previous chapters could elicit a polarising phenotype of prophage-
associated toxin expression was tested, to unexpected and insightful effect. The co-culture model was also applied 




 Storage and recovery of HTE cells and A549s 
All human cells were maintained in liquid nitrogen at -80C until required. For recovery, cells were thawed swiftly 
by gentle swirling in a water bath at 37C. Thawed 1 mL suspensions were then transferred to sterile 15 mL tubes 
and washed in 9 mL pre-warmed media, and supernatant discarded. The pellet was resuspended in either 5 mL or 
10 mL of pre-warmed media and transferred to T25 or T75 flasks (Corning), respectively. Flasks were incubated 
in a humidified environment at 37 C, supplemented with 5% (v/v) CO2 for 24 hours, before the media was 
changed to remove any residual DMSO. For splitting and seeding, cells were washed twice with pre-warmed PBS 
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and trypsinised using 1X Trypsin-EDTA solution (Insight Biotechnology) as and when appropriate, with digestion 
blocked using 10% (v/v) FCS. 
 
 S. pyogenes co-culture with HTE cells and A549s  
Lifted and resuspended HTE cells were live-dead stained using Trypan Blue (Sigma) enumerated using an 
Improved Neubauer counting chamber (Sigma) and seeded into 6-well plates (Corning) at 1.25 x 105 cells/mL 
(2.5 x 105 cells/well) in Green’s (flavin and adenine rich) Media (prepared per methods section 2.1.5), without 
antibiotics and incubated overnight to confluence. Overnight cultures of S. pyogenes were washed twice with pre-
warmed RPMI +10% (v/v) FCS, and adjusted to OD6001.0 in pre-warmed RPMI +10% (v/v)  FCS, and diluted by 
a further 1:5 to achieve an approximate MOI of 100 (1 x 107 CFU). An aliquot of each was retained for plating 
for CFU/mL enumeration. Prior to use, HTE monolayers were washed twice in pre-warmed RPMI +10% (v/v) 
FCS, which was then discarded to remove residual Green’s Media and cellular debris. 2 mL of the adjusted S. 
pyogenes suspension was added to each well containing either HTE monolayers, or empty wells intended to 
incubate 2 mL of the adjusted S. pyogenes RPMI +10% (v/v) FCS suspension alone. For RNA extraction, two 
HTE-seeded wells and two empty wells were used per isolate to ensure extraction of sufficient quantities of RNA. 
Single wells proved sufficient for DNA extraction, for both HTE-seeded wells, as well as those containing the 
adjusted bacterial/ RPMI +10% (v/v) FCS suspension alone. Once inoculated, plates were incubated for 6-hours 
in a humidified atmosphere at 37C, supplemented with 5% (v/v) CO2. At the end of the experiment, 100 L 
aliquots were removed for plating and CFU/mL enumeration from each well. For RNA extraction, isolate- and 
culture condition-matched wells were homogenised by pipetting, pooled and subsequently processed as a single 
sample, immediately, as previously described in the main methods (section 2.2.3). Wells from which DNA was 
to be extracted were homogenised, pelleted by centrifugation, and frozen at -20C until extraction proceeded as 
described in the main methods (section 2.2.2). 
6.4 Results 
 Growth of S. pyogenes in RPMI +10% (v/v) FCS and following HTE co-culture 
HTE wells seeded at 1.25 x 105 cells per mL (2.5 x 105 /well) were inoculated at an intended bacterial multiplicity 
of infection of 100, and a range of between 1 x 106 and 1.16 x 108 CFU/mL was achieved across experiments. All 
co-culture experiments were carried out using RPMI +10% (v/v) FCS, following noted and undesirable 
differences in fold-change between CFU/mL of bacterial inocula and CFU/mL post-incubation, between S. 
pyogenes cultured either Green’s or cultured in RPMI +10% (v/v) FCS (Figure 6.1).  Both lineages multiplied 




Figure 6.1: Differential growth of S. pyogenes in Green's versus RPMI +10% (v/v) FCS 
Fold-change in CFU/mL from the bacterial inoculum to CFU/mL recovered post-incubation of S. pyogenes with either HTE 
cells and cell culture media, or S. pyogenes and cell culture media (without HTE cells) using two types of media: Green’s 
Media or RPMI +10% (v/v) FCS. A) A marked fold-increase in CFU/mL from the inoculum was observed between wells 
that contained Green’s Media and S. pyogenes alone, compared to wells containing S. pyogenes co-cultured with HTE 
monolayers in Green’s Media. B) The fold-change from bacterial inoculum CFU/mL to post-incubation CFU/mL was 
considerably less between S. pyogenes cultured in well containing RPMI +10% (v/v) FCS alone, and wells containing S. 
pyogenes and HTE monolayers in RPMI +10% (v/v) FCS. Data represent the mean of duplicate averages. Horizontal bars 
indicate the data median. 
 
 Human tonsillar epithelium does not enhance prophage induction 
To emulate more infection-relevant conditions, and to determine if human cells could induce the emm4 prophage, 
prophage induction was probed by PCR using standardised DNA extracted from the BSAC isolates following 
incubation in RPMI +10% (v/v) FCS, with or without the presence of a confluent monolayer of HTE cells. 
Unfortunately, PCR was unsuccessful for the majority of the samples, which may have been due to a high level 
of eukaryotic DNA extracted from HTE cells. The potential for HTE cells to internalise and sequestrate phage 
was also considered. Though efforts were made to homogenise co-culture wells, eukaryotic cells in these wells 
were not subject to a lysis step. Thus, representative isolates were selected from M4complete and M4degraded isolates 
for which successful PCR was achieved. 
 
Prophage induction was not detected among the prophage of the M4degraded isolate, as expected, but unusual 
M4degraded isolate BSAC_bs1802, for which 1802.1 and the near-complete 10750.3 of this isolate were found 
to be induced under both conditions. Intriguingly, for those isolates with complete prophage, although induction 
was detected, this did not appear to be consistently enhanced by the presence of HTE cells (Figure 6.2).  
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Figure 6.2: Prophage induction following co-culture with human tonsillar epithelium 
DNA was extracted from BSAC emm4 isolates grown in RPMI +10% (v/v) FCS alone, or in RPMI +10% (v/v) FCS in the 
presence of a confluent monolayer of human tonsillar epithelium (HTE), and probed by PCR for integration (In) and excision 
(Out) of 10750.1/427.1, 10750.2/427.2, 10750.3/427.3. A) 10750.1 of M4complete BSAC_bs468 and 
BSAC_bs1388 were induced comparatively under both conditions. 427.1 of M4degraded BSAC_bs192 was not induced, but 
1802.1 was induced strongly under both conditions. Arrow indicates ~400bp. B) 10750.2 of M4complete BSAC_bs468 was 
induced under both conditions tested, whereas 427.2 of M4degraded BSAC_bs400 was not. Arrow indicates ~1kb C) 
10750.3 of M4complete isolates BSAC_bs468 and BSAC_bs1388 were induced under both conditions tested, as was unusual 
M4degraded 1802.3. M4degraded BSAC_bs400, was not induced. Arrow indicates ~1kb. DNA was standardised to 40 ng/L 






 Modulation of superantigen expression following HTE co-culture 
Prophage induction was not generally enhanced when M4complete and M4degraded isolates were co-cultured with HTE 
cells. Although an increase in prophage induction and replication may elicit an enhancement in gene expression 
through the provision of a greater quantity of templates for transcription, this may not be the sole mechanism by 
which prophage-associated toxins are regulated (Banks et al., 2003). Thus, transcripts were measured to further 
explore the relationship between prophage induction and gene expression in genotype emm4 S. pyogenes by 
converting extracted RNA samples to cDNA (per section 2.2.11 of the main methods) and applying the previously 
described qPCR method, normalised to a standard curve (per 2.2.9 section of the main methods). Surprisingly, 
the expression of speC was significantly reduced following HTE co-culture (p=0.0200, Wilcoxon signed rank 
test) (Figure 6.3A), although with no major difference between M4complete and M4degraded isolates (Figure 6.3B). 
Expression of speC by CovRS variant emm4 isolates, BSAC_bs468, BSAC_bs1388 and BSAC_bs1802, were the 





   
 
Figure 6.3. Expression of speC following co-culture with human tonsillar epithelium 
A) Copies of speC transcripts were lower in RPMI +10% (v/v) FCS alone (black circles) than following co-culture with HTE 
cells (white circles) in all emm4 isolates (p=0.002, Wilcoxon signed rank test). Variant covS isolates BSAC_bs468 (red circle) 
and BSAC_bs1388 (blue circle), and variant covR isolate BSAC_bs1802 (yellow circle) expressed little speC under either 
culture conditions. Data represent RNA samples measured in triplicate and normalised to copies of speC transcript per 10,000 
transcripts of housekeeping gene gyrA. Horizontal bars indicate the median. B) Data represented as fold-change in speC per 
10,000 gyrA following co-culture with HTE cells. Similar fold change was observed between M4complete isolates (black bars) 
and M4degraded isolates (white bars). 
 
Expression of spd3 was also measured for all 10 BSAC emm4 isolates by RT-qPCR, however, transcripts were 
below the limit of detection for all isolates both in RPMI +10% (v/v) FCS alone, and following co-culture with 
HTE cells (data not shown). When expression of ssa was measured, however, this was found to be significantly 
and uniformly enhanced among emm4 isolates following co-culture, relative to culture in RPMI +10% (v/v) FCS 
alone (p=0.0020, Wilcoxon signed rank test) (Figure 6.4A). Degraded isolate BSAC_bs192 expressed more ssa 


















































































Ala379Thr), BSAC_1388 and BSAC_bs1802 (CovR; Gly91Asp) expressed ssa transcript copies than other emm4 
in RPMI +10% (v/v) FCS alone. However, following co-culture, BSAC_bs1388 and BSAC_bs1802 did not 
respond as did the other emm4 by enhancing ssa transcription. Transcript copies of ssa was similar between 
M4complete and M4degraded isolates. The fold-change in ssa transcript copies among all isolates ranged between 1.2- 





Transcription of ssa was found to be enhanced among all emm4 isolates of both lineages by HTE cells (p=0.0020, Wilcoxon 
signed rank test). The single covR variant isolate BSAC_bs1802 is denoted with a yellow circle. Isolates with variant covS 
alleles, BSAC_bs468 and BSAC_bs1388, are indicated as red and blue circles, respectively. Data represent the mean of three 
individual experiments and horizontal bars indicate data median. B) Data presented as average fold-change in ssa transcript 
copies between emm4 isolates cultured in RPMI +10% (v/v) FCS alone, and following co-culture with HTE cells. No major 
difference was observed between M4complete isolates (black bars) and M4degraded isolates (white bars). Data represent the mean 
(+ standard error) of three independent RNA samples measured in triplicate and normalised to copies of ssa transcript per 























































































 Expression of ssa was also enhanced by A549 cells 
To determine if the phenomenon reported in the present work was tonsil-specific, the co-culture experiment was 
repeated with A549 cells, a pneumocyte cell line, and a smaller sample from the same 10 emm4 isolates: 
BSAC_bs192, BSAC_bs696, BSAC_bs916, BSAC_bs1052. A459 cells did elicit an increase in ssa transcript 
copy number among the isolates tested (Figure 6.5A). Neither M4complete nor M4degraded isolates expressed ssa more 
highly than the other in RPMI +10% (v/v) FCS alone, or following A549 co-culture, and fold-change ranged from 
2- to 7-fold (Figure 6.5B). 
 
Figure 6.5.: Expression of ssa by emm4 isolates following co-culture with A549s 
A) Co-culture of emm4 isolates with A549 cells (white circles) also enhanced the expression of ssa, relative to culture in 
RPMI +10% (v/v) FCS alone (black circles). Data represent singular RNA samples extracted from two M4complete 
(BSAC_bs192 and BSAC_bs696) isolates and two M4degraded (BSAC_bs916 and BSAC_bs1052) isolates, measured in 
triplicate and normalised to copies of ssa transcript per 10,000 copies of housekeeping gene gyrA transcripts. Horizontal bars 
indicate the data median. B) Data expressed as mean fold change in ssa transcript copies from culture in RPMI +10% (v/v) 
FCS alone in M4complete (black bars) and M4degraded (white bars), to ssa transcript copies detected following co-culture with 






















































































 Enhanced ssa expression was not associated with an increase in gene copies 
Enhanced expression of prophage-encoded virulence factors may be achieved following prophage induction, as a 
consequence of prophage induction (Banks et al., 2003; Broudy et al., 2002, 2001), though hitherto has not been 
supported by the present work. Following the increase in ssa transcription that was observed among both M4complete 
and M4degraded isolates with HTE-co-culture, gene copies of ssa were measured to determine if this was associated 
with a concomitant increase in prophage replication. Φ10750.3 can be induced to excise, however, as yet, it does 
not appear that M4degraded are capable of excision, including on co-culture with HTE cells. Gene copies were similar 
under both conditions for all emm4 isolates (p=0.1602, Wilcoxon signed rank test), and surprisingly, an increase 
in gene copies was not observed among M4complete isolates relative to M4degraded. One CovS variant M4complete 
isolate, BSAC_bs1388 (36aa-STOP), did exhibit a marked increase in ssa gene copies upon exposure to HTE, yet 
surprisingly, had exhibited the lowest fold-change in ssa transcripts of all emm4, ~1.2-fold. The unusual M4degraded 
isolate BSAC_bs1802, which carried a naturally occurring CovR variant (Gly91Asp) also appeared to 
demonstrate an increase in ssa gene copies, despite not having responded to HTE co-culture by appreciably 





A) The enhanced expression of ssa was not associated with an increase in gene copy number among emm4 isolates (p=0.1602, 
Wilcoxon signed rank test). BSAC_bs1802 (yellow circle) which carries a naturally occurring covR allele, and an isolate 
carrying a naturally occurring covS allele, BSAC_bs1388, (blue circle) demonstrated an increase in ssa gene copies.  An 
increase in ssa gene copy number was not observed of covS variant isolate BSAC_bs468 (red circle). Dotted line indicates 
the point at which copies of gyrA and ssa are approximately equivalent, 10,000 copies. Data represent the mean of calculated 
averages for all ten emm4 isolates measured in triplicate, across two experiments, and normalised to 10,000 copies gyrA. B) 
Data presented as mean fold-change in ssa gene copies between culture in RPMI +10% (v/v) FCS alone, and following co-
culture with human tonsillar epithelial cells. There was no difference in gene copy number between M4complete (black bars) 
and M4degraded (white bars). Data represent the mean of two independent DNA samples measured in triplicate and normalised 







































































Figure 6.6: Copies of ssa gene following co-culture with human tonsillar epithelium 
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 Expression of ssa is enhanced by human tonsillar epithelium among other genotypes 
Having found that ssa expression was enhanced among genotype emm4 isolates following co-culture with HTE 
cells, the co-culture model was applied to other genotypes which are frequently lysogenised by prophage carrying 
ssa. Genotypes emm3 and emm12 are two such emm-types (Beres et al., 2004; Chalker et al., 2017; Turner et al., 
2017, 2019). Isolates belonging to these genotypes in the BSAC collection were thus screened for ssa by BLAST 
to detect the gene among emm3 and emm12 isolates. Enhanced expression of ssa was observed among emm3 
isolates following co-culture (p=0.0312, Wilcoxon signed rank test). Similarly, emm12 isolates also exhibited 
enhanced expression of ssa following co-culture (p=0.0312, Wilcoxon signed rank test). Expression of ssa in 
RPMI +10% (v/v) FCS alone was highest among emm4 isolates, and emm12 isolates exhibited a higher baseline 
expression than did emm3 (Figure 6.7A). Expression of ssa by genotype emm4 isolates following HTE co-culture 
was higher than both emm3 and emm12 following co-culture. The expression of ssa by genotype emm3 isolates 
increased following co-culture with HTE cells, between 1- to 5-fold. A similar response was observed among 
emm12 isolates, increasing between 1- to 6-fold. A fold-change of between 1- and 13-fold was observed among 






A) Genotype emm3 (green diamonds) exhibited a borderline significant enhancement of ssa expression following co-culture 
(p=0.0312, Wilcoxon signed rank test), as did emm12 isolates (red squares) (p=0.0312, Wilcoxon signed rank test), as was 
previously observed in emm4, (reproduced from fig. 6.4 for reference; purple circles). Data represent the mean of three 
independent RNA samples measured in triplicate and normalised to transcript copies of ssa per 10,000 transcript copies of 
gyrA. Horizontal bars indicate the data median. B) Data represented as fold-change in ssa transcript copy number, per 10,000 
transcript copies of gyrA. Genotype emm4 isolates (reproduced from fig. 6.4; purple bar) increased ssa expression by 1-13-
fold following co-culture. Genotype emm3 (red bar) and emm12 isolates (green bar) increased ssa expression by 1-5-fold, 
and 1-6-fold, respectively. Error bars indicate mean (+standard error of the mean). 
 
6.5 Discussion 
The data in this Chapter demonstrated that co-culture of emm4 isolates with human tonsillar epithelial cells did 
not seem to trigger the induction of prophage. The finding that both HTE cells and A549s were able to enhance 
the expression of the streptococcal superantigen ssa is novel, and thought provoking. Particularly when contrasted 










































































Figure 6.7: Human tonsillar epithelium enhances ssa expression in other genotypes 
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with the reduction of speC expression. There was a noted dearth of evidence to support the hypotheses of Chapter 
4 that the enhanced expression of prophage-associated toxins may be associated with a concomitant increase in 
prophage induction, and an increase in gene copies following co-culture. In fact, in the case of Φ10750.3/Φ427.3, 
it appeared that neither prophage induction nor replication were necessary to achieve this effect. This was 
exemplified by the comparable levels of transcription attainable by M4complete and M4degraded, the latter harbouring 
cryptic elements. The finding that HTE cells have the capacity to enhance the expression of ssa in both genotype 
emm3 and emm12, as well as in emm4, is reassuring and novel.  
 
PCR on co-culture DNA extracts demonstrated that while M4complete prophage Φ10750.1, Φ10750.2, and Φ10750.3 
could be induced in RPMI +10% (v/v) FCS alone, or on co-culture with HTE cells, the veracity of M4degraded 
Φ427.1, Φ427.2, and Φ427.3 as non-inducible, cryptic prophage was strengthened. Unexpected difficulties were 
experienced when applying the prophage conformation PCR to DNA samples extracted from co-culture 
experiments, possibly due to the failure to preclude eukaryotic DNA on extraction. However, PCR was successful 
for a number of M4complete and M4degraded isolates. Φ10750.1 induction under both conditions was comparable, as 
was induction of Φ10750.2. One M4complete isolate for which the Φ10750.3 phage induction PCR was successful, 
BSAC_bs468, suggested that induction was in fact stronger in RPMI +10% (v/v) FCS compared to co-culture 
conditions, whereas BSAC_bs1388 appeared to show the opposite, and demonstrated the greatest increase in ssa 
gene copies. 
 
It had also been reported that human pharyngeal cells can enhance the expression of prophage-associated toxins, 
specifically speC and spd1 (Broudy et al., 2002, 2001), which as aforementioned, in the emm4 population, are 
encoded by Φ10750.1/ Φ427.1, and are among the canonical constellation of prophage in this genotype (Stephen 
B Beres et al., 2006; Chalker et al., 2017; Jacoba et al., 2016; Turner et al., 2019b, 2017). Expression of speC 
was in fact found to decrease following co-culture with HTE cells, and this was observed equally in both M4complete 
and M4degraded, decreasing on average ~0.5 fold. The DNase spd3 appeared to be neither expressed in RPMI +10% 
(v/v) FCS alone or following HTE co-culture, which was unexpected, as transcription at 3, 5 and 8 hours in THB 
was clearly detectable. This raises the possibility that spd3 expression may be repressed by a component of RPMI 
+10% (v/v) FCS, perhaps FCS in particular. Indeed, all  published S. pyogenes co-culture studies, of which, at the 
time of writing, there have been three (Broudy, Pancholi and Fischetti, 2001, 2002; Banks, Beres and Musser, 
2003), have co-cultured in cell culture media without serum. . This may go some way to explain discrepancies in 
these data. However, it is also possible that spd3 is not expressed early in colonisation and infection in response 
to exposure to the tonsillar epithelium or in the absence of other immunological or anatomical stimuli which are 
lacking in this model. It would be very interesting to explore this phenomenon further using whole tonsil explants, 
as has been achieved previously (Davies et al., 2019). 
 
In further support of an alternative hypothesis of a gene dosing effect in the elicitation of the enhancement of 
prophage-associated toxins, measurements of ssa gene copies confirmed that not only was induction of prophage 
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unnecessary to achieve an enhancement in transcription of the gene, but that replication of the element was neither 
necessary nor sufficient. This is a novel finding in the case of ssa-associated prophage and emm4, but corroborates 
existing literature that has demonstrated that a robust increase in toxin gene expression may be achieved, 
irrespective of, or indeed, in the absence of prophage induction, and may be associated with increased toxin 
production. Though presently, the literature is far from replete with studies investigating the role of prophage in 
toxin expression by S. pyogenes, the present work marries well with observations made of the speA-encoding 
emm3 prophage Φ315.5 following co-culture with human cells (Banks et al., 2003). Unlike speA, however, ssa 
transcription does not appear to be under the constitutive influence of CovRS (Sumby et al., 2006). However, 
there may be scope for hypotheses on the role of CovRS as a possible regulator of ssa expression and induction 
of the associated prophage, however. Indeed, two CovRS variant emm4 isolates exhibited a marked increase in 
ssa gene copies following co-culture, M4complete BSAC_bs1388 (CovS; 36aa-STOP), and M4degraded BSAC_1802 
(CovR; Gly91Asp), despite not having responded appreciably to co-culture by enhancing ssa expression. While 
these data may simply be coincidental, there is some evidence that the transcriptional regulator Rgg/RopB may 
influence prophage excision, as demonstrated using an emm5 (Dmitriev et al., 2006), but this has not been reported 
hitherto for CovRS, or indeed any other major regulators of S. pyogenes. The Rgg/RopB allele for BSAC_bs1388 
and BSAC_bs1802 are identical to the other MGAS10750- and M4degraded isolates, respectively, and is not 
predicted to affect activity (Ikebe et al., 2010). 
 
It appears that at the transcriptional level, both M4complete and M4degraded emm4 are appreciably similar with regards 
to the expression of prophage-associated toxins under conditions designed to emulate the host-pathogen interface. 
The findings that HTE modulates the expression of the streptococcal superantigen ssa in clinical isolates 
belonging to at least three major emm-types is novel and thought provoking, and certainly warrants further study. 
Preliminary, inferential data which appear to indicate the influence of CovRS over prophage induction and 
replication would also constitute an exciting and hitherto unappreciated role for this major regulator in the 
infection biology of S. pyogenes, as would the involvement of CovRS in the expression of ssa at the host-pathogen 
interface. 
 
 Chapter 6: Key findings 
 S. pyogenes isolates were found to modulate expression of superantigens following co-culture with HTE 
cells: 
– Expression of speC decreased following co-culture of emm4 isolates with HTE cells 
– Expression of ssa was enhanced following co-culture of emm4 isolates with HTE cells but this 
was not due to an increase in gene copies and appeared to be independent of prophage induction 
 The enhancing effect on ssa expression was not specific to HTE cells and was also observed following 
co-culture of emm4 isolates with A549 cells 
 Expression of ssa is not controlled by prophage induction and replication in emm4 isolates 
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 Genotype emm4 isolates with naturally occurring CovRS variant alleles exhibited substantially 
increased ssa gene copies following co-culture versus ‘wildtype’ emm4 isolates 
 Genotype emm3 and emm12 isolates also exhibited an enhancement in ssa expression following co-
culture with HTE cells 

































7.1 Genotype emm4 prophage 
 
 Two clades within clinical emm4 isolates 
A small collection of clinical emm4 isolates collected by BSAC (Turner et al., 2019b) were subject to WGS as 
part of prior work carried out by this laboratory. Preliminary analyses carried out by project supervisor Dr. Claire 
E. Turner revealed that these ten isolates broadly clustered evenly with completed reference genome MGAS10750 
(Beres and Musser, 2007), or MEW427 (Jacoba et al., 2016),. These data also suggested that those clustering with 
MEW427 had undergone multiple regions of recombination, which has in recent years been shown, not only to 
be a source of diversity in S. pyogenes, but also a mechanism by which successful new and unusual variants may 
emerge (Nasser et al., 2014; Sumby et al., 2005b; Turner et al., 2019b, 2015), though not, at the time of writing, 
in emm4. 
 
 Prophage degradation within MEW427 clade 
Comparison of the two completed reference genomes showed that these putative recombinant regions in fact 
represented variably sized regions of sequence loss within the prophages and SpyCI of MEW427, relative to the 
corresponding elements of MGAS10750. Prophage genes involved in prophage excision, regulation and 
replication, and to a lesser extent, tail fibre and capsid protein encoding genes, had been deleted or subject to 
marked sequence loss, in a similar pattern across the three prophage, albeit to varying extents. Φ427.1, Φ427.2, 
Φ427.3 having undergone ~78%, ~50%, and ~26% gene loss, respectively, relative to Φ10750.1, Φ10750.2, and 
Φ10750.3. Interestingly, the prophage-associated superantigen and DNase genes were retained in each case. 
Similar gene loss as observed in the ten emm4 BSAC isolates. Those clustering with MEW427 exhibited gene 
loss in Φ427.1, Φ427.2, Φ427.3, and SpyCIM4. BSAC isolates associated with the MGAS10750 clade carried 
near-identical, full-length copies of these elements. For Φ427.2 and Φ427.3, the integrase genes, required for 
prophage excision/integration, were truncated and predicted to be non-functional. Φ427.1 carried a full-length 
and presumably functional integrase, but was subject to such pronounced gene loss elsewhere on the element, that 
were it able to excise, it would be unable to form progeny virions. Degraded, elements are described in the 
literature, including occasionally in S. pyogenes (Canchaya et al., 2003, 2002; Green et al., 2005; Turner et al., 
2015), and recent a recent genomic survey suggests that such elements are common components of the 




 M4degraded prophage are cryptic 
Prophage induction was probed among the M4complete and M4degraded BSAC isolates, cultured under a variety of 
conditions over the course of the project, including exponential growth, following treatment with mitomycin C, 
in RPMI +10% (v/v) FCS, and following co-culture with HTE cells. Full-length prophage of M4complete isolates 
were induced under all conditions tested, whereas those of M4degraded isolates, (with the exception of unusual 
M4degraded isolate BSAC_bs1802), were not. These immobile prophage of M4degraded isolates were thus designated 
cryptic prophage.  
 
 A novel international emm4 lineage characterised by cryptic prophage 
Additional work to place the BSAC emm4 within an international context by project supervisor Dr. Claire E. 
Turner ratified initial hypotheses: emm4 isolates generally clustered with either MGAS10750 or MEW427 
(Remmington et al. 2020). Crucially, this demonstrated that within the wider emm4 population, represented by 
publicly available WGS data for 233 international emm4 isolates, was a lineage broadly associated with 
pronounced gene loss within prophage- and chromosomal island-encoding regions (Remmington et al. 2020). 
Curiously, while the population of North America almost exclusively comprised M4degraded isolates, the UK 
population was more diverse, with both lineages apparently co-existing (Remmington et al. 2020). More powerful 
and largescale epidemiological and genomic studies would be warranted to investigate this inquisitive finding, 
which could not be explained by consultation of clinical data, where available. 
 
There are a number of possibilities as to why prophage crypticism had occurred within M4degraded isolates. It was 
not possible to determine the temporal nature of the lineages emergence, but perhaps emm4 without inducible 
prophage are more resistant to environmental stressors, and prophage inducers, such as antibiotics (Allen et al., 
2011; Maiques et al., 2006; Zhang et al., 2000), extremes of pH (Miller-Ensminger et al., 2020), host-derived 
factors such as reactive oxygen species (Henningham et al., 2015), or even exposure to UV light and fluctuations 
in temperature (Yue et al., 2012), as has been demonstrated in a litany of bacterial species harbouring cryptic 
prophage. One interesting study demonstrated that S. pneumoniae, through the production of hydrogen peroxide, 
was able to exploit the lysogenic nature of Staphylococcus aureus competitors by triggering induction of prophage 
and lysis of lysogens (Selva et al., 2009). The primary anatomical niche of S. pyogenes, the human tonsil, is 
certainly shared with a diverse population of niche competitors, including S. pneumoniae (Adegbola et al., 2014). 
Neutralising the imminent threat of lysis by inactivating or degraded prophage represents a logical hypothesis for 
the pervasive prophage decay observed in M4degraded isolates. Induction of S. pyogenes prophage has been 
demonstrated in-vivo using murine models of nasopharyngeal infection (Broudy and Fischetti, 2003), and as 
aforementioned, in response to a factor secreted by human cells (Banks et al., 2003; Broudy et al., 2002, 2001). 
The capacity for rescue of these cryptic elements by ‘helper prophage’, as is observed among satellite prophage 
(Rezaei Javan et al., 2019), phage-inducible chromosomal islands (Penadés and Christie, 2015), are certainly 
precluded by the incapacity of these prophage to exit the genome. However, vertical transmission is virtually 
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assured, and perhaps cryptic prophage are still transmitted by recombination. A hypothesis for which there may 
be some support among contemporary emm89 isolates, which frequently (though not characteristically) harbour 
a degraded speC/spd1 prophage that may have been acquired by recombination; ΦM89.1 (Turner et al., 2015). 
 
7.2 Redundancy of prophage mobility regulation among emm4 S. pyogenes 
 
 Prophage induction is not associated with enhanced toxin transcription 
It had been hypothesised that the induction of prophage, and subsequent replication may elicit a gene dosing 
effect, providing a greater number of toxin gene templates for transcription, thus enhancing toxin production (gene 
duplication and amplification) as in other bacterial species (Andersson and Hughes, 2009; Sandegren and 
Andersson, 2009). Growth-phase experiments to detect spontaneous prophage induction and toxin transcription 
among M4complete isolates did not correlate with specific timepoints. Indeed, the expression of ssa and spd3 was 
very similar between M4complete and M4degraded isolates, and did not vary by growth phase, regardless of the fact that 
prophage clearly inducible in the former, and demonstrably cryptic in the latter. Interestingly, speC expression 
was elevated at 8-hours growth in THB among both M4complete and M4degraded. Despite this, when prophage 
induction and speC gene copies were measured, prior reports that induction of an undesignated M6 prophage 
enhanced SpeC and Spd1 expression (Broudy et al., 2002, 2001) were not supported, and surprisingly, an increase 
in gene copies did not appear to correlate with prophage induction. Certainly, when cultured in THB, it seemed 
that transcription of prophage-associated toxin genes was irrespective of induction of the associated prophage. 
 
 Genotype emm4 DNA MMR operon is not regulated by SpyCIM4 
The SpyCI are, compared to prophage, vastly understudied atoxigenic viral parasites. At the time of writing, the 
only perceptible role of SpyCI are as growth-phase-dependent regulators of the DNA  MMR operon 
(Nguyen and McShan, 2014; Scott et al., 2012). The finding that SpyCIM4 of either lineage could not be induced 
during growth, or when cultured with mitomycin C, was therefore unanticipated, given that in M4complete isolates, 
SpyCIM4 carry the necessary genetic apparatus to permit mobility, while those of M4degraded isolates do not. 
Surprisingly, transcripts for both mutL and mutS were nevertheless abundantly detected for all isolates in cDNA 
samples synthesised from RNA extracted from emm4 isolates grown to the timepoint at which SpyCI was 
purportedly at its most stably integrated, and expression of mutS at its lowest (Scott et al., 2012). It appears that 
in emm4, this operon is not regulated by the mobility of SpyCIM4. One study reports that experimental curing of 
SpyCI from emm1 isolates had dramatic consequences for global transcription, including a number of well-studied 
virulence factors; perhaps indicating that elements fulfil a hitherto unelucidated role in streptococcal biology 




7.3 Genotype emm4 at the host-pathogen interface 
 Phenotypic similarities between M4complete and M4degraded 
The phylogenetic distinction between M4complete and M4degraded isolates and the body of evidence attesting to the 
importance of prophage induction in toxin expression notwithstanding (Balasubramanian et al., 2019; Broudy et 
al., 2002, 2001; Ingrey et al., 2003), a polarising phenotype could not be demonstrated in most cases between the 
two lineages. Indeed, it appeared that these isolates were rather similar in their capacity to survive in whole human 
blood, may be similarly superantigenic, and exhibit comparable capacity for adhesion. 
 
One distinguishing characteristic of M4degraded was a significant attenuation in virulence of M4degraded isolates in 
the G. mellonella infection model. G. mellonella lack adaptive immunity, and are insensitive to streptococcal 
superantigens (Tsai et al., 2016). However, the immune system of G. mellonella does include phagocytic 
haemocytes, which extrude chromatin-rich matrices akin to NETs (Altincicek et al., 2008), which are sensitive to 
streptococcal DNases (Chalmers et al., 2017). As such, this finding might be attributable to differences in DNases 
activity. Higher levels of speC expression, and thus, inferentially, the co-transcribed DNase spd1, were attainable 
by M4complete, relative to M4degraded isolates after culture for 8-hours in THB, it was conceivable that DNases activity 
might explain this attenuation. However, chromosomally-encoded DNases might equally play a role. Intriguingly, 
the acquisition of an speC/spd1-encoding prophage, ΦUK-M3.1, by an epidemic genotype emm3 ST15 lineage in 
the United Kingdom (Al-Shahib et al., 2016), and associated with enhanced DNase activity, was insufficient to 
confer enhanced virulence in G. mellonella (Afshar et al., 2017). The chimeric emm4 allele that was identified in 
the present work, and in subsequent works (DebRoy et al., 2018; Frost et al., 2020), could also have some 
influence, by interfering with phagocytosis or perhaps other pathogenic mechanisms attributed to M and M-like 
proteins (Frost et al., 2020; Smeesters et al., 2010). M1 deletion mutants have previously exhibited attenuated 
virulence in the G. mellonella model, a phenotype that was reversed on complementation (Loh et al., 2013). Other 
phenotypes that have been ascribed to emergent lineages, such as enhanced nasopharyngeal shedding (Afshar et 
al., 2017), or enhanced colonisation and infection (Brouwer et al., 2020; Kasper et al., 2014). These cannot be 
observed in this crude model of systemic infection, which is intended to assay overall virulence, and is useful in 
that regard. However, it was clear from the nature of the BSAC emm4, which were all bloodstream isolates, that 
both lineages are able to cause severe disease and attain full virulence. 
 
Non-synonymous SNPs identified in genes encoding fibronectin-binding proteins, and other lineage-specific 
SNPs did not affect adhesion of either M4complete or M4degraded isolates. Indeed, neither lineage appeared to have 
been imbued with enhanced adhesion and biofilm formation on polystyrene, fibronectin, type IV collagen, or 
fibrinogen, though interesting predilection for emm4 adhesion to the latter was observed, perhaps due to the 
acapsular nature of the genotype (Flores et al., 2012). In S. pneumoniae, prophage induction may bolster biofilm 
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propagation (Carrolo et al., 2010), but the capacity for M4complete lysogens to form biofilms through a similar 
mechanism was not observed.  
 
 Human tonsillar epithelium modulates superantigen expression 
Previous studies have shown that a soluble factor secreted by human cells induces prophage and/or enhances 
expression of cognate virulence factors (Banks et al., 2003; Broudy et al., 2002, 2001). When emm4 were co-
cultured with HTE cells, induction of Φ10750.1 among M4complete isolates was, though achievable, similar to 
induction in RPMI +10% (v/v) FCS alone. Φ427.1 of M4degraded were not induced under either culture condition. 
Despite the differential induction of these prophage, the impact of HTE co-culture was the same: speC transcript 
copies were significantly lower on co-culture than in RPMI +10% (v/v) FCS alone. This contrasts with seminal 
literature on the topic which suggest that co-culture with pharyngeal cells induces prophage and enhances toxin 
expression (Broudy et al., 2002, 2001). Substantial differences in the methodologies implemented therein and 
herein notwithstanding, it did not appear that HTE cells increased expression of speC, nor did they appear to 
appreciably induce M4complete prophage Φ10750.1; indeed, speC expression decreased in spite of prophage 
induction. Induction of Φ10750.2 did not increase following HTE co-culture either, and again, Φ427.2 was shown 
to be cryptic. Transcripts of spd3 could not be detected in isolates of either lineage in RPMI +10% (v/v) FCS or 
on exposure to HTE cells, which lent support to the revised hypothesis that induction may be inconsequential to 
the transcription of cognate toxin genes. 
 
Induction of Φ10750.3 in co-culture experiments were conflicting. One M4complete isolate exhibited strong 
induction in response to co-culture, while another the opposite. Φ427.3 was not induced under either co-culture 
conditions, as expected. However, co-culture with HTE cells elicited a significant enhancement in transcript 
copies of ssa in both M4complete and M4degraded isolates alike, and again, this response appeared irrespective of the 
capacity for Φ10750.3/Φ427.3 to induce. Measurements of ssa gene copies demonstrated that the enhancement 
in ssa transcription was both independent of induction of the associated element, and subsequent prophage 
replication; gene dosage. Experimentation with emm3 and emm12 isolates showed that HTE-mediated 
enhancement of ssa was not genotype specific, which was reassuring. While fold-change in ssa transcript copies 
was similar between emm3 and emm12, baseline expression and expression following co-culture were higher in 
both emm4 and emm12 relative to emm3, perhaps due to homology between Φ10750.3 and ΦHKU.ssa. Indeed, 
ΦHKU.ssa is a chimera of Φ10750.3 and the emm12 Φ9429.1, which carries speC/spd1, and although in emm4, 
toxin expression appears irrespective of prophage induction, these phage may carry other genes that might 
influence expression. ΦHKU.ssa does not carry speC/spd1, instead the lysogenic conversion module is near-
identical to that of Φ10750.3, as is the distal lysogeny module; ΦHKU.ssa in turn exhibits appreciable homology 
with Φ315.2 (Figure 7.1). Unlike both ΦHKU.ssa and Φ10750.3/Φ427.3, which integrate at the same 5’ attB, the 
DNA-binding protein HU (Stephen B. Beres et al., 2006; Davies et al., 2015), the Φ315.2 attB is a 3’ tmRNA 
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(Beres et al., 2002), which could perhaps impact how the expression the toxin gene carried by the this phage is 
controlled.  
 
There is of course scope for the regulation of prophage toxins by bacterial regulatory networks, which may also 
contribute to variation between genotypes (Anbalagan and Chaussee, 2013; Sumby et al., 2006). Although the 
present work raises questions, it marries well with descriptions of co-culture experiments using an MGAS315 
emm3 strain with pharyngeal cells (Banks et al., 2003). This study reported that co-culture neither triggered the 
induction of the speA-associated Φ315.5, nor was this necessary to enhance the transcription of the superantigen. 
The authors went on to demonstrate greater quantities of SpeA in supernatant filtrates from co-culture conditions, 
relative to those from S. pyogenes grown in DMEM alone. It seems plausible that the expression of ssa may follow 
a similar theme, though among genotype emm1 isolates, speA expression is regulated, at least in part, by bacterial 
regulatory networks, notably CovRS and RofA (Lynskey et al., 2019a; Sumby et al., 2006). Indeed, there was 
evidence in the present work that CovRS may play a role in the regulatory networks which mediates the 
transcriptional response of ssa following expose to HTE cells, and induction of the associated prophage. 
Additional prophage-associated regulatory mechanisms may also yet be discovered. 
 
Figure 7.1: Homology between toxigenic prophage of emm3, emm4 and emm12 
A) Genotype emm12 prophage ΦHKU.ssa is a chimera of speC/spd1-associated emm12 prophage Φ2429.1 and ssa-associated 
emm4 prophage Φ10750.3. The majority of the sequence is Φ2429.1-derived. However, flanking lysogenic conversion and 
lysogeny modules of ΦHKU.ssa are near-identical to those of Φ10750.3. B) Genotype emm3 prophage Φ315.2 shares 
considerable homology with ΦHKU.ssa, notably the lysogenic conversion module, including ssa. Genes are colour coded 
per figure key: orange; speC/spd1, red; ssa, navy; integrase and excisionase genes. Remaining genes are shown grey. Shaded 
scale bar indicates % DNA sequence similarity. Prophage sequences were extracted from publicly available completed 




7.4 Bacterial regulation of prophage induction 
 
 Possible role for CovRS in prophage replication and toxin expression 
Expected variation between genotypes in the control of gene expression by major regulators of S. pyogenes 
notwithstanding, isolates carrying naturally occurring CovS variants BSAC_bs468 (Thr241Pro and Ala379Thr) 
and BSAC_bs1388 (36aa-STOP), and CovR variant isolate BSAC_bs1802 (Gly91Asp), did not exhibit major 
differential transcription of speC or spd3 under any conditions tested, nor did these variants appear phenotypically 
different to other emm4 over the course of the project. While speC and ssa are, at the time of writing, not known 
to be under the influence of this regulator, a genotype emm1 isolate was previously shown to highly express Spd3 
following CovRS mutation (Sumby et al., 2006). This was not observed in these isolates. Gene copies of speC 
and ssa were measured as part of two experiments; growth in THB and following HTE co-culture, respectively. 
BSAC_1388 and BSAC_bs1802 exhibited dramatic increases in gene copies in both experiments, compared to 
other emm4. This was not observed for the vast majority of the other emm4, apart from BSAC_bs1349, which did 
exhibit an increase in speC gene copies after 8 hours growth in THB, but not in co-culture experiments. These 
dramatic increases in gene copy number did not appear, however, to correlate with prophage induction at the 
corresponding timepoint of 8-hours growth in THB, nor following co-culture for either BSAC_bs1388 and 
BSAC_bs1802. It is possible that this is due to the induction of these prophage and the formation of prophage 
particles, which were subsequently extracted with the rest of the bacterial culture in both experiments. It was 
particularly interesting to note that despite having undergone marked replication, transcription of ssa following 
HTE co-culture for these two isolates did not change appreciably, relative to RPMI +10% (v/v) FCS alone, and 
certainly did not exhibit as robust of an enhancement in ssa expression as did the other emm4. This could certainly 
explain why the gene copies of speC and ssa in either case were so disproportionately in excess of gyrA gene 
copies, to which they were normalised. The creation of isogenic mutants would have verified these observations, 
but were unfortunately not successful, but efforts to investigate these observations are ongoing. 
 
7.5 Conclusions 
The relationship between prophage mobility and toxin expression seems substantially more complex than was 
anticipated, and at the host-pathogen interface, the mediators and regulators of these events are largely unknown. 
Perhaps unsurprisingly, considering the human-restricted nature of S. pyogenes, there appears an important role 
for host-derived factors, which have the potential to impact virulence factor expression both at transcriptional and 
post-translational levels (Banks et al., 2003; Broudy et al., 2002, 2001; Brouwer et al., 2020). Given their 
prevalence and apparent epidemiological importance (Al-Shahib et al., 2016; Stephen B. Beres et al., 2004; 
Davies et al., 2015; Tse et al., 2012), a better understanding of toxigenic prophage and their contribution to the 
biology of S. pyogenes might greatly improve our efforts to understand, monitor, prevent and control this highly 
lysogenised, highly adaptable and notoriously protean pathogen. 
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7.1 Future work 
The enhancement of ssa transcription in three major emm types by HTE cells is novel and exciting. This work 
requires validation to determine the impact these transcriptional events have on protein expression. Principally, 
this would involve the recombinant expression and purification of SSA, and the generation of an antibody to 
quantitate SSA by Western blot. Protein activity assays such as the highly sensitive tritiated thymidine 
incorporation assay may be necessary, as SSA is poorly mitogenic compared to other streptococcal superantigens 
such as SpeC and SMEZ (Afshar et al., 2017). The superantigenicity of this superantigen has very recently been 
measured using IL-2 as a marker of lymphocyte proliferation, and may prove valuable (Brouwer et al., 2020). 
The apparent thiol-mediated regulation of SSA activity described very recently should be considered for future 
work with this superantigen, particularly in-vitro experiments (Brouwer et al., 2020). 
 
In the context of host-pathogen interactions, the factor secreted by human cells that elicited the effects on toxin 
expression described herein and elsewhere (Banks et al., 2003; Broudy et al., 2002) remains unknown, and the 
identification of this factor and its mechanism of action would be a tantalising and impactful discovery. The 
present work determined that the ssa inducing factor was not specific to HTE cells, and this was demonstrated 
similarly in preliminary experiments with A549 cells. Prior publications have used pharyngeal cells, and a breast 
cancer cell line, thus, taken together, it seems clear that the inducer is not tonsil specific (Broudy et al., 2001). 
However, it would be interesting to explore with immortalised or primary cell lines the host restriction of this 
effect using zoonotic streptococci such as S. dysgalactiae sbsp. equisimilis, which occasionally also appear to 
carry ssa (Igwe et al., 2003), and myriad other superantigens also present in S. pyogenes and the equine restricted 
S. equi sbsp. equi (Holden et al., 2009; Turner et al., 2019b). It would be also valuable and insightful to explore 
whether these observations are recapitulated using whole human tonsil explants, as has been achieved previously 
(Davies et al., 2019), and may offer a more faithful reproduction of the anatomy of the tonsil and its associated 
immunological components. 
 
Animal models may also prove insightful in investigating the attenuated virulence associated with M4degraded 
emm4, though could be, in equal measure, both avoided or complimented by epidemiological analyses and NHS 
Demographic Batch Tracing, where possible, of patients from which emm4 are isolated, as has been achieved 
previously (Afshar et al., 2017). More powerful genomic analyses, such as BEAST analyses, may prove insightful 
in identifying the temporal nature of M4degraded emergence. The latter, however, may be due to complex 
sociological factors such a prescribing practice, the delineation of which may not be feasible or conclusive. 
 
If ratified, hypotheses on CovRS and potential influence on prophage induction and replication would be 
impactful, and constitute an exciting and hitherto unappreciated role for this well-studied major regulator. There 
was also evidence in the present work that CovRS may play a role in the regulation of ssa expression at the host-
pathogen interface. It would be particularly interesting to investigate whether this mechanism, if proven, extends 
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to prophage that encode toxins which are known to be under its regulatory control in other genotypes, such as 
speA (Sumby et al., 2006), and could extend to other bacterial regulators of prophage-encoded toxins, such as 
RofA and Rgg1/RopB (Dmitriev et al., 2006; Lynskey et al., 2019a). Efforts to investigate the relationship 
between CovRS and the transcriptional response of ssa among emm4 isolate following exposure to HTE cells are 
ongoing. This response may also involve other regulatory networks and other genes, however, and the creation of 
a transposon mutant library and repeating co-culture experiments using a more high-throughput format may prove 
illuminating. 
 
The benefits, if indeed there are any, of harbouring degraded prophage in emm4 S pyogenes are unclear, and the 
emergence of M4degraded may be due to a number of anatomical, immunological, pharmacological, epidemiological 
and sociological factors, or indeed the combination of multiple variables. The clear capacity for both emm4 
lineages to co-exist in the UK suggested that M4degraded were at least as fit as M4complete, though the relative paucity 
of the former in North America is intriguing, and may offer clues on the emergence of this lineage. Data in the 
present work suggested that toxin expression was very similar between both lineages, and may be irrespective of 
prophage. M4degraded were also found to be less virulent than M4complete. Perhaps M4degraded isolates are therefore 
better suited to colonisation or longer-term carriage, resilience to exogenous antibacterial factors in-vivo, or 
tolerance to geographically variable prescribing practices, as opposed to achieving success by more obvious and 







Figure 7.2: Graphical hypotheses: M4complete vs. M4degraded 
Aside from the enhanced virulence of M4complete isolates relative to M4degraded isolates, the two lineages appeared to be very 
similar. Factors contributing to the emergence of M4degraded are as yet unknown, but may reflect a number of different 
exogenous factors such as prescribing practices, approaches to infection, and niche competition, and may be mediated by 
prophage domestication. Further phenotypes may become apparent in more complex models of infection, and following more 








8.  Appendix 
 
Publications  
Remmington, A., & Turner, C. E. (2018). The DNases of pathogenic Lancefield streptococci. Microbiology. 
164(3), 242–250. https://doi.org/10.1099/mic.0.000612 
 
Remmington, A., Haywood, S., Edgar, J., Green, L. R., de Silva, T., & Turner, C. E. (2020). Cryptic prophages 
within a Streptococcus pyogenes genotype emm4 lineage. Microbial genomics, 10.1099/mgen.0.000482. 
Advance online publication. https://doi.org/10.1099/mgen.0.000482 
 
 Posters and presentations 
Remmington, A., Turner, C. E. "Identification of a lineage within the global population of Streptococcus 
pyogenes genotype emm4 characterized by prophage degradation", in Streptococcal Biology: Molecular 
Mechanisms at the Streptococcal-Host Interface, Gordon Research Conference (2018) Newry, ME, USA. 
(Poster) 
 
Remmington, A., Turner, C. E. "Identification of a lineage within the global population of Streptococcus 
pyogenes genotype emm4 characterized by prophage degradation", in Microbiology Society Annual 
Conference (2018) Birmingham, UK. (Poster). 
 
Remmington, A., Turner, C. E. "Streptococcus pyogenes: Investigating Unusual Phenotypes", in The Drugs 




















Abedon, S.T., LeJeune, J.T., 2005. Why Bacteriophage Encode Exotoxins and other Virulence Factors. 
Evolutionary Bioinformatics 1, 117693430500100. https://doi.org/10.1177/117693430500100001 
Ackermann, H.W., Prangishvili, D., 2012. Prokaryote viruses studied by electron microscopy. Archives of 
Virology 157, 1843–1849. https://doi.org/10.1007/s00705-012-1383-y 
Adegbola, R.A., DeAntonio, R., Hill, P.C., Roca, A., Usuf, E., Hoet, B., Greenwood, B.M., 2014. Carriage of 
Streptococcus pneumoniae and other respiratory bacterial pathogens in  low and lower-middle income 
countries: a systematic review and meta-analysis. PloS one 9, e103293. 
https://doi.org/10.1371/journal.pone.0103293 
Aertsen, A., Faster, D., Michiels, C.W., 2005. Induction of Shiga toxin-converting prophage in Escherichia coli 
by high hydrostatic pressure. Applied and Environmental Microbiology 71, 1155–1162. 
https://doi.org/10.1128/AEM.71.3.1155-1162.2005 
Afshar, B., Turner, C.E., Lamagni, T.L., Smith, K.C., Al-Shahib, A., Underwood, A., Holden, M.T.G., 
Efstratiou, A., Sriskandan, S., 2017. Enhanced nasopharyngeal infection and shedding associated with an 
epidemic lineage of emm3 Group A Streptococcus. Virulence 8, 1390–1400. 
https://doi.org/10.1080/21505594.2017.1325070 
Agniswamy, J., Lei, B., Musser, J.M., Sun, P.D., 2004. Insight of host immune evasion mediated by two 
variants of Group A Streptococcus Mac protein. Journal of Biological Chemistry 279, 52789–52796. 
https://doi.org/10.1074/jbc.M410698200 
Åkessont, P., Sjöholm, A.G., Björck, L., 1996. Protein SIC, a novel extracellular protein of Streptococcus 
pyogenes interfering with complement function. Journal of Biological Chemistry 271, 1081–1088. 
https://doi.org/10.1074/jbc.271.2.1081 
Aksyuk, A.A., Rossmann, M.G., 2011. Bacteriophage assembly. Viruses 3, 172–203. 
https://doi.org/10.3390/v3030172 
Al-Shahib, A., Underwood, A., Afshar, B., Turner, C.E., Lamagni, T., Sriskandan, S., Efstratiou, A., 2016. 
Emergence of a novel lineage containing a prophage in emm/M3 Group A Streptococcus associated with 
upsurge in invasive disease in the UK. Microbial Genomics 2, 1–9. https://doi.org/10.1099/mgen.0.000059 
Alasmari, S.Z., 2020.  In Vivo Imaging of Neutrophil Extracellular Traps (NETs): Visualization Methods and 
Outcomes. BioMed Research International, 1–6. https://doi.org/10.1155/2020/4192745 
Alexeeva, S., Guerra Martínez, J.A., Spus, M., Smid, E.J., 2018. Spontaneously induced prophages are abundant 
in a naturally evolved bacterial starter culture and deliver competitive advantage to the host. BMC 
Microbiology 18, 1–16. https://doi.org/10.1186/s12866-018-1229-1 
Allen-Hoffmann, B.L., Rheinwald, J.G., 1984. Polycyclic aromatic hydrocarbon mutagenesis of human 
epidermal keratinocytes in  culture. Proceedings of the National Academy of Sciences of the United States 
of America 81, 7802–7806. https://doi.org/10.1073/pnas.81.24.7802 
Allen, H.K., Looft, T., Bayles, D.O., Humphrey, S., Levine, U.Y., Alt, D., Stanton, T.B., 2011. Antibiotics in 
168 
 
feed induce prophages in swine fecal microbiomes. mBio 2, 1–9. https://doi.org/10.1128/mBio.00260-11 
Allhorn, M., Olsén, A., Collin, M., 2008. EndoS from Streptococcus pyogenes is hydrolyzed by the cysteine 
proteinase SpeB and requires glutamic acid 235 and tryptophans for IgG glycan-hydrolyzing activity. 
BMC Microbiology 8, 1–10. https://doi.org/10.1186/1471-2180-8-3 
Altincicek, B., Stötzel, S., Wygrecka, M., Preissner, K.T., Vilcinskas, A., 2008. Host-Derived Extracellular 
Nucleic Acids Enhance Innate Immune Responses, Induce Coagulation, and Prolong Survival upon 
Infection in Insects. The Journal of Immunology 181, 2705–2712. 
https://doi.org/10.4049/jimmunol.181.4.2705 
Anbalagan, S., Chaussee, M.S., 2013. Transcriptional Regulation of a Bacteriophage Encoded Extracellular 
DNase (Spd-3) by Rgg in Streptococcus pyogenes. PLoS ONE 8. 
https://doi.org/10.1371/journal.pone.0061312 
Andersson, D.I., Hughes, D., 2009. Gene amplification and adaptive evolution in bacteria. Annual Review of 
Genetics 43, 167–195. https://doi.org/10.1146/annurev-genet-102108-134805 
Areschoug, T., Waldemarsson, J., Gordon, S., 2008. Evasion of macrophage scavenger receptor A-mediated 
recognition by pathogenic streptococci. European Journal of Immunology 38, 3068–3079. 
https://doi.org/10.1002/eji.200838457 
Armitage, E.P., Senghore, E., Darboe, S., Barry, M., Camara, J., Bah, S., Marks, M., Cerami, C., Roca, A., 
Antonio, M., Turner, C.E., de Silva, T.I., 2019. High burden and seasonal variation of paediatric scabies 
and pyoderma prevalence in the Gambia: A cross-sectional study. PLoS Neglected Tropical Diseases 13, 
1–16. https://doi.org/10.1371/journal.pntd.0007801 
Ashbaugh, C. D., Alberti, S., Wessels, M.R., 1998. Molecular analysis of the capsule gene region of Group A 
Streptococcus: The hasAB genes are sufficient for capsule expression. Journal of Bacteriology 180, 4955–
4959. https://doi.org/10.1128/jb.180.18.4955-4959.1998 
Ashbaugh, C D., Warren, H.B., Carey, V.J., Wessels, M.R., 1998. Molecular analysis of the role of the Group A 
Streptococcal cysteine protease, hyaluronic acid capsule, and M protein in a murine model of human 
invasive soft-tissue infection. Journal of Clinical Investigation 102, 550–560. 
https://doi.org/10.1172/JCI3065 
Ashbaugh, C.D., Wessels, M.R., 2001. Absence of a cysteine protease effect on bacterial virulence in two 
murine models of human invasive Group A streptococcal infection. Infection and Immunity 69, 6683–
6688. https://doi.org/10.1128/IAI.69.11.6683-6686.2001 
Ashwinkumar Subramenium, G., Viszwapriya, D., Iyer, P.M., Balamurugan, K., Karutha Pandian, S., 2015. 
covR Mediated Antibiofilm Activity of 3-Furancarboxaldehyde Increases the Virulence of Group A 
Streptococcus. PLOS ONE 10, 1–19. https://doi.org/10.1371/journal.pone.0127210 
Athey, T.B.T., Teatero, S., Li, A., Marchand-Austin, A., Beall, B.W., Fittipaldia, N., 2014. Deriving Group A 
Streptococcus typing information from short-read whole-genome sequencing data. Journal of Clinical 
Microbiology 52, 1871–1876. https://doi.org/10.1128/JCM.00029-14 
Athey, T.B.T., Teatero, S., Sieswerda, L.E., Gubbay, J.B., Marchand-Austin, A., Li, A., Wasserscheid, J., 
169 
 
Dewar, K., McGeer, A., Williams, D., Fittipaldi, N., 2016. High incidence of invasive Group A 
Streptococcus disease caused by strains of uncommon emm types in Thunder Bay, Ontario, Canada. 
Journal of Clinical Microbiology 54, 83–92. https://doi.org/10.1128/JCM.02201-15 
Aziz, R.K., Edwards, R.A., Taylor, W.W., Low, D.E., McGeer, A., Kotb, M., 2005. Mosaic Prophages with 
Horizontally Acquired Genes Account for the Emergence and Diversification of the Globally 
Disseminated M1T1 Clone of Streptococcus pyogenes. Journal of Bacteriology 187, 3311 LP – 3318. 
https://doi.org/10.1128/JB.187.10.3311-3318.2005 
Bachelerie, F., Ben-Baruch, A., Burkhardt, A.M., Combadiere, C., Farber, J.M., Graham, G.J., Horuk, R., 
Sparre-Ulrich, A.H., Locati, M., Luster, A.D., Mantovani, A., Matsushima, K., Murphy, P.M., Nibbs, R., 
Nomiyama, H., Power, C.A., Proudfoot, A.E.I., Rosenkilde, M.M., Rot, A., Sozzani, S., Thelen, M., 
Yoshie, O., Zlotnik, A., 2014. International union of pharmacology. LXXXIX. Update on the extended 
family of chemokine receptors and introducing a new nomenclature for atypical chemokine receptors. 
Pharmacological Reviews 66, 1–79. https://doi.org/10.1124/pr.113.007724 
Balasubramanian, S., Osburne, M.S., BrinJones, H., Tai, A.K., Leong, J.M., 2019. Prophage induction, but not 
production of phage particles, is required for lethal disease in a microbiome-replete murine model of 
enterohemorrhagic E. coli infection. PLoS Pathogens 15, 1–27. 
https://doi.org/10.1371/journal.ppat.1007494 
Bankevich, A., Nurk, S., Antipov, D., Gurevich, A.A., Dvorkin, M., Kulikov, A.S., Lesin, V.M., Nikolenko, 
S.I., Pham, S., Prjibelski, A.D., Pyshkin, A. V., Sirotkin, A. V., Vyahhi, N., Tesler, G., Alekseyev, M.A., 
Pevzner, P.A., 2012. SPAdes: A new genome assembly algorithm and its applications to single-cell 
sequencing. Journal of Computational Biology 19, 455–477. https://doi.org/10.1089/cmb.2012.0021 
Banks, D.J., Beres, S.B., Musser, J.M., 2002. The fundamental contribution of phages to GAS evolution, 
genome diversification and strain emergence. Trends in Microbiology 10, 515–521. 
https://doi.org/10.1016/S0966-842X(02)02461-7 
Banks, D.J., Lei, B., Musser, J.M., 2016. Prophage Induction and Expression of Prophage-Encoded Virulence 
Factors in Group A Streptococcus Serotype M3 Strain MGAS315 71, 7079–7086. 
https://doi.org/10.1128/IAI.71.12.7079 
Barendt, S.M., Sham, L.-T., Winkler, M.E., 2011. Characterization of mutants deficient in the L,D-
carboxypeptidase (DacB) and WalRK  (VicRK) regulon, involved in peptidoglycan maturation of 
Streptococcus pneumoniae serotype 2 strain D39. Journal of bacteriology 193, 2290–2300. 
https://doi.org/10.1128/JB.01555-10 
Barnett, T.C., Bowen, A.C., Carapetis, J.R., 2019. The fall and rise of Group A Streptococcus diseases. 
Epidemiology and Infection 147, 1–6. https://doi.org/10.1017/S0950268818002285 
Basetti, S., Hodgson, J., Rawson, T.M., Majeed, A., 2017. Scarlet fever: A guide for general practitioners. 
London Journal of Primary Care 9, 77–79. https://doi.org/10.1080/17571472.2017.1365677 
Bastiat-Sempe, B., Love, J.F., Lomayesva, N., Wessels, M.R., 2014. Streptolysin O and NAD-glycohydrolase 
prevent phagolysosome acidification and promote Group A Streptococcus survival in macrophages. mBio 
170 
 
5, 1–11. https://doi.org/10.1128/mBio.01690-14 
Beachey, E.H., Bronze, M., Dale, J.B., Kraus, W., Poirier, T., Sargent, S., 1988. Protective and autoimmune 
epitopes of streptococcal M proteins. Vaccine 6, 192–196. https://doi.org/10.1016/S0264-410X(88)80027-
6 
Beall, B., Gherardi, G., Lovgren, M., Facklam, R.R., Forwick, B.A., Tyrrell, G.J., 2000. emm and sof gene 
sequence variation in relation to serological typing of opacity-factor-positive Group A streptococci. 
Microbiology 146, 1195–1209. https://doi.org/10.1099/00221287-146-5-1195 
Beckert, S., Kreikemeyer, B., Podbielski, A., 2001. Group A streptococcal rofA gene is involved in the control 
of several virulence genes and eukaryotic cell attachment and internalization. Infection and Immunity 69, 
534–537. https://doi.org/10.1128/IAI.69.1.534-537.2001 
Bednarz, M., Halliday, J.A., Herman, C., Golding, I., 2014. Revisiting bistability in the lysis/lysogeny circuit of 
bacteriophage lambda. PLoS ONE 9. https://doi.org/10.1371/journal.pone.0100876 
Ben Zakour, N.L., Davies, M.R., You, Y., Chen, J.H.K., Forde, B.M., Stanton-Cook, M., Yang, R., Cui, Y., 
Barnett, T.C., Venturini, C., Ong, C.L.Y., Tse, H., Dougan, G., Zhang, J., Yuen, K.Y., Beatson, S.A., 
Walker, M.J., 2015. Transfer of scarlet fever-associated elements into the Group A Streptococcus M1T1 
clone. Scientific Reports 5, 1–7. https://doi.org/10.1038/srep15877 
Berdygulova, Z., Westblade, L.F., Florens, L., Koonin, E. V., Chait, B.T., Ramanculov, E., Washburn, M.P., 
Darst, S.A., Severinov, K., Minakhin, L., 2011. Temporal regulation of gene expression of the thermus 
thermophilus bacteriophage P23-45. Journal of Molecular Biology 405, 125–142. 
https://doi.org/10.1016/j.jmb.2010.10.049 
Beres, S.B., Musser, J.M., 2007. Contribution of exogenous genetic elements to the Group A Streptococcus 
metagenome. PLoS ONE 2. https://doi.org/10.1371/journal.pone.0000800 
Beres, S.B., Richter, E.W., Nagiec, M.J., Sumby, P., Porcella, S.F., DeLeo, F.R., Musser, J.M., 2006. Molecular 
genetic anatomy of inter- and intraserotype variation in the human bacterial pathogen Group A 
Streptococcus. Proceedings of the National Academy of Sciences of the United States of America 103, 
7059–7064. https://doi.org/10.1073/pnas.0510279103 
Beres, S.B., Sylva, G.L., Barbian, K.D., Lei, B., Hoff, J.S., Mammarella, N.D., Liu, M.Y., Smoot, J.C., Porcella, 
S.F., Parkins, L.D., Campbell, D.S., Smith, T.M., McCormick, J.K., Leung, D.Y.M., Schlievert, P.M., 
Musser, J.M., 2002. Genome sequence of a serotype M3 strain of Group A Streptococcus: Phage-encoded 
toxins, the high-virulence phenotype, and clone emergence. Proceedings of the National Academy of 
Sciences of the United States of America 99, 10078–10083. https://doi.org/10.1073/pnas.152298499 
Beres, S.B., Sylva, G.L., Sturdevant, D.E., Granville, C.N., Liu, M., Ricklefs, S.M., Whitney, A.R., Parkins, 
L.D., Hoe, N.P., Adams, G.J., Low, D.E., DeLeo, F.R., McGeer, A., Musser, J.M., 2004. Genome-wide 
molecular dissection of serotype M3 Group A Streptococcus strains causing two epidemics of invasive 
infections. Proceedings of the National Academy of Sciences of the United States of America 101, 11833–
11838. https://doi.org/10.1073/pnas.0404163101 
Berkower, C., Ravins, M., Moses, A.E., Hanski, E., 1999. Expression of different Group A streptococcal M 
171 
 
proteins in an isogenic background demonstrates diversity in adherence to and invasion of eukaryotic cells. 
Molecular Microbiology 31, 1463–1475. https://doi.org/10.1046/j.1365-2958.1999.01289.x 
Bessen, D.E., Jones, K.F., Fischetti, V.A., 1989. Evidence for two distinct classes of streptococcal M protein 
and their relationship to rheumatic fever. Journal of Experimental Medicine 169, 269–283. 
https://doi.org/10.1084/jem.169.1.269 
Bessen, D.E., Sotir, C.M., Readdy, T.L., Hollingshead, S.K., 1996. Genetic Correlates of Throat and Skin 
Isolates of Group A Streptococci. The Journal of Infectious Diseases 173, 896–900. 
https://doi.org/10.1093/infdis/173.4.896 
Bisno, A.L., Stevens, D.L., 1996. Streptococcal infections of skin and soft tissues. The New England journal of 
medicine 334, 240–245. https://doi.org/10.1056/NEJM199601253340407 
Bisno, A.L., 1991. Group A streptococcal infections and acute rheumatic fever. N Engl J Med 325, 293–302. 
https://doi.org/10.1186/1476-069X-12-14 
Biswas, I., Scott, J.R., 2003. Identification of rocA, a positive regulator of covR expression in the Group A 
Streptococcus. Journal of Bacteriology 185, 3081–3090. https://doi.org/10.1128/JB.185.10.3081-
3090.2003 
Bobay, L.M., Touchon, M., Rocha, E.P.C., 2014. Pervasive domestication of defective prophages by bacteria. 
Proceedings of the National Academy of Sciences of the United States of America 111, 12127–12132. 
https://doi.org/10.1073/pnas.1405336111 
Botstein, D., 1980. a Theory of Modular Evolution for Bacteriophages. Annals of the New York Academy of 
Sciences 354, 484–491. https://doi.org/10.1111/j.1749-6632.1980.tb27987.x 
Boutry, C., Delplace, B., Clippe, A., Fontaine, L., Hols, P., 2013. SOS response activation and competence 
development are antagonistic mechanisms in Streptococcus thermophilus. Journal of Bacteriology 195, 
696–707. https://doi.org/10.1128/JB.01605-12 
Brandt, C.M., Spellerberg, B., 2009.  Human Infections Due to Streptococcus dysgalactiae Subspecies 
equisimilis . Clinical Infectious Diseases 49, 766–772. https://doi.org/10.1086/605085 
Brassil, B., Mores, C.R., Wolfe, A.J., Putonti, C., 2020. Characterization and spontaneous induction of urinary 
tract Streptococcus anginosus prophages. Journal of General Virology 101, 685–691. 
https://doi.org/10.1099/jgv.0.001407 
Brenciani, A., Bacciaglia, A., Vignaroli, C., Pugnaloni, A., Varaldo, P.E., Giovanetti, E., 2010. Φm46.1, the 
main Streptococcus pyogenes element carrying mef(A) and tet(O) genes. Antimicrobial Agents and 
Chemotherapy 54, 221–229. https://doi.org/10.1128/AAC.00499-09 
Brenciani, A., Ojo, K.K., Monachetti, A., Menzo, S., Roberts, M.C., Varaldo, P.E., Giovanetti, E., 2004. 
Distribution and molecular analysis of mef(A)-containing elements in tetracycline-susceptible and -
resistant Streptococcus pyogenes clinical isolates with efflux-mediated erythromycin resistance. Journal of 
Antimicrobial Chemotherapy 54, 991–998. https://doi.org/10.1093/jac/dkh481 
Bricker, A.L., Carey, V.J., Wessels, M.R., 2005. Role of NADase in virulence in experimental invasive Group 




Brinkmann, V., Reichard, U., Goosmann, C., Fauler, B., Uhlemann, Y., Weiss, D.S., Weinrauch, Y., 
Zychlinsky, A., 2004. Neutrophil Extracellular Traps Kill Bacteria. Science 303, 1532–1535. 
https://doi.org/10.1126/science.1092385 
Brockmann, S.O., Eichner, L., Eichner, M., 2018. Constantly high incidence of scarlet fever in Germany. The 
Lancet Infectious Diseases 18, 499–500. https://doi.org/10.1016/S1473-3099(18)30210-X 
Brook, I., Gober, A.E., 2006. Recovery of interfering and β-lactamase-producing bacteria from Group A β-
haemolytic streptococci carriers and non-carriers. Journal of Medical Microbiology 55, 1741–1744. 
https://doi.org/10.1099/jmm.0.46796-0 
Broudy, T.B., Fischetti, V.A., 2003. In Vivo Lysogenic Conversion of Tox− Streptococcus pyogenes to 
Tox+ with Lysogenic Streptococci or Free Phage. Society 71, 3782–3786. https://doi.org/10.1128/IAI.71.7.3782 
Broudy, T.B., Pancholi, V., Fischetti, V.A., 2002. The In Vitro Interaction of Streptococcus pyogenes with 
Human Pharyngeal Cells Induces a Phage-Encoded Extracellular DNase. Society 70, 2805–2811. 
https://doi.org/10.1128/IAI.70.6.2805 
Broudy, T.B., Pancholi, V., Fischetti, V.A., 2001. Induction of lysogenic bacteriophage and phage-associated 
toxin from Group A streptococci during coculture with human pharyngeal cells. Infection and Immunity 
69, 1440–1443. https://doi.org/10.1128/IAI.69.3.1440-1443.2001 
Brouwer, S., Barnett, T.C., Ly, D., Kasper, K.J., De Oliveira, D.M.P., Rivera-Hernandez, T., Cork, A.J., 
McIntyre, L., Jespersen, M.G., Richter, J., Schulz, B.L., Dougan, G., Nizet, V., Yuen, K.-Y., You, Y., 
McCormick, J.K., Sanderson-Smith, M.L., Davies, M.R., Walker, M.J., 2020. Prophage exotoxins enhance 
colonization fitness in epidemic scarlet fever-causing Streptococcus pyogenes. Nature Communications 
11, 5018. https://doi.org/10.1038/s41467-020-18700-5 
Brouwer, S., Barnett, T.C., Rivera-Hernandez, T., Rohde, M., Walker, M.J., 2016. Streptococcus pyogenes 
adhesion and colonization. FEBS Letters 590, 3739–3757. https://doi.org/10.1002/1873-3468.12254 
Brüssow, H., Desiere, F., 2001. Comparative phage genomics and the evolution of siphoviridae: Insights from 
dairy phages. Molecular Microbiology 39, 213–223. https://doi.org/10.1046/j.1365-2958.2001.02228.x 
Buchanan, J.T., Simpson, A.J., Aziz, R.K., Liu, G.Y., Kristian, S.A., Kotb, M., Feramisco, J., Nizet, V., 2006. 
DNase expression allows the pathogen Group A Streptococcus to escape killing in neutrophil extracellular 
traps. Current Biology 16, 396–400. https://doi.org/10.1016/j.cub.2005.12.039 
Burghout, P., Cron, L.E., Gradstedt, H., Quintero, B., Simonetti, E., Bijlsma, J.J.E., Bootsma, H.J., Hermans, 
P.W.M., 2010. Carbonic Anhydrase Is Essential for Streptococcus pneumoniae. Growth in Environmental 
Ambient Air. Journal of Bacteriology 192, 4054 LP – 4062. https://doi.org/10.1128/JB.00151-10 
Canchaya, C., Desiere, F., McShan, W.M., Ferretti, J.J., Parkhill, J., Brüssow, H., 2002. Genome analysis of an 
inducible prophage and prophage remnants integrated in the Streptococcus pyogenes strain SF370. 
Virology 302, 245–258. https://doi.org/10.1006/viro.2002.1570 
Canchaya, C., Proux, C., Fournous, G., Bruttin, A., Brussow, H., 2003. Prophage Genomics. Microbiology and 
Molecular Biology Reviews 67, 473–473. https://doi.org/10.1128/mmbr.67.3.473.2003 
173 
 
Carapetis, J.R., Jacoby, P., Carville, K., Ang, S.-J.J., Curtis, N., Andrews, R., 2014. Effectiveness of 
clindamycin and intravenous immunoglobulin, and risk of disease in  contacts, in invasive Group A 
streptococcal infections. Clinical infectious diseases : an official publication of the Infectious Diseases  
Society of America 59, 358–365. https://doi.org/10.1093/cid/ciu304 
Carapetis, J.R., Steer, A.C., Mulholland, E.K., Weber, M., 2005. The global burden of Group A streptococcal 
diseases. Lancet Infectious Diseases 5, 685–694. https://doi.org/10.1016/S1473-3099(05)70267-X 
Carlsson, F., Berggård, K., Stålhammar-Carlemalm, M., Lindahl, G., 2003. Evasion of phagocytosis through 
cooperation between two ligand-binding regions in Streptococcus pyogenes M protein. Journal of 
Experimental Medicine 198, 1057–1068. https://doi.org/10.1084/jem.20030543 
Carlsson, F., Sandin, C., Lindahl, G., 2005. Human fibrinogen bound to Streptococcus pyogenes M protein 
inhibits complement deposition via the classical pathway. Molecular Microbiology 56, 28–39. 
https://doi.org/10.1111/j.1365-2958.2005.04527.x 
Carroll, R.K., Musser, J.M., 2011. From transcription to activation: How Group A Streptococcus, the flesh-
eating pathogen, regulates SpeB cysteine protease production. Molecular Microbiology 81, 588–601. 
https://doi.org/10.1111/j.1365-2958.2011.07709.x 
Carroll, R.K., Shelburne, S.A., Olsen, R.J., Suber, B., Sahasrabhojane, P., Kumaraswami, M., Beres, S.B., Shea, 
P.R., Flores, A.R., Musser, J.M., 2011. Naturally occurring single amino acid replacements in a regulatory 
protein alter streptococcal gene expression and virulence in mice. Journal of Clinical Investigation 121, 
1956–1968. https://doi.org/10.1172/JCI45169 
Carrolo, M., Frias, M.J., Pinto, F.R., Melo-Cristino, J., Ramirez, M., 2010. Prophage spontaneous activation 
promotes DNA release enhancing biofilm formation in Streptococcus pneumoniae. PLoS ONE 5. 
https://doi.org/10.1371/journal.pone.0015678 
Cattoir, V., 2015. Mechanisms of antibiotic resistance - Streptococcus pyogenes. Frontiers in Microbiology 6, 
1–45. https://doi.org/10.3389/fmicb.2015.00034 
Chalker, V., Jironkin, A., Coelho, J., Al-Shahib, A., Platt, S., Kapatai, G., Daniel, R., Dhami, C., Laranjeira, M., 
Chambers, T., Guy, R., Lamagni, T., Harrison, T., Chand, M., Johnson, A.P., Underwood, A., Ramsay, 
M., Fry, N., Purohit, A., Brown, R., 2017. Genome analysis following a national increase in Scarlet Fever 
in England 2014. BMC Genomics 18, 4–13. https://doi.org/10.1186/s12864-017-3603-z 
Chalmers, C., Khemlani, A.H.J., Sohn, C.R., Loh, J.M.S., Tsai, C., Proft, T., 2017. Streptococcus pyogenes 
nuclease A (SpnA) mediated virulence does not exclusively depend on nuclease activity. 1, 42-48 Journal 
of Microbiology, Immunology and Infection. https://doi.org/10.1016/j.jmii.2017.09.006 
Chandrasekaran, S., Caparon, M.G., 2015. The Streptococcus pyogenesNAD+ glycohydrolase modulates 
epithelial cell PARylation and HMGB1 release. Cellular Microbiology 17, 1376–1390. 
https://doi.org/10.1111/cmi.12442 
Chaussee, M.A., Dmitriev, A. V., Callegari, E.A., Chaussee, M.S., 2008. Growth phase-associated changes in 




Cho, K.H., Caparon, M.G., 2005. Patterns of virulence gene expression differ between biofilm and tissue 
communities of Streptococcus pyogenes. Molecular Microbiology 57, 1545–1556. 
https://doi.org/10.1111/j.1365-2958.2005.04786.x 
Chochua, S., Metcalf, B.J., Li, Z., Rivers, J., Mathis, S., 2017. Population and Whole Genome Invasive Group 
A Streptococci Recovered in the United States in 2015. American Society for Microbiology 8, 1422–17. 
Chochua, S., Rivers, J., Mathis, S., Li, Z., Velusamy, S., McGee, L., Beneden, C. Van, Li, Y., Metcalf, B.J., 
Beall, B., 2019. Emergent invasive Group A Streptococcus dysgalactiae subsp. Equisimilis, United States, 
2015–2018. Emerging Infectious Diseases 25, 1543–1547. https://doi.org/10.3201/eid2508.181758 
Clancy, J., Petitpas, J., Dib-Hajj, F., Yuan, W., Cronan, M., Kamath, A. V., Bergeron, J., Retsema, J.A., 1996. 
Molecular cloning and functional analysis of a novel macrolide-resistance determinant, mefA, from 
Streptococcus pyogenes. Molecular Microbiology 22, 867–879. https://doi.org/10.1046/j.1365-
2958.1996.01521.x 
Cleary, P.P., Matsuka, Y. V., Huynh, T., Lam, H., Olmsted, S.B., 2004. Immunization with C5a peptidase from 
either Group A or B streptococci enhances clearance of Group A streptococci from intranasally infected 
mice. Vaccine 22, 4332–4341. https://doi.org/10.1016/j.vaccine.2004.04.030 
Cleary, P.P., Prahbu, U., Dale, J.B., Wexler, D.E., Handley, J., 1992. Streptococcal C5a peptidase is a highly 
specific endopeptidase. Infection and Immunity 60, 5219–5223. https://doi.org/10.1128/iai.60.12.5219-
5223.1992 
Cockerill, F.R., MacDonald, K.L., Thompson, R.L., Roberson, F., Kohner, P.C., Besser-Wiek, J., Manahan, 
J.M., Musser, J.M., Schlievert, P.M., Talbot, J., Frankfort, B., Steckelberg, J.M., Wilson, W.R., Osterholm, 
M.T., 1997. An outbreak of invasive Group A streptococcal disease associated with high carriage rates of 
the invasive clone among school-aged children. Journal of the American Medical Association 277, 38–43. 
https://doi.org/10.1001/jama.277.1.38 
Cole, J.N., McArthur, J.D., McKay, F.C., Sanderson-Smith, M.L., Cork, A.J., Ranson, M., Rohde, M., Itzek, A., 
Sun, H., Ginsburg, D., Kotb, M., Nizet, V., Chhatwal, G.S., Walker, M.J., 2006. Trigger for Group A 
streptococcal M1T1 invasive disease. The FASEB Journal 20, 1745–1747. https://doi.org/10.1096/fj.06-
5804fje 
Collin, M., Olsén, A., 2001. Effect of SpeB and EndoS from Streptococcus pyogenes on human 
immunoglobulins. Infection and Immunity 69, 7187–7189. https://doi.org/10.1128/IAI.69.11.7187-
7189.2001 
Collin, M., Svensson, M.D., Sjo, A.G., Jensenius, J.C., Sjo, U., Olse, A., 2002. EndoS and SpeB from 
Streptococcus pyogenes Inhibit Immunoglobulin-Mediated Opsonophagocytosis. 70, 6646–6651. 
https://doi.org/10.1128/IAI.70.12.6646 
Colonna, M., Facchetti, F., 2003. TREM‐1 (Triggering Receptor Expressed on Myeloid Cells): A New Player in 
Acute Inflammatory Responses. The Journal of Infectious Diseases 187, S397–S401. 
https://doi.org/10.1086/374754 
Commons, R.J., Smeesters, P.R., Proft, T., Fraser, J.D., Robins-Browne, R., Curtis, N., 2014. Streptococcal 
175 
 
superantigens: Categorization and clinical associations. Trends in Molecular Medicine 20, 48–62. 
https://doi.org/10.1016/j.molmed.2013.10.004 
Cortés, M.G., Wessels, M.R., 2009.  Inhibition of Dendritic Cell Maturation by Group A Streptococcus . The 
Journal of Infectious Diseases 200, 1152–1161. https://doi.org/10.1086/605696 
Cortés, M.G., Krog, J., Balázsi, G., 2019. Optimality of the spontaneous prophage induction rate. Journal of 
Theoretical Biology 483. https://doi.org/10.1016/j.jtbi.2019.110005 
Courtney, H.S., Hasty, D.L., Dale, J.B., 2006a. Anti-phagocytic mechanisms of Streptococcus pyogenes: 
Binding of fibrinogen to M-related protein. Molecular Microbiology 59, 936–947. 
https://doi.org/10.1111/j.1365-2958.2005.04977.x 
Courtney, H.S., Hasty, D.L., Dale, J.B., 2006b. Anti-phagocytic mechanisms of Streptococcus pyogenes: 
Binding of fibrinogen to M-related protein. Molecular Microbiology 59, 936–947. 
https://doi.org/10.1111/j.1365-2958.2005.04977.x 
Courtney, H.S., Li, Y., Twal, W.O., Argraves, W.S., 2009. Serum opacity factor is a streptococcal receptor for 
the extracellular matrix protein fibulin-1. Journal of Biological Chemistry 284, 12966–12971. 
https://doi.org/10.1074/jbc.M901143200 
Courtney, H.S., Pownall, H.J., 2010. The structure and function of serum opacity factor: A unique streptococcal 
virulence determinant that targets high-density lipoproteins. Journal of Biomedicine and Biotechnology 
2010. https://doi.org/10.1155/2010/956071 
Crater, D.L., Dougherty, B.A., Van de Rijn, I., 1995. Molecular characterization of hasC from an operon 
required for hyaluronic acid synthesis in Group A streptococci. Demonstration of UDP-glucose 
pyrophosphorylase activity. Journal of Biological Chemistry 270, 28676–28680. 
https://doi.org/10.1074/jbc.270.48.28676 
Cue, D., Lam, H., Cleary, P.P., 2001. Genetic dissection of the Streptococcus pyogenes M1 protein: Regions 
involved in fibronectin binding and intracellular invasion. Microbial Pathogenesis 31, 231–242. 
https://doi.org/10.1006/mpat.2001.0467 
Cunningham, M.W., 2000. Pathogenesis of Group A Streptococcal Infections. Clinical Microbiology Reviews 
13, 470 LP – 511. https://doi.org/10.1128/CMR.13.3.470 
da Silva Duarte, V., Giaretta, S., Campanaro, S., Treu, L., Armani, A., Tarrah, A., Oliveira de Paula, S., 
Giacomini, A., Corich, V., 2019. A Cryptic Non-Inducible Prophage Confers Phage-Immunity on the 
Streptococcus thermophilus M17PTZA496. Viruses 11. https://doi.org/10.3390/v11010007 
Dale, J.B., Chiang, E.Y., Hasty, D.L., Courtney, H.S., 2002. Antibodies against a synthetic peptide of SagA 
neutralize the cytolytic activity of streptolysin S from Group A streptococci. Infection and Immunity 70, 
2166–2170. https://doi.org/10.1128/IAI.70.4.2166-2170.2002 
Dale, J.B., Washburn, R.G., Marques, M.B., Wessels, M.R., 1996. Hyaluronate capsule and surface M protein 
in resistance to opsonization of Group A streptococci. Infection and Immunity 64, 1495–1501. 
https://doi.org/10.1128/iai.64.5.1495-1501.1996 
Danger, J.L., Cao, T.N., Cao, T.H., Sarkar, P., Treviño, J., Pflughoeft, K.J., Sumby, P., 2015a. The small 
176 
 
regulatory RNA FasX enhances Group A Streptococcus virulence and inhibits  pilus expression via 
serotype-specific targets. Molecular microbiology 96, 249–262. https://doi.org/10.1111/mmi.12935 
Danger, J.L., Makthal, N., Kumaraswami, M., Sumby, P., 2015b. The FasX Small Regulatory RNA Negatively 
Regulates the Expression of Two Fibronectin-Binding Proteins in Group A Streptococcus. Journal of 
Bacteriology 197, 3720 LP – 3730. https://doi.org/10.1128/JB.00530-15 
Datta, V., Myskowski, S.M., Kwinn, L.A., Chiem, D.N., Varki, N., Kansal, R.G., Kotb, M., Nizet, V., 2005. 
Mutational analysis of the Group A streptococcal operon encoding streptolysin S and its virulence role in 
invasive infection. Molecular Microbiology 56, 681–695. https://doi.org/10.1111/j.1365-
2958.2005.04583.x 
Davies, F.J., Olme, C., Lynskey, N.N., Turner, C.E., Sriskandan, S., 2019. Streptococcal superantigen-induced 
expansion of human tonsil T cells leads to altered T follicular helper cell phenotype, B cell death and 
reduced immunoglobulin release. Clinical and Experimental Immunology 197, 83–94. 
https://doi.org/10.1111/cei.13282 
Davies, M.R., Holden, M.T., Coupland, P., Chen, J.H.K., Venturini, C., Barnett, T.C., Zakour, N.L. Ben, Tse, 
H., Dougan, G., Yuen, K.-Y., Walker, M.J., 2015. Emergence of scarlet fever Streptococcus pyogenes 
emm12 clones in Hong Kong is associated with toxin acquisition and multidrug resistance. Nature 
Genetics 47, 84–87. https://doi.org/10.1038/ng.3147 
Davies, M.R., McIntyre, L., Mutreja, A., Lacey, J.A., Lees, J.A., Towers, R.J., Duchêne, S., Smeesters, P.R., 
Frost, H.R., Price, D.J., Holden, M.T.G., David, S., Giffard, P.M., Worthing, K.A., Seale, A.C., Berkley, 
J.A., Harris, S.R., Rivera-Hernandez, T., Berking, O., Cork, A.J., Torres, R.S.L.A., Lithgow, T., Strugnell, 
R.A., Bergmann, R., Nitsche-Schmitz, P., Chhatwal, G.S., Bentley, S.D., Fraser, J.D., Moreland, N.J., 
Carapetis, J.R., Steer, A.C., Parkhill, J., Saul, A., Williamson, D.A., Currie, B.J., Tong, S.Y.C., Dougan, 
G., Walker, M.J., 2019. Atlas of Group A streptococcal vaccine candidates compiled using large-scale 
comparative genomics. Nature Genetics 51, 1035–1043. https://doi.org/10.1038/s41588-019-0417-8 
DebRoy, S., Li, X., Kalia, A., Galloway-Pena, J., Shah, B.J., Fowler, V.G., Flores, A.R., Shelburne, S.A., 2018. 
Identification of a chimeric emm gene and novel emm pattern in currently circulating strains of emm4 
Group A Streptococcus. Microbial genomics 4, 1–6. https://doi.org/10.1099/mgen.0.000235 
Derré-Bobillot, A., Cortes-Perez, N.G., Yamamoto, Y., Kharrat, P., Couvé, E., Da Cunha, V., Decker, P., 
Boissier, M.-C., Escartin, F., Cesselin, B., Langella, P., Bermúdez-Humarán, L.G., Gaudu, P., 2013. 
Nuclease A (Gbs0661), an extracellular nuclease of Streptococcus agalactiae, attacks  the neutrophil 
extracellular traps and is needed for full virulence. Molecular microbiology 89, 518–531. 
https://doi.org/10.1111/mmi.12295 
Desiere, F., McShan, W.M., Van Sinderen, D., Ferretti, J.J., Brüssow, H., 2001. Comparative genomics reveals 
close genetic relationships between phages from dairy bacteria and pathogenic streptococci: Evolutionary 
implications for prophage-host interactions. Virology 288, 325–341. 
https://doi.org/10.1006/viro.2001.1085 
Di Nardo, A., Yamasaki, K., Dorschner, R.A., Lai, Y., Gallo, R.L., 2008.  Mast Cell Cathelicidin Antimicrobial 
177 
 
Peptide Prevents Invasive Group A Streptococcus Infection of the Skin . The Journal of Immunology 180, 
7565–7573. https://doi.org/10.4049/jimmunol.180.11.7565 
Dmitriev, A. V., McDowell, E.J., Kappeler, K. V., Chaussee, M.A., Rieck, L.D., Chaussee, M.S., 2006. The 
Rgg regulator of Streptococcus pyogenes influences utilization of nonglucose carbohydrates, prophage 
induction, and expression of the NAD-glycohydrolase virulence operont. Journal of Bacteriology 188, 
7230–7241. https://doi.org/10.1128/JB.00877-06 
Dokland, T., 1999. Scaffolding proteins and their role in viral assembly. Cellular and molecular life sciences : 
CMLS 56, 580–603. https://doi.org/10.1007/s000180050455 
Dunkelberger, J.R., Song, W.C., 2010. Complement and its role in innate and adaptive immune responses. Cell 
Research 20, 34–50. https://doi.org/10.1038/cr.2009.139 
Edwards, R.J., Pyzio, M., Gierula, M., Turner, C.E., Abdul-Salam, V.B., Sriskandan, S., 2018. Proteomic 
analysis at the sites of clinical infection with invasive Streptococcus pyogenes. Scientific Reports 8, 1–9. 
https://doi.org/10.1038/s41598-018-24216-2 
Edwards, R.J., Taylor, G.W., Ferguson, M., Murray, S., Rendell, N., Wrigley, A., Bai, Z., Boyle, J., Finney, 
S.J., Jones, A., Russell, H.H., Turner, C., Cohen, J., Faulkner, L., Sriskandan, S., 2005.  Specific C‐
Terminal Cleavage and Inactivation of Interleukin‐8 by Invasive Disease Isolates of Streptococcus 
pyogenes . The Journal of Infectious Diseases 192, 783–790. https://doi.org/10.1086/432485 
Efstratiou, A., 2000. Group A streptococci in the 1990s. Journal of Antimicrobial Chemotherapy 45, 3–12. 
https://doi.org/10.1093/jac/45.suppl_1.3 
Efstratiou, A., Lamagni, T., 2016. Epidemiology of Streptococcus pyogenes. Streptococcus pyogenes: Basic 
Biology to Clinical Manifestations 1–27. 
Egesten, A., Olin, A.I., Linge, H.M., Yadav, M., Mörgelin, M., Karlsson, A., Collin, M., 2009. SpeB of 
Streptococcus pyogenes differentially modulates antibacterial and receptor activating properties of human 
chemokines. PLoS ONE 4, 1–9. https://doi.org/10.1371/journal.pone.0004769 
Eraso, J.M., Kachroo, P., Olsen, R.J., Beres, S.B., Zhu, L., Badu, T., Shannon, S., Cantu, C.C., Saavedra, M.O., 
Kubiak, S.L., Porter, A.R., DeLeo, F.R., Musser, J.M., 2020. Genetic heterogeneity of the Spy1336/R28-
Spy1337 virulence axis in Streptococcus  pyogenes and effect on gene transcript levels and pathogenesis. 
PloS one 15, e0229064. https://doi.org/10.1371/journal.pone.0229064 
Eriksson, A., Norgren, M., 2003. Cleavage of antigen-bound immunoglobulin G by SpeB contributes to 
streptococcal persistence in opsonizing blood. Infection and Immunity 71, 211–217. 
https://doi.org/10.1128/IAI.71.1.211-217.2003 
Euler, C.W., Juncosa, B., Ryan, P.A., Deutsch, D.R., McShan, W.M., Fischetti, V.A., 2016. Targeted curing of 
all lysogenic bacteriophage from Streptococcus pyogenes using a novel counter-selection technique. PLoS 
ONE 11, 1–22. https://doi.org/10.1371/journal.pone.0146408 
Fagan, P.K., Reinschied, D., Gottschalk, B., Chhatwal, G.S., 2001. Identification and characterization of a novel 




Farenc, C., Spinelli, S., Vinogradov, E., Tremblay, D., Blangy, S., Sadovskaya, I., Moineau, S., Cambillau, C., 
2014. Molecular Insights on the Recognition of a Lactococcus lactis Cell Wall Pellicle by the Phage 1358 
Receptor Binding Protein. Journal of Virology 88, 7005–7015. https://doi.org/10.1128/jvi.00739-14 
Federle, M.J., McIver, K.S., Scott, J.R., 1999. A response regulator that represses transcription of several 
virulence operons in the Group A Streptococcus. Journal of Bacteriology 181, 3649–3657. 
https://doi.org/10.1128/jb.181.12.3649-3657.1999 
Fernández De Henestrosa, A.R., Ogi, T., Aoyagi, S., Chafin, D., Hayes, J.J., Ohmori, H., Woodgate, R., 2000. 
Identification of additional genes belonging to the LexA regulon in Escherichia coli. Molecular 
Microbiology 35, 1560–1572. https://doi.org/10.1046/j.1365-2958.2000.01826.x 
Fernie-King, B.A., Seilly, D.J., Davies, A., Lachmann, P.J., 2002. Streptococcal inhibitor of complement 
inhibits two additional components of the mucosal innate immune system: Secretory leukocyte proteinase 
inhibitor and lysozyme. Infection and Immunity 70, 4908–4916. https://doi.org/10.1128/IAI.70.9.4908-
4916.2002 
Fernie-King, B.A., Seilly, D.J., Willers, C., Würzner, R., Davies, A., Lachmann, P.J., 2001. Streptococcal 
inhibitor of complement (SIC) inhibits the membrane attack complex by preventing uptake of C567 onto 
cell membranes. Immunology 103, 390–398. https://doi.org/10.1046/j.1365-2567.2001.01249.x 
Ferretti, J.J., McShan, W.M., Ajdic, D., Savic, D.J., Savic, G., Lyon, K., Primeaux, C., Sezate, S., Suvorov, 
A.N., Kenton, S., Lai, H.S., Lin, S.P., Qian, Y., Jia, H.G., Najar, F.Z., Ren, Q., Zhu, H., Song, L., White, 
J., Yuan, X., Clifton, S.W., Roe, B.A., McLaughlin, R., 2001. Complete genome sequence of an M1 strain 
of Streptococcus pyogenes. Proceedings of the National Academy of Sciences of the United States of 
America 98, 4658–4663. https://doi.org/10.1073/pnas.071559398 
Fischetti, V.A., 2007. In vivo acquisition of prophage in Streptococcus pyogenes. Trends in Microbiology 15, 
297–300. https://doi.org/10.1016/j.tim.2007.05.003 
Fischetti, V.A., 1989. Streptococcal M protein: Molecular design and biological behavior. Clinical 
Microbiology Reviews 2, 285–314. https://doi.org/10.1128/CMR.2.3.285 
Flores, A.R., Chase McNeil, J., Shah, B., Van Beneden, C., Shelburne, S.A., 2019. Capsule-negative emm types 
are an increasing cause of pediatric Group A streptococcal infections at a large pediatric hospital in Texas. 
Journal of the Pediatric Infectious Diseases Society 8, 244–250. https://doi.org/10.1093/jpids/piy053 
Flores, A.R., Jewell, B.E., Fittipaldi, N., Beres, S.B., Musser, J.M., 2012. Human disease isolates of serotype 
M4 and M22 Group A Streptococcus lack genes required for hyaluronic acid capsule biosynthesis. mBio 3, 
4–8. https://doi.org/10.1128/mBio.00413-12 
Flores, A.R., Jewell, B.E., Olsen, R.J., Shelburne, S.A., Fittipaldi, N., Beres, S.B., Musser, J.M., 2014. 
Asymptomatic carriage of Group A Streptococcus is associated with elimination of capsule production. 
Infection and Immunity 82, 3958–3967. https://doi.org/10.1128/IAI.01788-14 
Flores, A.R., Luna, R.A., Runge, J.K., Shelburne, S.A., Baker, C.J., 2017. Cluster of fatal Group A 
streptococcal emm87 infections in a single family: Molecular basis for invasion and transmission. Journal 
of Infectious Diseases 215, 1648–1652. https://doi.org/10.1093/infdis/jix177 
179 
 
Fluckiger, U., Jones, K.F., Fischetti, V.A., 1998. Immunoglobulins to Group A streptococcal surface molecules 
decrease adherence to and invasion of human pharyngeal cells. Infection and Immunity 66, 974–979. 
https://doi.org/10.1128/iai.66.3.974-979.1998 
Fogg, G.C., Caparon, M.G., 1997. Constitutive expression of fibronectin binding in Streptococcus pyogenes as a 
result of anaerobic activation of rofA. Journal of Bacteriology 179, 6172–6180. 
https://doi.org/10.1128/jb.179.19.6172-6180.1997 
Franklin, L., Nobbs, A.H., Bricio-Moreno, L., Wright, C.J., Maddocks, S.E., Sahota, J.S., Ralph, J., O’Connor, 
M., Jenkinson, H.F., Kadioglu, A., 2013. The AgI/II Family Adhesin AspA Is Required for Respiratory 
Infection by Streptococcus pyogenes. PLoS ONE 8. https://doi.org/10.1371/journal.pone.0062433 
Friães, A., Pato, C., Melo-Cristino, J., Ramirez, M., 2015. Consequences of the variability of the CovRS and 
RopB regulators among Streptococcus pyogenes causing human infections. Scientific Reports 5, 1–12. 
https://doi.org/10.1038/srep12057 
Frias, M.J., Melo-Cristino, J., Ramirez, M., 2013. Export of the pneumococcal phage SV1 lysin requires 
choline-containing teichoic acids and is holin-independent. Molecular Microbiology 87, 430–445. 
https://doi.org/10.1111/mmi.12108 
Frígols, B., Quiles-Puchalt, N., Mir-Sanchis, I., Donderis, J., Elena, S.F., Buckling, A., Novick, R.P., Marina, 
A., Penadés, J.R., 2015. Virus Satellites Drive Viral Evolution and Ecology. PLoS Genetics 11, 1–19. 
https://doi.org/10.1371/journal.pgen.1005609 
Frost, H.R., Davies, M.R., Delforge, V., Lakhloufi, D., Sanderson-Smith, M., Srinivasan, V., Steer, A.C., 
Walker, M.J., Beall, B., Botteaux, A., Smeesters, P.R., 2020. Analysis of Global Collection of Group A 
Streptococcus Genomes Reveals that the Majority Encode a Trio of M and M-Like Proteins. mSphere 5, 
e00806-19. https://doi.org/10.1128/mSphere.00806-19 
Fuller, D.N., Raymer, D.M., Rickgauer, J.P., Robertson, R.M., Catalano, C.E., Anderson, D.L., Grimes, S., 
Smith, D.E., 2007. Measurements of single DNA molecule packaging dynamics in bacteriophage lambda  
reveal high forces, high motor processivity, and capsid transformations. Journal of molecular biology 373, 
1113–1122. https://doi.org/10.1016/j.jmb.2007.09.011 
Galloway-Peña, J., Clement, M.E., Kuinkel, B.K.S., Ruffin, F., Flores, A.R., Levinson, H., Shelburne, S.A., 
Moore, Z., Fowler, V.G., 2016. Application of whole-genome sequencing to an unusual outbreak of 
invasive Group A streptococcal disease. Open Forum Infectious Diseases 3, 1–4. 
https://doi.org/10.1093/ofid/ofw042 
Galloway-Peña, J., DebRoy, S., Brumlow, C., Li, X., Tran, T.T., Horstmann, N., Yao, H., Chen, K., Wang, F., 
Pan, B.F., Hawke, D.H., Thompson, E.J., Arias, C.A., Fowler, V.G., Bhatti, M.M., Kalia, A., Flores, A.R., 
Shelburne, S.A., 2018. Hypervirulent Group A Streptococcus emergence in an acaspular background is 
associated with marked remodeling of the bacterial cell surface. PLoS ONE 13, 1–23. 
https://doi.org/10.1371/journal.pone.0207897 
Garcia, M., Pimentel, M., Moniz-Pereira, J., 2002. Expression of mycobacteriophage Ms6 lysis genes is driven 
by two σ70-like promoters and is dependent on a transcription termination signal present in the leader 
180 
 
RNA. Journal of Bacteriology 184, 3034–3043. https://doi.org/10.1128/JB.184.11.3034-3043.2002 
Gasc, A.M., Sicard, N., Claverys, J.P., Sicard, A.M., 1980. Lack of SOS repair in Streptococcus pneumoniae. 
Mutation research 70, 157–165. https://doi.org/10.1016/0027-5107(80)90155-4 
Gerlach, D., Reichardt, W., Fleischer, B., Schmidt, K.H., 1994. Separation of mitogenic and pyrogenic activities 
from so-called erythrogenic toxin type B (Streptococcal Proteinase). Zentralblatt fur Bakteriologie 280, 
507–514. https://doi.org/10.1016/S0934-8840(11)80510-4 
Gillen, C.M., Courtney, H.S., Schulze, K., Rohde, M., Wilson, M.R., Timmer, A.M., Guzman, C.A., Nizet, V., 
Chhatwal, G.S., Walker, M.J., 2008. Opacity factor activity and epithelial cell binding by the serum 
opacity factor protein of Streptococcus pyogenes are functionally discrete. Journal of Biological Chemistry 
283, 6359–6366. https://doi.org/10.1074/jbc.M706739200 
Giovanetti, E., Brenciani, A., Lupidi, R., Roberts, M.C., Varaldo, P.E., 2003. Presence of the tet(O) gene in 
erythromycin- and tetracycline-resistant strains of Streptococcus pyogenes and linkage with either the 
mef(A) or the erm(A) gene. Antimicrobial Agents and Chemotherapy 47, 2844–2849. 
https://doi.org/10.1128/AAC.47.9.2844-2849.2003 
Giovanetti, E., Brenciani, A., Morroni, G., Tiberi, E., Pasquaroli, S., Mingoia, M., Varaldo, P.E., 2014. 
Transduction of the Streptococcus pyogenes bacteriophage Φm46.1, carrying resistance genes mef(A) and 
tet(O), to other Streptococcus species. Frontiers in Microbiology 5, 1–9. 
https://doi.org/10.3389/fmicb.2014.00746 
Giovanetti, E., Brenciani, A., Tiberi, E., Bacciaglia, A., Varaldo, P.E., 2012. ICESp2905, the erm(TR)-tet(O) 
element of Streptococcus pyogenes, is formed by two independent integrative and conjugative elements. 
Antimicrobial Agents and Chemotherapy 56, 591–594. https://doi.org/10.1128/AAC.05352-11 
Giovanetti, E., Brenciani, A., Vecchi, M., Manzin, A., Varaldo, P.E., 2005. Prophage association of mef(A) 
elements encoding efflux-mediated erythromycin resistance in Streptococcus pyogenes. Journal of 
Antimicrobial Chemotherapy 55, 445–451. https://doi.org/10.1093/jac/dki049 
Gogos, A., Federle, M.J., 2019. Modeling Streptococcus pyogenes pharyngeal colonization in the mouse. 
Frontiers in Cellular and Infection Microbiology 9, 1–12. https://doi.org/10.3389/fcimb.2019.00137 
Goldblatt, J., Lawrenson, R.A., Muir, L., Dattani, S., Hoffland, A., Tsuchiya, T., Kanegasaki, S., Sriskandan, S., 
Pease, J.E., 2019. A Requirement for Neutrophil Glycosaminoglycans in Chemokine:Receptor Interactions 
Is Revealed by the Streptococcal Protease SpyCEP. The Journal of Immunology 202, 3246–3255. 
https://doi.org/10.4049/jimmunol.1801688 
Goldmann, O., Rohde, M., Chhatwal, G.S., Medina, E., 2004. Role of Macrophages in Host Resistance to 
Group A Streptococci. Infection and Immunity 72, 2956–2963. https://doi.org/10.1128/IAI.72.5.2956-
2963.2004 
Goldmann, O., Thulin, P., Heinemann, K., Norrby-teglund, A., Rohde, M., Medina, E., 2008. Phagocytosis-
independent antimicrobial activity of mast cells by means of extracellular trap formation. Blood 111, 
3070–3080. https://doi.org/10.1182/blood-2007-07-104018.The 




Graham, M.R., Smoot, L.M., Migliaccio, C.A.L., Virtaneva, K., Sturdevant, D.E., Porcella, S.F., Federle, M.J., 
Adams, G.J., Scott, J.R., Musser, J.M., 2002. Virulence control in Group A Streptococcus by a two-
component gene regulatory system: Global expression profiling and in vivo infection modeling. 
Proceedings of the National Academy of Sciences of the United States of America 99, 13855–13860. 
https://doi.org/10.1073/pnas.202353699 
Graham, M.R., Virtaneva, K., Porcella, S.F., Barry, W.T., Gowen, B.B., Johnson, C.R., Wright, F.A., Musser, 
J.M., 2005. Group A Streptococcus transcriptome dynamics during growth in human blood reveals 
bacterial adaptive and survival strategies. American Journal of Pathology 166, 455–465. 
https://doi.org/10.1016/S0002-9440(10)62268-7 
Granok, A.B., Parsonage, D., Ross, R.P., Caparon, M.G., 2000. The RofA binding site in Streptococcus 
pyogenes is utilized in multiple transcriptional pathways. Journal of Bacteriology 182, 1529–1540. 
https://doi.org/10.1128/JB.182.6.1529-1540.2000 
Grayson, A.K., Hearnden, V., Bolt, R., Jebreel, A., Colley, H.E., Murdoch, C., 2018. Use of a Rho kinase 
inhibitor to increase human tonsil keratinocyte longevity for  three-dimensional, tissue engineered tonsil 
epithelium equivalents. Journal of tissue engineering and regenerative medicine 12, e1636–e1646. 
https://doi.org/10.1002/term.2590 
Grebe, T., Hakenbeck, R., 1996. Penicillin-binding proteins 2b and 2x of Streptococcus pneumoniae are primary  
resistance determinants for different classes of beta-lactam antibiotics. Antimicrobial agents and 
chemotherapy 40, 829–834. https://doi.org/10.1128/AAC.40.4.829 
Green, N.M., Zhang, S., Porcella, S.F., Nagiec, M.J., Barbian, K.D., Beres, S.B., LeFebvre, R.B., Musser, J.M., 
2005.  Genome Sequence of a Serotype M28 Strain of Group A Streptococcus: Potential New Insights into 
Puerperal Sepsis and Bacterial Disease Specificity . The Journal of Infectious Diseases 192, 760–770. 
https://doi.org/10.1086/430618 
Groth, A.C., Calos, M.P., 2004. Phage integrases: Biology and applications. Journal of Molecular Biology 335, 
667–678. https://doi.org/10.1016/j.jmb.2003.09.082 
Gryllos, I., Cywes, C., Shearer, M.H., Cary, M., Kennedy, R.C., Wessels, M.R., 2001. Regulation of capsule 
gene expression by Group A Streptococcus during pharyngeal colonization and invasive infection. 
Molecular Microbiology 42, 61–74. https://doi.org/10.1046/j.1365-2958.2001.02635.x 
Gryllos, I., Grifantini, R., Colaprico, A., Jiang, S., DeForce, E., Hakansson, A., Telford, J.L., Grandi, G., 
Wessels, M.R., 2007. Mg2+ signalling defines the Group A streptococcal CsrRS (CovRS) regulon. 
Molecular Microbiology 65, 671–683. https://doi.org/10.1111/j.1365-2958.2007.05818.x 
Gryllos, I., Tran-Winkler, H.J., Cheng, M.F., Chung, H., Bolcome, R., Lu, W., Lehrer, R.I., Wessels, M.R., 
2008. Induction of Group A Streptococcus virulence by a human antimicrobial peptide. Proceedings of the 
National Academy of Sciences of the United States of America 105, 16755–16760. 
https://doi.org/10.1073/pnas.0803815105 
Hagberg, C., Radulescu, A., Rex, J.H., 1997. Necrotizing Fasciitis Due to Group A Streptococcus after an 
182 
 
Accidental Needle-Stick Injury. New England Journal of Medicine 337, 1699. 
https://doi.org/10.1056/NEJM199712043372318 
Halperin, S.A., Ferrieri, P., Gray, E.D., Kaplan, E.L., Wannamaker, L.W., 1987. Antibody Response to 
Bacteriophage Hyaluronidase in Acute Glomerulonephritis After Group A Streptococcal Infection. Journal 
of Infectious Diseases 155, 253–261. https://doi.org/10.1093/infdis/155.2.253 
Hamada, S., Kawabata, S., Nakagawa, I., 2015. Molecular and genomic characterization of pathogenic traits of 
Group A Streptococcus pyogenes. Proceedings of the Japan Academy Series B: Physical and Biological 
Sciences 91, 539–559. https://doi.org/10.2183/pjab.91.539 
Han, H., Liu, C., Wang, Q., Xuan, C., Zheng, B., Tang, J., Yan, J., Zhang, J., Li, M., Cheng, H., Lu, G., Gao, 
G.F., 2012. The two-component system Ihk/Irr contributes to the virulence of Streptococcus suis serotype 
2 strain 05ZYH33 through alteration of the bacterial cell metabolism. Microbiology (United Kingdom) 
158, 1852–1866. https://doi.org/10.1099/mic.0.057448-0 
Harder, J., Franchi, L., Muñoz-Planillo, R., Park, J.-H., Reimer, T., Núñez, G., 2009.  Activation of the Nlrp3 
Inflammasome by Streptococcus pyogenes Requires Streptolysin O and NF-κB Activation but Proceeds 
Independently of TLR Signaling and P2X7 Receptor . The Journal of Immunology 183, 5823–5829. 
https://doi.org/10.4049/jimmunol.0900444 
Hasegawa, T., Minami, M., Okamoto, A., Tatsuno, I., Isaka, M., Ohta, M., 2010. Characterization of a 
virulence-associated and cell-wall-located DNase of Streptococcus pyogenes. Microbiology 156, 184–190. 
https://doi.org/10.1099/mic.0.031955-0 
Hendrickson, C., Euler, C.W., Nguyen, S. V., Rahman, M., McCullor, K.A., King, C.J., Fischetti, V.A., 
McShan, W.M., 2015. Elimination of chromosomal Island SpyCIM1 from Streptococcus pyogenes strain 
SF370 reverses the mutator phenotype and alters global transcription. PLoS ONE 10, 1–23. 
https://doi.org/10.1371/journal.pone.0145884 
Henningham, A., Döhrmann, S., Nizet, V., Cole, J.N., 2015. Mechanisms of Group A Streptococcus resistance 
to reactive oxygen species. FEMS microbiology reviews 39, 488–508. 
https://doi.org/10.1093/femsre/fuu009 
Henningham, A., Yamaguchi, M., Aziz, R.K., Kuipers, K., Buffalo, C.Z., Dahesh, S., Choudhury, B., Van 
Vleet, J., Yamaguchi, Y., Seymour, L.M., Ben Zakour, N.L., He, L., Smith, H. V., Grimwood, K., 
Beatson, S.A., Ghosh, P., Walker, M.J., Nizet, V., Colea, J.N., 2014. Mutual exclusivity of hyaluronan and 
hyaluronidase in invasive Group A Streptococcus. Journal of Biological Chemistry 289, 32303–32315. 
https://doi.org/10.1074/jbc.M114.602847 
Hertzén, E., Johansson, L., Kansal, R., Hecht, A., Dahesh, S., Janos, M., Nizet, V., Kotb, M., Norrby-Teglund, 
A., 2012. Intracellular Streptococcus pyogenes in human macrophages display an altered gene expression 
profile. PloS one 7, 1–10. https://doi.org/10.1371/journal.pone.0035218 
Hertzén, E., Johansson, L., Wallin, R., Schmidt, H., Kroll, M., Rehn, A.P., Kotb, M., Mörgelin, M., Norrby-
Teglund, A., 2010. M1 protein-dependent intracellular trafficking promotes persistence and replication of 




Herwald, H., Collin, M., Müller-Esterl, W., Björck, L., 1996. Streptococcal cysteine proteinase releases kinins: 
A novel virulence mechanism. Journal of Experimental Medicine 184, 665–673. 
https://doi.org/10.1084/jem.184.2.665 
Hoe, N.P., Ireland, R.M., DeLeo, F.R., Gowen, B.B., Dorward, D.W., Voyich, J.M., Liu, M., Burns, E.H., 
Culnan, D.M., Bretscher, A., Musser, J.M., 2002. Insight into the molecular basis of pathogen abundance: 
Group A Streptococcus inhibitor of complement inhibits bacterial adherence and internalization into 
human cells. Proceedings of the National Academy of Sciences of the United States of America 99, 7646–
7651. https://doi.org/10.1073/pnas.112039899 
Hoe, N.P., Nakashima, K., Lukomski, S., Grigsby, D., Liu, M., Kordari, P., Dou, S.J., Pan, X., Vuopio-Varkila, 
J., Salmelinna, S., McGeer, A., Low, D.E., Schwartz, B., Schuchat, A., Naidich, S., De Lorenzo, D., Fu, 
Y.X., Musser, J.M., 1999. Rapid selection of complement-inhibiting protein variants in Group A 
Streptococcus epidemic waves. Nature Medicine 5, 924–929. https://doi.org/10.1038/11369 
Holden, M.T.G., Heather, Z., Paillot, R., Steward, K.F., Webb, K., Ainslie, F., Jourdan, T., Bason, N.C., 
Holroyd, N.E., Mungall, K., Quail, M.A., Sanders, M., Simmonds, M., Willey, D., Brooks, K., Aanensen, 
D.M., Spratt, B.G., Jolley, K.A., Maiden, M.C.J., Kehoe, M., Chanter, N., Bentley, S.D., Robinson, C., 
Maskell, D.J., Parkhill, J., Waller, A.S., 2009. Genomic evidence for the evolution of Streptococcus equi 
host restriction, increased virulence, and genetic exchange with human pathogens. PLoS Pathogens 5. 
https://doi.org/10.1371/journal.ppat.1000346 
Holmes, R.K., 2000. Biology and molecular epidemiology of diphtheria toxin and the tox gene. The Journal of 
infectious diseases 181 Suppl, S156-67. https://doi.org/10.1086/315554 
Hondorp, E.R., McIver, K.S., 2007. The Mga virulence regulon: Infection where the grass is greener. Molecular 
Microbiology 66, 1056–1065. https://doi.org/10.1111/j.1365-2958.2007.06006.x 
Horst, S.A., Linnér, A., Beineke, A., Lehne, S., Höltje, C., Hecht, A., Norrby-Teglund, A., Medina, E., 
Goldmann, O., 2013. Prognostic value and therapeutic potential of TREM-1 in Streptococcus pyogenes-
induced sepsis. Journal of Innate Immunity 5, 581–590. https://doi.org/10.1159/000348283 
Horstmann, N., Sahasrabhojane, P., Suber, B., Kumaraswami, M., Olsen, R.J., Flores, A., Musser, J.M., 
Brennan, R.G., Shelburne, S.A., 2011. Distinct single amino acid replacements in the control of virulence 
regulator protein differentially impact streptococcal pathogenesis. PLoS Pathogens 7(10). 
https://doi.org/10.1371/journal.ppat.1002311 
Horstmann, N., Tran, C.N., Brumlow, C., DebRoy, S., Yao, H., Nogueras Gonzalez, G., Makthal, N., 
Kumaraswami, M., Shelburne, S.A., 2018. Phosphatase activity of the control of virulence sensor kinase 
CovS is critical for the pathogenesis of Group A Streptococcus. PLoS Pathogens 14, 1–26. 
https://doi.org/10.1371/journal.ppat.1007354 
Horstmann, R.D., Sievertsen, H.J., Leippe, M., Fischetti, V.A., 1992. Role of fibrinogen in complement 




Hsieh, C.L., Huang, H.M., Hsieh, S.Y., Zheng, P.X., Lin, Y.S., Chiang-Ni, C., Tsai, P.J., Wang, S.Y., Liu, C.C., 
Wu, J.J., 2018. NAD-glycohydrolase depletes intracellular NAD+ and inhibits acidification of 
autophagosomes to enhance multiplication of Group A Streptococcus in endothelial cells. Frontiers in 
Microbiology 9, 1–11. https://doi.org/10.3389/fmicb.2018.01733 
Hsueh, S.-C., Huang, Y.-T., Hsueh, P.-R., 2019. Streptococcus pyogenes cutaneous infection following sandfly 
bites. Journal of microbiology, immunology, and infection = Wei mian yu gan ran za zhi. 
https://doi.org/10.1016/j.jmii.2019.09.001 
Hu, M.C., Walls, M.A., Stroop, S.D., Reddish, M.A., Beall, B., Dale, J.B., 2002. Immunogenicity of a 26-valent 
Group A streptococcal vaccine. Infection and immunity 70, 2171–2177. 
https://doi.org/10.1128/iai.70.4.2171-2177.2002 
Huang, X., Li, D., Xi, L., Mylonakis, E., 2015. Galleria mellonella Larvae as an Infection Model for 
Penicillium marneffei. Mycopathologia 180, 159–164. https://doi.org/10.1007/s11046-015-9897-y 
Hyder, S.L., Streitfeld, M.M., 1978. Transfer of erythromycin resistance from clinically isolated lysogenic 
strains of  Streptococcus pyogenes via their endogenous phage. The Journal of infectious diseases 138, 
281–286. https://doi.org/10.1093/infdis/138.3.281 
Hynes, W., Johnson, C., Stokes, M., 2009. A single nucleotide mutation results in loss of enzymatic activity in 
the hyaluronate lyase gene of Streptococcus pyogenes. Microbial Pathogenesis 47, 308–313. 
https://doi.org/10.1016/j.micpath.2009.09.008 
Hynes, W.L., Hancock, L., Ferretti, J.J., 1995. Analysis of a second bacteriophage hyaluronidase gene from 
Strptococcus pyogenes: Evidence for a third hyaluronidase involved in extracellular enzymatic activity. 
Infection and Immunity 63, 3015–3020. https://doi.org/10.1128/iai.63.8.3015-3020.1995 
Hynes, W.L., Walton, S.L., 2000. Hyaluronidases of Gram-positive bacteria. FEMS Microbiology Letters 183, 
201–207. https://doi.org/10.1016/S0378-1097(99)00669-2 
Igwe, E.I., Shewmaker, P.L., Facklam, R.R., Farley, M.M., Van Beneden, C., Beall, B., 2003. Identification of 
superantigen genes speM, ssa, and smeZ in invasive strains of beta-hemolytic Group C and G streptococci 
recovered from humans. FEMS Microbiology Letters 229, 259–264. https://doi.org/10.1016/S0378-
1097(03)00842-5 
Ikebe, T., Ato, M., Matsumura, T., Hasegawa, H., Sata, T., Kobayashi, K., Watanabe, H., 2010. Highly frequent 
mutations in negative regulators of multiple virulence genes in Group A streptococcal toxic shock 
syndrome isolates. PLoS Pathogens 6, 1–17. https://doi.org/10.1371/journal.ppat.1000832 
Ingham, S.C., Wadhera, R.K., Chu, C.H., DeVita, M.D., 2006. Survival of Streptococcus pyogenes on foods and 
food contact surfaces. Journal of Food Protection 69, 1159–1163. https://doi.org/10.4315/0362-028X-
69.5.1159 
Ingrey, K.T., Ren, J., Prescott, J.F., 2003. A fluoroquinolone induces a novel mitogen-encoding bacteriophage 





Iwasaki, A., Medzhitov, R., 2004. Toll-like receptor control of the adaptive immune responses. Nature 
Immunology 5, 987–995. https://doi.org/10.1038/ni1112 
Jacoba, K.M., Spilkera, T., LiPuma, J.J., Dawida, S.R., Watsona, M.E., 2016. Complete genome sequence of 
emm4 Streptococcus pyogenes MEW427, a throat isolate from a child meeting clinical criteria for pediatric 
autoimmune neuropsychiatric disorders associated with Streptococcus (PANDAS). Genome 
Announcements 4, 1–2. https://doi.org/10.1128/genomeA.00127-16 
Jaggi, P., Tanz, R.R., Beall, B., Shulman, S.T., 2005. Age influences the emm type distribution of pediatric 
Group A streptococcal pharyngeal isolates. Pediatric Infectious Disease Journal 24, 1089–1092. 
https://doi.org/10.1097/01.inf.0000190023.89759.96 
Ji, Y., Carlson, B., Kondagunta, A., Cleary, P.P., 1997. Intranasal immunization with C5a peptidase prevents 
nasopharyngeal colonization of mice by the Group A Streptococcus. Infection and Immunity 65, 2080–
2087. https://doi.org/10.1128/iai.65.6.2080-2087.1997 
Ji, Y., Schnitzler, N., Demaster, E., Cleary, P., 1998. Impact of M49, Mrp, Enn, and C5a peptidase proteins on 
colonization of the mouse oral mucosa by Streptococcus pyogenes. Infection and Immunity 66, 5399–
5405. https://doi.org/10.1128/iai.66.11.5399-5405.1998 
Jiang, S.M., Ishmael, N., Hotopp, J.D., Puliti, M., Tissi, L., Kumar, N., Cieslewicz, M.J., Tettelin, H., Wessels, 
M.R., 2008. Variation in the group B Streptococcus CsrRS regulon and effects on pathogenicity. Journal 
of Bacteriology 190, 1956–1965. https://doi.org/10.1128/JB.01677-07 
Johnson, D.R., Kaplan, E.L., VanGheem, A., Facklam, R.R., Beall, B., 2006. Characterization of Group A 
streptococci (Streptococcus pyogenes): Correlation of M-protein and emm-gene type with T-protein 
agglutination pattern and serum opacity factor. Journal of Medical Microbiology 55, 157–164. 
https://doi.org/10.1099/jmm.0.46224-0 
Johnsson, E., Andersson, G., Lindahl, G., Hedén, L.O., 1994. Identification of the IgA-binding region in 
streptococcal protein Arp. The Journal of Immunology 153, 3557 LP – 3564. 
Jung, K., Fried, L., Behr, S., Heermann, R., 2012. Histidine kinases and response regulators in networks. 
Current Opinion in Microbiology 15, 118–124. https://doi.org/10.1016/j.mib.2011.11.009 
Kachroo, P., Eraso, J.M., Beres, S.B., Olsen, R.J., Zhu, L., Nasser, W., Bernard, P.E., Cantu, C.C., Saavedra, 
M.O., Arredondo, M.J., Strope, B., Do, H., Kumaraswami, M., Vuopio, J., Gröndahl-Yli-Hannuksela, K., 
Kristinsson, K.G., Gottfredsson, M., Pesonen, M., Pensar, J., Davenport, E.R., Clark, A.G., Corander, J., 
Caugant, D.A., Gaini, S., Magnussen, M.D., Kubiak, S.L., Nguyen, H.A.T., Long, S.W., Porter, A.R., 
DeLeo, F.R., Musser, J.M., 2019. Integrated analysis of population genomics, transcriptomics and 
virulence provides novel insights into Streptococcus pyogenes pathogenesis. Nature Genetics 51, 548–559. 
https://doi.org/10.1038/s41588-018-0343-1 
Kaneko, J., Kimura, T., Narita, S., Tomita, T., Kamio, Y., 1998. Complete nucleotide sequence and molecular 
characterization of the temperate staphylococcal bacteriophage φPVL carrying Panton-Valentine 




Kansal, R.G., McGeer, A., Low, D.E., Norrby-Teglund, A., Kotb, M., 2000. Inverse relation between disease 
severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates 
recovered from invasive Group A streptococcal infection cases. Infection and Immunity 68, 6362–6369. 
https://doi.org/10.1128/IAI.68.11.6362-6369.2000 
Kapatai, G., Coelho, J., Platt, S., Chalker, V.J., 2017. Whole genome sequencing of Group A Streptococcus: 
Development and evaluation of an automated pipeline for emm gene typing. PeerJ 2017, 1–15. 
https://doi.org/10.7717/peerj.3226 
Kaplan, E.L., Chhatwal, G.S., Rohde, M., 2006. Reduced Ability of Penicillin to Eradicate Ingested Group A 
Streptococci from Epithelial Cells: Clinical and Pathogenetic Implications. Clinical Infectious Diseases 43, 
1398–1406. https://doi.org/10.1086/508773 
Kapur, V., Majesky, M.W., Li, L.L., Black, R.A., Musser, J.M., 1993. Cleavage of interleukin 1β (IL-1β) 
precursor to produce active IL-1β by a conserved extracellular cysteine protease from Streptococcus 
pyogenes. Proceedings of the National Academy of Sciences of the United States of America 90, 7676–
7680. https://doi.org/10.1073/pnas.90.16.7676 
Kasper, K.J., Zeppa, J.J., Wakabayashi, A.T., Xu, S.X., Mazzuca, D.M., Welch, I., Baroja, M.L., Kotb, M., 
Cairns, E., Cleary, P.P., Haeryfar, S.M.M., McCormick, J.K., 2014. Bacterial Superantigens Promote 
Acute Nasopharyngeal Infection by Streptococcus pyogenes in a Human MHC Class II-Dependent 
Manner. PLoS Pathogens 10. https://doi.org/10.1371/journal.ppat.1004155 
Kawabata, S., Kuwata, H., Nakagawa, I., Morimatsu, S., Sano, K., Hamada, S., 1999. Capsular hyaluronic acid 
of Group A streptococci hampers their invasion into human pharyngeal epithelial cells. Microbial 
Pathogenesis 27, 71–80. https://doi.org/10.1006/mpat.1999.0283 
Kawai, T., Akira, S., 2010. The role of pattern-recognition receptors in innate immunity: Update on toll-like 
receptors. Nature Immunology 11, 373–384. https://doi.org/10.1038/ni.1863 
Kazmi, S.U., Kansal, R., Aziz, R.K., Hooshdaran, M., Norrby-Teglund, A., Low, D.E., Halim, A.B., Kotb, M., 
2001. Reciprocal, temporal expression of speA and speB by invasive M1T1 Group A streptococcal isolates 
in vivo. Infection and Immunity 69, 4988–4995. https://doi.org/10.1128/IAI.69.8.4988-4995.2001 
Kihlberg, B.M., Cooney, J., Caparon, M.G., Olsén, A., Björck, L., 1995. Biological properties of a 
Streptococcus pyogenes mutant generated by Tn916 insertion in mga. Microbial Pathogenesis 19, 299–
315. https://doi.org/10.1016/S0882-4010(96)80003-9 
Kim, Seungwook, Lee, S., Park, H., Kim, Sunjoo, 2019. Predominance of emm4 and antibiotic resistance of 
Streptococcus pyogenes in acute pharyngitis in a southern region of Korea. Journal of Medical 
Microbiology 68, 1053–1058. https://doi.org/10.1099/jmm.0.001005 







Kolaczkowska, E., Jenne, C.N., Surewaard, B.G.J., Thanabalasuriar, A., Lee, W.Y., Sanz, M.J., Mowen, K., 
Opdenakker, G., Kubes, P., 2015. Molecular mechanisms of NET formation and degradation revealed by 
intravital imaging in the liver vasculature. Nature Communications 6, 1–13. 
https://doi.org/10.1038/ncomms7673 
Krebs, B., Kaufhold, A., Boyle, M.D.P., Podbielski, A., 1996. Different alleles of the fcrA/mrp gene of 
Streptococcus pyogenes encode M-related proteins exhibiting an identical immunoglobulin-binding 
pattern. Medical Microbiology and Immunology 185, 39–47. https://doi.org/10.1007/s004300050013 
Kreikemeyer, B., Boyle, M.D., Buttaro, B.A., Heinemann, M., Podbielski, A., 2001. Group A streptococcal 
growth phase-associated virulence factor regulation by a novel  operon (Fas) with homologies to two-
component-type regulators requires a small RNA molecule. Molecular microbiology 39, 392–406. 
https://doi.org/10.1046/j.1365-2958.2001.02226.x 
Kreikemeyer, B., Klenk, M., Podbielski, A., 2004. The intracellular status of Streptococcus pyogenes: Role of 
extracellular matrix-binding proteins and their regulation. International Journal of Medical Microbiology 
294, 177–188. https://doi.org/10.1016/j.ijmm.2004.06.017 
Kreikemeyer, B., McIver, K.S., Podbielski, A., 2003. Virulence factor regulation and regulatory networks in 
Streptococcus pyogenes and their impact on pathogen-host interactions. Trends in Microbiology 11, 224–
232. https://doi.org/10.1016/S0966-842X(03)00098-2 
Krüger, A., Lucchesi, P.M.A., 2015. Shiga toxins and stx phages: highly diverse entities. Microbiology. 161, 
451–462. https://doi.org/10.1099/mic.0.000003 
Krut, O., Bekeredjian-Ding, I., 2018. Contribution of the Immune Response to Phage Therapy. The Journal of 
Immunology 200, 3037–3044. https://doi.org/10.4049/jimmunol.1701745 
Laabei, M., Ermert, D., 2018. Catch Me if you can: Streptococcus pyogenes complement evasion strategies. 
Journal of Innate Immunity 11, 3–12. https://doi.org/10.1159/000492944 
Labrie, S.J., Samson, J.E., Moineau, S., 2010. Bacteriophage resistance mechanisms. Nature Reviews 
Microbiology 8, 317–327. https://doi.org/10.1038/nrmicro2315 
Lamagni, T.L., Neal, S., Keshishian, C., Alhaddad, N., George, R., Duckworth, G., Vuopio-Varkila, J., 
Efstratiou, A., 2008. Severe Streptococcus pyogenes infections, United Kingdom, 2003-2004. Emerging 
Infectious Diseases 14, 201–209. https://doi.org/10.3201/eid1402.070888 
Lamagni, T.L., Neal, S., Keshishian, C., Powell, D., Potz, N., Pebody, R., George, R., Duckworth, G., Vuopio-
Varkila, J., Efstratiou, A., 2009. Predictors of death after severe Streptococcus pyogenes infection. 
Emerging Infectious Diseases 15, 1304–1307. https://doi.org/10.3201/eid1508.090264 
Lamb, L. E., Siggins, M.K., Scudamore, C., Macdonald, W., Turner, C.E., Lynskey, N.N., Tan, L.K.K., 
Sriskandan, S., 2018. Impact of contusion injury on intramuscular emm1 Group A Streptococcus infection 
and lymphatic spread. Virulence 9, 1074–1084. https://doi.org/10.1080/21505594.2018.1482180 
Lamb, L E, Zhi, X., Alam, F., Pyzio, M., Scudamore, C.L., Wiles, S., Sriskandan, S., 2018. Modelling invasive 




Lancefield, R.C., 1959. Persistence of type-specific antibodies in man following infection with Group A 
streptococci. The Journal of experimental medicine 110, 271–292. https://doi.org/10.1084/jem.110.2.271 
LaPenta, D., Rubens, C., Chi, E., Cleary, P.P., 1994. Group A streptococci efficiently invade human respiratory 
epithelial cells. Proceedings of the National Academy of Sciences of the United States of America 91, 
12115–12119. https://doi.org/10.1073/pnas.91.25.12115 
Lefébure, T., Richards, V.P., Lang, P., Pavinski-Bitar, P., Stanhope, M.J., 2012. Gene repertoire evolution of 
Streptococcus pyogenes inferred from phylogenomic analysis with Streptococcus canis and Streptococcus 
dysgalactiae. PLoS ONE 7. https://doi.org/10.1371/journal.pone.0037607 
Lei, B., DeLeo, F.R., Hoe, N.P., Graham, M.R., Mackie, S.M., Cole, R.L., Liu, M., Hill, H.R., Low, D.E., 
Federle, M.J., Scott, J.R., Musser, J.M., 2001. Evasion of human innate and acquired immunity by a 
bacterial homolog of CD11b that inhibits opsonophagocytosis. Nature Medicine 7, 1298–1305. 
https://doi.org/10.1038/nm1201-1298 
Lei, B., DeLeo, F.R., Reid, S.D., Voyich, J.M., Magoun, L., Liu, M., Braughton, K.R., Ricklefs, S., Hoe, N.P., 
Cole, R.L., Leong, J.M., Musser, J.M., 2002. Opsonophagocytosis-inhibiting Mac protein of Group A 
Streptococcus: Identification and characteristics of two genetic complexes. Infection and Immunity 70, 
6880–6890. https://doi.org/10.1128/IAI.70.12.6880-6890.2002 
Lembke, C., Podbielski, A., Hidalgo-Grass, C., Jonas, L., Hanski, E., Kreikemeyer, B., 2006. Characterization 
of biofilm formation by clinically relevant serotypes of Group A streptococci. Applied and Environmental 
Microbiology 72, 2864–2875. https://doi.org/10.1128/AEM.72.4.2864-2875.2006 
Li, J., Liu, G., Feng, W., Zhou, Y., Liu, M., Wiley, J.A., Lei, B., 2014. Neutrophils select hypervirulent CovRS 
mutants of M1T1 Group A Streptococcus during subcutaneous infection of mice. Infection and Immunity 
82, 1579–1590. https://doi.org/10.1128/IAI.01458-13 
Lieber, M., Smith, B., Szakal, A., Nelson-Rees, W., Todaro, G., 1976. A continuous tumor-cell line from a 
human lung carcinoma with properties of type II  alveolar epithelial cells. International journal of cancer 
17, 62–70. https://doi.org/10.1002/ijc.2910170110 
Lin, A., Loughman, J.A., Zinselmeyer, B.H., Miller, M.J., Caparon, M.G., 2009. Streptolysin S inhibits 
neutrophil recruitment during the early stages of Streptococcus pyogenes infection. Infection and 
Immunity 77, 5190–5201. https://doi.org/10.1128/IAI.00420-09 
Liu, Z., Treviño, J., Ramirez-Peña, E., Sumby, P., 2012. The small regulatory RNA FasX controls pilus 
expression and adherence in the human  bacterial pathogen Group A Streptococcus. Molecular 
microbiology 86, 140–154. https://doi.org/10.1111/j.1365-2958.2012.08178.x 
Lizano, S., Luo, F., Tengra, F.K., Bessen, D.E., 2008. Impact of orthologous gene replacement on the circuitry 
governing pilus gene transcription in streptococci. PLoS ONE. 3(10): e3450. 
https://doi.org/10.1371/journal.pone.0003450 
Loh, J.M.S., Adenwalla, N., Wiles, S., Proft, T., 2013. Galleria mellonella larvae as an infection model for 
Group A Streptococcus. Virulence 4, 419–428. https://doi.org/10.4161/viru.24930 
Loof, T.G., Goldmann, O., Gessner, A., Herwald, H., Medina, E., 2010. Aberrant inflammatory response to 
189 
 
Streptococcus pyogenes in mice lacking myeloid differentiation factor 88. American Journal of Pathology 
176, 754–763. https://doi.org/10.2353/ajpath.2010.090422 
Loof, T.G., Goldmann, O., Medina, E., 2008. Immune recognition of Streptococcus pyogenes by dendritic cells. 
Infection and Immunity 76, 2785–2792. https://doi.org/10.1128/IAI.01680-07 
Loof, T.G., Rohde, M., Chhatwal, G.S., Jung, S., Medina, E., 2007.  The Contribution of Dendritic Cells to Host 
Defenses against Streptococcus pyogenes . The Journal of Infectious Diseases 196, 1794–1803. 
https://doi.org/10.1086/523647 
López, E., Domenech, A., Ferrándiz, M.J., Frias, M.J., Ardanuy, C., Ramirez, M., García, E., Liñares, J., De La 
Campa, A.G., 2014. Induction of prophages by fluoroquinolones in Streptococcus pneumoniae: 
Implications for emergence of resistance in genetically-related clones. PLoS ONE 9, 1–8. 
https://doi.org/10.1371/journal.pone.0094358 
Luca-Harari, B., Darenberg, J., Neal, S., Siljander, T., Strakova, L., Tanna, A., Creti, R., Ekelund, K., Koliou, 
M., Tassios, P.T., Van Der Linden, M., Straut, M., Vuopio-Varkila, J., Bouvet, A., Efstratiou, A., Schalén, 
C., Henriques-Normark, B., Jasir, A., 2009. Clinical and microbiological characteristics of severe 
Streptococcus pyogenes disease in Europe. Journal of Clinical Microbiology 47, 1155–1165. 
https://doi.org/10.1128/JCM.02155-08 
Luke, K., Radek, A., Liu, X.P., Campbell, J., Uzan, M., Haselkorn, R., Kogan, Y., 2002. Microarray analysis of 
gene expression during bacteriophage T4 infection. Virology 299, 182–191. 
https://doi.org/10.1006/viro.2002.1409 
Lukomski, S., Burns, E.H., Wyde, P.R., Podbielski, A., Rurangirwa, J., Moore-Poveda, D.K., Musser, J.M., 
1998. Genetic inactivation of an extracellular cysteine protease (SpeB) expressed by Streptococcus 
pyogenes decreases resistance to phagocytosis and dissemination to organs. Infection and Immunity 66, 
771–776. https://doi.org/10.1128/iai.66.2.771-776.1998 
Lukomski, S., Montgomery, C.A., Rurangirwa, J., Geske, R.S., Barrish, J.P., Adams, G.J., Musser, J.M., 1999. 
Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of 
invasive skin infection and dissemination in mice. Infection and Immunity 67, 1779–1788. 
Luo, F., Lizano, S., Bessen, D.E., 2008. Heterogeneity in the polarity of Nra regulatory effects on streptococcal 
pilus gene transcription and virulence. Infection and Immunity 76, 2490–2497. 
https://doi.org/10.1128/IAI.01567-07 
Lynskey, N.N., Banerji, S., Johnson, L.A., Holder, K.A., Reglinski, M., Wing, P.A.C., Rigby, D., Jackson, 
D.G., Sriskandan, S., 2015. Rapid Lymphatic Dissemination of Encapsulated Group A Streptococci via 
Lymphatic Vessel Endothelial Receptor-1 Interaction. PLoS Pathogens 11, 1–19. 
https://doi.org/10.1371/journal.ppat.1005137 
Lynskey, N.N., Goulding, D., Gierula, M., Turner, C.E., Dougan, G., Edwards, R.J., Sriskandan, S., 2013. RocA 
Truncation Underpins Hyper-Encapsulation, Carriage Longevity and Transmissibility of Serotype M18 
Group A Streptococci. PLoS Pathogens 9, 1–15. https://doi.org/10.1371/journal.ppat.1003842 
Lynskey, N.N., Jauneikaite, E., Li, H.K., Zhi, X., Turner, C.E., Mosavie, M., Pearson, M., Asai, M., Lobkowicz, 
190 
 
L., Chow, J.Y., Parkhill, J., Lamagni, T., Chalker, V.J., Sriskandan, S., 2019a. Emergence of dominant 
toxigenic M1T1 Streptococcus pyogenes clone during increased scarlet fever activity in England: a 
population-based molecular epidemiological study. The Lancet Infectious Diseases 19, 1209–1218. 
https://doi.org/10.1016/S1473-3099(19)30446-3 
Lynskey, N.N., Reglinski, M., Calay, D., Siggins, M.K., Mason, J.C., Botto, M., Sriskandan, S., 2017. Multi-
functional mechanisms of immune evasion by the streptococcal complement inhibitor C5a peptidase. PLoS 
Pathogens 13, 1–29. https://doi.org/10.1371/journal.ppat.1006493 
Lynskey, N.N., Velarde, J.J., Finn, M.B., Dove, S.L., Wessels, M.R., 2019b. RocA binds CsrRS to modulate 
CsrRS-mediated gene regulation in Group A Streptococcus. mBio 10, 1–15. 
https://doi.org/10.1128/mBio.01495-19 
Lyon, W.R., Caparon, M.G., 2004. Role for Serine Protease HtrA (DegP) of Streptococcus pyogenes in the 
Biogenesis of Virulence Factors SpeB and the Hemolysin Streptolysin S. Infection and Immunity 72, 
1618–1625. https://doi.org/10.1128/IAI.72.3.1618-1625.2004 
Ma, F., Guo, X., Fan, H., 2017. Extracellular Nucleases of Streptococcus equi subsp. zooepidemicus Degrade  
Neutrophil Extracellular Traps and Impair Macrophage Activity of the Host. Applied and environmental 
microbiology 83. https://doi.org/10.1128/AEM.02468-16 
Ma, X., Kikuta, H., Ishiguro, N., Yoshioka, M., Ebihara, T., Murai, T., Kobayashi, I., Kobayashi, K., 2002. 
Association of the prtF1 gene (encoding fibronectin-binding protein F1) and the sic gene (encoding the 
streptococcal inhibitor of complement) with emm types of Group A streptococci isolated from Japanese 
children with pharyngitis. Journal of Clinical Microbiology 40, 3835–3837. 
https://doi.org/10.1128/JCM.40.10.3835-3837.2002 
Machado, N.O., 2011. Necrotizing fasciitis: The importance of early diagnosis, prompt surgical debridement 
and adjuvant therapy. North American Journal of Medical Sciences 3, 107–118. 
https://doi.org/10.4297/najms.2011.3107 
Maclennan, A.P., 1956a. The production of capsules, hyaluronic acid and hyaluronidase by Group A and group 
C streptococci. Journal of general microbiology 14, 134–142. https://doi.org/10.1099/00221287-14-1-134 
Madden, J.C., Ruiz, N., Caparon, M., 2001. Cytolysin-mediated translocation (CMT): A functional equivalent 
of type III secretion in Gram-positive bacteria. Cell 104, 143–152. https://doi.org/10.1016/S0092-
8674(01)00198-2 
Maiques, E., Úbeda, C., Campoy, S., Salvador, N., Lasa, Í., Novick, R.P., Barbé, J., Penadés, J.R., 2006. β-
lactam antibiotics induce the SOS response and horizontal transfer of virulence factors in Staphylococcus 
aureus. Journal of Bacteriology 188, 2726–2729. https://doi.org/10.1128/JB.188.7.2726-2729.2006 
Marks, Laura R., Mashburn-Warren, L., Federle, M.J., Hakansson, A.P., 2014. Streptococcus pyogenes biofilm 
growth in vitro and in vivo and its role in colonization, virulence, and genetic exchange. Journal of 





Marks, Laura R, Reddinger, R.M., Hakansson, A.P., 2014. Biofilm formation enhances fomite survival of 
Streptococcus pneumoniae and  Streptococcus pyogenes. Infection and immunity 82, 1141–1146. 
https://doi.org/10.1128/IAI.01310-13 
Marouni, M.J., Barzilai, A., Keller, N., Rubinstein, E., Sela, S., 2004. Intracellular survival of persistent Group 
A streptococci in cultured epithelial cells. International Journal of Medical Microbiology 294, 27–33. 
https://doi.org/10.1016/j.ijmm.2004.01.001 
Martin, J., 2016. The Streptococcus pyogenes Carrier State. Streptococcus pyogenes: Basic Biology to Clinical 
Manifestations 1–13. 
Mashburn-Warren, L., Goodman, S.D., Federle, M.J., Prehna, G., 2018. The conserved mosaic prophage protein 
paratox inhibits the natural competence regulator ComR in Streptococcus pyogenes. Scientific Reports 8, 
1–15. https://doi.org/10.1038/s41598-018-34816-7 
Mashburn-Warren, L., Morrison, D.A., Federle, M.J., 2012. The cryptic competence pathway in Streptococcus 
pyogenes is controlled by a peptide pheromone. Journal of Bacteriology 194, 4589–4600. 
https://doi.org/10.1128/JB.00830-12 
Massell, B.F., Honikman, L.H., Amezcua, J., 1969. Rheumatic Fever Following Streptococcal Vaccination: 
Report of Three Cases. JAMA 207, 1115–1119. https://doi.org/10.1001/jama.1969.03150190037007 
Matsui, H., Sekiya, Y., Takahashi, Tetsufumi, Nakamura, M., Imanishi, K., Yoshida, H., Murayama, S.Y., 
Takahashi, Takashi, Tsuchimoto, K., Uchiyama, T., Ubukata, K., 2011. Dermal mast cells reduce 
progressive tissue necrosis caused by subcutaneous infection with Streptococcus pyogenes in mice. Journal 
of Medical Microbiology 60, 128–134. https://doi.org/10.1099/jmm.0.020495-0 
McCullor, K., Postoak, B., Rahman, M., King, C., Michael McShana, W., 2018. Genomic sequencing of high-
efficiency transducing streptococcal bacteriophage A25: Consequences of escape from lysogeny. Journal 
of Bacteriology 200. https://doi.org/10.1128/JB.00358-18 
McIver, K.S., Heath, A.S., Scott, J.R., 1995. Regulation of virulence by environmental signals in Group A 
streptococci: Influence of osmolarity, temperature, gas exchange, and iron limitation on emm transcription. 
Infection and Immunity 63, 4540–4542. https://doi.org/10.1128/iai.63.11.4540-4542.1995 
McNeil, S.A., Halperin, S.A., Langley, J.M., Smith, B., Warren, A., Sharratt, G.P., Baxendale, D.M., Reddish, 
M.A., Hu, M.C., Stroop, S.D., Linden, J., Fries, L.F., Vink, P.E., Dale, J.B., 2005. Safety and 
Immunogenicity of 26-Valent Group A Streptococcus Vaccine in Healthy Adult Volunteers. Clinical 
Infectious Diseases 41, 1114–1122. https://doi.org/10.1086/444458 
McShan, W.M., Nguyen, S. V., 2019. The bacteriophages of Streptococcus pyogenes. Streptococcus pyogenes : 








Mearkle, R., Saavedra-Campos, M., Lamagni, T., Usdin, M., Coelho, J., Chalker, V., Sriskandan, S., Cordery, 
R., Rawlings, C., Balasegaram, S., 2017. Household transmission of invasive Group A Streptococcus 
infections in England: a  population-based study, 2009, 2011 to 2013. Euro surveillance : bulletin 
Europeen sur les maladies transmissibles = European  communicable disease bulletin 22. 
https://doi.org/10.2807/1560-7917.ES.2017.22.19.30532 
Medina, E., Goldmann, O., Rohde, M., Lengeling, A., Chhatwals, G.S., 2001. Genetic Control of Susceptibility 
to Group A Streptococcal Infection in Mice. The Journal of Infectious Diseases 184, 846–852. 
https://doi.org/10.1086/323292 
Medina, E., Rohde, M., Chhatwal, G.S., 2003. Intracellular survival of Streptococcus pyogenes in 
polymorphonuclear cells results in increased bacterial virulence. Infection and Immunity 71, 5376–5380. 
https://doi.org/10.1128/IAI.71.9.5376-5380.2003 
Menschner, L., Falke, U., Konrad, P., Toepfner, N., Berner, R., 2020. Survival of Group A Streptococcus 
(GAS) is Enhanced Under Desiccated Culture Conditions. Current Microbiology. 
https://doi.org/10.1007/s00284-020-01967-8 
Michel, B., 2005. After 30 years of study, the bacterial SOS response still surprises us. PLoS Biology 3, 1174–
1176. https://doi.org/10.1371/journal.pbio.0030255 
Michos, A., Gryllos, I., Håkansson, A., Srivastava, A., Kokkotou, E., Wessels, M.R., 2006. Enhancement of 
streptolysin O activity and intrinsic cytotoxic effects of the Group A streptococcal toxin, NAD-
glycohydrolase. Journal of Biological Chemistry 281, 8216–8223. 
https://doi.org/10.1074/jbc.M511674200 
Miller-Ensminger, T., Garretto, A., Stark, N., Putonti, C., 2020. Mimicking prophage induction in the body: 
induction in the lab with pH gradients. PeerJ 8, e9718. https://doi.org/10.7717/peerj.9718 
Miller, E.W., Cao, T.N., Pflughoeft, K.J., Sumby, P., 2014. RNA-mediated regulation in Gram-positive 
pathogens: an overview punctuated with  examples from the Group A Streptococcus. Molecular 
microbiology 94, 9–20. https://doi.org/10.1111/mmi.12742 
Mishalian, I., Ordan, M., Peled, A., Maly, A., Eichenbaum, M.B., Ravins, M., Aychek, T., Jung, S., Hanski, E., 
2011.  Recruited Macrophages Control Dissemination of Group A Streptococcus from Infected Soft 
Tissues . The Journal of Immunology 187, 6022–6031. https://doi.org/10.4049/jimmunol.1101385 
Mishra, P., Akhtar, M.S., Bhakuni, V., 2006. Unusual structural features of the bacteriophage-associated 
hyaluronate lyase (hylp2). Journal of Biological Chemistry 281, 7143–7150. 
https://doi.org/10.1074/jbc.M510991200 
Mishra, P., Bhakuni, V., 2009. Self-assembly of bacteriophage-associated hyaluronate lyase (HYLP2) into an 
enzymatically active fibrillar film. Journal of Biological Chemistry 284, 5240–5249. 
https://doi.org/10.1074/jbc.M806730200 
Mogensen, T.H., 2009. Pathogen recognition and inflammatory signaling in innate immune defenses. Clinical 




Mortensen, R., Nissen, T.N., Blauenfeldt, T., Christensen, J.P., Andersen, P., Dietrich, J., 2015.  Adaptive 
Immunity against Streptococcus pyogenes in Adults Involves Increased IFN-γ and IgG3 Responses 
Compared with Children . The Journal of Immunology 195, 1657–1664. 
https://doi.org/10.4049/jimmunol.1500804 
Murialdo, H., Becker, A., 1978. Head morphogenesis of complex double-stranded deoxyribonucleic acid 
bacteriophages. Microbiological reviews 42, 529–576. 
Musser, J.M., Beres, S.B., Zhu, L., Olsen, R.J., Vuopio, J., Hyyryläinen, H.-L., Gröndahl-Yli-Hannuksela, K., 
Kristinsson, K.G., Darenberg, J., Henriques-Normark, B., Hoffmann, S., Caugant, D.A., Smith, A.J., 
Lindsay, D.S.J., Boragine, D., Palzkill, T., 2020.  Reduced in vitro susceptibility of Streptococcus 
pyogenes to beta-lactam antibiotics associated with mutations in the pbp2x gene is geographically 
widespread . Journal of Clinical Microbiology. https://doi.org/10.1128/jcm.01993-19 
Musser, J.M., DeLeo, F.R., 2005. Toward a genome-wide systems biology analysis of host-pathogen 
interactions in Group A Streptococcus. American Journal of Pathology 167, 1461–1472. 
https://doi.org/10.1016/S0002-9440(10)61232-1 
Musser, J.M., Gray, B.M., Schlievert, P.M., Pichichero, M.E., 1992. Erratum: Streptococcus pyogenes 
pharyngitis: Characterization of strains by multilocus enzyme genotype, M and T protein serotype, and 
pyrogenic exotoxin gene probing (Journal of Clinical Microbiology (1992) 30 (602)). Journal of Clinical 
Microbiology 30, 1905. https://doi.org/10.1128/JCM.30.7.1905-1905.1992 
Nakagawa, I., Kurokawa, K., Yamashita, A., Nakata, M., Tomiyasu, Y., Okahashi, N., Kawabata, S., Yamazaki, 
K., Shiba, T., Yasunaga, T., Hayashi, H., Hattori, M., Hamada, S., 2003. Genome Sequence of an M3 
Strain of  Streptococcus pyogenes reveals a large-scale genomic rearrangement in invasive strains and new 
insights into phage evolution. Genome 1042–1055. https://doi.org/10.1101/gr.1096703.1 
Nanda, A.M., Thormann, K., Frunzke, J., 2015. Impact of spontaneous prophage induction on the fitness of 
bacterial populations and host-microbe interactions. Journal of Bacteriology 197, 410–419. 
https://doi.org/10.1128/JB.02230-14 
Nasser, W., Beres, S.B., Olsen, R.J., Dean, M.A., Rice, K.A., Long, S.W., Kristinsson, K.G., Gottfredsson, M., 
Vuopio, J., Raisanen, K., Caugant, D.A., Steinbakk, M., Low, D.E., McGeer, A., Darenberg, J., Henriques-
Normark, B., Van Beneden, C.A., Hoffmann, S., Musser, J.M., 2014. Evolutionary pathway to increased 
virulence and epidemic Group A Streptococcus disease derived from 3,615 genome sequences. 
Proceedings of the National Academy of Sciences of the United States of America 111. 
https://doi.org/10.1073/pnas.1403138111 
Nelson, D.C., Garbe, J., Collin, M., 2011.  The cysteine proteinase SpeB from Streptococcus pyogenes – a 
potent modifier of immunologically important host and bacterial proteins . Biological Chemistry 392. 
https://doi.org/10.1515/bc-2011-208 
Nguyen, S. V., McShan, W.M., 2014. Chromosomal islands of Streptococcus pyogenes and related streptococci: 




Nizet, V., Beall, B., Bast, D.J., Datta, V., Kilburn, L., Low, D.E., De Azavedo, J.C.S., 2000. Genetic locus for 
streptolysin S production by Group A Streptococcus. Infection and Immunity 68, 4245–4254. 
https://doi.org/10.1128/IAI.68.7.4245-4254.2000 
Nobrega, F.L., Vlot, M., de Jonge, P.A., Dreesens, L.L., Beaumont, H.J.E., Lavigne, R., Dutilh, B.E., Brouns, 
S.J.J., 2018. Targeting mechanisms of tailed bacteriophages. Nature Reviews Microbiology 16, 760–773. 
https://doi.org/10.1038/s41579-018-0070-8 
Nooh, M.M., Aziz, R.K., Kotb, M., Eroshkin, A., Chuang, W.J., Proft, T., Kansal, R., 2006. Streptococcal 
mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the 
streptococcal cysteine protease, SpeB. Journal of Biological Chemistry 281, 35281–35288. 
https://doi.org/10.1074/jbc.M605544200 
Nordenfelt, P., Waldemarson, S., Linder, A., Mörgelin, M., Karlsson, C., Malmström, J., Björck, L., 2012. 
Antibody orientation at bacterial surfaces is related to invasive infection. Journal of Experimental 
Medicine 209, 2367–2381. https://doi.org/10.1084/jem.20120325 
Norrby-Teglund, A., Kaul, R., Low, D.E., McGeer, A., Newton, D.W., Andersson, J., Andersson, U., Kotb, M., 
1996. Plasma from patients with severe invasive Group A streptococcal infections treated with normal 
polyspecific IgG inhibits streptococcal superantigen-induced T cell proliferation and cytokine production. 
The Journal of Immunology 156, 3057 LP – 3064. 
Novick, R.P., 2003. Mobile genetic elements and bacterial toxinoses: The superantigen-encoding pathogenicity 
islands of Staphylococcus aureus. Plasmid 49, 93–105. https://doi.org/10.1016/S0147-619X(02)00157-9 
Novick, R.P., Christie, G.E., Penadés, J.R., 2010. The phage-related chromosomal islands of Gram-positive 
bacteria. Nature Reviews Microbiology 8, 541–551. https://doi.org/10.1038/nrmicro2393 
Nozawa, T., Furukawa, N., Aikawa, C., Watanabe, T., Haobam, B., Kurokawa, K., Maruyama, F., Nakagawa, 
I., 2011. CRISPR inhibition of prophage acquisition in Streptococcus pyogenes. PLoS ONE 6(5), 19543. 
https://doi.org/10.1371/journal.pone.0019543 
Nuwayhid, Z.B., Aronoff, D.M., Mulla, Z.D., 2007. Blunt Trauma as a Risk Factor for Group A Streptococcal 
Necrotizing Fasciitis. Annals of Epidemiology 17, 878–881. 
https://doi.org/10.1016/j.annepidem.2007.05.011 
O’Neill, A.M., Thurston, T.L., Holden, D.W., 2016. Cytosolic Replication of Group A Streptococcus in Human. 
mBio 7, 1–12. https://doi.org/10.1128/mBio.00020-16.Invited 
O’Toole, G.A., 2011. Microtiter dish biofilm formation assay. Journal of visualized experiments : JoVE. 
https://doi.org/10.3791/2437 
Oda, M., Domon, H., Kurosawa, M., Isono, T., Maekawa, T., Yamaguchi, M., Kawabata, S., Terao, Y., 2017. 
Streptococcus pyogenes phospholipase A2 induces the expression of adhesion molecules on human 






Olsen, R.J., Ebru Watkins, M., Cantu, C.C., Beres, S.B., Musser, J.M., 2011. Virulence of serotype M3 Group A 
Streptococcus strains in wax worms (Galleria mellonella larvae). Virulence 2, 111–119. 
https://doi.org/10.4161/viru.2.2.14338 
Olsen, R.J., Laucirica, D.R., Watkins, M.E., Feske, M.L., Garcia-Bustillos, J.R., Vu, C., Cantu, C., Shelburne, 
S.A., Fittipaldi, N., Kumaraswami, M., Shea, P.R., Flores, A.R., Beres, S.B., Lovgren, M., Tyrrell, G.J., 
Efstratiou, A., Low, D.E., Van Beneden, C.A., Musser, J.M., 2012. Polymorphisms in regulator of 
protease B (RopB) alter disease phenotype and strain virulence of serotype M3 Group A Streptococcus. 
Journal of Infectious Diseases 205, 1719–1729. https://doi.org/10.1093/infdis/jir825 
Oppenheim, A.B., Kobiler, O., Stavans, J., Court, D.L., Adhya, S., 2005. Switches in Bacteriophage Lambda 
Development. Annual Review of Genetics 39, 409–429. 
https://doi.org/10.1146/annurev.genet.39.073003.113656 
Orlova, E. V., Gowen, B., Dröge, A., Stiege, A., Weise, F., Lurz, R., Van Heel, M., Tavares, P., 2003. Structure 
of a viral DNA gatekeeper at 10 Å resolution by cryo-electron microscopy. EMBO Journal 22, 1255–1262. 
https://doi.org/10.1093/emboj/cdg123 
Påhlman, L.I., Mörgelin, M., Eckert, J., Johansson, L., Russell, W., Riesbeck, K., Soehnlein, O., Lindbom, L., 
Norrby-Teglund, A., Schumann, R.R., Björck, L., Herwald, H., 2006. Streptococcal M Protein: A 
Multipotent and Powerful Inducer of Inflammation. The Journal of Immunology 177, 1221–1228. 
https://doi.org/10.4049/jimmunol.177.2.1221 
Pan, X., Ge, J., Li, M., Wu, B., Wang, C., Wang, J., Feng, Y., Yin, Z., Zheng, F., Cheng, G., Sun, W., Ji, H., 
Hu, D., Shi, P., Feng, X., Hao, X., Dong, R., Hu, F., Tang, J., 2009. The orphan response regulator CovR: 
A globally negative modulator of virulence in Streptococcus suis serotype 2. Journal of Bacteriology 191, 
2601–2612. https://doi.org/10.1128/JB.01309-08 
Panchaud, A., Guy, L., Collyn, F., Haenni, M., Nakata, M., Podbielski, A., Moreillon, P., Roten, C.A.H., 2009. 
M-protein and other intrinsic virulence factors of Streptococcus pyogenes are encoded on an ancient 
pathogenicity island. BMC Genomics 10, 1–11. https://doi.org/10.1186/1471-2164-10-198 
Pang, T., Fleming, T.C., Pogliano, K., Young, R., 2013. Visualization of pinholin lesions in vivo. Proceedings of 
the National Academy of Sciences of the United States of America 110. 
https://doi.org/10.1073/pnas.1222283110 
Participants, T.P. of I.G.A.S.I.W., 2002. Prevention of Invasive Group A Streptococcal Disease among 
Household Contacts of Case Patients and among Postpartum and Postsurgical Patients: Recommendations 
from the Centers for Disease Control and Prevention. Clinical Infectious Diseases 35, 950–959. 
https://doi.org/10.1086/342692 
Pastural, É., McNeil, S.A., MacKinnon-Cameron, D., Ye, L., Langley, J.M., Stewart, R., Martin, L.H., Hurley, 
G.J., Salehi, S., Penfound, T.A., Halperin, S., Dale, J.B., 2020. Safety and immunogenicity of a 30-valent 
M protein-based Group A streptococcal  vaccine in healthy adult volunteers: A randomized, controlled 




Peiser, L., Mukhopadhyay, S., Gordon, S., 2002. Scavenger receptors in innate immunity. Current Opinion in 
Immunology 14, 123–128. https://doi.org/10.1016/S0952-7915(01)00307-7 
Pelucchi, C., Grigoryan, L., Galeone, C., Esposito, S., Huovinen, P., Little, P., Verheij, T., 2012. Guideline for 
the management of acute sore throat: ESCMID Sore Throat Guideline Group. Clinical Microbiology and 
Infection 18, 1–28. https://doi.org/10.1111/j.1469-0691.2012.03766.x 
Penadés, J.R., Christie, G.E., 2015. The Phage-Inducible Chromosomal Islands: A Family of Highly Evolved 
Molecular Parasites. Annual Review of Virology 2, 181–201. https://doi.org/10.1146/annurev-virology-
031413-085446 
Pence, M.A., Rooijakkers, S.H.M., Cogen, A.L., Cole, J.N., Hollands, A., Gallo, R.L., Nizet, V., 2010. 
Streptococcal inhibitor of complement promotes innate immune resistance phenotypes of invasive M1T1 
Group A Streptococcus. Journal of Innate Immunity 2, 587–595. https://doi.org/10.1159/000317672 
Pereira, L.B., 2014. Impetigo. Anais Brasileiros de Dermatologia 89, 293–299. https://doi.org/10.1590/abd1806-
4841.20142283 
Perez, N., Treviño, J., Liu, Z., Ho, S.C.M., Babitzke, P., Sumby, P., 2009. A genome-wide analysis of small 
regulatory RNAs in the human pathogen Group A Streptococcus. PLoS ONE 4. 
https://doi.org/10.1371/journal.pone.0007668 
Persson, H., Vindebro, R., Von Pawel-Rammingen, U., 2013. The streptococcal cysteine protease SpeB is not a 
natural immunoglobulin-cleaving enzyme. Infection and Immunity 81, 2236–2241. 
https://doi.org/10.1128/IAI.00168-13 
Pichichero, M.E., Casey, J.R., 2007. Systematic review of factors contributing to penicillin treatment failure in 
Streptococcus pyogenes pharyngitis. Otolaryngology - Head and Neck Surgery 137, 851–857. 
https://doi.org/10.1016/j.otohns.2007.07.033 
Platt, N., Gordon, S., 2001. Is the class A macrophage scavenger receptor (SR-A) multifunctional? - The 
mouse’s tale. Journal of Clinical Investigation 108, 649–654. https://doi.org/10.1172/JCI200113903 
Podbielski, A., Peterson, J.A., Cleary, P., 1992. Surface protein‐CAT reporter fusions demonstrate differential 
gene expression in the wr regulon of Streptococcus pyogenes. Molecular Microbiology 6, 2253–2265. 
https://doi.org/10.1111/j.1365-2958.1992.tb01401.x 
Podbielski, A., Schnitzler, N., Beyhs, P., Boyle, M.D., 1996. M-related protein (Mrp) contributes to Group A 
streptococcal resistance to  phagocytosis by human granulocytes. Molecular microbiology 19, 429–441. 
https://doi.org/10.1046/j.1365-2958.1996.377910.x 
Podbielski, A., Woischnik, M., Leonard, B.A.B., Schmidt, K.H., 1999. Characterization of nra, a global 
negative regulator gene in Group A streptococci. Molecular Microbiology 31, 1051–1064. 
https://doi.org/10.1046/j.1365-2958.1999.01241.x 
Pohane, A.A., Jain, V., 2015. Insights into the regulation of bacteriophage endolysin: Multiple means to the 
same end. Microbiology. 161, 2269–2276. https://doi.org/10.1099/mic.0.000190 
Pospiech, A., Neumann, B., 1995. A versatile quick-prep of genomic DNA from gram-positive bacteria. Trends 
in Genetics. 11, 217–218. https://doi.org/10.1016/s0168-9525(00)89052-6 
197 
 
Proft, T., Fraser, J.D., 2016. Streptococcal Superantigens: Biological properties and potential role in disease. 
Streptococcus pyogenes: Basic Biology to Clinical Manifestations 1–41. 
Proft, T., Sriskandan, S., Yang, L., Fraser, J.D., 2003. Superantigens and streptococcal toxic shock syndrome. 
Emerging Infectious Diseases 9, 1211–1218. https://doi.org/10.3201/eid0910.030042 
Raeder, R., Woischnik, M., Podbielski, A., Boyle, M.D.P., 1998. A secreted streptococcal cysteine protease can 
cleave a surface- expressed M1 protein and alter the immunoglobulin binding properties. Research in 
Microbiology 149, 539–548. https://doi.org/10.1016/S0923-2508(99)80001-1 
Raithatha, A.H., Bryden, D.C., 2012. Use of intravenous immunoglobulin therapy in the treatment of septic 
shock, in  particular severe invasive Group A streptococcal disease. Indian journal of critical care 
medicine : peer-reviewed, official publication of  Indian Society of Critical Care Medicine. 
https://doi.org/10.4103/0972-5229.94433 
Ramirez-Peña, E., Treviño, J., Liu, Z., Perez, N., Sumby, P., 2010. The Group A Streptococcus small regulatory 
RNA FasX enhances streptokinase activity  by increasing the stability of the ska mRNA transcript. 
Molecular microbiology 78, 1332–1347. https://doi.org/10.1111/j.1365-2958.2010.07427.x 
Rao, V.B., Feiss, M., 2008. The Bacteriophage DNA Packaging Motor. Annual Review of Genetics 42, 647–
681. https://doi.org/10.1146/annurev.genet.42.110807.091545 
Reglinski, M., Gierula, M., Lynskey, N.N., Edwards, R.J., Sriskandan, S., 2015. Identification of the 
Streptococcus pyogenes surface antigens recognised by pooled  human immunoglobulin. Scientific reports 
5, 15825. https://doi.org/10.1038/srep15825 
Reglinski, M., Lynskey, N.N., Sriskandan, S., 2016. Modification of the classical Lancefield assay of Group A 
streptococcal killing to  reduce inter-donor variation. Journal of microbiological methods 124, 69–71. 
https://doi.org/10.1016/j.mimet.2016.03.015 
Reglinski, M., Sriskandan, S., 2014. Streptococcus pyogenes, Molecular Medical Microbiology: Second 
Edition. Elsevier Ltd. https://doi.org/10.1016/B978-0-12-397169-2.00038-X 
Reglinski, M., Sriskandan, S., Turner, C.E., 2019. Identification of two new core chromosome-encoded 
superantigens in Streptococcus pyogenes; speQ and speR. Journal of Infection 78, 358–363. 
https://doi.org/10.1016/j.jinf.2019.02.005 
Rego, S., Heal, T.J., Pidwill, G.R., Till, M., Robson, A., Lamont, R.J., Sessions, R.B., Jenkinson, H.F., Race, 
P.R., Nobbs, A.H., 2016. Structural and functional analysis of cell wall-anchored polypeptide adhesin 
BspA in Streptococcus agalactiae. Journal of Biological Chemistry 291, 15985–16000. 
https://doi.org/10.1074/jbc.M116.726562 
Remmington, A., Haywood, S., Edgar, J., Turner, C., 2020. Cryptic prophages within a Streptococcus pyogenes 
genotype emm4 lineage. Microbial Genomics.  https://doi.org/10.1101/2020.05.19.103838 






Retnoningrum, D.S., Cleary, P.P., 1994. M12 protein from Streptococcus pyogenes is a receptor for 
immunoglobulin G3 and human albumin. Infection and Immunity 62, 2387–2394. 
https://doi.org/10.1128/iai.62.6.2387-2394.1994 
Rezaei Javan, R., Ramos-Sevillano, E., Akter, A., Brown, J., Brueggemann, A.B., 2019. Prophages and satellite 
prophages are widespread in Streptococcus and may play a role in pneumococcal pathogenesis. Nature 
Communications 10, 1–14. https://doi.org/10.1038/s41467-019-12825-y 
Rios-Doria, J., Day, K.C., Kuefer, R., Rashid, M.G., Chinnaiyan, A.M., Rubin, M.A., Day, M.L., 2003. The role 
of calpain in the proteolytic cleavage of E-cadherin in prostate and mammary epithelial cells. Journal of 
Biological Chemistry 278, 1372–1379. https://doi.org/10.1074/jbc.M208772200 
Robinson, J.H., Kehoe, M.A., 1992. Group A streptococcal M proteins: virulence factors and protective 
antigens. Immunology Today 13, 362–367. https://doi.org/10.1016/0167-5699(92)90173-5 
Rodriguez-Iturbe, B., Musser, J.M., 2008. The current state of poststreptococcal glomerulonephritis. Journal of 
the American Society of Nephrology 19, 1855–1864. https://doi.org/10.1681/ASN.2008010092 
Rutherford, K., Parkhill, J., Crook, J., Horsnell, T., Rice, P., Rajandream, M.-A., Barrell, B., 2000. Artemis: 
sequence visualization and annotation . Bioinformatics 16, 944–945. 
https://doi.org/10.1093/bioinformatics/16.10.944 
Ryan, P.A., Juncosa, B., 2016. Group A Streptococcal Adherence. Streptococcus pyogenes: Basic Biology to 
Clinical Manifestations 1–25. 
Sablier, F., Slaouti, T., Drèze, P.-A., El Fouly, P.E., Allemeersch, D., Van Melderen, L., Smeesters, P.R., 2010. 
Nosocomial transmission of necrotising fasciitis. Lancet (London, England) 375, 1052. 
https://doi.org/10.1016/S0140-6736(10)60052-9 
Sakaguchi, Y., Hayashi, T., Kurokawa, K., Nakayama, K., Oshima, K., Fujinaga, Y., Ohnishi, M., Ohtsubo, E., 
Hattori, M., Oguma, K., 2005. The genome sequence of Clostridium botulinum type C neurotoxin-
converting phage and the molecular mechanisms of unstable lysogeny. Proceedings of the National 
Academy of Sciences of the United States of America 102, 17472 LP – 17477. 
https://doi.org/10.1073/pnas.0505503102 
Salim, K.Y., Cvitkovitch, D.G., Chang, P., Bast, D.J., Handfield, M., Hillman, J.D., de Azavedo, J.C.S., 2005. 
Identification of Group A Streptococcus Antigenic Determinants Upregulated in vivo. Infection and 
Immunity 73, 6026 LP – 6038. https://doi.org/10.1128/IAI.73.9.6026-6038.2005 
Sandegren, L., Andersson, D.I., 2009. Bacterial gene amplification: Implications for the evolution of antibiotic 
resistance. Nature Reviews Microbiology 7, 578–588. https://doi.org/10.1038/nrmicro2174 
Santagati, M., Iannelli, F., Oggioni, M.R., Stefani, S., Pozzi, G., 2000. Characterization of a genetic element 
carrying the macrolide efflux gene mef(A) in Streptococcus pneumoniae. Antimicrobial Agents and 
Chemotherapy 44, 2585–2587. https://doi.org/10.1128/AAC.44.9.2585-2587.2000 
Savva, C.G., Dewey, J.S., Moussa, S.H., To, K.H., Holzenburg, A., Young, R., 2014. Stable micron-scale holes 




Schrager, H.M., Rheinwald, J.G., Wessels, M.R., 1996. Hyaluronic acid capsule and the role of streptococcal 
entry into keratinocytes in invasive skin infection. Journal of Clinical Investigation 98, 1954–1958. 
https://doi.org/10.1172/JCI118998 
Schwarz-Linek, U., Höök, M., Potts, J.R., 2006. Fibronectin-binding proteins of Gram-positive cocci. Microbes 
and Infection 8, 2291–2298. https://doi.org/10.1016/j.micinf.2006.03.011 
Scott, J., Nguyen, S. V., King, C.J., Hendrickson, C., McShan, W.M., 2012. Phage-like Streptococcus pyogenes 
chromosomal islands (SpyCI) and mutator phenotypes: Control by growth state and rescue by a SpyCI-
encoded promoter. Frontiers in Microbiology 3, 1–15. https://doi.org/10.3389/fmicb.2012.00317 
Scott, J., Thompson-Mayberry, P., Lahmamsi, S., King, C.J., McShan, W.M., 2008. Phage-associated mutator 
phenotype in Group A Streptococcus. Journal of Bacteriology 190, 6290–6301. 
https://doi.org/10.1128/JB.01569-07 
Seemann, T., 2014. Prokka: rapid prokaryotic genome annotation. Bioinformatics 30, 2068–2069. 
https://doi.org/10.1093/bioinformatics/btu153 
Sela, S., Barzilai, A., 1999. Why do we fail with penicillin in the treatment of Group A Streptococcus 
infections? Annals of medicine. https://doi.org/10.3109/07853899908995895 
Selva, L., Viana, D., Regev-Yochay, G., Trzcinski, K., Corpa, J.M., Lasa, Í., Novick, R.P., Penadés, J.R., 2009. 
Killing niche competitors by remote-control bacteriophage induction. Proceedings of the National 
Academy of Sciences of the United States of America 106, 1234–1238. 
https://doi.org/10.1073/pnas.0809600106 
Shaikh, N., Leonard, E., Martin, J.M., 2010. Prevalence of streptococcal pharyngitis and streptococcal carriage 
in children: A meta-analysis. Pediatrics 126. https://doi.org/10.1542/peds.2009-2648 
Sharma, H., Turner, C.E., Siggins, M.K., El-Bahrawy, M., Pichon, B., Kearns, A., Sriskandan, S., 2019. Toxic 
Shock Syndrome Toxin 1 Evaluation and Antibiotic Impact in a Transgenic Model  of Staphylococcal Soft 
Tissue Infection. mSphere 4. https://doi.org/10.1128/mSphere.00665-19 
Sharma, O., O’Seaghdha, M., Velarde, J.J., Wessels, M.R., 2016. NAD+-Glycohydrolase Promotes Intracellular 
Survival of Group A Streptococcus. PLoS Pathogens 12, 1–21. 
https://doi.org/10.1371/journal.ppat.1005468 
Shea, P.R., Beres, S.B., Flores, A.R., Ewbank, A.L., Gonzalez-Lugo, J.H., Martagon-Rosado, A.J., Martinez-
Gutierrez, J.C., Rehman, H.A., Serrano-Gonzalez, M., Fittipaldi, N., Ayers, S.D., Webb, P., Willey, B.M., 
Low, D.E., Musser, J.M., 2011. Distinct signatures of diversifying selection revealed by genome analysis 
of respiratory tract and invasive bacterial populations. Proceedings of the National Academy of Sciences 
of the United States of America 108, 5039–5044. https://doi.org/10.1073/pnas.1016282108 
Sherry, S., Johnson, A., Tillett, W.S., 1949. The action of streptococcal desoxyribose nuclease in vitro and on 
purulent pleural exudations of patients. The Journal of clinical investigation 28, 1094–1104. 
https://doi.org/10.1172/jci102142 
Shet, A., Kaplan, E., 2004. Addressing the Burden of Group A Streptococcal Disease in India. Indian Journal of 
Pediatrics 71, 41–48. https://doi.org/10.1007/BF02725655 
200 
 
Shet, A., Kaplan, E.L., Johnson, D.R., Cleary, P.P., 2003. Immune Response to Group A Streptococcal C5a 
Peptidase in Children: Implications for Vaccine Development. The Journal of Infectious Diseases 188, 
809–817. https://doi.org/10.1086/377700 
Siggins, M.K., Lynskey, N.N., Lamb, L.E., Johnson, L.A., Huse, K.K., Pearson, M., Banerji, S., Turner, C.E., 
Woollard, K., Jackson, D.G., Sriskandan, S., 2020. Extracellular bacterial lymphatic metastasis drives 
Streptococcus pyogenes systemic infection. Nature Communications 11, 4697. 
https://doi.org/10.1038/s41467-020-18454-0 
Silva-Costa, C., Carriço, J.A., Ramirez, M., Melo-Cristino, J., 2014. Scarlet fever is caused by a limited number 
of Streptococcus pyogenes lineages and is associated with the exotoxin genes ssa, speA and speC. The 
Pediatric infectious disease journal 33, 306–310. https://doi.org/10.1097/INF.0000000000000088 
Singh, S.K., Bharati, A.P., Singh, N., Pandey, P., Joshi, P., Singh, K., Mitra, K., Gayen, J.R., Sarkar, J., Akhtar, 
M.S., 2014. The prophage-encoded hyaluronate lyase has broad substrate specificity and is regulated by 
the N-terminal domain. Journal of Biological Chemistry 289, 35225–35236. 
https://doi.org/10.1074/jbc.M113.507673 
Sitkiewicz, I., Green, N.M., Guo, N., Bongiovanni, A.M., Witkin, S.S., Musser, J.M., 2010. Adaptation of 
Group A Streptococcus to human amniotic fluid. PLoS ONE 5. 
https://doi.org/10.1371/journal.pone.0009785 
Sitkiewicz, I., Green, N.M., Guo, N., Mereghetti, L., Musser, J.M., 2011. Lateral gene transfer of streptococcal 
ICE element RD2 (region of difference 2) encoding secreted proteins. BMC Microbiology 11. 
https://doi.org/10.1186/1471-2180-11-65 
Sitkiewicz, I., Nagiec, M.J., Sumby, P., Butler, S.D., Cywes-Bentley, C., Musser, J.M., 2006. Emergence of a 
bacterial clone with enhanced virulence by acquisition of a phage encoding a secreted phospholipase A2. 
Proceedings of the National Academy of Sciences of the United States of America 103, 16009–16014. 
https://doi.org/10.1073/pnas.0607669103 
Sitto, F., Battistuzzi, F.U., 2020. Estimating Pangenomes with Roary. Molecular Biology and Evolution 37, 
933–939. https://doi.org/10.1093/molbev/msz284 
Smeesters, P.R., McMillan, D.J., Sriprakash, K.S., 2010. The streptococcal M protein: A highly versatile 
molecule. Trends in Microbiology 18, 275–282. https://doi.org/10.1016/j.tim.2010.02.007 
Smoot, J.C., Barbian, K.D., Van Gompel, J.J., Smoot, L.M., Chaussee, M.S., Sylva, G.L., Sturdevant, D.E., 
Ricklefs, S.M., Porcella, S.F., Parkins, L.D., Beres, S.B., Campbell, D.S., Smith, T.M., Zhang, Q., Kapur, 
V., Daly, J.A., Veasy, L.G., Musser, J.M., 2002a. Genome sequence and comparative microarray analysis 
of serotype M18 Group A Streptococcus strains associated with acute rheumatic fever outbreaks. 







Smoot, J.C., Korgenski, E.K., Daly, J.A., Veasy, L.G., Musser, J.M., 2002b. Molecular analysis of Group A 
Streptococcus type emm18 isolates temporally associated with acute rheumatic fever outbreaks in Salt 
Lake City, Utah. Journal of Clinical Microbiology 40, 1805–1810. https://doi.org/10.1128/JCM.40.5.1805-
1810.2002 
Soderholm, A.T., Barnett, T.C., Sweet, M.J., Walker, M.J., 2017. Group A streptococcal pharyngitis: immune 
responses involved in bacterial clearance and GAS-associated immunopathologies. Journal of Leukocyte 
Biology jlb.4MR0617-227RR. https://doi.org/10.1189/jlb.4mr0617-227rr 
Spanos, W.C., Geiger, J., Anderson, M.E., Harris, G.F., Bossler, A.D., Smith, R.B., Klingelhutz, A.J., Lee, J.H., 
2008. Deletion of the PDZ motif of HPV16 E6 preventing immortalization and anchorage-independent 
growth in human tonsil epithelial cells. Head & Neck 30, 139—147. https://doi.org/10.1002/hed.20673 
Sriskandan, S., Ferguson, M., Elliot, V., Faulkner, L., Cohen, J., 2006. Human intravenous immunoglobulin for 
experimental streptococcal toxic shock:  bacterial clearance and modulation of inflammation. The Journal 
of antimicrobial chemotherapy 58, 117–124. https://doi.org/10.1093/jac/dkl173 
Sriskandan, S., Moves, D., Lee Buttery, K., Krausz, T., Evans, T.J., Polak, J., Cohen, J., 1996. Streptococcal 
pyrogenic exotoxin A release, distribution, and role in a murine model of fasciitis and multiorgan failure 
due to Streptococcus pyogenes. Journal of Infectious Diseases 173, 1399–1407. 
https://doi.org/10.1093/infdis/173.6.1399 
Sriskandan, S., Unnikrishnan, M., Krausz, T., Cohen, J., 2000. Mitogenic factor (MF) is the major DNase of 
serotype M89 Streptococcus pyogenes. Microbiology 146, 2785–2792. 
https://doi.org/https://doi.org/10.1099/00221287-146-11-2785 
Sriskandan, S., Unnikrishnan, M., Krausz, T., Cohen, J., 1999. Molecular analysis of the role of streptococcal 
pyrogenic exotoxin A (SPEA) in invasive soft-tissue infection resulting from Streptococcus pyogenes. 
Molecular Microbiology 33, 778–790. https://doi.org/10.1046/j.1365-2958.1999.01525.x 
Sriskandan, S., Unnikrishnan, M., Krausz, T., Dewchand, H., Van Noorden, S., Cohen, J., Altmann, D.M., 
2001. Enhanced Susceptibility to Superantigen-Associated Streptococcal Sepsis in Human Leukocyte 
Antigen-DQ Transgenic Mice. The Journal of Infectious Diseases 184, 166–173. 
https://doi.org/10.1086/322018 
Starr, C.R., Engleberg, N.C., 2006. Role of hyaluronidase in subcutaneous spread and growth of Group A 
Streptococcus. Infection and Immunity 74, 40–48. https://doi.org/10.1128/IAI.74.1.40-48.2006 
Steer, Andrew C., Batzloff, M.R., Mulholland, K., Carapetis, J.R., 2009. Group A streptococcal vaccines: Facts 
versus fantasy. Current Opinion in Infectious Diseases 22, 544–552. 
https://doi.org/10.1097/QCO.0b013e328332bbfe 
Steer, A.C., Carapetis, J.R., Dale, J.B., Fraser, J.D., Good, M.F., Guilherme, L., Moreland, N.J., Mulholland, 
E.K., Schodel, F., Smeesters, P.R., 2016. Status of research and development of vaccines for Streptococcus 
pyogenes. Vaccine 34, 2953–2958. https://doi.org/10.1016/j.vaccine.2016.03.073 
 
Steer, A.C., Lamagni, T., Curtis, N., Carapetis, J.R., 2012. Invasive Group A streptococcal disease: 
202 
 
Epidemiology, pathogenesis and management. Drugs 72, 1213–1227. https://doi.org/10.2165/11634180-
000000000-00000 
Steer, A.C, Law, I., Matatolu, L., Beall, B.W., Carapetis, J.R., 2009. Global emm type distribution of Group A 
streptococci: systematic review and  implications for vaccine development. The Lancet. Infectious diseases 
9, 611–616. https://doi.org/10.1016/S1473-3099(09)70178-1 
Stevens, D.L., Bryant, A.E., 2017. Necrotizing Soft-Tissue Infections. New England Journal of Medicine 377, 
2253–2265. https://doi.org/10.1056/NEJMra1600673 
Stevens, D.L., Bryant, A.E., 2016. Impetigo, Erysipelas and Cellulitis. Streptococcus pyogenes: Basic Biology 
to Clinical Manifestations 1–18. 
Stockbauer, K.E., Grigsby, D., Pan, X., Fu, Y.X., Perea Mejia, L.M., Cravioto, A., Musser, J.M., 1998. 
Hypervariability generated by natural selection in an extracellular complement-inhibiting protein of 
serotype M1 strains of Group A Streptococcus. Proceedings of the National Academy of Sciences of the 
United States of America 95, 3128–3133. https://doi.org/10.1073/pnas.95.6.3128 
Stollerman, G.H., Dale, J.B., 2008. The importance of the Group A Streptococcus capsule in the pathogenesis of 
human  infections: a historical perspective. Clinical infectious diseases : an official publication of the 
Infectious Diseases  Society of America 46, 1038–1045. https://doi.org/10.1086/529194 
Sullivan, M.J., Petty, N.K., Beatson, S.A., 2011. Easyfig: a genome comparison visualizer. Bioinformatics 
(Oxford, England) 27, 1009–1010. https://doi.org/10.1093/bioinformatics/btr039 
Sumby, P., Barbian, K.D., Gardner, D.J., Whitney, A.R., Welty, D.M., Long, R.D., Bailey, J.R., Parnell, M.J., 
Hoe, N.P., Adams, G.G., Deleo, F.R., Musser, J.M., 2005a. Extracellular deoxyribonuclease made by 
Group A Streptococcus assists pathogenesis  by enhancing evasion of the innate immune response. 
Proceedings of the National Academy of Sciences of the United States of America 102, 1679–1684. 
https://doi.org/10.1073/pnas.0406641102 
Sumby, P., Porcella, S.F., Madrigal, A.G., Barbian, K.D., Virtaneva, K., Ricklefs, S.M., Sturdevant, D.E., 
Graham, M.R., Vuopio‐Varkila, J., Hoe, N.P., Musser, J.M., 2005b.  Evolutionary Origin and Emergence 
of a Highly Successful Clone of Serotype M1 Group A Streptococcus Involved Multiple Horizontal Gene 
Transfer Events . The Journal of Infectious Diseases 192, 771–782. https://doi.org/10.1086/432514 
Sumby, P., Whitney, A.R., Graviss, E.A., DeLeo, F.R., Musser, J.M., 2006. Genome-wide analysis of Group A 
streptococci reveals a mutation that modulates global phenotype and disease specificity. PLoS Pathogens 
2, 0041–0049. https://doi.org/10.1371/journal.ppat.0020005 
Sumby, P., Zhang, S., Whitney, A.R., Falugi, F., Grandi, G., Graviss, E.A., DeLeo, F.R., Musser, J.M., 2005c. 
A chemokine-degrading extracellular protease made by Group A Streptococcus alters pathogenesis by 




Sumitomo, T., Nakata, M., Higashino, M., Jin, Y., Terao, Y., Fujinaga, Y., Kawabata, S., 2011. Streptolysin S 
203 
 
contributes to Group A streptococcal translocation across an epithelial barrier. Journal of Biological 
Chemistry 286, 2750–2761. https://doi.org/10.1074/jbc.M110.171504 
Swe, P.M., Christian, L.D., Lu, H.C., Sriprakash, K.S., Fischer, K., 2017. Complement inhibition by Sarcoptes 
scabiei protects Streptococcus pyogenes - An in vitro study to unravel the molecular mechanisms behind 
the poorly understood predilection of S. pyogenes to infect mite-induced skin lesions. PLoS Neglected 
Tropical Diseases 11, 1–20. https://doi.org/10.1371/journal.pntd.0005437 
Takeda, K., Kaisho, T., Akira, S., 2003.  Toll -Like Receptors . Annual Review of Immunology 21, 335–376. 
https://doi.org/10.1146/annurev.immunol.21.120601.141126 
Talkington, D.F., Schwartz, B., Black, C.M., Todd, J.K., Elliott, J., Breiman, R.F., Facklam, R.R., 1993. 
Association of phenotypic and genotypic characteristics of invasive Streptococcus pyogenes isolates with 
clinical components of streptococcal toxic shock syndrome. Infection and Immunity 61, 3369–3374. 
Tamayo, E., Montes, M., García-Medina, G., García-Arenzana, J.M., Pérez-Trallero, E., 2010. Spread of a 
highly mucoid Streptococcus pyogenes emm3/ST15 clone. BMC Infectious Diseases 10, 2–6. 
https://doi.org/10.1186/1471-2334-10-233 
Tamura, F., Nakagawa, R., Akuta, T., Okamoto, S., Hamada, S., Maeda, H., Kawabata, S., Akaike, T., 2004. 
Proapoptotic effect of proteolytic activation of matrix metalloproteinases by Streptococcus pyogenes thiol 
proteinase (Streptococcus pyrogenic exotoxin B). Infection and Immunity 72, 4836–4847. 
https://doi.org/10.1128/IAI.72.8.4836-4847.2004 
Terao, Y., Kawabata, S., Kunitomo, E., Murakami, J., Nakagawa, I., Hamada, S., 2001. Fba, a novel 
fibronectin-binding protein from Streptococcus pyogenes, promotes bacterial entry into epithelial cells, and 
the fba gene is positively transcribed under the Mga regulator. Molecular Microbiology 42, 75–86. 
https://doi.org/10.1046/j.1365-2958.2001.02579.x 
Thomas, C.A., Li, Y., Kodama, T., Suzuki, H., Silverstein, S.C., El Khoury, J., 2000. Protection from lethal 
Gram-positive infection by macrophage scavenger receptor-dependent phagocytosis. Journal of 
Experimental Medicine 191, 147–155. https://doi.org/10.1084/jem.191.1.147 
Thulin, P., Johansson, L., Low, D.E., Gan, B.S., Kotb, M., McGeer, A., Norrby-Teglund, A., 2006. Viable 
Group A streptococci in macrophages during acute soft tissue infection. PLoS Medicine 3, 371–379. 
https://doi.org/10.1371/journal.pmed.0030053 
Todd, E.W., 1927. A Method of Measuring the Increase or Decrease of the Population of Hæmolytic  
Streptococci in Blood. British journal of experimental pathology. 
Travassos, L.H., Girardin, S.E., Philpott, D.J., Blanot, D., Nahori, M.A., Werts, C., Boneca, I.G., 2004. Toll-like 
receptor 2-dependent bacterial sensing does not occur via peptidoglycan recognition. EMBO Reports 5, 
1000–1006. https://doi.org/10.1038/sj.embor.7400248 
Tsai, C.J.Y., Loh, J.M.S., Proft, T., 2016. Galleria mellonella infection models for the study of bacterial 
diseases and for antimicrobial drug testing. Virulence 7, 214–229. 
https://doi.org/10.1080/21505594.2015.1135289 
Tsai, P.J., Lin, Y.S., Kuo, C.F., Lei, H.Y., Wu, J.J., 1999. Group A Streptococcus induces apoptosis in human 
204 
 
epithelial cells. Infection and Immunity 67, 4334–4339. https://doi.org/10.1128/iai.67.9.4334-4339.1999 
Tse, H., Bao, J.Y.J., Davies, M.R., Maamary, P., Tsoi, H.W., Tong, A.H.Y., Ho, T.C.C., Lin, C.H., Gillen, 
C.M., Barnett, T.C., Chen, J.H.K., Lee, M., Yam, W.C., Wong, C.K., Ong, C.L.Y., Chan, Y.W., Wu, 
C.W., Ng, T., Lim, W.W.L., Tsang, T.H.F., Tse, C.W.S., Dougan, G., Walker, M.J., Lok, S., Yuen, K.Y., 
2012. Molecular characterization of the 2011 Hong Kong scarlet fever outbreak. Journal of Infectious 
Diseases 206, 341–351. https://doi.org/10.1093/infdis/jis362 
Turner, C.E., Abbott, J., Lamagni, T., Holden, M.T.G., David, S., Jones, M.D., Game, L., Efstratiou, A., 
Sriskandan, S., 2015. Emergence of a new highly successful acapsular Group A Streptococcus clade of 
genotype emm89 in the United Kingdom. mBio 6, 1–11. https://doi.org/10.1128/mBio.00622-15 
Turner, C.E., Bedford, L., Brown, N.M., Judge, K., Török, M.E., Parkhill, J., Peacock, S.J., 2017. Community 
outbreaks of Group A Streptococcus revealed by genome sequencing. Scientific Reports 7, 1–9. 
https://doi.org/10.1038/s41598-017-08914-x 
Turner, C.E., Bubba, L., Efstratiou, A., 2019a. Pathogenicity Factors in Group C and G Streptococci. 
Microbiology Spectrum 7, 264–274. https://doi.org/10.1128/microbiolspec.gpp3-0020-2018 
Turner, C.E., Dryden, M., Holden, M.T.G., Davies, F.J., Lawrenson, R.A., Farzaneh, L., Bentley, S.D., 
Efstratiou, A., Sriskandan, S., 2013. Molecular analysis of an outbreak of lethal postpartum sepsis caused 
by Streptococcus pyogenes. Journal of Clinical Microbiology 51, 2089–2095. 
https://doi.org/10.1128/JCM.00679-13 
Turner, C.E., Holden, M.T.G., Blane, B., Horner, C., Peacock, S.J., Sriskandan, S., 2019b. The emergence of 
successful Streptococcus pyogenes lineages through convergent pathways of capsule loss and 
recombination directing high toxin expression. mBio 10, 1–20. https://doi.org/10.1128/mBio.02521-19 
Turner, C.E., Kurupati, P., Jones, M.D., Edwards, R.J., Sriskandan, S., 2009.  Emerging Role of the Interleukin‐
8 Cleaving Enzyme SpyCEP in Clinical Streptococcus pyogenes Infection . The Journal of Infectious 
Diseases 200, 555–563. https://doi.org/10.1086/603541 
Turner, C. E., Kurupati, P., Wiles, S., Edwards, R.J., Sriskandan, S., 2009. Impact of immunization against 
SpyCEP during invasive disease with two streptococcal species: Streptococcus pyogenes and 
Streptococcus equi. Vaccine 27, 4923–4929. https://doi.org/10.1016/j.vaccine.2009.06.042 
Turner, C.E., Pyzio, M., Song, B., Lamagni, T., Meltzer, M., Chow, J.Y., Efstratiou, A., Curtis, S., Sriskandan, 
S., 2016. Scarlet fever upsurge in england and molecular-genetic analysis in North-West London, 2014. 
Emerging Infectious Diseases 22, 1075–1078. https://doi.org/10.3201/eid2206.151726 
Turner, C.E., Sommerlad, M., McGregor, K., Davies, F.J., Pichon, B., Chong, D.L.W., Farzaneh, L., Holden, 
M.T.G., Spratt, B.G., Efstratiou, A., Sriskandan, S., 2012. Superantigenic Activity of emm3 Streptococcus 




Uchiyama, S., Andreoni, F., Schuepbach, R.A., Nizet, V., Zinkernagel, A.S., 2012. DNase Sda1 allows invasive 
205 
 
M1T1 Group A Streptococcus to prevent TLR9-dependent recognition. PLoS Pathogens 8, 1–12. 
https://doi.org/10.1371/journal.ppat.1002736 
Unnikrishnan, M., Altmann, D.M., Proft, T., Wahid, F., Cohen, J., Fraser, J.D., Sriskandan, S., 2002.  The 
Bacterial Superantigen Streptococcal Mitogenic Exotoxin Z Is the Major Immunoactive Agent of 
Streptococcus pyogenes . The Journal of Immunology 169, 2561–2569. 
https://doi.org/10.4049/jimmunol.169.5.2561 
Unnikrishnan, M., Cohen, J., Sriskandan, S., 1999. Growth-phase-dependent expression of virulence factors in 
an M1T1 clinical isolate of Streptococcus pyogenes. Infection and Immunity 67, 5495–5499. 
https://doi.org/10.1128/iai.67.10.5495-5499.1999 
Uribe-Quero, E., Rosales, C., 2017. Control of phagocytosis by microbial pathogens. Frontiers in Immunology 
8, 1–23. https://doi.org/10.3389/fimmu.2017.01368 
Valderrama, J.A., Nizet, V., 2018. Group A Streptococcus encounters with host macrophages. Future 
Microbiology 13, 119–134. https://doi.org/10.2217/fmb-2017-0142 
Van Belleghem, J.D., Dąbrowska, K., Vaneechoutte, M., Barr, J.J., Bollyky, P.L., 2019. Interactions between 
bacteriophage, bacteria, and the mammalian immune system. Viruses 11. 
https://doi.org/10.3390/v11010010 
Vannice, K.S., Ricaldi, J., Nanduri, S., Fang, F.C., Lynch, J.B., Bryson-Cahn, C., Wright, T., Duchin, J., Kay, 
M., Chochua, S., Van Beneden, C.A., Beall, B., 2019. Streptococcus pyogenes pbp2x Mutation Confers 
Reduced Susceptibility to β-Lactam Antibiotics. Clinical Infectious Diseases 2017–2020. 
https://doi.org/10.1093/cid/ciz1000 
Varhimo, E., Savijoki, K., Jalava, J., Kuipers, O.P., Varmanen, P., 2007. Identification of a novel streptococcal 
gene cassette mediating SOS mutagenesis in Streptococcus uteris. Journal of Bacteriology 189, 5210–
5222. https://doi.org/10.1128/JB.00473-07 
Vega, L.A., Sanson, M.A., Shah, B.J., Flores, A.R., 2020. The strain-dependent effect of capsule on 
transmission and persistence in an infant mouse model of Group A Streptococcus infection. Infection and 
Immunity 1–39. https://doi.org/10.1128/iai.00709-19 
Velarde, J.J., O’Seaghdha, M., Baddal, B., Bastiat-Sempe, B., Wessels, M.R., 2017. Binding of NAD 
Glycohydrolase to Streptolysin O Stabilizes Both Toxins and Promotes Virulence of Group A 
Streptococcus mBio 8, e01382-17. https://doi.org/10.1128/mBio.01382-17 
Velineni, S., Timoney, J.F., 2015. Capsular hyaluronic acid of equine isolates of Streptococcus zooepidemicus is 
upregulated at temperatures below 35°C. Equine Veterinary Journal 47, 333–338. 
https://doi.org/10.1111/evj.12272 
Ventura, M., Bruttin, A., Canchaya, C., Brüssow, H., 2002a. Transcription analysis of Streptococcus 
thermophilus phages in the lysogenic state. Virology 302, 21–32. https://doi.org/10.1006/viro.2002.1571 
 
 
Ventura, M., Foley, S., Bruttin, A., Chennoufi, S.C., Canchaya, C., Brüssow, H., 2002b. Transcription mapping 
206 
 
as a tool in phage genomics: The case of the temperate Streptococcus thermophilus phage Sfi21. Virology 
296, 62–76. https://doi.org/10.1006/viro.2001.1331 
Venturini, C., Ong, C. lynn Y., Gillen, C.M., Ben-Zakour, N.L., Maamary, P.G., Nizet, V., Beatson, S.A., 
Walker, M.J., 2013. Acquisition of the Sda1-encoding bacteriophage does not enhance virulence of the 
serotype M1 Streptococcus pyogenes strain SF370. Infection and Immunity 81, 2062–2069. 
https://doi.org/10.1128/IAI.00192-13 
Vincents, B., Vindebro, R., Abrahamson, M., von Pawel-Rammingen, U., 2008. The Human Protease Inhibitor 
Cystatin C Is an Activating Cofactor for the Streptococcal Cysteine Protease IdeS. Chemistry and Biology 
15, 960–968. https://doi.org/10.1016/j.chembiol.2008.07.021 
Vindenes, T., McQuillen, D., 2015. Acute Lymphangitis. New England Journal of Medicine 372, 649–649. 
https://doi.org/10.1056/nejmicm1406569 
Virtaneva, K., Porcella, S.F., Graham, M.R., Ireland, R.M., Johnson, C.A., Ricklefs, S.M., Babar, I., Parkins, 
L.D., Romero, R.A., Corn, G.J., Gardner, D.J., Bailey, J.R., Parnell, M.J., Musser, J.M., 2005. 
Longitudinal analysis of the Group A Streptococcus transcriptome in experimental pharyngitis in 
cynomolgus macaques. Proceedings of the National Academy of Sciences of the United States of America 
102, 9014–9019. https://doi.org/10.1073/pnas.0503671102 
Vlaminckx, B.J.M., Mascini, E.M., Schellekens, J., Schouls, L.M., Paauw, A., Fluit, A.C., Novak, R., Verhoef, 
J., Schmitz, F.J., 2003. Site-Specific Manifestations of Invasive Group A Streptococcal Disease: Type 
Distribution and Corresponding Patterns of Virulence Determinants. Journal of Clinical Microbiology 41, 
4941–4949. https://doi.org/10.1128/JCM.41.11.4941-4949.2003 
Von Köckritz-Blickwede, M., Nizet, V., 2009. Innate immunity turned inside-out: Antimicrobial defense by 
phagocyte extracellular traps. Journal of Molecular Medicine 87, 775–783. https://doi.org/10.1007/s00109-
009-0481-0 
Von Pawel-Rammingen, U., 2012. Streptococcal IdeS and its impact on immune response and inflammation. 
Journal of Innate Immunity 4, 132–140. https://doi.org/10.1159/000332940 
Voyich, J.M., Musser, J.M., DeLeo, F.R., 2004. Streptococcus pyogenes and human neutrophils: A paradigm for 
evasion of innate host defense by bacterial pathogens. Microbes and Infection 6, 1117–1123. 
https://doi.org/10.1016/j.micinf.2004.05.022 
Voyich, J.M., Sturdevant, D.E., Braughton, K.R., Kobayashi, S.D., Lei, B., Virtaneva, K., Dorward, D.W., 
Musser, J.M., DeLeo, F.R., 2003. Genome-wide protective response used by Group A Streptococcus to 
evade destruction by human polymorphonuclear leukocytes. Proceedings of the National Academy of 
Sciences of the United States of America 100, 1996–2001. https://doi.org/10.1073/pnas.0337370100 
Walker, M.J., 2015. Emergence of scarlet fever Streptococcus pyogenes emm12 clones in Hong Kong is 
associated with toxin acquisition and multidrug resistance. Nature genetics 47, 84–87. 
https://doi.org/10.1038/ng.3147 
 
Walker, M.J., Barnett, T.C., McArthur, J.D., Cole, J.N., Gillen, C.M., Henningham, A., Sriprakash, K.S., 
207 
 
Sanderson-Smith, M.L., Nizet, V., 2014. Disease manifestations and pathogenic mechanisms of Group A 
Streptococcus. Clinical Microbiology Reviews 27, 264–301. https://doi.org/10.1128/CMR.00101-13 
Walker, M.J., Hollands, A., Sanderson-Smith, M.L., Cole, J.N., Kirk, J.K., Henningham, A., McArthur, J.D., 
Dinkla, K., Aziz, R.K., Kansal, R.G., Simpson, A.J., Buchanan, J.T., Chhatwal, G.S., Kotb, M., Nizet, V., 
2007. DNase Sda1 provides selection pressure for a switch to invasive Group A streptococcal infection. 
Nature Medicine 13, 981–985. https://doi.org/10.1038/nm1612 
Wang, X., Kim, Y., Ma, Q., Hong, S.H., Pokusaeva, K., Sturino, J.M., Wood, T.K., 2010. Cryptic prophages 
help bacteria cope with adverse environments. Nature Communications 1. 
https://doi.org/10.1038/ncomms1146 
Watts, V., Balasegaram, S., Brown, C.S., Mathew, S., Mearkle, R., Ready, D., Saliba, V., Lamagni, T., 2019. 
Increased risk for invasive Group A Streptococcus disease for household contacts of scarlet fever cases, 
England, 2011-2016. Emerging Infectious Diseases 25, 529–537. https://doi.org/10.3201/eid2503.181518 
Weiss, K., Laverdière, M., Lovgren, M., Delorme, J., Poirier, L., Béliveau, C., 1999. Group A Streptococcus 
carriage among close contacts of patients with invasive infections. American Journal of Epidemiology 149, 
863–868. https://doi.org/10.1093/oxfordjournals.aje.a009902 
Wessels, M.R., 2019. Capsular Polysaccharide of Group A Streptococcus. Microbiology Spectrum 7, 1–21. 
https://doi.org/10.1128/microbiolspec.gpp3-0050-2018 
Wessels, M.R., 2016. Cell Wall and Surface Molecules: Capsule. Streptococcus pyogenes: Basic Biology to 
Clinical Manifestations 53–63. 
Whitehead, B.D., Smith, H. V., Nourse, C., 2011. Invasive Group A streptococcal disease in children in 
Queensland. Epidemiology and Infection 139, 623–628. https://doi.org/10.1017/S0950268810001378 
Wilkening, R. V., Federle, M.J., 2017. Evolutionary Constraints Shaping Streptococcus pyogenes–Host 
Interactions. Trends in Microbiology 25, 562–572. https://doi.org/10.1016/j.tim.2017.01.007 
Wood, T.F., Potter, M.A., Jonasson, O., 1993. Streptococcal toxic shock-like syndrome. The importance of 
surgical intervention. Annals of surgery 217, 109–114. https://doi.org/10.1097/00000658-199302000-
00003 
Xia, G., Wolz, C., 2014. Phages of Staphylococcus aureus and their impact on host evolution. Infection, 
Genetics and Evolution 21, 593–601. https://doi.org/10.1016/j.meegid.2013.04.022 
Yates, R.M., Hermetter, A., Russell, D.G., 2005. The kinetics of phagosome maturation as a function of 
phagosome/lysosome fusion and acquisition of hydrolytic activity. Traffic 6, 413–420. 
https://doi.org/10.1111/j.1600-0854.2005.00284.x 
Yinduo, J.I., McLandsborough, L., Kondagunta, A., Cleary, P.P., 1996. C5a peptidase alters clearance and 
trafficking of Group A streptococci by infected mice. Infection and Immunity 64, 503–510. 
https://doi.org/10.1128/iai.64.2.503-510.1996 
Young, R., 2014. Phage lysis: Three steps, three choices, one outcome. Journal of Microbiology 52, 243–258. 
https://doi.org/10.1007/s12275-014-4087-z 
Yue, W.-F., Du, M., Zhu, M.-J., 2012. High Temperature in Combination with UV Irradiation Enhances 
208 
 
Horizontal Transfer of stx2 Gene from E. coli O157:H7 to Non-Pathogenic E. coli. PLOS ONE 7, 1–7. 
https://doi.org/10.1371/journal.pone.0031308 
Yuste, J., Ali, S., Sriskandan, S., Hyams, C., Botto, M., Brown, J.S., 2006.  Roles of the Alternative 
Complement Pathway and C1q during Innate Immunity to Streptococcus pyogenes . The Journal of 
Immunology 176, 6112–6120. https://doi.org/10.4049/jimmunol.176.10.6112 
Zeppa, J.J., Kasper, K.J., Mohorovic, I., Mazzuca, D.M., Haeryfar, S.M.M., McCormick, J.K., 2017. 
Nasopharyngeal infection by Streptococcus pyogenes requires superantigen-responsive Vβ-specific T 
cells. Proceedings of the National Academy of Sciences of the United States of America 114, 10226–
10231. https://doi.org/10.1073/pnas.1700858114 
Žgur-Bertok, D., 2013. DNA Damage Repair and Bacterial Pathogens. PLoS Pathogens 9, 9–12. 
https://doi.org/10.1371/journal.ppat.1003711 
Zhang, S., Green, N.M., Sitkiewicz, I., LeFebvre, R.B., Musser, J.M., 2006. Identification and characterization 
of an antigen I/II family protein produced by Group A Streptococcus. Infection and Immunity 74, 4200–
4213. https://doi.org/10.1128/IAI.00493-06 
Zhang, X., McDaniel, A.D., Wolf, L.E., Keusch, G.T., Waldor, M.K., Acheson, D.W.K., 2000. Quinolone 
Antibiotics Induce Shiga Toxin–Encoding Bacteriophages, Toxin Production, and Death in Mice. The 
Journal of Infectious Diseases 181, 664–670. https://doi.org/10.1086/315239 
Zhou, L., Liu, L., Yang, J., Li, Y., Bai, W., Liu, N., Li, W., Gao, Y., Xu, L., Liu, Z., Han, R., 2016. LDL acts as 
an opsonin enhancing the phagocytosis of Group A Streptococcus by monocyte and whole human blood. 
Medical Microbiology and Immunology 205, 155–162. https://doi.org/10.1007/s00430-015-0436-8 
Zhu, L., Charbonneau, A.R.L., Waller, A.S., Olsen, R.J., Beres, S.B., Musser, J.M., 2017.  Novel Genes 
Required for the Fitness of Streptococcus pyogenes in Human Saliva . mSphere 2, 1–13. 
https://doi.org/10.1128/mspheredirect.00460-17 
Zhu, L., Olsen, R.J., Beres, S.B., Saavedra, O., Kubiak, S.L., 2020. Genome-Wide Screens Identify Group A 
Streptococcus Surface Proteins Promoting Female Genital Tract Colonization and Virulence. The 
American Journal of Pathology 190. https://doi.org/10.1016/j.ajpath.2019.12.003 
Zhu, L., Olsen, R.J., Nasser, W., Beres, S.B., Vuopio, J., Kristinsson, K.G., Gottfredsson, M., Porter, A.R., 
DeLeo, F.R., Musser, J.M., 2015a. A molecular trigger for intercontinental epidemics of Group A 
Streptococcus. Journal of Clinical Investigation 125, 3545–3559. https://doi.org/10.1172/JCI82478 
Zhu, L., Olsen, R.J., Nasser, W., De La Riva Morales, I., Mussera, J.M., 2015b. Trading capsule for increased 
cytotoxin production: Contribution to virulence of a newly emerged clade of emm89 Streptococcus 
pyogenes. mBio 6, 1–10. https://doi.org/10.1128/mbio.01378-15 
Zinkernagel, A.S., Timmer, A.M., Pence, M.A., Locke, J.B., Buchanan, J.T., Turner, C.E., Mishalian, I., 
Sriskandan, S., Hanski, E., Nizet, V., 2008. The IL-8 Protease SpyCEP/ScpC of Group A Streptococcus 





Zlotnik, A., Yoshie, O., 2012. The Chemokine Superfamily Revisited. Immunity 36, 705–716. 
https://doi.org/10.1016/j.immuni.2012.05.008 
